	DRUG_NAME	TARGET_NAME	smiles
0	levobupivacaine	Potassium voltage-gated channel subfamily H member 2	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
1	levobupivacaine	Sodium channel protein type 1 subunit alpha	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
2	levobupivacaine	Sodium channel protein type 4 subunit alpha	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
3	levobupivacaine	Prostaglandin E2 receptor EP1 subtype	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
4	levobupivacaine	Cytochrome P450 2D6	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
5	levobupivacaine	5-hydroxytryptamine receptor 3A	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6	levobupivacaine	Potassium voltage-gated channel subfamily D member 3	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
7	levobupivacaine	Potassium voltage-gated channel subfamily A member 5	CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
8	(S)-nicardipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
9	(S)-nitrendipine	Intermediate conductance calcium-activated potassium channel protein 4	CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
10	(S)-nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1D	CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
11	(S)-nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1F	CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
12	(S)-nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1C	CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
13	(S)-nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1S	CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
14	levdobutamine	Beta-1 adrenergic receptor	C[C@@H](CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
15	azacitidine	DNA (cytosine-5)-methyltransferase 1	NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
16	azacitidine	DNA (cytosine-5)-methyltransferase 3A	NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
17	fluorouracil	Thymidylate synthase	FC1=CNC(=O)NC1=O
18	fluorouracil	Multidrug resistance-associated protein 5	FC1=CNC(=O)NC1=O
19	fluorouracil	ATP-binding cassette sub-family C member 11	FC1=CNC(=O)NC1=O
20	fluorouracil	Uracil phosphoribosyltransferase	FC1=CNC(=O)NC1=O
21	abarelix	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
22	acamprosate	GABA-A receptor alpha-1/beta-3/gamma-2	CC(=O)NCCCS(O)(=O)=O
23	acamprosate	Glutamate [NMDA] receptor	CC(=O)NCCCS(O)(=O)=O
24	acarbose	Maltase-glucoamylase, intestinal	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
25	acarbose	Pancreatic alpha-amylase	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
26	acarbose	Alpha-amylase 1	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
27	acarbose	Lysosomal alpha-glucosidase	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
28	acarbose	Sucrase-isomaltase, intestinal	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
29	acarbose	Alpha-amylase	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
30	acarbose	Oligo-1,6-glucosidase	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
31	acebutolol	Beta-1 adrenergic receptor	CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
32	acebutolol	Beta-2 adrenergic receptor	CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
33	acebutolol	5-hydroxytryptamine receptor 1A	CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
34	aceclofenac	Transthyretin	OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
35	aceclofenac	Aldose reductase	OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
36	aceclofenac	Mitogen-activated protein kinase 1	OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
37	aceclofenac	Prostaglandin G/H synthase 2	OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
38	acemetacin	Prostaglandin G/H synthase 2	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
39	acemetacin	Prostaglandin G/H synthase 1	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
40	acemetacin	Lactoylglutathione lyase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
41	acenocoumarol	Vitamin K epoxide reductase complex subunit 1	[H]C(CC(C)=O)(C1=CC=C(C=C1)[N+]([O-])=O)C1=C(O)C2=C(OC1=O)C=CC=C2
42	aceprometazine	Histamine H1 receptor	CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O)N(C)C
43	paracetamol	Prostaglandin G/H synthase 2	CC(=O)NC1=CC=C(O)C=C1
44	paracetamol	Transient receptor potential cation channel subfamily V member 1	CC(=O)NC1=CC=C(O)C=C1
45	paracetamol	Nuclear receptor subfamily 1 group I member 3	CC(=O)NC1=CC=C(O)C=C1
46	paracetamol	Carbonic anhydrase 2	CC(=O)NC1=CC=C(O)C=C1
47	paracetamol	Carbonic anhydrase 1	CC(=O)NC1=CC=C(O)C=C1
48	paracetamol	Carbonic anhydrase 4	CC(=O)NC1=CC=C(O)C=C1
49	paracetamol	Carbonic anhydrase 9	CC(=O)NC1=CC=C(O)C=C1
50	paracetamol	Carbonic anhydrase 12	CC(=O)NC1=CC=C(O)C=C1
51	paracetamol	Carbonic anhydrase 7	CC(=O)NC1=CC=C(O)C=C1
52	paracetamol	Carbonic anhydrase 3	CC(=O)NC1=CC=C(O)C=C1
53	paracetamol	Carbonic anhydrase 14	CC(=O)NC1=CC=C(O)C=C1
54	paracetamol	Arachidonate 5-lipoxygenase-activating protein	CC(=O)NC1=CC=C(O)C=C1
55	paracetamol	Arachidonate 15-lipoxygenase	CC(=O)NC1=CC=C(O)C=C1
56	paracetamol	Carbonic anhydrase 13	CC(=O)NC1=CC=C(O)C=C1
57	paracetamol	Carbonic anhydrase 15	CC(=O)NC1=CC=C(O)C=C1
58	paracetamol	Myoglobin	CC(=O)NC1=CC=C(O)C=C1
59	paracetamol	Cannabinoid receptor 1	CC(=O)NC1=CC=C(O)C=C1
60	acetazolamide	Carbonic anhydrase 2, isoform A; LD26647p	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
61	acetazolamide	Carbonic anhydrase 1; GH09688p	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
62	acetazolamide	Carbonic anhydrase 2	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
63	acetazolamide	Carbonic anhydrase 1	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
64	acetazolamide	Carbonic anhydrase 4	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
65	acetazolamide	Carbonic anhydrase 9	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
66	acetazolamide	Carbonic anhydrase 12	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
67	acetazolamide	Aquaporin-1	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
68	acetazolamide	Carbonic anhydrase 5A, mitochondrial	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
69	acetazolamide	Carbonic anhydrase 5B, mitochondrial	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
70	acetazolamide	Carbonic anhydrase 7	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
71	acetazolamide	Carbonic anhydrase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
72	acetazolamide	Carbonic anhydrase 3	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
73	acetazolamide	Carbonic anhydrase 6	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
74	acetazolamide	Carbonic anhydrase 14	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
75	acetazolamide	Carbonic anhydrase 13	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
76	acetazolamide	Carbonic anhydrase 15	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
77	acetazolamide	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
78	acetazolamide	Alpha carbonic anhydrase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
79	acetazolamide	Endochitinase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
80	acetazolamide	Astrosclerin-3	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
81	acetazolamide	Beta-carbonic anhydrase 1	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
82	acetazolamide	Delta carbonic anhydrase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
83	acetazolamide	Carbonic anhydrase V	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
84	acetazolamide	Carbonic anhydrase, alpha family	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
85	acetazolamide	Carbonate dehydratase	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
86	acetazolamide	Carbonic anhydrase-related protein 11	CC(=O)NC1=NN=C(S1)S(N)(=O)=O
87	acetohexamide	Sulfonylurea receptor 1, Kir6.2	CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
88	acetophenazine	D(2) dopamine receptor	CC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1
89	acetophenazine	Androgen receptor	CC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1
90	racecadotril	Angiotensin-converting enzyme	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1
91	racecadotril	Neprilysin	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1
92	racecadotril	Endothelin-converting enzyme 1	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1
93	racecadotril	Thermolysin	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1
94	acetylcholine	Muscarinic acetylcholine receptor M1	CC(=O)OCC[N+](C)(C)C
95	acetylcholine	Muscarinic acetylcholine receptor M2	CC(=O)OCC[N+](C)(C)C
96	acetylcholine	Muscarinic acetylcholine receptor M3	CC(=O)OCC[N+](C)(C)C
97	acetylcholine	Muscarinic acetylcholine receptor M4	CC(=O)OCC[N+](C)(C)C
98	acetylcholine	Muscarinic acetylcholine receptor M5	CC(=O)OCC[N+](C)(C)C
99	acetylcholine	Neuronal acetylcholine receptor subunit alpha-7	CC(=O)OCC[N+](C)(C)C
100	acetylcholine	Acetylcholine-binding protein	CC(=O)OCC[N+](C)(C)C
101	acetylcholine	Acetylcholine receptor subunit delta	CC(=O)OCC[N+](C)(C)C
102	acetylcholine	Neuronal acetylcholine receptor; alpha2/beta2	CC(=O)OCC[N+](C)(C)C
103	acetylcholine	Neuronal acetylcholine receptor; alpha3/beta2	CC(=O)OCC[N+](C)(C)C
104	acetylcholine	Neuronal acetylcholine receptor; alpha3/beta4	CC(=O)OCC[N+](C)(C)C
105	acetylcholine	Neuronal acetylcholine receptor; alpha4/beta2	CC(=O)OCC[N+](C)(C)C
106	acetylcholine	Neuronal acetylcholine receptor; alpha4/beta4	CC(=O)OCC[N+](C)(C)C
107	acetylcholine	Muscarinic acetylcholine receptor	CC(=O)OCC[N+](C)(C)C
108	acetylcholine	Nicotinic acetylcholine receptor alpha8 subunit	CC(=O)OCC[N+](C)(C)C
109	acetyldigitoxin	Sodium/potassium-transporting ATPase	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
110	acetylsalicylic acid	Prostaglandin G/H synthase 2	CC(=O)OC1=CC=CC=C1C(O)=O
111	acetylsalicylic acid	Prostaglandin G/H synthase 1	CC(=O)OC1=CC=CC=C1C(O)=O
112	acetylsalicylic acid	Acidic phospholipase A2 3	CC(=O)OC1=CC=CC=C1C(O)=O
113	acetylsalicylic acid	Gamma-glutamyltranspeptidase 1	CC(=O)OC1=CC=CC=C1C(O)=O
114	acetylsalicylic acid	Acid-sensing ion channel 3	CC(=O)OC1=CC=CC=C1C(O)=O
115	acetylsalicylic acid	Nicotinate phosphoribosyltransferase	CC(=O)OC1=CC=CC=C1C(O)=O
116	acipimox	Hydroxycarboxylic acid receptor 2	CC1=CN=C(C=[N+]1[O-])C(O)=O
117	acitretin	Retinoic acid receptor alpha	COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
118	acitretin	Bile salt export pump	COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
119	acitretin	Retinoic acid receptor gamma	COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
120	aclatonium	Muscarinic acetylcholine receptor	CC(OC(C)=O)C(=O)OCC[N+](C)(C)C
121	acrivastine	Multidrug resistance protein 1	CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC(\C=C\C(O)=O)=N1
122	acrivastine	Histamine H1 receptor	CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC(\C=C\C(O)=O)=N1
123	adapalene	Glycine receptor subunit alpha-1	COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O
124	adapalene	Retinoic acid receptor alpha	COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O
125	adapalene	Retinoic acid receptor beta	COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O
126	adapalene	Retinoic acid receptor gamma	COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O
127	adenosine	Adenosine receptor A2a	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
128	adenosine	Adenosine receptor A1	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
129	adenosine	Adenosine receptor A2b	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
130	adenosine	Adenosine receptor A3	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
131	adenosine	Adenosine kinase	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
132	adenosine	Adenosine deaminase	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
133	adenosine	Mitogen-activated protein kinase kinase kinase 7	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
134	adenosine	Adenosylhomocysteinase	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
135	adenosine	Adenosine A2 receptor	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
136	adenosine	Phosphatidylinositol 4-kinase type 2-alpha	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
137	adenosine	Phosphatidylinositol 4-kinase type 2-beta	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
138	adenosine	Glyceraldehyde-3-phosphate dehydrogenase liver	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
139	adenosine	cAMP-dependent protein kinase A	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
140	adenosine	Histone-lysine N-methyltransferase, H3 lysine-79 specific	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
141	adinazolam	Translocator protein	CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
142	adinazolam	GABA-A receptor	CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
143	agomelatine	5-hydroxytryptamine receptor 2A	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
144	agomelatine	5-hydroxytryptamine receptor 2B	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
145	agomelatine	Melatonin receptor	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
146	agomelatine	5-hydroxytryptamine receptor 2C	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
147	agomelatine	Melatonin receptor type 1A	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
148	agomelatine	Melatonin receptor type 1B	COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
149	alacepril	Angiotensin-converting enzyme	C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
150	salbutamol	Beta-1 adrenergic receptor	CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1
151	salbutamol	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1
152	alendronic acid	Farnesyl pyrophosphate synthase	NCCCC(O)(P(O)(O)=O)P(O)(O)=O
153	alendronic acid	Protein farnesyltransferase subunit beta	NCCCC(O)(P(O)(O)=O)P(O)(O)=O
154	alfentanil	Mu-type opioid receptor	CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O
155	alfentanil	Multidrug resistance protein 1	CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O
156	alfentanil	Opioid receptor	CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O
157	alfuzosin	Alpha-1A adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1
158	alfuzosin	Alpha-1D adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1
159	alfuzosin	Alpha-1B adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1
160	alfuzosin	Acetylcholinesterase	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1
161	alfuzosin	Solute carrier family 22 member 1	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1
162	aliskiren	Cytochrome P450 3A4	[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C
163	aliskiren	Multidrug resistance protein 1	[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C
164	aliskiren	Renin	[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C
165	aliskiren	Renin-1	[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C
166	aliskiren	Protease	[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C
167	allopurinol	Xanthine dehydrogenase/oxidase	OC1=NC=NC2=C1C=NN2
168	allopurinol	Hypoxanthine-guanine phosphoribosyltransferase	OC1=NC=NC2=C1C=NN2
169	allopurinol	Shiga toxin subunit A	OC1=NC=NC2=C1C=NN2
170	almotriptan	5-hydroxytryptamine receptor 1B	CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
171	almotriptan	5-hydroxytryptamine receptor 1D	CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
172	almotriptan	5-hydroxytryptamine receptor 1F	CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
173	alosetron	Potassium voltage-gated channel subfamily H member 2	CN1C2=C(C3=C1C=CC=C3)C(=O)N(CC1=C(C)N=CN1)CC2
174	alosetron	5-hydroxytryptamine receptor 2B	CN1C2=C(C3=C1C=CC=C3)C(=O)N(CC1=C(C)N=CN1)CC2
175	alosetron	5-hydroxytryptamine receptor 3A	CN1C2=C(C3=C1C=CC=C3)C(=O)N(CC1=C(C)N=CN1)CC2
176	alosetron	Cytochrome P450 1A2	CN1C2=C(C3=C1C=CC=C3)C(=O)N(CC1=C(C)N=CN1)CC2
177	alfacalcidol	Sodium-dependent noradrenaline transporter	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)C
178	alfacalcidol	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)C
179	alprazolam	Cytochrome P450 3A4	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
180	alprazolam	Platelet-activating factor receptor	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
181	alprazolam	Cholecystokinin receptor type A	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
182	alprazolam	Bromodomain-containing protein 4	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
183	alprazolam	GABA-A receptor alpha-1/beta-2/gamma-2	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
184	alprazolam	GABA-A receptor alpha-2/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
185	alprazolam	GABA-A receptor alpha-3/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
186	alprazolam	GABA-A receptor alpha-5/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12
187	alprenolol	5-hydroxytryptamine receptor 1A	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
188	alprenolol	5-hydroxytryptamine receptor 2A	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
189	alprenolol	Beta-3 adrenergic receptor	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
190	alprenolol	Squalene synthase	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
191	alprenolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
192	alprenolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=C(CC=C)C=CC=C1
193	alprostadil	Prostaglandin E2 receptor EP1 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
194	alprostadil	Prostaglandin E2 receptor EP3 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
195	alprostadil	Prostacyclin receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
196	alprostadil	Prostaglandin E2 receptor EP2 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
197	alprostadil	Prostaglandin E2 receptor EP4 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
198	alprostadil	Prostaglandin D2 receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
199	alprostadil	Cation channel sperm-associated protein 1	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
200	alprostadil	Cation channel sperm-associated protein 2	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
201	alprostadil	Cation channel sperm-associated protein 3	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
202	alprostadil	Cation channel sperm-associated protein 4	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
203	alvimopan	Mu-type opioid receptor	C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
204	alvimopan	Kappa-type opioid receptor	C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
205	alvimopan	Delta-type opioid receptor	C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
206	amantadine	Sigma non-opioid intracellular receptor 1	NC12CC3CC(CC(C3)C1)C2
207	amantadine	Multidrug and toxin extrusion protein 1	NC12CC3CC(CC(C3)C1)C2
208	amantadine	Matrix protein 2	NC12CC3CC(CC(C3)C1)C2
209	amantadine	Glutamate [NMDA] receptor	NC12CC3CC(CC(C3)C1)C2
210	ambenonium	Acetylcholinesterase	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=C(Cl)C=CC=C1)CC1=C(Cl)C=CC=C1
211	ambroxol	Sodium-dependent serotonin transporter	NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
212	ambroxol	Cytochrome P450 2D6	NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
213	ambroxol	Sodium channel protein type 10 subunit alpha	NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
214	ambroxol	Glucosylceramidase	NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
215	amcinonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC1(CCCC1)O2)C(=O)COC(C)=O
216	amiloride	Amiloride-sensitive sodium channel subunit alpha	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
217	amiloride	Urokinase-type plasminogen activator	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
218	amiloride	Adenosine receptor A2a	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
219	amiloride	Amine oxidase [flavin-containing] A	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
220	amiloride	Sodium/hydrogen exchanger 1	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
221	amiloride	Solute carrier family 22 member 1	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
222	amiloride	Acid-sensing ion channel 2	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
223	amiloride	Acid-sensing ion channel 1	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
224	amiloride	Membrane primary amine oxidase	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
225	amiloride	Acid-sensing ion channel 3	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
226	amiloride	Amiloride-sensitive sodium channel, ENaC	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
227	amiloride	Sodium/hydrogen exchanger	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
228	amiloride	Sodium/hydrogen exchanger 5	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
229	amiloride	Sodium/hydrogen exchanger 2	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1
230	aminocaproic acid	Plasminogen	NCCCCCC(O)=O
231	aminocaproic acid	Tissue-type plasminogen activator	NCCCCCC(O)=O
232	aminoglutethimide	Aromatase	CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
233	aminoglutethimide	Thromboxane-A synthase	CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
234	aminoglutethimide	Cholesterol side-chain cleavage enzyme, mitochondrial	CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
235	aminoglutethimide	Cytochrome P450 11A1	CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
236	amiodarone	Beta-1 adrenergic receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
237	amiodarone	Sodium channel protein type 5 subunit alpha	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
238	amiodarone	Mu-type opioid receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
239	amiodarone	D(1A) dopamine receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
240	amiodarone	D(2) dopamine receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
241	amiodarone	Alpha-2A adrenergic receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
242	amiodarone	Sigma non-opioid intracellular receptor 1	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
243	amiodarone	Thyroid hormone receptor alpha	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
244	amiodarone	Thyroid hormone receptor beta	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
245	amiodarone	Potassium voltage-gated channel subfamily H member 2	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
246	amiodarone	Cytochrome P450 3A4	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
247	amiodarone	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
248	amiodarone	Multidrug resistance protein 1	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
249	amiodarone	Sodium-dependent serotonin transporter	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
250	amiodarone	Sodium-dependent noradrenaline transporter	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
251	amiodarone	5-hydroxytryptamine receptor 2A	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
252	amiodarone	5-hydroxytryptamine receptor 2B	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
253	amiodarone	5-hydroxytryptamine receptor 2C	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
254	amiodarone	5-hydroxytryptamine receptor 6	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
255	amiodarone	Alpha-2B adrenergic receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
256	amiodarone	D(3) dopamine receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
257	amiodarone	Histamine H2 receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
258	amiodarone	Muscarinic acetylcholine receptor M1	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
259	amiodarone	Muscarinic acetylcholine receptor M2	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
260	amiodarone	Muscarinic acetylcholine receptor M3	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
261	amiodarone	Muscarinic acetylcholine receptor M4	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
262	amiodarone	Muscarinic acetylcholine receptor M5	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
263	amiodarone	Beta-3 adrenergic receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
264	amiodarone	Sodium-dependent dopamine transporter	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
265	amiodarone	Adenosine receptor A3	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
266	amiodarone	D(4) dopamine receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
267	amiodarone	Kappa-type opioid receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
268	amiodarone	Delta-type opioid receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
269	amiodarone	Cytochrome P450 2C9	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
270	amiodarone	Voltage-dependent T-type calcium channel subunit alpha-1H	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
271	amiodarone	Endothelin-1 receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
272	amiodarone	Squalene monooxygenase	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
273	amiodarone	Tyrosine-protein kinase Fyn	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
274	amiodarone	Receptor tyrosine-protein kinase erbB-2	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
275	amiodarone	Squalene synthase	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
276	amiodarone	C-C chemokine receptor type 2	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
277	amiodarone	Substance-K receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
278	amiodarone	Androgen receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
279	amiodarone	Lethal factor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
280	amiodarone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
281	amiodarone	Potassium voltage-gated channel subfamily A member 7	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
282	amiodarone	5-hydroxytryptamine receptor 1B	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
283	amiodarone	B2 bradykinin receptor	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
284	amiodarone	Melanocortin receptor 4	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
285	amiodarone	Melanocortin receptor 5	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
286	amiodarone	Melanocortin receptor 3	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
287	amiodarone	C-C chemokine receptor type 4	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
288	amiodarone	Membrane-associated progesterone receptor component 1	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
289	amiodarone	C-8 sterol isomerase	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
290	amiodarone	Cruzipain	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
291	amiodarone	THAP domain-containing protein 1	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
292	amiodarone	Lysine-specific demethylase PHF2	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
293	amiodarone	Lysine-specific demethylase 5A	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
294	amiodarone	Lysine-specific demethylase 7A	CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
295	amisulpride	Alpha-2A adrenergic receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
296	amisulpride	5-hydroxytryptamine receptor 2A	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
297	amisulpride	5-hydroxytryptamine receptor 2B	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
298	amisulpride	5-hydroxytryptamine receptor 6	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
299	amisulpride	5-hydroxytryptamine receptor 7	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
300	amisulpride	5-hydroxytryptamine receptor 1B	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
301	amisulpride	5-hydroxytryptamine receptor 1D	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
302	amisulpride	Alpha-2C adrenergic receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
303	amisulpride	D(4) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
304	amisulpride	D(3) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
305	amisulpride	D(2) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC
306	amitriptyline	Sodium channel protein type 5 subunit alpha	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
307	amitriptyline	D(1A) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
308	amitriptyline	D(2) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
309	amitriptyline	Alpha-2A adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
310	amitriptyline	Sigma non-opioid intracellular receptor 1	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
311	amitriptyline	Potassium voltage-gated channel subfamily H member 2	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
312	amitriptyline	Sodium-dependent serotonin transporter	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
313	amitriptyline	Sodium-dependent noradrenaline transporter	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
314	amitriptyline	5-hydroxytryptamine receptor 1A	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
315	amitriptyline	5-hydroxytryptamine receptor 2A	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
316	amitriptyline	5-hydroxytryptamine receptor 2B	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
317	amitriptyline	5-hydroxytryptamine receptor 2C	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
318	amitriptyline	5-hydroxytryptamine receptor 6	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
319	amitriptyline	5-hydroxytryptamine receptor 7	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
320	amitriptyline	Alpha-1A adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
321	amitriptyline	Alpha-2B adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
322	amitriptyline	D(3) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
323	amitriptyline	D(1B) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
324	amitriptyline	Histamine H1 receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
325	amitriptyline	Histamine H2 receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
326	amitriptyline	Histamine H4 receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
327	amitriptyline	Muscarinic acetylcholine receptor M1	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
328	amitriptyline	Muscarinic acetylcholine receptor M2	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
329	amitriptyline	Muscarinic acetylcholine receptor M3	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
330	amitriptyline	Muscarinic acetylcholine receptor M4	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
331	amitriptyline	Muscarinic acetylcholine receptor M5	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
332	amitriptyline	Aldehyde oxidase	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
333	amitriptyline	Alpha-2C adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
334	amitriptyline	Sodium channel protein type 2 subunit alpha	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
335	amitriptyline	Sodium channel protein type 9 subunit alpha	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
336	amitriptyline	Sodium-dependent dopamine transporter	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
337	amitriptyline	Alpha-1D adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
338	amitriptyline	Proto-oncogene tyrosine-protein kinase receptor Ret	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
339	amitriptyline	High affinity nerve growth factor receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
340	amitriptyline	Solute carrier family 22 member 1	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
341	amitriptyline	Alpha-1B adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
342	amitriptyline	5-hydroxytryptamine receptor 1B	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
343	amitriptyline	Transporter	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
344	amitriptyline	Solute carrier family 22 member 2	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
345	amitriptyline	Muscarinic acetylcholine receptor	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
346	amitriptyline	G protein-activated inward rectifier potassium channel 2	CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
347	amlexanox	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1
348	amlexanox	Serine/threonine-protein kinase TBK1	CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1
349	amlexanox	G-protein coupled receptor 35	CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1
350	amlexanox	Phosphodiesterase 4	CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1
351	amlodipine	Alpha-2A adrenergic receptor	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
352	amlodipine	5-hydroxytryptamine receptor 6	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
353	amlodipine	Alpha-1A adrenergic receptor	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
354	amlodipine	Aldehyde oxidase	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
355	amlodipine	Alpha-2C adrenergic receptor	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
356	amlodipine	Sodium-dependent dopamine transporter	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
357	amlodipine	Alpha-1D adrenergic receptor	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
358	amlodipine	Alpha-1B adrenergic receptor	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
359	amlodipine	Voltage-dependent calcium channel gamma-1 subunit	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
360	amlodipine	Voltage-dependent L-type calcium channel subunit alpha-1C	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
361	amlodipine	Carbonic anhydrase 1	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
362	amlodipine	Voltage-dependent calcium channel subunit alpha-2/delta-1	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
363	amlodipine	Voltage-dependent L-type calcium channel subunit alpha-1D	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
364	amlodipine	Voltage-dependent T-type calcium channel subunit alpha-1H	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
365	amlodipine	Potassium channel subfamily K member 2	[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC
366	amoxapine	D(1A) dopamine receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
367	amoxapine	D(2) dopamine receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
368	amoxapine	Alpha-2A adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
369	amoxapine	Multidrug resistance protein 1	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
370	amoxapine	Sodium-dependent serotonin transporter	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
371	amoxapine	Sodium-dependent noradrenaline transporter	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
372	amoxapine	5-hydroxytryptamine receptor 1A	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
373	amoxapine	5-hydroxytryptamine receptor 2A	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
374	amoxapine	5-hydroxytryptamine receptor 2B	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
375	amoxapine	5-hydroxytryptamine receptor 2C	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
376	amoxapine	5-hydroxytryptamine receptor 6	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
377	amoxapine	5-hydroxytryptamine receptor 7	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
378	amoxapine	Alpha-2B adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
379	amoxapine	D(3) dopamine receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
380	amoxapine	Histamine H1 receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
381	amoxapine	Muscarinic acetylcholine receptor M1	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
382	amoxapine	Muscarinic acetylcholine receptor M2	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
383	amoxapine	Muscarinic acetylcholine receptor M3	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
384	amoxapine	Muscarinic acetylcholine receptor M4	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
385	amoxapine	Muscarinic acetylcholine receptor M5	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
386	amoxapine	Alpha-2C adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
387	amoxapine	Sodium-dependent dopamine transporter	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
388	amoxapine	Cytochrome P450 2D6	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
389	amoxapine	D(4) dopamine receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
390	amoxapine	Alpha-1D adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
391	amoxapine	5-hydroxytryptamine receptor 3A	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
392	amoxapine	Sodium- and chloride-dependent glycine transporter 2	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
393	amoxapine	Alpha-1B adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
394	amoxapine	Alpha-1A adrenergic receptor	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
395	amoxapine	GABA-A receptor alpha-1/beta-2/gamma-2	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1
396	amfetamine	Alpha-2A adrenergic receptor	CC(N)CC1=CC=CC=C1
397	amfetamine	Sodium-dependent serotonin transporter	CC(N)CC1=CC=CC=C1
398	amfetamine	Sodium-dependent noradrenaline transporter	CC(N)CC1=CC=CC=C1
399	amfetamine	Alpha-1A adrenergic receptor	CC(N)CC1=CC=CC=C1
400	amfetamine	Sodium-dependent dopamine transporter	CC(N)CC1=CC=CC=C1
401	amfetamine	Cocaine- and amphetamine-regulated transcript protein	CC(N)CC1=CC=CC=C1
402	amfetamine	Amine oxidase [flavin-containing] A	CC(N)CC1=CC=CC=C1
403	amfetamine	5-hydroxytryptamine receptor 2B	CC(N)CC1=CC=CC=C1
404	amfetamine	Transporter	CC(N)CC1=CC=CC=C1
405	amfetamine	Serotonin (5-HT) receptor	CC(N)CC1=CC=CC=C1
406	amfetamine	Serotonin 1 (5-HT1) receptor	CC(N)CC1=CC=CC=C1
407	amfetamine	Serotonin 2 (5-HT2) receptor	CC(N)CC1=CC=CC=C1
408	amfetamine	Trace amine-associated receptor 1	CC(N)CC1=CC=CC=C1
409	amrinone	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	NC1=CC(=CNC1=O)C1=CC=NC=C1
410	amrinone	Dual specificity protein kinase TTK	NC1=CC(=CNC1=O)C1=CC=NC=C1
411	amrinone	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	NC1=CC(=CNC1=O)C1=CC=NC=C1
412	amrinone	Phosphodiesterase 4	NC1=CC(=CNC1=O)C1=CC=NC=C1
413	anagrelide	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
414	anagrelide	cGMP-dependent 3',5'-cyclic phosphodiesterase	ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
415	anastrozole	Aromatase	CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N
416	anileridine	Mu-type opioid receptor	CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C1=CC=CC=C1
417	anisindione	Vitamin K-dependent gamma-carboxylase	COC1=CC=C(C=C1)C1C(=O)C2=C(C=CC=C2)C1=O
418	anisindione	Arachidonate 5-lipoxygenase	COC1=CC=C(C=C1)C1C(=O)C2=C(C=CC=C2)C1=O
419	octatropine methylbromide	Muscarinic acetylcholine receptor M1	CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C
420	octatropine methylbromide	Muscarinic acetylcholine receptor M3	CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C
421	antazoline	Histamine H1 receptor	C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1
422	apomorphine	D(1A) dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
423	apomorphine	D(2) dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
424	apomorphine	Alpha-2A adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
425	apomorphine	5-hydroxytryptamine receptor 1A	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
426	apomorphine	5-hydroxytryptamine receptor 2A	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
427	apomorphine	5-hydroxytryptamine receptor 2B	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
428	apomorphine	5-hydroxytryptamine receptor 2C	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
429	apomorphine	Alpha-1A adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
430	apomorphine	Alpha-2B adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
431	apomorphine	D(3) dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
432	apomorphine	D(1B) dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
433	apomorphine	5-hydroxytryptamine receptor 1B	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
434	apomorphine	5-hydroxytryptamine receptor 1D	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
435	apomorphine	Alpha-2C adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
436	apomorphine	D(4) dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
437	apomorphine	Alpha-1D adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
438	apomorphine	Alpha-1B adrenergic receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
439	apomorphine	Solute carrier family 22 member 1	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
440	apomorphine	Transient receptor potential cation channel subfamily A member 1	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
441	apomorphine	5-hydroxytryptamine receptor 7	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
442	apomorphine	Zinc finger protein mex-5	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
443	apomorphine	Opioid receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
444	apomorphine	Serotonin (5-HT) receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
445	apomorphine	Adrenergic receptor alpha-2	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
446	apomorphine	Dopamine receptor	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
447	apomorphine	Adrenergic receptor alpha-1	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
448	apomorphine	Mannose-6-phosphate isomerase	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
449	apomorphine	Cytoplasmic zinc-finger protein	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
450	apomorphine	E3 ubiquitin-protein ligase Mdm2	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23
451	apraclonidine	Alpha-2A adrenergic receptor	NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
452	apraclonidine	Alpha-2B adrenergic receptor	NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
453	apraclonidine	Alpha-2C adrenergic receptor	NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
454	apraclonidine	Adrenergic receptor alpha-1	NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
455	aprepitant	Cytochrome P450 3A4	C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
456	aprepitant	Substance-P receptor	C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
457	aprepitant	Neuromedin-K receptor	C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
458	aprindine	Sodium channel protein type 5 subunit alpha	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
459	aprindine	Potassium voltage-gated channel subfamily H member 2	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
460	aprindine	Cytochrome P450 2D6	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
461	aprindine	Proteasome subunit alpha type-1	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
462	aprindine	Sodium/calcium exchanger 1	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
463	aprindine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
464	aprindine	Calmodulin	CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1
465	aranidipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)=O
466	arbutamine	Beta-1 adrenergic receptor	O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1
467	argatroban	Prothrombin	C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
468	argatroban	Coagulation factor X	C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
469	argatroban	Tissue-type plasminogen activator	C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
470	argatroban	Cationic trypsin	C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
471	aripiprazole	Beta-1 adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
472	aripiprazole	Beta-2 adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
473	aripiprazole	D(1A) dopamine receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
474	aripiprazole	D(2) dopamine receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
475	aripiprazole	Alpha-2A adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
476	aripiprazole	Potassium voltage-gated channel subfamily H member 2	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
477	aripiprazole	Multidrug resistance protein 1	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
478	aripiprazole	Sodium-dependent serotonin transporter	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
479	aripiprazole	Sodium-dependent noradrenaline transporter	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
480	aripiprazole	5-hydroxytryptamine receptor 2A	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
481	aripiprazole	5-hydroxytryptamine receptor 2B	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
482	aripiprazole	5-hydroxytryptamine receptor 2C	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
483	aripiprazole	5-hydroxytryptamine receptor 6	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
484	aripiprazole	5-hydroxytryptamine receptor 7	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
485	aripiprazole	Alpha-1A adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
486	aripiprazole	Alpha-2B adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
487	aripiprazole	D(3) dopamine receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
488	aripiprazole	D(1B) dopamine receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
489	aripiprazole	Histamine H1 receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
490	aripiprazole	Muscarinic acetylcholine receptor M1	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
491	aripiprazole	Muscarinic acetylcholine receptor M2	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
492	aripiprazole	Muscarinic acetylcholine receptor M3	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
493	aripiprazole	Muscarinic acetylcholine receptor M4	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
494	aripiprazole	Muscarinic acetylcholine receptor M5	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
495	aripiprazole	5-hydroxytryptamine receptor 1B	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
496	aripiprazole	5-hydroxytryptamine receptor 1D	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
497	aripiprazole	Alpha-2C adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
498	aripiprazole	Sodium-dependent dopamine transporter	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
499	aripiprazole	D(4) dopamine receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
500	aripiprazole	5-hydroxytryptamine receptor 3A	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
501	aripiprazole	Alpha-1B adrenergic receptor	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
502	aripiprazole	5-hydroxytryptamine receptor 5A	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
503	aripiprazole	5-hydroxytryptamine receptor 1E	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
504	aripiprazole	5-hydroxytryptamine receptor 1A	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
505	aripiprazole	Histone H1.0	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl
506	astemizole	Sodium/nucleoside cotransporter 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
507	astemizole	Beta-1 adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
508	astemizole	Mu-type opioid receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
509	astemizole	D(1A) dopamine receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
510	astemizole	D(2) dopamine receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
511	astemizole	Alpha-2A adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
512	astemizole	Sigma non-opioid intracellular receptor 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
513	astemizole	Potassium voltage-gated channel subfamily H member 2	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
514	astemizole	Cytochrome P450 3A4	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
515	astemizole	Multidrug resistance protein 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
516	astemizole	Sodium-dependent serotonin transporter	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
517	astemizole	Sodium-dependent noradrenaline transporter	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
518	astemizole	5-hydroxytryptamine receptor 1A	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
519	astemizole	5-hydroxytryptamine receptor 2A	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
520	astemizole	5-hydroxytryptamine receptor 2B	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
521	astemizole	5-hydroxytryptamine receptor 2C	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
522	astemizole	5-hydroxytryptamine receptor 6	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
523	astemizole	Alpha-2B adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
524	astemizole	D(3) dopamine receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
525	astemizole	Histamine H2 receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
526	astemizole	Histamine H4 receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
527	astemizole	Muscarinic acetylcholine receptor M1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
528	astemizole	Muscarinic acetylcholine receptor M2	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
529	astemizole	Muscarinic acetylcholine receptor M3	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
530	astemizole	Muscarinic acetylcholine receptor M4	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
531	astemizole	Muscarinic acetylcholine receptor M5	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
532	astemizole	Beta-3 adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
533	astemizole	Alpha-2C adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
534	astemizole	Sodium-dependent dopamine transporter	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
535	astemizole	Adenosine receptor A3	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
536	astemizole	D(4) dopamine receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
537	astemizole	Alpha-1D adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
538	astemizole	5-hydroxytryptamine receptor 3A	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
539	astemizole	Kappa-type opioid receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
540	astemizole	ATP-binding cassette sub-family G member 2	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
541	astemizole	Glycine receptor subunit alpha-1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
542	astemizole	Calmodulin	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
543	astemizole	Delta-type opioid receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
544	astemizole	Somatostatin receptor type 5	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
545	astemizole	Epidermal growth factor receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
546	astemizole	Substance-P receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
547	astemizole	Tyrosine-protein kinase Lck	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
548	astemizole	Tyrosine-protein kinase Fyn	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
549	astemizole	Receptor tyrosine-protein kinase erbB-2	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
550	astemizole	Substance-K receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
551	astemizole	Potassium voltage-gated channel subfamily H member 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
552	astemizole	Alpha-1B adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
553	astemizole	5-hydroxytryptamine receptor 1B	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
554	astemizole	Melanocortin receptor 4	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
555	astemizole	Melanocortin receptor 5	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
556	astemizole	Melanocortin receptor 3	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
557	astemizole	Membrane-associated progesterone receptor component 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
558	astemizole	Alpha-1A adrenergic receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
559	astemizole	Multidrug and toxin extrusion protein 1	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
560	astemizole	Protein farnesyltransferase	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
561	astemizole	Polycomb protein EED	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
562	astemizole	HLA class I histocompatibility antigen, A-3 alpha chain	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
563	astemizole	Transmembrane protein 97	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
564	astemizole	Histamine H1 receptor	COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1
565	atenolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
566	atenolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
567	atenolol	Adenosine receptor A3	CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
568	atenolol	5-hydroxytryptamine receptor 1A	CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
569	atomoxetine	Potassium voltage-gated channel subfamily H member 2	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
570	atomoxetine	Sodium-dependent serotonin transporter	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
571	atomoxetine	Sodium-dependent noradrenaline transporter	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
572	atomoxetine	Sodium-dependent dopamine transporter	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
573	atomoxetine	Cytochrome P450 2D6	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
574	atomoxetine	G protein-activated inward rectifier potassium channel 2	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
575	atomoxetine	Transporter	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
576	atomoxetine	Kir3.1/Kir3.2	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
577	atomoxetine	Kir3.1/Kir3.4	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
578	atomoxetine	Krueppel-like factor 10	CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1
579	atorvastatin	Nuclear receptor subfamily 1 group I member 3	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
580	atorvastatin	Cytochrome P450 3A4	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
581	atorvastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
582	atorvastatin	Histone deacetylase 2	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
583	atorvastatin	Histone deacetylase 1	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
584	atorvastatin	Histone deacetylase 6	CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
585	atracurium	Neuronal acetylcholine receptor subunit alpha-2	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
586	atracurium	Neuronal acetylcholine receptor subunit alpha-7	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
587	atracurium	Small conductance calcium-activated potassium channel protein 3	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
588	atracurium	Acetylcholine receptor	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
589	atracurium	Neuronal acetylcholine receptor subunit alpha-3	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
590	atracurium	Neuronal acetylcholine receptor subunit alpha-4	COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1
591	atropine	Alpha-2A adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
592	atropine	5-hydroxytryptamine receptor 2A	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
593	atropine	5-hydroxytryptamine receptor 2C	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
594	atropine	Histamine H1 receptor	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
595	atropine	Muscarinic acetylcholine receptor M1	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
596	atropine	Muscarinic acetylcholine receptor M2	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
597	atropine	Muscarinic acetylcholine receptor M3	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
598	atropine	Muscarinic acetylcholine receptor M4	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
599	atropine	Muscarinic acetylcholine receptor M5	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
600	atropine	Alpha-1D adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
601	atropine	Solute carrier family 22 member 1	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
602	atropine	Acetylcholinesterase	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
603	atropine	Muscarinic receptor M1	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
604	atropine	Muscarinic acetylcholine receptor	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
605	atropine	Nicotinic acetylcholine receptor alpha 5 subunit	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C
606	azasetron	5-hydroxytryptamine receptor 3A	[H]C1(CN2CCC1CC2)NC(=O)C1=C2OCC(=O)N(C)C2=CC(Cl)=C1
607	azatadine	Histamine H1 receptor	CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2
608	azelastine	Potassium voltage-gated channel subfamily H member 2	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
609	azelastine	Multidrug resistance protein 1	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
610	azelastine	5-hydroxytryptamine receptor 2B	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
611	azelastine	5-hydroxytryptamine receptor 2C	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
612	azelastine	Alpha-1A adrenergic receptor	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
613	azelastine	Histamine H1 receptor	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
614	azelastine	Muscarinic acetylcholine receptor M1	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
615	azelastine	Alpha-1B adrenergic receptor	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
616	azelastine	Histamine H3 receptor	[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O
617	azelnidipine	Voltage-gated L-type calcium channel	CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1
618	baclofen	GABA B receptor	NCC(CC(O)=O)C1=CC=C(Cl)C=C1
619	baclofen	GABA-B receptor	NCC(CC(O)=O)C1=CC=C(Cl)C=C1
620	baclofen	Adenosine receptor A3	NCC(CC(O)=O)C1=CC=C(Cl)C=C1
621	baclofen	GABA-A receptor; anion channel	NCC(CC(O)=O)C1=CC=C(Cl)C=C1
622	balsalazide	Prostaglandin G/H synthase 2	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
623	balsalazide	Prostaglandin G/H synthase 1	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
624	balsalazide	Arachidonate 5-lipoxygenase	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
625	balsalazide	Peroxisome proliferator-activated receptor gamma	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
626	bamipine	Histamine H1 receptor	CN1CCC(CC1)N(CC1=CC=CC=C1)C1=CC=CC=C1
627	barnidipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1
628	beclometasone dipropionate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
629	beclometasone dipropionate	Interleukin-5	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
630	beclometasone dipropionate	Mineralocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
631	beclometasone dipropionate	Progesterone receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
632	beclometasone dipropionate	Matrix metalloproteinase-9	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
633	beclometasone dipropionate	Androgen receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
634	beclometasone dipropionate	Probable G-protein coupled receptor 97	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
635	belotecan	DNA topoisomerase 1	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CCNC(C)C)C4=CC=CC=C4N=C13)C2=O
636	benazepril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O
637	bendroflumethiazide	Carbonic anhydrase 2	NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
638	bendroflumethiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
639	bendroflumethiazide	Carbonic anhydrase 1	NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
640	bendroflumethiazide	Carbonic anhydrase 4	NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
641	bendroflumethiazide	Calcium-activated potassium channel subunit alpha-1	NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
642	benoxaprofen	Arachidonate 5-lipoxygenase	CC(C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(Cl)C=C2)C=C1
643	benoxaprofen	Bile salt export pump	CC(C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(Cl)C=C2)C=C1
644	diphenidol	D(2) dopamine receptor	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
645	diphenidol	Sigma non-opioid intracellular receptor 1	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
646	diphenidol	5-hydroxytryptamine receptor 2A	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
647	diphenidol	D(3) dopamine receptor	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
648	diphenidol	Muscarinic acetylcholine receptor M1	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
649	diphenidol	Muscarinic acetylcholine receptor M2	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
650	diphenidol	Muscarinic acetylcholine receptor M3	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
651	diphenidol	Muscarinic acetylcholine receptor M4	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
652	diphenidol	Muscarinic acetylcholine receptor M5	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
653	diphenidol	Cytochrome P450 2D6	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
654	diphenidol	Alpha-1B adrenergic receptor	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
655	diphenidol	Sodium channel alpha subunits; brain (Types I, II, III)	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
656	benzbromarone	5-hydroxytryptamine receptor 2B	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
657	benzbromarone	Adenosine receptor A3	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
658	benzbromarone	Multidrug resistance-associated protein 1	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
659	benzbromarone	Cytochrome P450 2C9	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
660	benzbromarone	Aldo-keto reductase family 1 member C1	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
661	benzbromarone	Tyrosine-protein phosphatase non-receptor type 1	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
662	benzbromarone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
663	benzbromarone	Mitogen-activated protein kinase 14	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
664	benzbromarone	Mitogen-activated protein kinase 1	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
665	benzbromarone	M1-family alanyl aminopeptidase	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
666	benzbromarone	Envelope glycoprotein gp160	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
667	benzbromarone	Polymerase acidic protein	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
668	benzbromarone	Eyes absent homolog 2	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
669	benzbromarone	Eyes absent homolog 3	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
670	benzbromarone	Solute carrier family 22 member 12	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2
671	benzocaine	Sodium channel protein type 1 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
672	benzocaine	Sodium channel protein type 2 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
673	benzocaine	Sodium channel protein type 3 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
674	benzocaine	Sodium channel protein type 4 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
675	benzocaine	Sodium channel protein type 8 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
676	benzocaine	Sodium channel protein type 9 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
677	benzocaine	Sodium channel protein type 11 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
678	benzocaine	Sodium channel protein type 10 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
679	benzocaine	Sodium channel protein type 7 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
680	benzocaine	Sodium channel protein type 5 subunit alpha	CCOC(=O)C1=CC=C(N)C=C1
681	benzphetamine	Alpha-2A adrenergic receptor	C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
682	benzphetamine	Sodium-dependent noradrenaline transporter	C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
683	benzphetamine	Alpha-1A adrenergic receptor	C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
684	benzphetamine	Synaptic vesicular amine transporter	C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
685	benzquinamide	Prostaglandin G/H synthase 2	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
686	benzquinamide	D(2) dopamine receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
687	benzquinamide	D(3) dopamine receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
688	benzquinamide	D(4) dopamine receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
689	benzquinamide	Alpha-2A adrenergic receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
690	benzquinamide	Alpha-2B adrenergic receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
691	benzquinamide	Alpha-2C adrenergic receptor	CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O
692	benzthiazide	Carbonic anhydrase 2	NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
693	benzthiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
694	benzthiazide	Carbonic anhydrase 1	NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
695	benzthiazide	Carbonic anhydrase 4	NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
696	benzthiazide	Calcium-activated potassium channel subunit alpha-1	NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
697	benzatropine	Alpha-2A adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
698	benzatropine	Sigma non-opioid intracellular receptor 1	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
699	benzatropine	Sodium-dependent serotonin transporter	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
700	benzatropine	Sodium-dependent noradrenaline transporter	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
701	benzatropine	5-hydroxytryptamine receptor 2A	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
702	benzatropine	5-hydroxytryptamine receptor 2B	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
703	benzatropine	5-hydroxytryptamine receptor 2C	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
704	benzatropine	5-hydroxytryptamine receptor 6	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
705	benzatropine	Alpha-2B adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
706	benzatropine	D(3) dopamine receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
707	benzatropine	Histamine H1 receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
708	benzatropine	Histamine H2 receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
709	benzatropine	Muscarinic acetylcholine receptor M1	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
710	benzatropine	Muscarinic acetylcholine receptor M2	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
711	benzatropine	Muscarinic acetylcholine receptor M3	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
712	benzatropine	Muscarinic acetylcholine receptor M4	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
713	benzatropine	Muscarinic acetylcholine receptor M5	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
714	benzatropine	Alpha-2C adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
715	benzatropine	Sodium-dependent dopamine transporter	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
716	benzatropine	Alpha-1D adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
717	benzatropine	Alpha-1B adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
718	benzatropine	Membrane-associated progesterone receptor component 1	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
719	benzatropine	Alpha-1A adrenergic receptor	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
720	benzatropine	Sodium-dependent neutral amino acid transporter B(0)AT1	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
721	bepotastine	Histamine H1 receptor	OC(=O)CCCN1CCC(CC1)O[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
722	bepridil	Sodium channel protein type 5 subunit alpha	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
723	bepridil	Potassium voltage-gated channel subfamily H member 2	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
724	bepridil	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
725	bepridil	Voltage-dependent T-type calcium channel subunit alpha-1H	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
726	bepridil	Lethal factor	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
727	bepridil	Potassium voltage-gated channel subfamily KQT member 4	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
728	bepridil	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
729	bepridil	Voltage-dependent L-type calcium channel subunit alpha-1C	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
730	bepridil	Sodium channel alpha subunits; brain (Types I, II, III)	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
731	bepridil	Potassium channel subfamily T member 1	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
732	bepridil	Voltage-dependent L-type calcium channel subunit alpha-1D	CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
733	beraprost	Prostaglandin E2 receptor EP3 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=C(O2)C(CCCC(O)=O)=CC=C1
734	beraprost	Prostaglandin E2 receptor EP4 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=C(O2)C(CCCC(O)=O)=CC=C1
735	beraprost	Prostacyclin receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=C(O2)C(CCCC(O)=O)=CC=C1
736	betahistine	Histamine H3 receptor	CNCCC1=CC=CC=N1
737	betamethasone	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
738	betamethasone	Annexin A1	[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
739	betamethasone acetate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
740	betamethasone benzoate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)C3=CC=CC=C3)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
741	betamethasone dipropionate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
742	betamethasone valerate	Glucocorticoid receptor	[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CCCC)C(=O)CO
743	betaxolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1
744	betaxolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1
745	betazole	Histamine H2 receptor	NCCC1=NNC=C1
746	bethanechol	Muscarinic acetylcholine receptor M1	CC(C[N+](C)(C)C)OC(N)=O
747	bethanechol	Muscarinic acetylcholine receptor M2	CC(C[N+](C)(C)C)OC(N)=O
748	bethanechol	Muscarinic acetylcholine receptor M3	CC(C[N+](C)(C)C)OC(N)=O
749	bethanechol	Muscarinic acetylcholine receptor M4	CC(C[N+](C)(C)C)OC(N)=O
750	bethanechol	Muscarinic acetylcholine receptor	CC(C[N+](C)(C)C)OC(N)=O
751	bethanechol	Muscarinic receptor 2	CC(C[N+](C)(C)C)OC(N)=O
752	betanidine	Sodium-dependent noradrenaline transporter	CNC(NC)=NCC1=CC=CC=C1
753	bevantolol	Beta-1 adrenergic receptor	COC1=C(OC)C=C(CCNCC(O)COC2=CC(C)=CC=C2)C=C1
754	bexarotene	Retinoic acid receptor alpha	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
755	bexarotene	Peroxisome proliferator-activated receptor gamma	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
756	bexarotene	Retinoic acid receptor RXR-alpha	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
757	bexarotene	Retinoic acid receptor RXR-beta	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
758	bexarotene	Retinoic acid receptor RXR-gamma	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
759	bexarotene	Retinoic acid receptor beta	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
760	bexarotene	Retinoic acid receptor gamma	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
761	bexarotene	Cytochrome P450 26A1	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
762	bexarotene	Cytochrome P450 26B1	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
763	bexarotene	Oxysterols receptor LXR-beta	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
764	bexarotene	Oxysterols receptor LXR-alpha	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O
765	bezafibrate	Lipoprotein lipase	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
766	bezafibrate	Peroxisome proliferator-activated receptor alpha	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
767	bezafibrate	Peroxisome proliferator-activated receptor gamma	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
768	bezafibrate	Peroxisome proliferator-activated receptor delta	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
769	bezafibrate	Fatty acid-binding protein, intestinal	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
770	bezafibrate	Fatty acid-binding protein, liver	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
771	bezafibrate	3-hydroxy-3-methylglutaryl-coenzyme A reductase	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
772	bicalutamide	Androgen receptor	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
773	bicalutamide	Cytochrome P450 2C19	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
774	bicalutamide	Progesterone receptor	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
775	bimatoprost	Aldo-keto reductase family 1 member C3	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
776	bimatoprost	Prostaglandin F2-alpha receptor	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
777	biperiden	Muscarinic acetylcholine receptor M1	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
778	biperiden	Muscarinic acetylcholine receptor M2	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
779	biperiden	Muscarinic acetylcholine receptor M3	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
780	biperiden	Muscarinic acetylcholine receptor M4	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
781	biperiden	Muscarinic acetylcholine receptor M5	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
782	biperiden	Neuronal acetylcholine receptor subunit alpha-2	[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1
783	bisoprolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
784	bisoprolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
785	bisoprolol	Beta-3 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
786	bisulepine	Histamine H1 receptor	CN(C)CC\C=C1/C2=C(SC=C2)SCC2=C1C=CC=C2
787	bitolterol	Beta-2 adrenergic receptor	CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C
788	bivalirudin	Prothrombin	[H]N[C@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O
789	blonanserin	Sigma non-opioid intracellular receptor 1	CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
790	blonanserin	Alpha-1A adrenergic receptor	CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
791	blonanserin	D(2) dopamine receptor	CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
792	blonanserin	5-hydroxytryptamine receptor 2A	CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
793	bopindolol	5-hydroxytryptamine receptor 1A	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
794	bopindolol	5-hydroxytryptamine receptor 2A	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
795	bopindolol	5-hydroxytryptamine receptor 2B	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
796	bopindolol	Beta-3 adrenergic receptor	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
797	bopindolol	Cytochrome P450 2D6	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
798	bopindolol	Beta-1 adrenergic receptor	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
799	bopindolol	Beta-2 adrenergic receptor	CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
800	bortezomib	Carbonic anhydrase 2	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
801	bortezomib	Carbonic anhydrase 1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
802	bortezomib	Carbonic anhydrase 4	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
803	bortezomib	Carbonic anhydrase 9	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
804	bortezomib	Carbonic anhydrase 12	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
805	bortezomib	Prothrombin	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
806	bortezomib	Carbonic anhydrase 5A, mitochondrial	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
807	bortezomib	Carbonic anhydrase 5B, mitochondrial	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
808	bortezomib	Carbonic anhydrase 7	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
809	bortezomib	Cytochrome P450 2C19	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
810	bortezomib	26S proteasome non-ATPase regulatory subunit 1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
811	bortezomib	Proteasome subunit alpha type-1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
812	bortezomib	Neutrophil elastase	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
813	bortezomib	Carbonic anhydrase 3	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
814	bortezomib	Carbonic anhydrase 6	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
815	bortezomib	Cathepsin G	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
816	bortezomib	Carbonic anhydrase 14	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
817	bortezomib	Chymase	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
818	bortezomib	Chymotrypsinogen B	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
819	bortezomib	Proteasome subunit beta type-8	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
820	bortezomib	Lysosomal protective protein	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
821	bortezomib	Carbonic anhydrase 13	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
822	bortezomib	Carbonic anhydrase 15	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
823	bortezomib	Proteasome subunit beta type-1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
824	bortezomib	Proteasome subunit beta type-2	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
825	bortezomib	Proteasome subunit beta type-5	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
826	bortezomib	Beta-carbonic anhydrase 1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
827	bortezomib	PH and SEC7 domain-containing protein 1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
828	bortezomib	Nuclear factor NF-kappa-B complex	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
829	bortezomib	Alpha-chymotrypsin	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
830	bortezomib	Proteasome subunit beta	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
831	bortezomib	Proteasome subunit beta type-9	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
832	bortezomib	Proteasome subunit beta type-10	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
833	bosentan	Nuclear receptor subfamily 1 group I member 2	COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1
834	bosentan	Bile salt export pump	COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1
835	bosentan	Endothelin-1 receptor	COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1
836	bosentan	Endothelin B receptor	COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1
837	bretylium	Beta-1 adrenergic receptor	CC[N+](C)(C)CC1=C(Br)C=CC=C1
838	bretylium	Beta-2 adrenergic receptor	CC[N+](C)(C)CC1=C(Br)C=CC=C1
839	bretylium	Sodium-dependent noradrenaline transporter	CC[N+](C)(C)CC1=C(Br)C=CC=C1
840	brimonidine	Alpha-2A adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
841	brimonidine	5-hydroxytryptamine receptor 1A	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
842	brimonidine	Alpha-1A adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
843	brimonidine	Alpha-2B adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
844	brimonidine	Alpha-2C adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
845	brimonidine	Alpha-1D adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
846	brimonidine	Alpha-1B adrenergic receptor	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
847	brimonidine	Adrenergic receptor alpha-2	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
848	brimonidine	Adrenergic receptor alpha-1	BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
849	brinzolamide	Carbonic anhydrase 2	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
850	brinzolamide	Carbonic anhydrase 1	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
851	brinzolamide	Carbonic anhydrase 4	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
852	brinzolamide	Carbonic anhydrase 9	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
853	brinzolamide	Carbonic anhydrase 12	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
854	brinzolamide	Carbonic anhydrase 5A, mitochondrial	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
855	brinzolamide	Carbonic anhydrase 5B, mitochondrial	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
856	brinzolamide	Carbonic anhydrase 7	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
857	brinzolamide	Carbonic anhydrase	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
858	brinzolamide	Carbonic anhydrase 6	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
859	brinzolamide	Carbonic anhydrase 14	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
860	brinzolamide	Carbonic anhydrase 13	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
861	brinzolamide	Carbonic anhydrase 15	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
862	brinzolamide	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
863	brinzolamide	Alpha carbonic anhydrase	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
864	brinzolamide	Astrosclerin-3	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
865	brinzolamide	Beta-carbonic anhydrase 1	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
866	brinzolamide	Delta carbonic anhydrase	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
867	brinzolamide	Carbonic anhydrase, alpha family	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
868	brinzolamide	Carbonate dehydratase	CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
869	bromfenac	Prostaglandin G/H synthase 2	NC1=C(C=CC=C1CC(O)=O)C(=O)C1=CC=C(Br)C=C1
870	bromfenac	Prostaglandin G/H synthase 1	NC1=C(C=CC=C1CC(O)=O)C(=O)C1=CC=C(Br)C=C1
871	bromfenac	Cyclooxygenase	NC1=C(C=CC=C1CC(O)=O)C(=O)C1=CC=C(Br)C=C1
872	bromocriptine	Beta-1 adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
873	bromocriptine	Beta-2 adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
874	bromocriptine	D(1A) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
875	bromocriptine	D(2) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
876	bromocriptine	Alpha-2A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
877	bromocriptine	Cytochrome P450 3A4	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
878	bromocriptine	5-hydroxytryptamine receptor 1A	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
879	bromocriptine	5-hydroxytryptamine receptor 2A	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
880	bromocriptine	5-hydroxytryptamine receptor 2B	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
881	bromocriptine	5-hydroxytryptamine receptor 2C	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
882	bromocriptine	5-hydroxytryptamine receptor 6	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
883	bromocriptine	Alpha-1A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
884	bromocriptine	Alpha-2B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
885	bromocriptine	D(3) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
886	bromocriptine	D(1B) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
887	bromocriptine	5-hydroxytryptamine receptor 1B	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
888	bromocriptine	5-hydroxytryptamine receptor 1D	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
889	bromocriptine	Alpha-2C adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
890	bromocriptine	D(4) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
891	bromocriptine	Alpha-1D adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
892	bromocriptine	Alpha-1B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
893	bromocriptine	Androgen receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
894	bromocriptine	5-hydroxytryptamine receptor 7	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
895	bromocriptine	Vesicular glutamate transporter 3	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
896	bromocriptine	Adrenergic receptor alpha-2	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
897	bromocriptine	Dopamine receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
898	bromocriptine	Cerebral cortex alpha adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C
899	bromazine	Histamine H1 receptor	CN(C)CCOC(C1=CC=CC=C1)C1=CC=C(Br)C=C1
900	bromperidol	D(1A) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
901	bromperidol	D(2) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
902	bromperidol	Sigma non-opioid intracellular receptor 1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
903	bromperidol	Alpha-1A adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
904	bromperidol	D(3) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
905	bromperidol	Histamine H1 receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
906	bromperidol	Muscarinic acetylcholine receptor M1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
907	bromperidol	Muscarinic acetylcholine receptor M2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
908	bromperidol	Muscarinic acetylcholine receptor M3	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
909	bromperidol	Muscarinic acetylcholine receptor M4	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
910	bromperidol	Muscarinic acetylcholine receptor M5	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
911	bromperidol	D(4) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
912	brompheniramine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
913	brompheniramine	Histamine H1 receptor	CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
914	brompheniramine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
915	buclizine	Histamine H1 receptor	CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1
916	budesonide	Multidrug resistance protein 1	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
917	budesonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
918	budesonide	Interleukin-5	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
919	budesonide	Interferon gamma	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
920	budesonide	Mineralocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
921	budesonide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
922	budesonide	Matrix metalloproteinase-9	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
923	budesonide	Androgen receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO
924	bumetanide	Solute carrier family 12 member 1	CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
925	bumetanide	Sodium/potassium-transporting ATPase subunit alpha-1	CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
926	bumetanide	Solute carrier family 12 member 2	CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
927	bumetanide	G-protein coupled receptor 35	CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
928	bunazosin	Alpha-1A adrenergic receptor	CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
929	bunazosin	Alpha-2B adrenergic receptor	CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
930	bunazosin	Alpha-1B adrenergic receptor	CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
931	bunazosin	Ribosyldihydronicotinamide dehydrogenase [quinone]	CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
932	levobunolol	Beta-1 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
933	levobunolol	Beta-2 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
934	levobunolol	Sigma non-opioid intracellular receptor 1	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
935	levobunolol	Sodium-dependent serotonin transporter	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
936	levobunolol	5-hydroxytryptamine receptor 1A	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
937	levobunolol	Beta-3 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1
938	bupivacaine	Sodium channel protein type 5 subunit alpha	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
939	bupivacaine	Potassium voltage-gated channel subfamily H member 2	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
940	bupivacaine	Sodium channel protein type 1 subunit alpha	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
941	bupivacaine	Sodium channel protein type 4 subunit alpha	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
942	bupivacaine	Prostaglandin E2 receptor EP1 subtype	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
943	bupivacaine	Cytochrome P450 2D6	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
944	bupivacaine	5-hydroxytryptamine receptor 3A	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
945	bupivacaine	Potassium voltage-gated channel subfamily D member 3	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
946	bupivacaine	Potassium voltage-gated channel subfamily A member 5	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
947	bupivacaine	Potassium channel subfamily K member 3	CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
948	bupranolol	Beta-1 adrenergic receptor	CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
949	bupranolol	Beta-2 adrenergic receptor	CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
950	bupranolol	Beta-3 adrenergic receptor	CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
951	buprenorphine	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O
952	buprenorphine	Potassium voltage-gated channel subfamily H member 2	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O
953	buprenorphine	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O
954	buprenorphine	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O
955	buprenorphine	Nociceptin receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O
956	bupropion	Sodium-dependent serotonin transporter	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
957	bupropion	Sodium-dependent noradrenaline transporter	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
958	bupropion	Alpha-1A adrenergic receptor	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
959	bupropion	Sodium-dependent dopamine transporter	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
960	bupropion	Cytochrome P450 2D6	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
961	bupropion	Neuronal acetylcholine receptor subunit alpha-7	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
962	bupropion	Cytochrome P450 2C19	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
963	bupropion	Membrane-associated progesterone receptor component 1	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
964	bupropion	Neuronal acetylcholine receptor; alpha3/beta4	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
965	bupropion	Neuronal acetylcholine receptor; alpha3/beta2	CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
966	buserelin	Lutropin-choriogonadotropic hormone receptor	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
967	buserelin	Gonadotropin-releasing hormone receptor	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
968	buspirone	D(2) dopamine receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
969	buspirone	Sigma non-opioid intracellular receptor 1	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
970	buspirone	Potassium voltage-gated channel subfamily H member 2	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
971	buspirone	Cytochrome P450 3A4	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
972	buspirone	5-hydroxytryptamine receptor 1A	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
973	buspirone	5-hydroxytryptamine receptor 2A	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
974	buspirone	5-hydroxytryptamine receptor 2B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
975	buspirone	5-hydroxytryptamine receptor 2C	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
976	buspirone	Alpha-1A adrenergic receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
977	buspirone	D(3) dopamine receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
978	buspirone	D(4) dopamine receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
979	buspirone	Alpha-1D adrenergic receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
980	buspirone	5-hydroxytryptamine receptor 1B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
981	buspirone	Membrane-associated progesterone receptor component 1	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
982	buspirone	5-hydroxytryptamine receptor 7	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
983	buspirone	D(1A) dopamine receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
984	buspirone	Alpha-2A adrenergic receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
985	buspirone	Solute carrier family 22 member 2	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
986	buspirone	Multidrug and toxin extrusion protein 1	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
987	buspirone	Multidrug and toxin extrusion protein 2	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
988	buspirone	Serotonin 1 (5-HT1) receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
989	buspirone	Adrenergic receptor alpha-2	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
990	buspirone	Dopamine receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
991	buspirone	Adrenergic receptor alpha-1	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
992	buspirone	Serotonin 2 (5-HT2) receptor	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
993	secbutabarbital	GABA-A receptor alpha-1/beta-2/gamma-2	CCC(C)C1(CC)C(=O)NC(=O)NC1=O
994	butalbital	GABA-A receptor alpha-1/beta-3/gamma-2	CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
995	butorphanol	Mu-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
996	butorphanol	Kappa-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
997	butorphanol	Delta-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
998	cabergoline	D(1A) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
999	cabergoline	D(2) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1000	cabergoline	Alpha-2A adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1001	cabergoline	5-hydroxytryptamine receptor 1A	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1002	cabergoline	5-hydroxytryptamine receptor 2A	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1003	cabergoline	5-hydroxytryptamine receptor 2B	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1004	cabergoline	5-hydroxytryptamine receptor 2C	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1005	cabergoline	Alpha-1A adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1006	cabergoline	Alpha-2B adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1007	cabergoline	D(3) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1008	cabergoline	D(1B) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1009	cabergoline	5-hydroxytryptamine receptor 1B	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1010	cabergoline	5-hydroxytryptamine receptor 1D	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1011	cabergoline	Alpha-2C adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1012	cabergoline	D(4) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1013	cabergoline	Alpha-1D adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1014	cabergoline	Alpha-1B adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
1015	caffeine	Adenosine receptor A2a	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1016	caffeine	Potassium voltage-gated channel subfamily H member 2	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1017	caffeine	Adenosine receptor A1	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1018	caffeine	Adenosine receptor A2b	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1019	caffeine	Adenosine receptor A3	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1020	caffeine	Acetylcholinesterase	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1021	caffeine	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1022	caffeine	Glycogen phosphorylase, muscle form	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1023	caffeine	Adenosine A2 receptor	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1024	caffeine	Adenosine receptor	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1025	caffeine	Guanine deaminase	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1026	caffeine	Adenosine A2a receptor	CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1027	calcifediol	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)(C)O
1028	calcipotriene	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@@H](O)C1CC1
1029	calcitriol	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
1030	calcitriol	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
1031	calcitriol	Vitamin D 25-hydroxylase	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
1032	calcitriol	Vitamin D-binding protein	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
1033	calcitriol	Vitamin D3 receptor A	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
1034	camostat	Prothrombin	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1035	camostat	Trypsin-1	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1036	camostat	Kallikrein-1	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1037	camostat	Plasminogen	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1038	camostat	Solute carrier family 22 member 2	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1039	camostat	Multidrug and toxin extrusion protein 1	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1040	camostat	Multidrug and toxin extrusion protein 2	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1041	camostat	Serine protease hepsin	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1042	camostat	Hepatocyte growth factor activator	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1043	camostat	Transmembrane protease serine 2	CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1
1044	candesartan cilexetil	Thromboxane-A synthase	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1045	candesartan cilexetil	Type-1 angiotensin II receptor	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1046	candesartan cilexetil	Cruzipain	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1047	candesartan cilexetil	DNULL polymerase kappa	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1048	candesartan cilexetil	DNULL polymerase iota	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1049	candesartan cilexetil	DNULL polymerase eta	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1050	candesartan cilexetil	Cytochrome P450 3A4	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1051	candesartan cilexetil	Sodium-dependent noradrenaline transporter	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1052	candesartan cilexetil	Alpha-2B adrenergic receptor	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1053	candesartan cilexetil	Beta-3 adrenergic receptor	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1054	candesartan cilexetil	Adenosine receptor A3	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1055	candesartan cilexetil	Cytochrome P450 2C9	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1056	candesartan cilexetil	Epidermal growth factor receptor	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1057	candesartan cilexetil	Receptor tyrosine-protein kinase erbB-2	CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
1058	canrenone	Mineralocorticoid receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@]12C
1059	capecitabine	Thymidylate synthase	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
1060	captopril	Prostaglandin G/H synthase 2	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1061	captopril	Prostaglandin G/H synthase 1	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1062	captopril	Angiotensin-converting enzyme	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1063	captopril	Prothrombin	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1064	captopril	Renin	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1065	captopril	Leukotriene A-4 hydrolase	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1066	captopril	Succinyl-diaminopimelate desuccinylase	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1067	captopril	Beta-lactamase	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1068	captopril	Beta-lactamase II	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1069	captopril	Beta-lactamase class B VIM-2	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1070	captopril	Beta-lactamase NDM-1	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1071	carbachol	Muscarinic acetylcholine receptor M1	C[N+](C)(C)CCOC(N)=O
1072	carbachol	Muscarinic acetylcholine receptor M2	C[N+](C)(C)CCOC(N)=O
1073	carbachol	Muscarinic acetylcholine receptor M3	C[N+](C)(C)CCOC(N)=O
1074	carbachol	Muscarinic acetylcholine receptor M4	C[N+](C)(C)CCOC(N)=O
1075	carbachol	Muscarinic acetylcholine receptor M5	C[N+](C)(C)CCOC(N)=O
1076	carbachol	Neuronal acetylcholine receptor subunit alpha-7	C[N+](C)(C)CCOC(N)=O
1077	carbachol	Acetylcholine receptor subunit delta	C[N+](C)(C)CCOC(N)=O
1078	carbachol	Acetylcholinesterase	C[N+](C)(C)CCOC(N)=O
1079	carbachol	Muscarinic acetylcholine receptor	C[N+](C)(C)CCOC(N)=O
1080	carbachol	Acetylcholine receptor subunit alpha	C[N+](C)(C)CCOC(N)=O
1081	carbachol	Neuronal acetylcholine receptor; alpha2/beta2	C[N+](C)(C)CCOC(N)=O
1082	carbachol	Neuronal acetylcholine receptor; alpha3/beta2	C[N+](C)(C)CCOC(N)=O
1083	carbachol	Neuronal acetylcholine receptor; alpha3/beta4	C[N+](C)(C)CCOC(N)=O
1084	carbachol	Neuronal acetylcholine receptor; alpha4/beta2	C[N+](C)(C)CCOC(N)=O
1085	carbachol	Neuronal acetylcholine receptor; alpha4/beta4	C[N+](C)(C)CCOC(N)=O
1086	carbamazepine	Sodium channel protein type 5 subunit alpha	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1087	carbamazepine	Sodium-dependent serotonin transporter	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1088	carbamazepine	Histamine H1 receptor	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1089	carbamazepine	Sodium channel protein type 4 subunit alpha	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1090	carbamazepine	Sodium channel protein type 9 subunit alpha	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1091	carbamazepine	Nuclear receptor subfamily 1 group I member 2	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1092	carbamazepine	GABA-A receptor alpha-1/beta-2/gamma-2	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1093	carbamazepine	Neuronal acetylcholine receptor; alpha2/beta4	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1094	carbamazepine	Frizzled-8	NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2
1095	carbenoxolone	Corticosteroid 11-beta-dehydrogenase isozyme 1	[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CCC(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
1096	carbenoxolone	Corticosteroid 11-beta-dehydrogenase isozyme 2	[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CCC(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
1097	carbetocin	Vasopressin V1a receptor	[H][C@]1(CSCCCC(=O)N[C@@H](CC2=CC=C(OC)C=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
1098	carbetocin	Vasopressin V2 receptor	[H][C@]1(CSCCCC(=O)N[C@@H](CC2=CC=C(OC)C=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
1099	carbetocin	Oxytocin receptor	[H][C@]1(CSCCCC(=O)N[C@@H](CC2=CC=C(OC)C=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
1100	carbidopa	Aromatic-L-amino-acid decarboxylase	C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
1101	carbidopa	Tyrosine-protein kinase Lck	C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
1102	carbidopa	Tyrosine-protein kinase Fyn	C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
1103	carbidopa	Lysine-specific demethylase 4E	C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
1104	carbimazole	Lactoperoxidase	CCOC(=O)N1C=CN(C)C1=S
1105	carbimazole	Thyroid peroxidase	CCOC(=O)N1C=CN(C)C1=S
1106	carbinoxamine	Histamine H1 receptor	[H]C(OCCN(C)C)(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1107	carboprost	Prostaglandin F2-alpha receptor	CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
1108	carbutamide	Sulfonylurea receptor 1, Kir6.2	CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
1109	carmustine	Glutathione reductase, mitochondrial	ClCCNC(=O)N(CCCl)N=O
1110	carfenazine	D(2) dopamine receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1
1111	carfenazine	5-hydroxytryptamine receptor 2A	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1
1112	carprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC2=C(C=C1)C1=CC(Cl)=CC=C1N2
1113	carprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC2=C(C=C1)C1=CC(Cl)=CC=C1N2
1114	carprofen	Fatty-acid amide hydrolase 1	CC(C(O)=O)C1=CC2=C(C=C1)C1=CC(Cl)=CC=C1N2
1115	carprofen	Complement C5	CC(C(O)=O)C1=CC2=C(C=C1)C1=CC(Cl)=CC=C1N2
1116	carteolol	Beta-1 adrenergic receptor	CC(C)(C)NCC(O)COC1=C2CCC(=O)NC2=CC=C1
1117	carteolol	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)COC1=C2CCC(=O)NC2=CC=C1
1118	carvedilol	Ryanodine receptor 2	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1119	carvedilol	5-hydroxytryptamine receptor 4	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1120	carvedilol	Beta-1 adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1121	carvedilol	Beta-2 adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1122	carvedilol	D(1A) dopamine receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1123	carvedilol	D(2) dopamine receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1124	carvedilol	Alpha-2A adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1125	carvedilol	Potassium voltage-gated channel subfamily H member 2	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1126	carvedilol	Sodium-dependent serotonin transporter	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1127	carvedilol	Sodium-dependent noradrenaline transporter	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1128	carvedilol	5-hydroxytryptamine receptor 1A	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1129	carvedilol	5-hydroxytryptamine receptor 2A	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1130	carvedilol	5-hydroxytryptamine receptor 2B	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1131	carvedilol	5-hydroxytryptamine receptor 2C	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1132	carvedilol	5-hydroxytryptamine receptor 6	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1133	carvedilol	Alpha-1A adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1134	carvedilol	Alpha-2B adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1135	carvedilol	D(3) dopamine receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1136	carvedilol	Beta-3 adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1137	carvedilol	Alpha-2C adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1138	carvedilol	Sodium-dependent dopamine transporter	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1139	carvedilol	Alpha-1D adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1140	carvedilol	Potassium channel subfamily K member 2	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1141	carvedilol	Solute carrier family 22 member 1	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1142	carvedilol	Potassium channel subfamily K member 10	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1143	carvedilol	Alpha-1B adrenergic receptor	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1144	carvedilol	5-hydroxytryptamine receptor 1B	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1145	carvedilol	Solute carrier family 22 member 2	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1146	carvedilol	Multidrug and toxin extrusion protein 1	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1147	carvedilol	Toll-like receptor 4	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1148	carvedilol	Amyloid beta A4 protein	COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1
1149	celecoxib	Prostaglandin G/H synthase 2	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1150	celecoxib	Prostaglandin G/H synthase 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1151	celecoxib	D(1A) dopamine receptor	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1152	celecoxib	Sodium-dependent serotonin transporter	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1153	celecoxib	Sodium-dependent noradrenaline transporter	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1154	celecoxib	Alpha-2B adrenergic receptor	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1155	celecoxib	Beta-3 adrenergic receptor	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1156	celecoxib	Sodium-dependent dopamine transporter	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1157	celecoxib	Cytochrome P450 2D6	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1158	celecoxib	Adenosine receptor A3	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1159	celecoxib	Carbonic anhydrase 2	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1160	celecoxib	Carbonic anhydrase 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1161	celecoxib	Carbonic anhydrase 4	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1162	celecoxib	Carbonic anhydrase 9	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1163	celecoxib	Carbonic anhydrase 12	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1164	celecoxib	Carbonic anhydrase 5A, mitochondrial	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1165	celecoxib	Carbonic anhydrase 5B, mitochondrial	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1166	celecoxib	Carbonic anhydrase 7	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1167	celecoxib	cGMP-specific 3',5'-cyclic phosphodiesterase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1168	celecoxib	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1169	celecoxib	Histone deacetylase 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1170	celecoxib	Histone deacetylase 6	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1171	celecoxib	Carbonic anhydrase 3	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1172	celecoxib	Carbonic anhydrase 6	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1173	celecoxib	Carbonic anhydrase 14	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1174	celecoxib	Mitogen-activated protein kinase 14	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1175	celecoxib	Cytochrome c oxidase subunit 2	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1176	celecoxib	3-phosphoinositide-dependent protein kinase 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1177	celecoxib	Progesterone receptor	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1178	celecoxib	Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1179	celecoxib	Carbonic anhydrase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1180	celecoxib	Carbonic anhydrase 13	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1181	celecoxib	Carbonic anhydrase 15	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1182	celecoxib	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1183	celecoxib	Alpha carbonic anhydrase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1184	celecoxib	Astrosclerin-3	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1185	celecoxib	Beta-carbonic anhydrase 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1186	celecoxib	Delta carbonic anhydrase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1187	celecoxib	Prostaglandin E synthase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1188	celecoxib	Cytochrome c oxidase subunit 1	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1189	celecoxib	Carbonic anhydrase, alpha family	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1190	celecoxib	Carbonate dehydratase	CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
1191	celiprolol	Beta-2 adrenergic receptor	CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1
1192	celiprolol	5-hydroxytryptamine receptor 1A	CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1
1193	celiprolol	Beta-1 adrenergic receptor	CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1
1194	cerivastatin	Nuclear receptor subfamily 1 group I member 3	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
1195	cerivastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
1196	ceruletide	Cholecystokinin receptor type A	CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O
1197	cetirizine	Potassium voltage-gated channel subfamily H member 2	OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1198	cetirizine	Histamine H1 receptor	OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1199	cetirizine	Angiopoietin-1 receptor	OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1200	cetrorelix	Lutropin-choriogonadotropic hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
1201	cetrorelix	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
1202	cevimeline	Muscarinic acetylcholine receptor M1	CC1OC2(CS1)CN1CCC2CC1
1203	cevimeline	Muscarinic acetylcholine receptor M2	CC1OC2(CS1)CN1CCC2CC1
1204	cevimeline	Muscarinic acetylcholine receptor M3	CC1OC2(CS1)CN1CCC2CC1
1205	cevimeline	Muscarinic acetylcholine receptor M4	CC1OC2(CS1)CN1CCC2CC1
1206	cevimeline	Muscarinic acetylcholine receptor M5	CC1OC2(CS1)CN1CCC2CC1
1207	chlordiazepoxide	Histamine H1 receptor	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1208	chlordiazepoxide	Thyrotropin-releasing hormone receptor	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1209	chlordiazepoxide	Acetylcholinesterase	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1210	chlordiazepoxide	Translocator protein	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1211	chlordiazepoxide	Cholinesterase	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1212	chlordiazepoxide	GABA-A receptor alpha-1/beta-2/gamma-2	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1213	chlordiazepoxide	GABA-A receptor alpha-2/beta-3/gamma-2	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1214	chlordiazepoxide	GABA-A receptor alpha-3/beta-3/gamma-2	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1215	chlordiazepoxide	GABA-A receptor alpha-5/beta-3/gamma-2	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1216	chlordiazepoxide	GABA-A receptor alpha-1/beta-3/gamma-2	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1217	chlordiazepoxide	GABA-A receptor; anion channel	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1218	chlordiazepoxide	Cholecystokinin receptor	CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1
1219	chloroprocaine	Sodium channel protein type 10 subunit alpha	CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
1220	chlorothiazide	Carbonic anhydrase 2	NS(=O)(=O)C1=C(Cl)C=C2N=CNS(=O)(=O)C2=C1
1221	chlorothiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=C(Cl)C=C2N=CNS(=O)(=O)C2=C1
1222	chlorotrianisene	Estrogen receptor	COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1
1223	chlorotrianisene	Estrogen receptor beta	COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1
1224	chlorphenamine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1225	chlorphenamine	Sodium-dependent serotonin transporter	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1226	chlorphenamine	5-hydroxytryptamine receptor 2B	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1227	chlorphenamine	Histamine H1 receptor	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1228	chlorphenamine	Histamine H4 receptor	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1229	chlorphenamine	Cytochrome P450 2D6	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1230	chlorphenamine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1231	chlorphenamine	Lethal(3)malignant brain tumor-like protein 1	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1232	chlorphenamine	Lethal(3)malignant brain tumor-like protein 3	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1233	chlorphenamine	MBT domain-containing protein 1	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1234	chlorphenamine	Chloroquine resistance transporter	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1235	chlorphenamine	Sodium-dependent noradrenaline transporter	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1236	chlorphenamine	Sodium-dependent dopamine transporter	CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
1237	chlorphentermine	Sodium-dependent serotonin transporter	CC(C)(N)CC1=CC=C(Cl)C=C1
1238	chlorphentermine	Sodium-dependent dopamine transporter	CC(C)(N)CC1=CC=C(Cl)C=C1
1239	chlorpromazine	Mu-type opioid receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1240	chlorpromazine	D(1A) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1241	chlorpromazine	D(2) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1242	chlorpromazine	Alpha-2A adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1243	chlorpromazine	Sigma non-opioid intracellular receptor 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1244	chlorpromazine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1245	chlorpromazine	Multidrug resistance protein 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1246	chlorpromazine	Sodium-dependent serotonin transporter	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1247	chlorpromazine	Sodium-dependent noradrenaline transporter	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1248	chlorpromazine	5-hydroxytryptamine receptor 1A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1249	chlorpromazine	5-hydroxytryptamine receptor 2A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1250	chlorpromazine	5-hydroxytryptamine receptor 2B	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1251	chlorpromazine	5-hydroxytryptamine receptor 2C	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1252	chlorpromazine	5-hydroxytryptamine receptor 6	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1253	chlorpromazine	5-hydroxytryptamine receptor 7	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1254	chlorpromazine	Alpha-1A adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1255	chlorpromazine	Alpha-2B adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1256	chlorpromazine	D(3) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1257	chlorpromazine	D(1B) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1258	chlorpromazine	Histamine H1 receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1259	chlorpromazine	Histamine H2 receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1260	chlorpromazine	Histamine H4 receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1261	chlorpromazine	Muscarinic acetylcholine receptor M1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1262	chlorpromazine	Muscarinic acetylcholine receptor M2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1263	chlorpromazine	Muscarinic acetylcholine receptor M3	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1264	chlorpromazine	Muscarinic acetylcholine receptor M4	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1265	chlorpromazine	Muscarinic acetylcholine receptor M5	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1266	chlorpromazine	Aldehyde oxidase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1267	chlorpromazine	5-hydroxytryptamine receptor 1B	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1268	chlorpromazine	5-hydroxytryptamine receptor 1D	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1269	chlorpromazine	Alpha-2C adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1270	chlorpromazine	Sodium-dependent dopamine transporter	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1271	chlorpromazine	Cytochrome P450 2D6	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1272	chlorpromazine	D(4) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1273	chlorpromazine	Alpha-1D adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1274	chlorpromazine	5-hydroxytryptamine receptor 3A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1275	chlorpromazine	Alpha-1B adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1276	chlorpromazine	Kappa-type opioid receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1277	chlorpromazine	Calmodulin	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1278	chlorpromazine	Delta-type opioid receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1279	chlorpromazine	5-hydroxytryptamine receptor 5A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1280	chlorpromazine	5-hydroxytryptamine receptor 1E	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1281	chlorpromazine	Epidermal growth factor receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1282	chlorpromazine	Potassium channel subfamily K member 2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1283	chlorpromazine	Tyrosine-protein kinase Fyn	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1284	chlorpromazine	Receptor tyrosine-protein kinase erbB-2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1285	chlorpromazine	Ryanodine receptor 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1286	chlorpromazine	Major prion protein	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1287	chlorpromazine	Solute carrier family 22 member 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1288	chlorpromazine	Substance-K receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1289	chlorpromazine	Trypanothione reductase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1290	chlorpromazine	Arachidonate 15-lipoxygenase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1291	chlorpromazine	Melanocortin receptor 4	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1292	chlorpromazine	Melanocortin receptor 5	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1293	chlorpromazine	Melanocortin receptor 3	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1294	chlorpromazine	Membrane-associated progesterone receptor component 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1295	chlorpromazine	Transient receptor potential cation channel subfamily V member 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1296	chlorpromazine	Pleiotropic ABC efflux transporter of multiple drugs	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1297	chlorpromazine	Solute carrier family 22 member 2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1298	chlorpromazine	Acetylcholine receptor subunit alpha	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1299	chlorpromazine	Glutamate [NMDA] receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1300	chlorpromazine	Glutamate NMDA receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1301	chlorpromazine	Muscarinic acetylcholine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1302	chlorpromazine	Dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1303	chlorpromazine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1304	chlorpromazine	Serotonin 2 (5-HT2) receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1305	chlorpromazine	Adenylate cyclase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1306	chlorpromazine	FAD-linked sulfhydryl oxidase ALR	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1307	chlorpromazine	Sphingomyelin phosphodiesterase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1308	chlorpropamide	Solute carrier family 22 member 6	CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
1309	chlorpropamide	Sulfonylurea receptor 1, Kir6.2	CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
1310	chlorprothixene	D(1A) dopamine receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1311	chlorprothixene	D(2) dopamine receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1312	chlorprothixene	5-hydroxytryptamine receptor 2A	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1313	chlorprothixene	5-hydroxytryptamine receptor 6	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1314	chlorprothixene	D(3) dopamine receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1315	chlorprothixene	D(1B) dopamine receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1316	chlorprothixene	Histamine H1 receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1317	chlorprothixene	Muscarinic acetylcholine receptor M1	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1318	chlorprothixene	Muscarinic acetylcholine receptor M2	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1319	chlorprothixene	Muscarinic acetylcholine receptor M3	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1320	chlorprothixene	Muscarinic acetylcholine receptor M4	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1321	chlorprothixene	Muscarinic acetylcholine receptor M5	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1322	chlorprothixene	D(4) dopamine receptor	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1323	chlorprothixene	Solute carrier family 22 member 1	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1324	chlorprothixene	5-hydroxytryptamine receptor 7	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1325	chlorprothixene	Pleiotropic ABC efflux transporter of multiple drugs	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
1326	chlortalidone	Carbonic anhydrase 2	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1327	chlortalidone	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1328	chlortalidone	Carbonic anhydrase 1	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1329	chlortalidone	Carbonic anhydrase 4	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1330	chlortalidone	Carbonic anhydrase 9	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1331	chlortalidone	Carbonic anhydrase 12	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1332	chlortalidone	Carbonic anhydrase 5A, mitochondrial	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1333	chlortalidone	Carbonic anhydrase 5B, mitochondrial	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1334	chlortalidone	Carbonic anhydrase 7	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1335	chlortalidone	Carbonic anhydrase 3	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1336	chlortalidone	Carbonic anhydrase 6	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1337	chlortalidone	Carbonic anhydrase 14	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1338	chlortalidone	Carbonic anhydrase 13	NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12
1339	chlorzoxazone	Intermediate conductance calcium-activated potassium channel protein 4	ClC1=CC2=C(OC(=O)N2)C=C1
1340	chlorzoxazone	Nitric oxide synthase, inducible	ClC1=CC2=C(OC(=O)N2)C=C1
1341	chlorzoxazone	Nitric oxide synthase, brain	ClC1=CC2=C(OC(=O)N2)C=C1
1342	chlorzoxazone	Nitric oxide synthase, endothelial	ClC1=CC2=C(OC(=O)N2)C=C1
1343	chlorzoxazone	Small conductance calcium-activated potassium channel protein 2	ClC1=CC2=C(OC(=O)N2)C=C1
1344	chlorzoxazone	Calcium-activated potassium channel subunit alpha-1	ClC1=CC2=C(OC(=O)N2)C=C1
1345	ciclesonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C
1346	cilastatin	Dipeptidase 1	[H][C@@]1(CC1(C)C)C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O
1347	cilazapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O
1348	cilnidipine	Voltage-dependent N-type calcium channel subunit alpha-1B	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
1349	cilnidipine	Voltage-gated L-type calcium channel	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
1350	cilostazol	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1
1351	cilostazol	Cytochrome P450 2C9	O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1
1352	cilostazol	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1
1353	cimetidine	5-hydroxytryptamine receptor 2A	CNC(NCCSCC1=C(C)NC=N1)=NC#N
1354	cimetidine	Histamine H2 receptor	CNC(NCCSCC1=C(C)NC=N1)=NC#N
1355	cimetidine	Multidrug and toxin extrusion protein 1	CNC(NCCSCC1=C(C)NC=N1)=NC#N
1356	cimetidine	Multidrug and toxin extrusion protein 2	CNC(NCCSCC1=C(C)NC=N1)=NC#N
1357	cinacalcet	Cytochrome P450 2D6	C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2
1358	cinacalcet	Glycine receptor subunit alpha-1	C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2
1359	cinacalcet	Extracellular calcium-sensing receptor	C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2
1360	cinacalcet	Metabotropic glutamate receptor 5	C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2
1361	cinalukast	Cysteinyl leukotriene receptor 1	CCC(CC)(CC(=O)NC1=CC=CC(\C=C\C2=NC(=CS2)C2CCC2)=C1)C(O)=O
1362	ciprofibrate	Peroxisome proliferator-activated receptor alpha	CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O
1363	cisapride	5-hydroxytryptamine receptor 4	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1364	cisapride	D(1A) dopamine receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1365	cisapride	D(2) dopamine receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1366	cisapride	Alpha-2A adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1367	cisapride	Sigma non-opioid intracellular receptor 1	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1368	cisapride	Potassium voltage-gated channel subfamily H member 2	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1369	cisapride	Cytochrome P450 3A4	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1370	cisapride	Sodium-dependent serotonin transporter	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1371	cisapride	5-hydroxytryptamine receptor 1A	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1372	cisapride	5-hydroxytryptamine receptor 2A	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1373	cisapride	5-hydroxytryptamine receptor 2B	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1374	cisapride	5-hydroxytryptamine receptor 2C	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1375	cisapride	5-hydroxytryptamine receptor 7	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1376	cisapride	Alpha-2B adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1377	cisapride	D(3) dopamine receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1378	cisapride	Alpha-2C adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1379	cisapride	Cytochrome P450 2D6	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1380	cisapride	Alpha-1D adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1381	cisapride	3-hydroxy-3-methylglutaryl-coenzyme A reductase	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1382	cisapride	Alpha-1B adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1383	cisapride	Membrane-associated progesterone receptor component 1	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1384	cisapride	Alpha-1A adrenergic receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1385	cisapride	Serotonin 3 (5-HT3) receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1386	cisapride	Serotonin 1 (5-HT1) receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1387	cisapride	Adrenergic receptor alpha-2	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1388	cisapride	Serotonin 2 (5-HT2) receptor	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1389	cisatracurium	Acetylcholine receptor	COC1=C(OC)C=C(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C=C2)C=C1
1390	citalopram	Sigma non-opioid intracellular receptor 1	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1391	citalopram	Potassium voltage-gated channel subfamily H member 2	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1392	citalopram	Sodium-dependent serotonin transporter	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1393	citalopram	Sodium-dependent noradrenaline transporter	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1394	citalopram	5-hydroxytryptamine receptor 2A	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1395	citalopram	5-hydroxytryptamine receptor 2B	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1396	citalopram	5-hydroxytryptamine receptor 2C	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1397	citalopram	Histamine H1 receptor	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1398	citalopram	Muscarinic acetylcholine receptor M1	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1399	citalopram	Sodium-dependent dopamine transporter	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1400	citalopram	Alpha-1D adrenergic receptor	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1401	citalopram	Solute carrier family 22 member 1	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1402	citalopram	Alpha-1B adrenergic receptor	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1403	citalopram	Alpha-1A adrenergic receptor	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1404	citalopram	5-hydroxytryptamine receptor 1A	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1405	citalopram	Transporter	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
1406	clemastine	D(1A) dopamine receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1407	clemastine	D(2) dopamine receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1408	clemastine	Alpha-2A adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1409	clemastine	Sigma non-opioid intracellular receptor 1	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1410	clemastine	Potassium voltage-gated channel subfamily H member 2	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1411	clemastine	Sodium-dependent noradrenaline transporter	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1412	clemastine	5-hydroxytryptamine receptor 2A	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1413	clemastine	5-hydroxytryptamine receptor 2B	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1414	clemastine	5-hydroxytryptamine receptor 2C	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1415	clemastine	5-hydroxytryptamine receptor 6	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1416	clemastine	Alpha-2B adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1417	clemastine	D(3) dopamine receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1418	clemastine	Histamine H1 receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1419	clemastine	Histamine H2 receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1420	clemastine	Muscarinic acetylcholine receptor M1	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1421	clemastine	Muscarinic acetylcholine receptor M2	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1422	clemastine	Muscarinic acetylcholine receptor M3	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1423	clemastine	Muscarinic acetylcholine receptor M4	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1424	clemastine	Muscarinic acetylcholine receptor M5	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1425	clemastine	Alpha-2C adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1426	clemastine	Sodium-dependent dopamine transporter	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1427	clemastine	Cytochrome P450 2D6	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1428	clemastine	Alpha-1D adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1429	clemastine	Cytochrome P450 2C19	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1430	clemastine	Solute carrier family 22 member 1	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1431	clemastine	Alpha-1B adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1432	clemastine	5-hydroxytryptamine receptor 1B	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1433	clemastine	Membrane-associated progesterone receptor component 1	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1434	clemastine	Alpha-1A adrenergic receptor	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1435	clemastine	Transmembrane protein 97	CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
1436	clevidipine	Voltage-dependent L-type calcium channel subunit alpha-1C	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
1437	clevidipine	Voltage-dependent L-type calcium channel subunit alpha-1D	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
1438	clidinium	Muscarinic acetylcholine receptor M1	C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
1439	clidinium	Muscarinic acetylcholine receptor M3	C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
1440	clobazam	GABA-A receptor alpha-1/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2N(C2=CC=CC=C2)C(=O)CC1=O
1441	clofarabine	DNA polymerase alpha catalytic subunit	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1442	clofarabine	Ribonucleoside-diphosphate reductase large subunit	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1443	clofarabine	Ribonucleoside-diphosphate reductase subunit M2	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1444	clofarabine	Ribose-phosphate pyrophosphokinase 1	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1445	clofarabine	Uridine-cytidine kinase 1	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1446	clofarabine	Uridine-cytidine kinase 2	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1447	clofarabine	cGMP-dependent 3',5'-cyclic phosphodiesterase	NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1
1448	clofibrate	Peroxisome proliferator-activated receptor alpha	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
1449	clofibrate	Fatty acid-binding protein, liver	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
1450	clomifene	Prostaglandin G/H synthase 1	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1451	clomifene	Alpha-2A adrenergic receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1452	clomifene	Sigma non-opioid intracellular receptor 1	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1453	clomifene	Potassium voltage-gated channel subfamily H member 2	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1454	clomifene	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1455	clomifene	Sodium-dependent serotonin transporter	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1456	clomifene	Sodium-dependent noradrenaline transporter	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1457	clomifene	5-hydroxytryptamine receptor 2A	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1458	clomifene	5-hydroxytryptamine receptor 2B	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1459	clomifene	5-hydroxytryptamine receptor 2C	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1460	clomifene	5-hydroxytryptamine receptor 6	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1461	clomifene	Alpha-2B adrenergic receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1462	clomifene	D(3) dopamine receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1463	clomifene	Histamine H1 receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1464	clomifene	Muscarinic acetylcholine receptor M1	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1465	clomifene	Muscarinic acetylcholine receptor M2	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1466	clomifene	Muscarinic acetylcholine receptor M3	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1467	clomifene	Muscarinic acetylcholine receptor M4	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1468	clomifene	Muscarinic acetylcholine receptor M5	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1469	clomifene	Beta-3 adrenergic receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1470	clomifene	Alpha-2C adrenergic receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1471	clomifene	Sodium-dependent dopamine transporter	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1472	clomifene	Cytochrome P450 2D6	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1473	clomifene	Adenosine receptor A3	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1474	clomifene	Estrogen receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1475	clomifene	Epidermal growth factor receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1476	clomifene	Tyrosine-protein kinase Fyn	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1477	clomifene	Receptor tyrosine-protein kinase erbB-2	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1478	clomifene	Substance-K receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1479	clomifene	Androgen receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1480	clomifene	Alpha-1B adrenergic receptor	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1481	clomifene	Membrane-associated progesterone receptor component 1	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1482	clomifene	C-8 sterol isomerase	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
1483	clomipramine	D(1A) dopamine receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1484	clomipramine	D(2) dopamine receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1485	clomipramine	Alpha-2A adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1486	clomipramine	Sigma non-opioid intracellular receptor 1	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1487	clomipramine	Sodium-dependent serotonin transporter	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1488	clomipramine	Sodium-dependent noradrenaline transporter	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1489	clomipramine	5-hydroxytryptamine receptor 2A	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1490	clomipramine	5-hydroxytryptamine receptor 2B	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1491	clomipramine	5-hydroxytryptamine receptor 2C	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1492	clomipramine	5-hydroxytryptamine receptor 6	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1493	clomipramine	Alpha-1A adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1494	clomipramine	Alpha-2B adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1495	clomipramine	D(3) dopamine receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1496	clomipramine	Histamine H1 receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1497	clomipramine	Histamine H2 receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1498	clomipramine	Muscarinic acetylcholine receptor M1	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1499	clomipramine	Muscarinic acetylcholine receptor M2	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1500	clomipramine	Muscarinic acetylcholine receptor M3	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1501	clomipramine	Muscarinic acetylcholine receptor M4	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1502	clomipramine	Muscarinic acetylcholine receptor M5	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1503	clomipramine	Aldehyde oxidase	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1504	clomipramine	Alpha-2C adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1505	clomipramine	Sodium-dependent dopamine transporter	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1506	clomipramine	Cytochrome P450 2D6	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1507	clomipramine	Alpha-1D adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1508	clomipramine	Glutathione S-transferase P	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1509	clomipramine	Solute carrier family 22 member 1	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1510	clomipramine	Trypanothione reductase	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1511	clomipramine	Alpha-1B adrenergic receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1512	clomipramine	Membrane-associated progesterone receptor component 1	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1513	clomipramine	Serotonin (5-HT) receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1514	clomipramine	Serotonin 1 (5-HT1) receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1515	clomipramine	Adrenergic receptor alpha-2	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1516	clomipramine	Serotonin 2 (5-HT2) receptor	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1517	clomipramine	G protein-activated inward rectifier potassium channel 2	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2
1518	clonazepam	GABA-A receptor alpha-1/beta-2/gamma-2	[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C2=C1)C1=C(Cl)C=CC=C1
1519	clonazepam	GABA-A receptor; anion channel	[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C2=C1)C1=C(Cl)C=CC=C1
1520	clonidine	Alpha-2A adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1521	clonidine	5-hydroxytryptamine receptor 1A	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1522	clonidine	Alpha-1A adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1523	clonidine	Alpha-2B adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1524	clonidine	Alpha-2C adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1525	clonidine	Alpha-1D adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1526	clonidine	Alpha-1B adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1527	clonidine	Nischarin	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1528	clonidine	Solute carrier family 22 member 1	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1529	clonidine	Beta-1 adrenergic receptor	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1530	clonidine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1531	clonidine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1532	clonidine	Solute carrier family 22 member 2	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1533	clonidine	Multidrug and toxin extrusion protein 1	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1534	clonidine	Adrenergic receptor alpha-2	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1535	clonidine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	ClC1=CC=CC(Cl)=C1NC1=NCCN1
1536	clopidogrel	Sodium-dependent serotonin transporter	COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C1=C(Cl)C=CC=C1
1537	clopidogrel	P2Y purinoceptor 12	COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C1=C(Cl)C=CC=C1
1538	clopidogrel	Cytochrome P450 2B6	COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C1=C(Cl)C=CC=C1
1539	clorazepate	GABA-A receptor alpha-1/beta-2/gamma-2	OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O
1540	clorazepate	GABA-A receptor alpha-2/beta-3/gamma-2	OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O
1541	clorazepate	GABA-A receptor alpha-3/beta-3/gamma-2	OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O
1542	clorazepate	GABA-A receptor alpha-5/beta-3/gamma-2	OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O
1543	clozapine	Beta-1 adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1544	clozapine	Beta-2 adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1545	clozapine	D(1A) dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1546	clozapine	D(2) dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1547	clozapine	Alpha-2A adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1548	clozapine	Sigma non-opioid intracellular receptor 1	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1549	clozapine	Potassium voltage-gated channel subfamily H member 2	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1550	clozapine	Sodium-dependent serotonin transporter	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1551	clozapine	Sodium-dependent noradrenaline transporter	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1552	clozapine	5-hydroxytryptamine receptor 1A	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1553	clozapine	5-hydroxytryptamine receptor 2A	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1554	clozapine	5-hydroxytryptamine receptor 2B	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1555	clozapine	5-hydroxytryptamine receptor 2C	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1556	clozapine	5-hydroxytryptamine receptor 6	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1557	clozapine	5-hydroxytryptamine receptor 7	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1558	clozapine	Alpha-1A adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1559	clozapine	Alpha-2B adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1560	clozapine	D(3) dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1561	clozapine	D(1B) dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1562	clozapine	Histamine H1 receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1563	clozapine	Histamine H2 receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1564	clozapine	Histamine H4 receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1565	clozapine	Muscarinic acetylcholine receptor M1	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1566	clozapine	Muscarinic acetylcholine receptor M2	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1567	clozapine	Muscarinic acetylcholine receptor M3	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1568	clozapine	Muscarinic acetylcholine receptor M4	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1569	clozapine	Muscarinic acetylcholine receptor M5	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1570	clozapine	Aldehyde oxidase	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1571	clozapine	5-hydroxytryptamine receptor 1B	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1572	clozapine	5-hydroxytryptamine receptor 1D	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1573	clozapine	Alpha-2C adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1574	clozapine	Adenosine receptor A3	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1575	clozapine	D(4) dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1576	clozapine	Alpha-1D adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1577	clozapine	5-hydroxytryptamine receptor 3A	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1578	clozapine	Alpha-1B adrenergic receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1579	clozapine	UDP-glucuronosyltransferase 1-4	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1580	clozapine	5-hydroxytryptamine receptor 5A	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1581	clozapine	5-hydroxytryptamine receptor 1F	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1582	clozapine	5-hydroxytryptamine receptor 1E	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1583	clozapine	Transporter	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1584	clozapine	Histamine H3 receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1585	clozapine	Serotonin 3 (5-HT3) receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1586	clozapine	Muscarinic acetylcholine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1587	clozapine	Serotonin 1 (5-HT1) receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1588	clozapine	Adrenergic receptor alpha-2	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1589	clozapine	Dopamine receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1590	clozapine	Serotonin 2 (5-HT2) receptor	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1591	clozapine	Adenylate cyclase	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1592	clozapine	Histone H1.0	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1593	clozapine	Calmodulin	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1594	clozapine	Calmodulin-1	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2
1595	cocaine	Sodium channel protein type 5 subunit alpha	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1596	cocaine	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1597	cocaine	Potassium voltage-gated channel subfamily H member 2	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1598	cocaine	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1599	cocaine	Sodium-dependent noradrenaline transporter	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1600	cocaine	Alpha-1A adrenergic receptor	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1601	cocaine	Histamine H1 receptor	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1602	cocaine	5-hydroxytryptamine receptor 1B	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1603	cocaine	Sodium-dependent dopamine transporter	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1604	cocaine	5-hydroxytryptamine receptor 3A	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1605	cocaine	Sodium- and chloride-dependent GABA transporter 1	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1606	cocaine	Sodium channel protein type 11 subunit alpha	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1607	cocaine	Kappa-type opioid receptor	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1608	cocaine	Cocaine- and amphetamine-regulated transcript protein	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1609	cocaine	Muscarinic acetylcholine receptor M1	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1610	cocaine	Transporter	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1611	cocaine	Serotonin 3 receptor (5HT3)	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1612	cocaine	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1613	cocaine	Dopamine transporter	[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1
1614	codeine	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC
1615	codeine	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC
1616	codeine	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC
1617	codeine	Opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC
1618	conivaptan	Vasopressin V1a receptor	CC1=NC2=C(N1)C1=C(C=CC=C1)N(CC2)C(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C2=CC=CC=C2)C=C1
1619	conivaptan	Vasopressin V2 receptor	CC1=NC2=C(N1)C1=C(C=CC=C1)N(CC2)C(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C2=CC=CC=C2)C=C1
1620	conivaptan	Oxytocin receptor	CC1=NC2=C(N1)C1=C(C=CC=C1)N(CC2)C(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C2=CC=CC=C2)C=C1
1621	cortisone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1622	cortisone acetate	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1623	cortisone acetate	Corticosteroid-binding globulin	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1624	cortisone acetate	Potassium voltage-gated channel subfamily A member 1	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1625	cortisone acetate	Sex hormone-binding globulin	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1626	cortisone acetate	Multidrug and toxin extrusion protein 1	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1627	cortisone acetate	Protein farnesyltransferase	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
1628	cortivazol	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C=C(C)C2=CC3=C(C[C@]12C)C=NN3C1=CC=CC=C1
1629	cyclizine	Alpha-2A adrenergic receptor	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1630	cyclizine	5-hydroxytryptamine receptor 2A	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1631	cyclizine	5-hydroxytryptamine receptor 2B	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1632	cyclizine	5-hydroxytryptamine receptor 2C	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1633	cyclizine	D(3) dopamine receptor	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1634	cyclizine	Histamine H1 receptor	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1635	cyclizine	Muscarinic acetylcholine receptor M1	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1636	cyclizine	Muscarinic acetylcholine receptor M2	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1637	cyclizine	Muscarinic acetylcholine receptor M3	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1638	cyclizine	Muscarinic acetylcholine receptor M4	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1639	cyclizine	Muscarinic acetylcholine receptor M5	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1640	cyclizine	Sodium-dependent dopamine transporter	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1641	cyclizine	Cytochrome P450 2D6	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1642	cyclizine	Alpha-1D adrenergic receptor	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1643	cyclizine	Amine oxidase [flavin-containing] B	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1644	cyclizine	Alpha-1B adrenergic receptor	CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
1645	cyclobenzaprine	Multidrug resistance protein 1	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1646	cyclobenzaprine	Sodium-dependent serotonin transporter	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1647	cyclobenzaprine	Sodium-dependent noradrenaline transporter	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1648	cyclobenzaprine	5-hydroxytryptamine receptor 2A	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1649	cyclobenzaprine	5-hydroxytryptamine receptor 2B	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1650	cyclobenzaprine	5-hydroxytryptamine receptor 2C	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1651	cyclobenzaprine	5-hydroxytryptamine receptor 6	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1652	cyclobenzaprine	5-hydroxytryptamine receptor 7	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1653	cyclobenzaprine	Histamine H1 receptor	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1654	cyclobenzaprine	Muscarinic acetylcholine receptor M1	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1655	cyclobenzaprine	Muscarinic acetylcholine receptor M2	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1656	cyclobenzaprine	Muscarinic acetylcholine receptor M3	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1657	cyclobenzaprine	Aldehyde oxidase	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1658	cyclobenzaprine	Proto-oncogene tyrosine-protein kinase receptor Ret	CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1659	cyclopentolate	Muscarinic acetylcholine receptor M3	CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1
1660	ciclosporin	Cytochrome P450 3A4	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1661	ciclosporin	Multidrug resistance protein 1	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1662	ciclosporin	Canalicular multispecific organic anion transporter 1	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1663	ciclosporin	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1664	ciclosporin	Dihydroorotate dehydrogenase (quinone), mitochondrial	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1665	ciclosporin	Peptidyl-prolyl cis-trans isomerase A	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1666	ciclosporin	Multidrug resistance-associated protein 1	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1667	ciclosporin	ATP-binding cassette sub-family G member 2	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1668	ciclosporin	fMet-Leu-Phe receptor	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1669	ciclosporin	Bile salt export pump	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1670	ciclosporin	Solute carrier organic anion transporter family member 1B1	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1671	ciclosporin	Peptidyl-prolyl cis-trans isomerase FKBP4	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1672	ciclosporin	Substance-K receptor	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1673	ciclosporin	Peptidyl-prolyl cis-trans isomerase B	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1674	ciclosporin	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1675	ciclosporin	Reverse transcriptase/RNaseH	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1676	ciclosporin	Peptidyl-prolyl cis-trans isomerase FKBP1B	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1677	ciclosporin	Peptidyl-prolyl cis-trans isomerase D	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1678	ciclosporin	Solute carrier organic anion transporter family member 1B3	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1679	ciclosporin	Sodium/bile acid cotransporter	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1680	ciclosporin	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C
1681	cyclothiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1682	cyclothiazide	Glutamate receptor 1	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1683	cyclothiazide	Glutamate receptor 2	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1684	cyclothiazide	Glutamate receptor 4	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1685	cyclothiazide	Glutamate receptor 3	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1686	cyclothiazide	Glutamate receptor ionotropic, AMPA	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl
1687	cycrimine	Muscarinic acetylcholine receptor M1	OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1
1688	cyproheptadine	D(1A) dopamine receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1689	cyproheptadine	D(2) dopamine receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1690	cyproheptadine	Alpha-2A adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1691	cyproheptadine	Potassium voltage-gated channel subfamily H member 2	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1692	cyproheptadine	Multidrug resistance protein 1	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1693	cyproheptadine	Sodium-dependent serotonin transporter	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1694	cyproheptadine	Sodium-dependent noradrenaline transporter	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1695	cyproheptadine	5-hydroxytryptamine receptor 1A	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1696	cyproheptadine	5-hydroxytryptamine receptor 2A	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1697	cyproheptadine	5-hydroxytryptamine receptor 2B	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1698	cyproheptadine	5-hydroxytryptamine receptor 2C	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1699	cyproheptadine	5-hydroxytryptamine receptor 6	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1700	cyproheptadine	5-hydroxytryptamine receptor 7	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1701	cyproheptadine	Alpha-1A adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1702	cyproheptadine	Alpha-2B adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1703	cyproheptadine	D(3) dopamine receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1704	cyproheptadine	Histamine H1 receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1705	cyproheptadine	Histamine H2 receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1706	cyproheptadine	Histamine H4 receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1707	cyproheptadine	Muscarinic acetylcholine receptor M1	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1708	cyproheptadine	Muscarinic acetylcholine receptor M2	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1709	cyproheptadine	Muscarinic acetylcholine receptor M3	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1710	cyproheptadine	Muscarinic acetylcholine receptor M4	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1711	cyproheptadine	Muscarinic acetylcholine receptor M5	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1712	cyproheptadine	5-hydroxytryptamine receptor 1D	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1713	cyproheptadine	Alpha-2C adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1714	cyproheptadine	Alpha-1D adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1715	cyproheptadine	Alpha-1B adrenergic receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1716	cyproheptadine	Calmodulin	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1717	cyproheptadine	5-hydroxytryptamine receptor 1B	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1718	cyproheptadine	Muscarinic acetylcholine receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1719	cyproheptadine	Dopamine receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1720	cyproheptadine	Sodium channel alpha subunits; brain (Types I, II, III)	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1721	cyproheptadine	Serotonin 2 (5-HT2) receptor	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1722	cyproheptadine	Histone-lysine N-methyltransferase SETD7	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2
1723	cyproterone acetate	Mu-type opioid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C
1724	cyproterone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C
1725	cyproterone acetate	Androgen receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C
1726	cyproterone acetate	Progesterone receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C
1727	cyproterone acetate	Adenosine receptor A1	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C
1728	cytarabine	Prostatic acid phosphatase	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
1729	cytarabine	Enoyl-[acyl-carrier-protein] reductase [NADH]	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
1730	cytarabine	DNA polymerase beta	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
1731	cytarabine	DNA polymerase (alpha/delta/epsilon)	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
1732	cytarabine	E3 ubiquitin-protein ligase Mdm2	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
1733	dabigatran etexilate	Ribosyldihydronicotinamide dehydrogenase [quinone]	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1734	dabigatran etexilate	Plasminogen	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1735	dabigatran etexilate	Prothrombin	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1736	dabigatran etexilate	Coagulation factor X	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1737	dabigatran etexilate	Tissue-type plasminogen activator	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1738	dabigatran etexilate	Vitamin K-dependent protein C	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1739	dabigatran etexilate	Solute carrier family 22 member 2	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1740	dabigatran etexilate	Multidrug and toxin extrusion protein 1	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1741	dabigatran etexilate	Multidrug and toxin extrusion protein 2	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1742	dabigatran etexilate	Trypsin	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1743	dabigatran etexilate	Serine protease hepsin	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1744	dabigatran etexilate	Thrombin	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1
1745	danazol	Mu-type opioid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1746	danazol	D(1A) dopamine receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1747	danazol	Alpha-2A adrenergic receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1748	danazol	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1749	danazol	Sodium-dependent noradrenaline transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1750	danazol	5-hydroxytryptamine receptor 2A	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1751	danazol	Alpha-2B adrenergic receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1752	danazol	D(3) dopamine receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1753	danazol	Muscarinic acetylcholine receptor M3	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1754	danazol	Glucocorticoid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1755	danazol	Beta-3 adrenergic receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1756	danazol	Alpha-2C adrenergic receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1757	danazol	Sodium-dependent dopamine transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1758	danazol	Adenosine receptor A3	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1759	danazol	Kappa-type opioid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1760	danazol	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1761	danazol	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1762	danazol	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1763	danazol	Cytochrome P450 2C9	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1764	danazol	Steryl-sulfatase	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1765	danazol	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1766	danazol	Substance-K receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
1767	dantrolene	Ryanodine receptor 1	[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
1768	dantrolene	Ryanodine receptor 3	[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
1769	dantrolene	CDGSH iron-sulfur domain-containing protein 1	[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
1770	dapiprazole	5-hydroxytryptamine receptor 1A	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1771	dapiprazole	5-hydroxytryptamine receptor 2A	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1772	dapiprazole	5-hydroxytryptamine receptor 2B	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1773	dapiprazole	5-hydroxytryptamine receptor 2C	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1774	dapiprazole	Alpha-1A adrenergic receptor	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1775	dapiprazole	Alpha-2B adrenergic receptor	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1776	dapiprazole	Alpha-1D adrenergic receptor	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1777	dapiprazole	Alpha-1B adrenergic receptor	CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1
1778	darifenacin	Beta-1 adrenergic receptor	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1779	darifenacin	Beta-2 adrenergic receptor	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1780	darifenacin	D(2) dopamine receptor	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1781	darifenacin	Muscarinic acetylcholine receptor M1	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1782	darifenacin	Muscarinic acetylcholine receptor M2	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1783	darifenacin	Muscarinic acetylcholine receptor M3	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1784	darifenacin	Muscarinic acetylcholine receptor M4	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1785	darifenacin	Muscarinic acetylcholine receptor M5	NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
1786	dasatinib	Tyrosine-protein kinase JAK3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1787	dasatinib	Platelet-derived growth factor receptor beta	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1788	dasatinib	Tyrosine-protein kinase ABL1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1789	dasatinib	Mast/stem cell growth factor receptor Kit	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1790	dasatinib	Epidermal growth factor receptor	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1791	dasatinib	Serine/threonine-protein kinase mTOR	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1792	dasatinib	Breakpoint cluster region protein	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1793	dasatinib	Proto-oncogene tyrosine-protein kinase Src	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1794	dasatinib	Tyrosine-protein kinase Lck	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1795	dasatinib	Tyrosine-protein kinase Yes	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1796	dasatinib	Tyrosine-protein kinase Fyn	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1797	dasatinib	Ephrin type-A receptor 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1798	dasatinib	RAF proto-oncogene serine/threonine-protein kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1799	dasatinib	Serine/threonine-protein kinase B-raf	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1800	dasatinib	Receptor-type tyrosine-protein kinase FLT3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1801	dasatinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1802	dasatinib	Vascular endothelial growth factor receptor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1803	dasatinib	Vascular endothelial growth factor receptor 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1804	dasatinib	Macrophage colony-stimulating factor 1 receptor	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1805	dasatinib	Platelet-derived growth factor receptor alpha	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1806	dasatinib	Receptor tyrosine-protein kinase erbB-2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1807	dasatinib	Fibroblast growth factor receptor 3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1808	dasatinib	Tyrosine-protein kinase HCK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1809	dasatinib	Receptor tyrosine-protein kinase erbB-4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1810	dasatinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1811	dasatinib	Tyrosine-protein kinase JAK2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1812	dasatinib	Tyrosine-protein kinase SYK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1813	dasatinib	Myosin light chain kinase 2, skeletal/cardiac muscle	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1814	dasatinib	Tyrosine-protein kinase CSK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1815	dasatinib	Ephrin type-A receptor 8	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1816	dasatinib	Tyrosine-protein kinase Lyn	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1817	dasatinib	Cytoplasmic tyrosine-protein kinase BMX	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1818	dasatinib	Serine/threonine-protein kinase Nek2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1819	dasatinib	LIM domain kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1820	dasatinib	Fibroblast growth factor receptor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1821	dasatinib	Serine/threonine-protein kinase 10	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1822	dasatinib	Abelson tyrosine-protein kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1823	dasatinib	Mitogen-activated protein kinase 11	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1824	dasatinib	Ephrin type-A receptor 5	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1825	dasatinib	Ephrin type-A receptor 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1826	dasatinib	Fibroblast growth factor receptor 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1827	dasatinib	Ephrin type-A receptor 6	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1828	dasatinib	TRAF2 and NCK-interacting protein kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1829	dasatinib	Casein kinase I isoform epsilon	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1830	dasatinib	Tyrosine-protein kinase Fgr	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1831	dasatinib	Aurora kinase A	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1832	dasatinib	Serine/threonine-protein kinase 36	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1833	dasatinib	Ephrin type-A receptor 3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1834	dasatinib	Mitogen-activated protein kinase 14	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1835	dasatinib	Tyrosine-protein kinase FRK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1836	dasatinib	Mitogen-activated protein kinase kinase kinase kinase 5	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1837	dasatinib	Mitogen-activated protein kinase kinase kinase 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1838	dasatinib	Cyclin-G-associated kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1839	dasatinib	Receptor-interacting serine/threonine-protein kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1840	dasatinib	Ephrin type-B receptor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1841	dasatinib	Serine/threonine-protein kinase 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1842	dasatinib	Activated CDC42 kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1843	dasatinib	STE20-like serine/threonine-protein kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1844	dasatinib	Epithelial discoidin domain-containing receptor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1845	dasatinib	Ephrin type-B receptor 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1846	dasatinib	Activin receptor type-1B	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1847	dasatinib	Serine/threonine-protein kinase receptor R3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1848	dasatinib	Activin receptor type-1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1849	dasatinib	TGF-beta receptor type-2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1850	dasatinib	Dual specificity mitogen-activated protein kinase kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1851	dasatinib	Dual specificity mitogen-activated protein kinase kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1852	dasatinib	Tyrosine-protein kinase ITK/TSK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1853	dasatinib	Protein-tyrosine kinase 6	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1854	dasatinib	Proto-oncogene tyrosine-protein kinase LCK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1855	dasatinib	Tyrosine-protein kinase BTK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1856	dasatinib	Tyrosine-protein kinase Tec	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1857	dasatinib	Ephrin type-B receptor 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1858	dasatinib	Non-receptor tyrosine-protein kinase TYK2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1859	dasatinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1860	dasatinib	Wee1-like protein kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1861	dasatinib	Serine/threonine-protein kinase 25	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1862	dasatinib	Mitogen-activated protein kinase kinase kinase MLT	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1863	dasatinib	Tyrosine-protein kinase TXK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1864	dasatinib	LIM domain kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1865	dasatinib	Serine/threonine-protein kinase 26	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1866	dasatinib	Serine/threonine-protein kinase NLK	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1867	dasatinib	Eukaryotic translation initiation factor 2-alpha kinase 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1868	dasatinib	Serine/threonine-protein kinase SIK2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1869	dasatinib	Activin receptor type-2A	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1870	dasatinib	Activin receptor type-2B	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1871	dasatinib	Serine/threonine-protein kinase TNNI3K	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1872	dasatinib	Discoidin domain-containing receptor 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1873	dasatinib	Myotonin-protein kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1874	dasatinib	Chaperone activity of bc1 complex-like, mitochondrial	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1875	dasatinib	Serine/threonine-protein kinase MRCK gamma	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1876	dasatinib	Mitogen-activated protein kinase kinase kinase kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1877	dasatinib	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1878	dasatinib	Mitogen-activated protein kinase kinase kinase kinase 3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1879	dasatinib	Aurora kinase B	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1880	dasatinib	Tyrosine-protein kinase Blk	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1881	dasatinib	Bone morphogenetic protein receptor type-1A	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1882	dasatinib	Mitogen-activated protein kinase kinase kinase kinase 4	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1883	dasatinib	Serine/threonine-protein kinase MRCK alpha	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1884	dasatinib	Serine/threonine-protein kinase MRCK beta	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1885	dasatinib	Serine/threonine-protein kinase SIK1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1886	dasatinib	Tyrosine-protein kinase Srms	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1887	dasatinib	Dual specificity testis-specific protein kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1888	dasatinib	TGF-beta receptor type-1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1889	dasatinib	Ephrin type-A receptor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1890	dasatinib	Ephrin type-B receptor 3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1891	dasatinib	Tubulin alpha-1A chain	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1892	dasatinib	Mitogen-activated protein kinase kinase kinase kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1893	dasatinib	Misshapen-like kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1894	dasatinib	Ephrin type-B receptor 6	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1895	dasatinib	Mitogen-activated protein kinase kinase kinase 13	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1896	dasatinib	Mitogen-activated protein kinase kinase kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1897	dasatinib	Mitogen-activated protein kinase kinase kinase 3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1898	dasatinib	Mitogen-activated protein kinase kinase kinase 7	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1899	dasatinib	Serine/threonine-protein kinase TAO3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1900	dasatinib	Serine/threonine-protein kinase ULK3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1901	dasatinib	Mitogen-activated protein kinase kinase kinase 19	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1902	dasatinib	Serine/threonine-protein kinase 35	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1903	dasatinib	Receptor tyrosine-protein kinase erbB-3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1904	dasatinib	Serine/threonine-protein kinase SIK3	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1905	dasatinib	Wee1-like protein kinase 2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1906	dasatinib	Bone morphogenetic protein receptor type-1B	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1907	dasatinib	Quinolone resistance protein NorA	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1908	dasatinib	Serine/threonine-protein kinase SBK1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1909	dasatinib	Serine/threonine-protein kinase VRK2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1910	dasatinib	Serine/threonine-protein kinase TAO2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1911	dasatinib	Dual specificity mitogen-activated protein kinase kinase 5	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1912	dasatinib	Serine/threonine-protein kinase Nek11	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1913	dasatinib	Calcium-dependent protein kinase 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1914	dasatinib	MAP kinase p38	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1915	dasatinib	Dual specificity mitogen-activated protein kinase kinase; MEK1/2	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1916	dasatinib	Bcr/Abl fusion protein	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1917	dasatinib	Myelin transcription factor 1	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
1918	daunorubicin	Multidrug resistance protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1919	daunorubicin	DNA topoisomerase 2-alpha	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1920	daunorubicin	Multidrug resistance-associated protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1921	daunorubicin	ATP-binding cassette sub-family G member 2	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1922	daunorubicin	Multidrug resistance-associated protein 6	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1923	daunorubicin	72 kDa type IV collagenase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1924	daunorubicin	ORF 73	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O
1925	decamethonium	Muscarinic acetylcholine receptor M2	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
1926	decamethonium	Acetylcholinesterase	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
1927	decamethonium	Histamine H3 receptor	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
1928	decamethonium	Neuronal acetylcholine receptor; alpha4/beta2	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
1929	decamethonium	Muscle-type nicotinic acetylcholine receptor	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
1930	decitabine	DNA (cytosine-5)-methyltransferase 1	NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
1931	decitabine	DNA (cytosine-5)-methyltransferase 3A	NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
1932	delapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2
1933	demecarium	Acetylcholinesterase	CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
1934	denopamine	Solute carrier family 22 member 1	COC1=CC=C(CCNC[C@H](O)C2=CC=C(O)C=C2)C=C1OC
1935	denopamine	Beta-1 adrenergic receptor	COC1=CC=C(CCNC[C@H](O)C2=CC=C(O)C=C2)C=C1OC
1936	deserpidine	Synaptic vesicular amine transporter	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
1937	desflurane	Potassium channel subfamily K member 2	FC(F)OC(F)C(F)(F)F
1938	desflurane	Potassium channel subfamily K member 3	FC(F)OC(F)C(F)(F)F
1939	desflurane	Potassium channel subfamily K member 9	FC(F)OC(F)C(F)(F)F
1940	desflurane	Potassium channel subfamily K member 10	FC(F)OC(F)C(F)(F)F
1941	desflurane	Potassium channel subfamily K member 18	FC(F)OC(F)C(F)(F)F
1942	desflurane	Glycine receptor (alpha-1/beta)	FC(F)OC(F)C(F)(F)F
1943	desflurane	GABA-A receptor; anion channel	FC(F)OC(F)C(F)(F)F
1944	desipramine	D(1A) dopamine receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1945	desipramine	D(2) dopamine receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1946	desipramine	Alpha-2A adrenergic receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1947	desipramine	Potassium voltage-gated channel subfamily H member 2	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1948	desipramine	Sodium-dependent serotonin transporter	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1949	desipramine	Sodium-dependent noradrenaline transporter	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1950	desipramine	5-hydroxytryptamine receptor 1A	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1951	desipramine	5-hydroxytryptamine receptor 2A	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1952	desipramine	5-hydroxytryptamine receptor 2B	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1953	desipramine	5-hydroxytryptamine receptor 2C	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1954	desipramine	Alpha-1A adrenergic receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1955	desipramine	Alpha-2B adrenergic receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1956	desipramine	Histamine H1 receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1957	desipramine	Muscarinic acetylcholine receptor M1	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1958	desipramine	Muscarinic acetylcholine receptor M2	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1959	desipramine	Muscarinic acetylcholine receptor M3	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1960	desipramine	Muscarinic acetylcholine receptor M4	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1961	desipramine	Muscarinic acetylcholine receptor M5	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1962	desipramine	5-hydroxytryptamine receptor 1B	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1963	desipramine	Sodium-dependent dopamine transporter	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1964	desipramine	Voltage-dependent calcium channel gamma-1 subunit	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1965	desipramine	Solute carrier family 22 member 1	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1966	desipramine	Transporter	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1967	desipramine	Serotonin (5-HT) receptor	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1968	desipramine	Sodium channel alpha subunits; brain (Types I, II, III)	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1969	desipramine	Equilibrative nucleoside transporter 4	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1970	desipramine	G protein-activated inward rectifier potassium channel 4	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1971	desipramine	G protein-activated inward rectifier potassium channel 2	CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
1972	deslanoside	Sodium/potassium-transporting ATPase	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
1973	desloratadine	Multidrug resistance protein 1	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1974	desloratadine	Sodium-dependent serotonin transporter	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1975	desloratadine	Sodium-dependent noradrenaline transporter	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1976	desloratadine	5-hydroxytryptamine receptor 2A	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1977	desloratadine	5-hydroxytryptamine receptor 2B	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1978	desloratadine	5-hydroxytryptamine receptor 2C	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1979	desloratadine	5-hydroxytryptamine receptor 6	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1980	desloratadine	Alpha-2B adrenergic receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1981	desloratadine	D(3) dopamine receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1982	desloratadine	Histamine H1 receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1983	desloratadine	Histamine H2 receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1984	desloratadine	Histamine H4 receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1985	desloratadine	Muscarinic acetylcholine receptor M1	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1986	desloratadine	Muscarinic acetylcholine receptor M2	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1987	desloratadine	Muscarinic acetylcholine receptor M3	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1988	desloratadine	Muscarinic acetylcholine receptor M4	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1989	desloratadine	Muscarinic acetylcholine receptor M5	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1990	desloratadine	Sodium-dependent dopamine transporter	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1991	desloratadine	Alpha-1B adrenergic receptor	ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1
1992	desmopressin	Vasopressin V1a receptor	NC(=O)CCC1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O
1993	desmopressin	Vasopressin V1b receptor	NC(=O)CCC1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O
1994	desmopressin	Oxytocin receptor	NC(=O)CCC1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O
1995	desmopressin	Vasopressin V2 receptor	NC(=O)CCC1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O
1996	desogestrel	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
1997	desogestrel	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
1998	desoximetasone	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
1999	desoximetasone	Annexin A1	[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2000	desoximetasone	Progesterone receptor	[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2001	desoxycortone	5-hydroxytryptamine receptor 2A	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2002	desoxycortone	5-hydroxytryptamine receptor 2B	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2003	desoxycortone	5-hydroxytryptamine receptor 2C	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2004	desoxycortone	Glucocorticoid receptor	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2005	desoxycortone	Mineralocorticoid receptor	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2006	desoxycortone	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2007	desoxycortone	Sex hormone-binding globulin	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2008	desoxycorticosterone acetate	Mineralocorticoid receptor	[H][C@@]12CC[C@H](C(=O)COC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2009	desoxycorticosterone pivalate	Mineralocorticoid receptor	[H][C@@]12CC[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2010	dexamethasone	Prostaglandin G/H synthase 2	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2011	dexamethasone	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2012	dexamethasone	Annexin A1	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2013	dexamethasone	Interleukin-5	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2014	dexamethasone	Mineralocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2015	dexamethasone	Interleukin-4	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2016	dexamethasone	Androgen receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2017	dexamethasone	Progesterone receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2018	dexamethasone	Fatty acid-binding protein, liver	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2019	dexamethasone	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2020	dexamethasone acetate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
2021	dexbrompheniramine	Histamine H1 receptor	CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1
2022	dexetimide	Muscarinic acetylcholine receptor M2	O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1
2023	dexetimide	Muscarinic acetylcholine receptor	O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1
2024	dexketoprofen	Prostaglandin G/H synthase 2	C[C@H](C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
2025	dexketoprofen	Prostaglandin G/H synthase 1	C[C@H](C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
2026	dexmedetomidine	Alpha-2A adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2027	dexmedetomidine	Alpha-1A adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2028	dexmedetomidine	Alpha-2B adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2029	dexmedetomidine	Alpha-2C adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2030	dexmedetomidine	Alpha-1D adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2031	dexmedetomidine	Alpha-1B adrenergic receptor	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2032	dexmedetomidine	Adrenergic receptor alpha-2	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2033	dexmedetomidine	Adrenergic receptor alpha-1	C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
2034	dexmethylphenidate	Sodium-dependent noradrenaline transporter	[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1
2035	dexmethylphenidate	Sodium-dependent dopamine transporter	[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1
2036	dexmethylphenidate	Transporter	[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1
2037	dexmethylphenidate	Dopamine receptor	[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1
2038	dexniguldipine	Alpha-2A adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2039	dexniguldipine	Multidrug resistance protein 1	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2040	dexniguldipine	Alpha-1A adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2041	dexniguldipine	Alpha-2B adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2042	dexniguldipine	Alpha-2C adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2043	dexniguldipine	Adenosine receptor A3	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2044	dexniguldipine	Alpha-1D adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2045	dexniguldipine	Alpha-1B adrenergic receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2046	dexniguldipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2047	dexniguldipine	D(2) dopamine receptor	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2048	dexniguldipine	Adenosine receptor A1	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2049	dexniguldipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1
2050	dexamfetamine	Alpha-2A adrenergic receptor	C[C@H](N)CC1=CC=CC=C1
2051	dexamfetamine	Sodium-dependent serotonin transporter	C[C@H](N)CC1=CC=CC=C1
2052	dexamfetamine	Sodium-dependent noradrenaline transporter	C[C@H](N)CC1=CC=CC=C1
2053	dexamfetamine	5-hydroxytryptamine receptor 1A	C[C@H](N)CC1=CC=CC=C1
2054	dexamfetamine	Alpha-1A adrenergic receptor	C[C@H](N)CC1=CC=CC=C1
2055	dexamfetamine	Sodium-dependent dopamine transporter	C[C@H](N)CC1=CC=CC=C1
2056	dexamfetamine	Cocaine- and amphetamine-regulated transcript protein	C[C@H](N)CC1=CC=CC=C1
2057	dexamfetamine	Amine oxidase [flavin-containing] A	C[C@H](N)CC1=CC=CC=C1
2058	dexamfetamine	Synaptic vesicular amine transporter	C[C@H](N)CC1=CC=CC=C1
2059	dexamfetamine	Trace amine-associated receptor 1	C[C@H](N)CC1=CC=CC=C1
2060	dexamfetamine	Serotonin (5-HT) receptor	C[C@H](N)CC1=CC=CC=C1
2061	dextropropoxyphene	Sodium channel protein type 5 subunit alpha	[H][C@@](C)(CN(C)C)[C@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1
2062	dextropropoxyphene	Mu-type opioid receptor	[H][C@@](C)(CN(C)C)[C@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1
2063	dextropropoxyphene	Glutamate receptor ionotropic, NMDA 3A	[H][C@@](C)(CN(C)C)[C@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1
2064	dextrothyroxine	Thyroid hormone receptor beta	N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
2065	dextrothyroxine	Thyroid hormone receptor	N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
2066	dextrothyroxine	Glutamate NMDA receptor	N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
2067	dezocine	Mu-type opioid receptor	[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N
2068	dezocine	Kappa-type opioid receptor	[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N
2069	diazepam	GABA A receptor alpha-5/beta-2/gamma-3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2070	diazepam	Gamma-aminobutyric acid receptor subunit alpha-5	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2071	diazepam	Cytochrome P450 3A4	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2072	diazepam	Alpha-1A adrenergic receptor	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2073	diazepam	Adenosine receptor A3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2074	diazepam	Aldo-keto reductase family 1 member C1	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2075	diazepam	Aldo-keto reductase family 1 member C2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2076	diazepam	Aldo-keto reductase family 1 member C3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2077	diazepam	Fatty acid-binding protein, liver	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2078	diazepam	Acetylcholinesterase	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2079	diazepam	Translocator protein	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2080	diazepam	Thyrotropin-releasing hormone receptor	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2081	diazepam	Cholinesterase	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2082	diazepam	Gamma-aminobutyric acid receptor subunit alpha-1	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2083	diazepam	Gamma-aminobutyric acid receptor subunit alpha-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2084	diazepam	GABA-A receptor alpha-1/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2085	diazepam	GABA-A receptor alpha-2/beta-3/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2086	diazepam	GABA-A receptor alpha-3/beta-3/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2087	diazepam	GABA-A receptor alpha-5/beta-3/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2088	diazepam	GABA-A receptor alpha-1/beta-2/gamma-3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2089	diazepam	GABA-A receptor alpha-1/beta-3/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2090	diazepam	GABA-A receptor; anion channel	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2091	diazepam	GABA A receptor alpha-3/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2092	diazepam	GABA A receptor alpha-6/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2093	diazepam	GABA-A receptor; alpha-1/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2094	diazepam	GABA A receptor alpha-2/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2095	diazepam	GABA A receptor alpha-5/beta-3/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2096	diazepam	GABA A receptor alpha-3/beta-2/gamma-3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2097	diazepam	GABA A receptor alpha-5/beta-3/gamma-3	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2098	diazepam	GABA A receptor alpha-5/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
2099	diazoxide	Nicotinamide phosphoribosyltransferase	CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1
2100	diazoxide	Sulfonylurea receptor 1, Kir6.2	CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1
2101	diazoxide	ATP-sensitive inward rectifier potassium channel 11	CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1
2102	cinchocaine	Sodium channel protein type 5 subunit alpha	CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
2103	cinchocaine	Sodium channel protein type 10 subunit alpha	CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
2104	cinchocaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
2105	phenazone	Nicotinate phosphoribosyltransferase	CN1N(C(=O)C=C1C)C1=CC=CC=C1
2106	phenazone	Transient receptor potential cation channel subfamily A member 1	CN1N(C(=O)C=C1C)C1=CC=CC=C1
2107	dichlorphenamide	Carbonic anhydrase 2	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2108	dichlorphenamide	Carbonic anhydrase 1	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2109	dichlorphenamide	Carbonic anhydrase 4	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2110	dichlorphenamide	Cytochrome P450 2C9	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2111	dichlorphenamide	Carbonic anhydrase 9	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2112	dichlorphenamide	Carbonic anhydrase 12	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2113	dichlorphenamide	Carbonic anhydrase 5A, mitochondrial	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2114	dichlorphenamide	Carbonic anhydrase 5B, mitochondrial	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2115	dichlorphenamide	Carbonic anhydrase 7	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2116	dichlorphenamide	Carbonic anhydrase	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2117	dichlorphenamide	Carbonic anhydrase 6	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2118	dichlorphenamide	Carbonic anhydrase 14	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2119	dichlorphenamide	Carbonic anhydrase 13	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2120	dichlorphenamide	Carbonic anhydrase 15	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2121	dichlorphenamide	Alpha carbonic anhydrase	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2122	dichlorphenamide	Astrosclerin-3	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2123	dichlorphenamide	Beta-carbonic anhydrase 1	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2124	dichlorphenamide	Delta carbonic anhydrase	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2125	dichlorphenamide	Carbonic anhydrase, alpha family	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2126	dichlorphenamide	Carbonate dehydratase	NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
2127	diclofenac	Prostaglandin G/H synthase 2	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2128	diclofenac	Prostaglandin G/H synthase 1	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2129	diclofenac	Transthyretin	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2130	diclofenac	Aldo-keto reductase family 1 member C3	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2131	diclofenac	Peroxisome proliferator-activated receptor gamma	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2132	diclofenac	Fatty acid-binding protein, liver	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2133	diclofenac	Interleukin-8	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2134	diclofenac	Transient receptor potential cation channel subfamily A member 1	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2135	diclofenac	Aldo-keto reductase family 1 member B10	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2136	diclofenac	Acid-sensing ion channel 3	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2137	diclofenac	C-X-C chemokine receptor type 1	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2138	diclofenac	UDP-glucuronosyltransferase 1-1	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2139	diclofenac	UDP-glucuronosyltransferase 1-7	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2140	diclofenac	UDP-glucuronosyltransferase 1-6	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2141	diclofenac	UDP-glucuronosyltransferase 1-9	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2142	diclofenac	UDP-glucuronosyltransferase 1-10	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2143	diclofenac	Transient receptor potential cation channel subfamily M member 3	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1
2144	dicoumarol	Cytochrome P450 2C9	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2145	dicoumarol	NAD(P)H dehydrogenase [quinone] 1	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2146	dicoumarol	Aldose reductase	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2147	dicoumarol	Mitogen-activated protein kinase 1	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2148	dicoumarol	Proprotein convertase subtilisin/kexin type 7	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2149	dicoumarol	G-protein coupled receptor 35	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2150	dicoumarol	Enoyl-[acyl-carrier-protein] reductase [NADH]	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2151	dicoumarol	Urease	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2152	dicoumarol	ATP phosphoribosyltransferase	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2153	dicoumarol	NULLD(P)H dehydrogenase [quinone] 1	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2154	dicoumarol	Vitamin K epoxide reductase complex subunit 1	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12
2155	dicycloverine	Sigma non-opioid intracellular receptor 1	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2156	dicycloverine	Potassium voltage-gated channel subfamily H member 2	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2157	dicycloverine	5-hydroxytryptamine receptor 2A	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2158	dicycloverine	5-hydroxytryptamine receptor 2B	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2159	dicycloverine	5-hydroxytryptamine receptor 2C	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2160	dicycloverine	5-hydroxytryptamine receptor 6	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2161	dicycloverine	D(3) dopamine receptor	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2162	dicycloverine	Histamine H2 receptor	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2163	dicycloverine	Muscarinic acetylcholine receptor M1	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2164	dicycloverine	Muscarinic acetylcholine receptor M2	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2165	dicycloverine	Muscarinic acetylcholine receptor M3	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2166	dicycloverine	Muscarinic acetylcholine receptor M4	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2167	dicycloverine	Muscarinic acetylcholine receptor M5	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2168	dicycloverine	Membrane-associated progesterone receptor component 1	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2169	dicycloverine	SMR1-alpha2	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2170	dicycloverine	Sodium channel alpha subunits; brain (Types I, II, III)	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
2171	dienestrol	Estrogen receptor	C\C=C(\C(=C\C)\C1=CC=C(O)C=C1)/C1=CC=C(O)C=C1
2172	dienogest	Progesterone receptor	[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
2173	diethylpropion	Sodium-dependent noradrenaline transporter	CCN(CC)C(C)C(=O)C1=CC=CC=C1
2174	diethylpropion	Sodium-dependent dopamine transporter	CCN(CC)C(C)C(=O)C1=CC=CC=C1
2175	diethylstilbestrol	Sodium/nucleoside cotransporter 1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2176	diethylstilbestrol	Beta-1 adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2177	diethylstilbestrol	Prostaglandin G/H synthase 1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2178	diethylstilbestrol	Mu-type opioid receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2179	diethylstilbestrol	D(1A) dopamine receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2180	diethylstilbestrol	D(2) dopamine receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2181	diethylstilbestrol	Adenosine receptor A2a	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2182	diethylstilbestrol	Alpha-2A adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2183	diethylstilbestrol	Sodium-dependent serotonin transporter	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2184	diethylstilbestrol	Sodium-dependent noradrenaline transporter	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2185	diethylstilbestrol	5-hydroxytryptamine receptor 2A	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2186	diethylstilbestrol	5-hydroxytryptamine receptor 2B	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2187	diethylstilbestrol	5-hydroxytryptamine receptor 2C	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2188	diethylstilbestrol	5-hydroxytryptamine receptor 6	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2189	diethylstilbestrol	Alpha-2B adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2190	diethylstilbestrol	D(3) dopamine receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2191	diethylstilbestrol	Muscarinic acetylcholine receptor M1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2192	diethylstilbestrol	Muscarinic acetylcholine receptor M3	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2193	diethylstilbestrol	Glucocorticoid receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2194	diethylstilbestrol	Alpha-2C adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2195	diethylstilbestrol	Sodium-dependent dopamine transporter	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2196	diethylstilbestrol	Adenosine receptor A1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2197	diethylstilbestrol	Adenosine receptor A3	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2198	diethylstilbestrol	Nuclear receptor subfamily 1 group I member 2	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2199	diethylstilbestrol	Alpha-1D adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2200	diethylstilbestrol	Kappa-type opioid receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2201	diethylstilbestrol	Estrogen receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2202	diethylstilbestrol	Delta-type opioid receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2203	diethylstilbestrol	Acetylcholinesterase	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2204	diethylstilbestrol	Estrogen receptor beta	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2205	diethylstilbestrol	Estrogen-related receptor gamma	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2206	diethylstilbestrol	Cysteinyl leukotriene receptor 1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2207	diethylstilbestrol	Vasopressin V1a receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2208	diethylstilbestrol	Tyrosine-protein kinase Fyn	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2209	diethylstilbestrol	Thromboxane-A synthase	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2210	diethylstilbestrol	Steroid hormone receptor ERR2	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2211	diethylstilbestrol	Mitogen-activated protein kinase 14	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2212	diethylstilbestrol	Substance-K receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2213	diethylstilbestrol	Androgen receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2214	diethylstilbestrol	Arachidonate 15-lipoxygenase	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2215	diethylstilbestrol	Progesterone receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2216	diethylstilbestrol	Alpha-1A adrenergic receptor	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2217	diethylstilbestrol	UDP-glucose 4-epimerase	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2218	diethylstilbestrol	Steroid hormone receptor ERR1	CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2219	difenoxin	Mu-type opioid receptor	OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1
2220	diflunisal	Prostaglandin G/H synthase 2	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2221	diflunisal	Prostaglandin G/H synthase 1	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2222	diflunisal	Carbonic anhydrase 2	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2223	diflunisal	Transthyretin	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2224	diflunisal	Carbonic anhydrase 1	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2225	diflunisal	Dihydrofolate reductase	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
2226	digitoxin	Sodium/potassium-transporting ATPase subunit alpha-2	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2227	digitoxin	Potassium voltage-gated channel subfamily H member 2	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2228	digitoxin	Sodium/potassium-transporting ATPase subunit alpha-1	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2229	digitoxin	Signal transducer and activator of transcription 3	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2230	digitoxin	Sodium/potassium-transporting ATPase	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2231	digoxin	Sodium/potassium-transporting ATPase subunit alpha-2	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2232	digoxin	Potassium voltage-gated channel subfamily H member 2	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2233	digoxin	Nuclear receptor ROR-gamma	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2234	digoxin	Sodium/potassium-transporting ATPase subunit alpha-1	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2235	digoxin	Signal transducer and activator of transcription 3	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2236	digoxin	Sodium/potassium-transporting ATPase	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
2237	dihydrocodeine	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CC[C@@H]2O)=CC=C3OC
2238	dihydroergotamine	5-hydroxytryptamine receptor 4	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2239	dihydroergotamine	D(1A) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2240	dihydroergotamine	D(2) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2241	dihydroergotamine	Alpha-2A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2242	dihydroergotamine	Cytochrome P450 3A4	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2243	dihydroergotamine	5-hydroxytryptamine receptor 1A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2244	dihydroergotamine	5-hydroxytryptamine receptor 2A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2245	dihydroergotamine	5-hydroxytryptamine receptor 2B	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2246	dihydroergotamine	5-hydroxytryptamine receptor 2C	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2247	dihydroergotamine	5-hydroxytryptamine receptor 6	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2248	dihydroergotamine	5-hydroxytryptamine receptor 7	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2249	dihydroergotamine	Alpha-1A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2250	dihydroergotamine	Alpha-2B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2251	dihydroergotamine	D(3) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2252	dihydroergotamine	5-hydroxytryptamine receptor 1B	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2253	dihydroergotamine	5-hydroxytryptamine receptor 1D	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2254	dihydroergotamine	Alpha-2C adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2255	dihydroergotamine	Alpha-1D adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2256	dihydroergotamine	Alpha-1B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2257	dihydroergotamine	5-hydroxytryptamine receptor 5A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2258	dihydroergotamine	5-hydroxytryptamine receptor 1F	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2259	dihydroergotamine	5-hydroxytryptamine receptor 1E	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2260	dihydroergotamine	Gastrin/cholecystokinin type B receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2261	dihydroergotamine	Solute carrier family 22 member 2	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2262	dihydroergotamine	Multidrug and toxin extrusion protein 1	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2263	dihydroergotamine	Multidrug and toxin extrusion protein 2	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2264	dihydroergotamine	Adrenergic receptor alpha-2	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
2265	diltiazem	Potassium voltage-gated channel subfamily H member 2	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2266	diltiazem	Cytochrome P450 3A4	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2267	diltiazem	Multidrug resistance protein 1	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2268	diltiazem	5-hydroxytryptamine receptor 2A	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2269	diltiazem	5-hydroxytryptamine receptor 3A	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2270	diltiazem	Voltage-dependent calcium channel gamma-1 subunit	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2271	diltiazem	Voltage-dependent L-type calcium channel subunit alpha-1C	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2272	diltiazem	Voltage-dependent T-type calcium channel subunit alpha-1H	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2273	diltiazem	Voltage-dependent L-type calcium channel subunit alpha-1S	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2274	diltiazem	Solute carrier family 22 member 1	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2275	diltiazem	Voltage-dependent L-type calcium channel subunit alpha-1D	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2276	diltiazem	Sodium channel alpha subunits; brain (Types I, II, III)	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2277	diltiazem	Voltage-gated L-type calcium channel	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2278	diltiazem	Potassium voltage-gated channel subfamily C member 1	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2279	diltiazem	Potassium voltage-gated channel subfamily A member 7	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2280	diltiazem	Voltage-dependent L-type calcium channel subunit alpha-1F	COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
2281	dimenhydrinate	Alpha-2A adrenergic receptor	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2282	dimenhydrinate	Sigma non-opioid intracellular receptor 1	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2283	dimenhydrinate	Sodium-dependent noradrenaline transporter	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2284	dimenhydrinate	5-hydroxytryptamine receptor 2A	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2285	dimenhydrinate	5-hydroxytryptamine receptor 2B	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2286	dimenhydrinate	5-hydroxytryptamine receptor 2C	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2287	dimenhydrinate	Alpha-2B adrenergic receptor	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2288	dimenhydrinate	Histamine H1 receptor	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2289	dimenhydrinate	Muscarinic acetylcholine receptor M1	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2290	dimenhydrinate	Muscarinic acetylcholine receptor M2	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2291	dimenhydrinate	Muscarinic acetylcholine receptor M3	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2292	dimenhydrinate	Muscarinic acetylcholine receptor M4	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2293	dimenhydrinate	Muscarinic acetylcholine receptor M5	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2294	dimenhydrinate	Sodium-dependent dopamine transporter	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2295	dimenhydrinate	Cytochrome P450 2D6	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2296	dimenhydrinate	Alpha-1D adrenergic receptor	CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2297	dimethyltubocurarinium	Acetylcholine receptor	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(OC)C(OC6=CC1=C(CC[N+]2(C)C)C=C6OC)=C5)=CC(OC)=C4OC)C=C3
2298	dimethyltubocurarinium	Neuronal acetylcholine receptor; alpha2/beta2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(OC)C(OC6=CC1=C(CC[N+]2(C)C)C=C6OC)=C5)=CC(OC)=C4OC)C=C3
2299	dinoprost	Prostaglandin E2 receptor EP1 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2300	dinoprost	Prostaglandin D2 receptor 2	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2301	dinoprost	Prostaglandin E2 receptor EP3 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2302	dinoprost	Thromboxane A2 receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2303	dinoprost	Prostaglandin E2 receptor EP2 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2304	dinoprost	Prostaglandin E2 receptor EP4 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2305	dinoprost	Prostaglandin D2 receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2306	dinoprost	Prostaglandin F2-alpha receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
2307	dinoprostone	Prostaglandin E2 receptor EP1 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2308	dinoprostone	Prostaglandin D2 receptor 2	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2309	dinoprostone	Prostaglandin E2 receptor EP3 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2310	dinoprostone	Prostacyclin receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2311	dinoprostone	Thromboxane A2 receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2312	dinoprostone	Prostaglandin E2 receptor EP2 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2313	dinoprostone	Prostaglandin E2 receptor EP4 subtype	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2314	dinoprostone	Prostaglandin D2 receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2315	dinoprostone	Prostaglandin F2-alpha receptor	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2316	dinoprostone	Solute carrier family 22 member 6	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2317	dinoprostone	Solute carrier family 22 member 20	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2318	dinoprostone	Cation channel sperm-associated protein 1	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2319	dinoprostone	Cation channel sperm-associated protein 2	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2320	dinoprostone	Cation channel sperm-associated protein 3	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2321	dinoprostone	Cation channel sperm-associated protein 4	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2322	diphemanil	Muscarinic acetylcholine receptor M1	C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1
2323	diphemanil	Muscarinic acetylcholine receptor M3	C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1
2324	diphenhydramine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2325	diphenhydramine	Sodium-dependent noradrenaline transporter	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2326	diphenhydramine	5-hydroxytryptamine receptor 2A	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2327	diphenhydramine	5-hydroxytryptamine receptor 2B	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2328	diphenhydramine	5-hydroxytryptamine receptor 2C	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2329	diphenhydramine	Histamine H1 receptor	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2330	diphenhydramine	Histamine H4 receptor	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2331	diphenhydramine	Muscarinic acetylcholine receptor M1	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2332	diphenhydramine	Muscarinic acetylcholine receptor M2	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2333	diphenhydramine	Muscarinic acetylcholine receptor M3	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2334	diphenhydramine	Muscarinic acetylcholine receptor M4	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2335	diphenhydramine	Muscarinic acetylcholine receptor M5	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2336	diphenhydramine	Cytochrome P450 2D6	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2337	diphenhydramine	Solute carrier family 22 member 2	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2338	diphenhydramine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2339	diphenhydramine	Sodium-dependent serotonin transporter	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2340	diphenhydramine	Sodium-dependent dopamine transporter	CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
2341	diphenoxylate	Mu-type opioid receptor	CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1
2342	diphenoxylate	Potassium voltage-gated channel subfamily A member 3	CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1
2343	diphenylpyraline	Histamine H1 receptor	CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2344	diphenylpyraline	Muscarinic acetylcholine receptor M1	CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2345	diphenylpyraline	Sodium-dependent dopamine transporter	CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2346	diphenylpyraline	Cytochrome P450 2D6	CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2347	dipivefrine	Alpha-2A adrenergic receptor	CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
2348	dipivefrine	Alpha-2B adrenergic receptor	CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
2349	dipivefrine	Alpha-2C adrenergic receptor	CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
2350	dipyridamole	Sodium/nucleoside cotransporter 1	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2351	dipyridamole	cGMP-specific 3',5'-cyclic phosphodiesterase	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2352	dipyridamole	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2353	dipyridamole	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2354	dipyridamole	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2355	dipyridamole	Equilibrative nucleoside transporter 1	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2356	dipyridamole	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2357	dipyridamole	cGMP-dependent 3',5'-cyclic phosphodiesterase	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2358	dipyridamole	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2359	dipyridamole	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2360	dipyridamole	Arachidonate 15-lipoxygenase	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2361	dipyridamole	Cyclic nucleotide phosphodiesterase PDE3A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2362	dipyridamole	Cyclic AMP-specific phosphodiesterase SSPDE4A1A	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2363	dipyridamole	Phosphodiesterase 3	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2364	dipyridamole	Phosphodiesterase 7	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2365	dipyridamole	Phosphodiesterase 6	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2366	dipyridamole	Phosphodiesterase 1	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2367	dipyridamole	Equilibrative nucleoside transporter 4	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2368	dipyridamole	Protein prune homolog	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2369	dipyridamole	ORF 73	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2370	dipyridamole	Replicase polyprotein 1ab	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO
2371	disopyramide	Sodium channel protein type 5 subunit alpha	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2372	disopyramide	Potassium voltage-gated channel subfamily H member 2	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2373	disopyramide	Histamine H1 receptor	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2374	disopyramide	Muscarinic acetylcholine receptor M1	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2375	disopyramide	Muscarinic acetylcholine receptor M2	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2376	disopyramide	Muscarinic acetylcholine receptor M3	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2377	disopyramide	G protein-activated inward rectifier potassium channel 4	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2378	disopyramide	Solute carrier family 22 member 1	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2379	disopyramide	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C
2380	distigmine	Acetylcholinesterase	CN(CCCCCCN(C)C(=O)OC1=C[N+](C)=CC=C1)C(=O)OC1=C[N+](C)=CC=C1
2381	disulfiram	Sodium/nucleoside cotransporter 1	CCN(CC)C(=S)SSC(=S)N(CC)CC
2382	disulfiram	Mu-type opioid receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2383	disulfiram	Translocator protein	CCN(CC)C(=S)SSC(=S)N(CC)CC
2384	disulfiram	D(1A) dopamine receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2385	disulfiram	D(2) dopamine receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2386	disulfiram	Alpha-2A adrenergic receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2387	disulfiram	Sodium-dependent noradrenaline transporter	CCN(CC)C(=S)SSC(=S)N(CC)CC
2388	disulfiram	5-hydroxytryptamine receptor 2B	CCN(CC)C(=S)SSC(=S)N(CC)CC
2389	disulfiram	5-hydroxytryptamine receptor 6	CCN(CC)C(=S)SSC(=S)N(CC)CC
2390	disulfiram	Alpha-2B adrenergic receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2391	disulfiram	D(3) dopamine receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2392	disulfiram	Sodium-dependent dopamine transporter	CCN(CC)C(=S)SSC(=S)N(CC)CC
2393	disulfiram	Adenosine receptor A3	CCN(CC)C(=S)SSC(=S)N(CC)CC
2394	disulfiram	D(4) dopamine receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2395	disulfiram	Kappa-type opioid receptor	CCN(CC)C(=S)SSC(=S)N(CC)CC
2396	disulfiram	Cytochrome P450 1A2	CCN(CC)C(=S)SSC(=S)N(CC)CC
2397	disulfiram	Amine oxidase [flavin-containing] A	CCN(CC)C(=S)SSC(=S)N(CC)CC
2398	disulfiram	Aldehyde dehydrogenase, mitochondrial	CCN(CC)C(=S)SSC(=S)N(CC)CC
2399	disulfiram	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CCN(CC)C(=S)SSC(=S)N(CC)CC
2400	disulfiram	C-C chemokine receptor type 5	CCN(CC)C(=S)SSC(=S)N(CC)CC
2401	disulfiram	C-X-C chemokine receptor type 2	CCN(CC)C(=S)SSC(=S)N(CC)CC
2402	disulfiram	C-C chemokine receptor type 2	CCN(CC)C(=S)SSC(=S)N(CC)CC
2403	disulfiram	Mitogen-activated protein kinase 3	CCN(CC)C(=S)SSC(=S)N(CC)CC
2404	disulfiram	Arachidonate 15-lipoxygenase	CCN(CC)C(=S)SSC(=S)N(CC)CC
2405	disulfiram	5-hydroxytryptamine receptor 1B	CCN(CC)C(=S)SSC(=S)N(CC)CC
2406	disulfiram	C-C chemokine receptor type 4	CCN(CC)C(=S)SSC(=S)N(CC)CC
2407	disulfiram	Membrane-associated progesterone receptor component 1	CCN(CC)C(=S)SSC(=S)N(CC)CC
2408	disulfiram	Monoglyceride lipase	CCN(CC)C(=S)SSC(=S)N(CC)CC
2409	disulfiram	Bifunctional protein GlmU	CCN(CC)C(=S)SSC(=S)N(CC)CC
2410	disulfiram	Protein-lysine 6-oxidase	CCN(CC)C(=S)SSC(=S)N(CC)CC
2411	disulfiram	Lysine-specific demethylase 5A	CCN(CC)C(=S)SSC(=S)N(CC)CC
2412	disulfiram	Lysyl oxidase homolog 3	CCN(CC)C(=S)SSC(=S)N(CC)CC
2413	disulfiram	Lysyl oxidase homolog 4	CCN(CC)C(=S)SSC(=S)N(CC)CC
2414	disulfiram	Histone-lysine N-methyltransferase EHMT2	CCN(CC)C(=S)SSC(=S)N(CC)CC
2415	disulfiram	Histone-lysine N-methyltransferase EHMT1	CCN(CC)C(=S)SSC(=S)N(CC)CC
2416	disulfiram	Lysyl oxidase homolog 2	CCN(CC)C(=S)SSC(=S)N(CC)CC
2417	disulfiram	Gasdermin-D	CCN(CC)C(=S)SSC(=S)N(CC)CC
2418	levomenthol	Transient receptor potential cation channel subfamily A member 1	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
2419	levomenthol	Transient receptor potential cation channel subfamily M member 8	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
2420	dobutamine	Beta-1 adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2421	dobutamine	Beta-2 adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2422	dobutamine	Sigma non-opioid intracellular receptor 1	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2423	dobutamine	Sodium-dependent serotonin transporter	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2424	dobutamine	Sodium-dependent noradrenaline transporter	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2425	dobutamine	Alpha-2B adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2426	dobutamine	D(3) dopamine receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2427	dobutamine	Sodium-dependent dopamine transporter	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2428	dobutamine	Carbonic anhydrase 2	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2429	dobutamine	Alpha-1D adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2430	dobutamine	Carbonic anhydrase 1	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2431	dobutamine	Carbonic anhydrase 4	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2432	dobutamine	Carbonic anhydrase 9	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2433	dobutamine	Carbonic anhydrase 12	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2434	dobutamine	Epidermal growth factor receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2435	dobutamine	Carbonic anhydrase 5A, mitochondrial	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2436	dobutamine	Carbonic anhydrase 5B, mitochondrial	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2437	dobutamine	Carbonic anhydrase 7	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2438	dobutamine	Tyrosine-protein kinase Lck	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2439	dobutamine	Tyrosine-protein kinase Fyn	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2440	dobutamine	Catechol O-methyltransferase	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2441	dobutamine	Carbonic anhydrase 3	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2442	dobutamine	Carbonic anhydrase 6	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2443	dobutamine	Carbonic anhydrase 14	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2444	dobutamine	Solute carrier family 22 member 1	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2445	dobutamine	Arachidonate 15-lipoxygenase	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2446	dobutamine	Alpha-1B adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2447	dobutamine	Membrane-associated progesterone receptor component 1	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2448	dobutamine	Alpha-1A adrenergic receptor	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2449	dobutamine	Carbonic anhydrase 13	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2450	dobutamine	Carbonic anhydrase 15	CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
2451	docetaxel	Cytochrome P450 3A4	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2452	docetaxel	Multidrug resistance protein 1	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2453	docetaxel	Multidrug resistance-associated protein 7	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2454	docetaxel	Epidermal growth factor receptor	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2455	docetaxel	Substance-K receptor	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2456	docetaxel	Growth hormone-releasing hormone receptor	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2457	docetaxel	Tubulin beta	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2458	docetaxel	Nucleotide-binding oligomerization domain-containing protein 2	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
2459	dofetilide	Potassium voltage-gated channel subfamily H member 2	CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
2460	dofetilide	Potassium channel subfamily K member 2	CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
2461	dofetilide	Potassium voltage-gated channel subfamily H member 1	CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
2462	domperidone	Mu-type opioid receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2463	domperidone	D(2) dopamine receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2464	domperidone	Alpha-2A adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2465	domperidone	Potassium voltage-gated channel subfamily H member 2	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2466	domperidone	Multidrug resistance protein 1	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2467	domperidone	Sodium-dependent serotonin transporter	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2468	domperidone	Sodium-dependent noradrenaline transporter	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2469	domperidone	5-hydroxytryptamine receptor 2A	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2470	domperidone	5-hydroxytryptamine receptor 2B	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2471	domperidone	5-hydroxytryptamine receptor 2C	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2472	domperidone	Alpha-1A adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2473	domperidone	Alpha-2B adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2474	domperidone	D(3) dopamine receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2475	domperidone	Histamine H1 receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2476	domperidone	Aldehyde oxidase	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2477	domperidone	Alpha-2C adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2478	domperidone	Cytochrome P450 2D6	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2479	domperidone	Alpha-1D adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2480	domperidone	Alpha-1B adrenergic receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2481	domperidone	Kappa-type opioid receptor	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2482	domperidone	Calmodulin	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2483	domperidone	Retinoic acid receptor RXR-alpha	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2484	domperidone	Solute carrier family 22 member 2	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2485	domperidone	Multidrug and toxin extrusion protein 1	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2486	domperidone	Multidrug and toxin extrusion protein 2	ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2
2487	donepezil	Sigma non-opioid intracellular receptor 1	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2488	donepezil	Potassium voltage-gated channel subfamily H member 2	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2489	donepezil	Multidrug resistance protein 1	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2490	donepezil	Sodium-dependent serotonin transporter	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2491	donepezil	Acetylcholinesterase	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2492	donepezil	Amine oxidase [flavin-containing] B	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2493	donepezil	Cholinesterase	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2494	donepezil	Histamine H3 receptor	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2495	donepezil	Beta-secretase 1	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2496	donepezil	Butyrylcholinesterase; Protein Bche	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2497	donepezil	Choline O-acetyltransferase	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2498	donepezil	Butyrylcholinesterase	COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2
2499	dopamine	Beta-1 adrenergic receptor	NCCC1=CC(O)=C(O)C=C1
2500	dopamine	Beta-2 adrenergic receptor	NCCC1=CC(O)=C(O)C=C1
2501	dopamine	D(1A) dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2502	dopamine	D(2) dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2503	dopamine	Sodium-dependent noradrenaline transporter	NCCC1=CC(O)=C(O)C=C1
2504	dopamine	5-hydroxytryptamine receptor 1A	NCCC1=CC(O)=C(O)C=C1
2505	dopamine	D(3) dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2506	dopamine	D(1B) dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2507	dopamine	Sodium-dependent dopamine transporter	NCCC1=CC(O)=C(O)C=C1
2508	dopamine	D(4) dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2509	dopamine	Trace amine-associated receptor 1	NCCC1=CC(O)=C(O)C=C1
2510	dopamine	Melatonin receptor type 1A	NCCC1=CC(O)=C(O)C=C1
2511	dopamine	Melatonin receptor type 1B	NCCC1=CC(O)=C(O)C=C1
2512	dopamine	Lysine-specific demethylase 4E	NCCC1=CC(O)=C(O)C=C1
2513	dopamine	Dopamine beta-hydroxylase	NCCC1=CC(O)=C(O)C=C1
2514	dopamine	Opioid receptor	NCCC1=CC(O)=C(O)C=C1
2515	dopamine	Adrenergic receptor alpha-2	NCCC1=CC(O)=C(O)C=C1
2516	dopamine	Dopamine receptor	NCCC1=CC(O)=C(O)C=C1
2517	dopamine	Adrenergic receptor alpha-1	NCCC1=CC(O)=C(O)C=C1
2518	dopamine	Adenylate cyclase	NCCC1=CC(O)=C(O)C=C1
2519	dopamine	Adenosine A2b receptor	NCCC1=CC(O)=C(O)C=C1
2520	dopamine	FAD-linked sulfhydryl oxidase ALR	NCCC1=CC(O)=C(O)C=C1
2521	dopamine	M18 aspartyl aminopeptidase	NCCC1=CC(O)=C(O)C=C1
2522	dorzolamide	Carbonic anhydrase 2	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2523	dorzolamide	Carbonic anhydrase 1	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2524	dorzolamide	Carbonic anhydrase 4	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2525	dorzolamide	Carbonic anhydrase 9	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2526	dorzolamide	Carbonic anhydrase 12	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2527	dorzolamide	Carbonic anhydrase 5A, mitochondrial	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2528	dorzolamide	Carbonic anhydrase 5B, mitochondrial	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2529	dorzolamide	Carbonic anhydrase 7	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2530	dorzolamide	Carbonic anhydrase	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2531	dorzolamide	Carbonic anhydrase 3	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2532	dorzolamide	Carbonic anhydrase 6	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2533	dorzolamide	Carbonic anhydrase 14	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2534	dorzolamide	Carbonic anhydrase 13	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2535	dorzolamide	Carbonic anhydrase 15	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2536	dorzolamide	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2537	dorzolamide	Alpha carbonic anhydrase	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2538	dorzolamide	Astrosclerin-3	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2539	dorzolamide	Beta-carbonic anhydrase 1	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2540	dorzolamide	Delta carbonic anhydrase	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2541	dorzolamide	Carbonic anhydrase, alpha family	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2542	dorzolamide	Carbonate dehydratase	CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
2543	dosulepin	Sodium-dependent serotonin transporter	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2544	dosulepin	Sodium-dependent noradrenaline transporter	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2545	dosulepin	5-hydroxytryptamine receptor 2A	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2546	dosulepin	Alpha-1A adrenergic receptor	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2547	dosulepin	Alpha-2B adrenergic receptor	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2548	dosulepin	Histamine H1 receptor	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2549	dosulepin	Muscarinic acetylcholine receptor M1	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2550	dosulepin	Muscarinic acetylcholine receptor M2	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2551	dosulepin	Muscarinic acetylcholine receptor M3	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2552	dosulepin	Muscarinic acetylcholine receptor M4	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2553	dosulepin	Muscarinic acetylcholine receptor M5	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2554	dosulepin	Sodium-dependent dopamine transporter	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
2555	doxapram	Cytochrome P450 2D6	CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
2556	doxapram	Potassium channel subfamily K member 3	CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
2557	doxapram	Potassium channel subfamily K member 9	CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
2558	doxazosin	5-hydroxytryptamine receptor 4	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2559	doxazosin	Beta-2 adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2560	doxazosin	Alpha-2A adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2561	doxazosin	Potassium voltage-gated channel subfamily H member 2	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2562	doxazosin	Multidrug resistance protein 1	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2563	doxazosin	Sodium-dependent serotonin transporter	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2564	doxazosin	5-hydroxytryptamine receptor 2B	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2565	doxazosin	5-hydroxytryptamine receptor 2C	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2566	doxazosin	Alpha-1A adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2567	doxazosin	Alpha-2C adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2568	doxazosin	Sodium-dependent dopamine transporter	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2569	doxazosin	Alpha-1D adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2570	doxazosin	Alpha-1B adrenergic receptor	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2571	doxazosin	Interstitial collagenase	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2572	doxazosin	HLA class I histocompatibility antigen, A-3 alpha chain	[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1
2573	doxepin	D(1A) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2574	doxepin	D(2) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2575	doxepin	Alpha-2A adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2576	doxepin	Sigma non-opioid intracellular receptor 1	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2577	doxepin	Sodium-dependent serotonin transporter	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2578	doxepin	Sodium-dependent noradrenaline transporter	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2579	doxepin	5-hydroxytryptamine receptor 1A	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2580	doxepin	5-hydroxytryptamine receptor 2A	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2581	doxepin	5-hydroxytryptamine receptor 2B	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2582	doxepin	5-hydroxytryptamine receptor 2C	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2583	doxepin	5-hydroxytryptamine receptor 6	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2584	doxepin	5-hydroxytryptamine receptor 7	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2585	doxepin	Alpha-1A adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2586	doxepin	Alpha-2B adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2587	doxepin	D(3) dopamine receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2588	doxepin	Histamine H2 receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2589	doxepin	Histamine H4 receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2590	doxepin	Muscarinic acetylcholine receptor M1	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2591	doxepin	Muscarinic acetylcholine receptor M2	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2592	doxepin	Muscarinic acetylcholine receptor M3	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2593	doxepin	Muscarinic acetylcholine receptor M4	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2594	doxepin	Muscarinic acetylcholine receptor M5	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2595	doxepin	Alpha-2C adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2596	doxepin	Alpha-1D adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2597	doxepin	Solute carrier family 22 member 1	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2598	doxepin	Alpha-1B adrenergic receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2599	doxepin	Solute carrier family 22 member 2	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2600	doxepin	Serotonin (5-HT) receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2601	doxepin	Histamine H1 receptor	CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2
2602	doxercalciferol	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C
2603	doxorubicin	5-hydroxytryptamine receptor 4	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2604	doxorubicin	Multidrug resistance protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2605	doxorubicin	Muscarinic acetylcholine receptor M1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2606	doxorubicin	Canalicular multispecific organic anion transporter 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2607	doxorubicin	DNA topoisomerase 2-alpha	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2608	doxorubicin	Multidrug resistance-associated protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2609	doxorubicin	ATP-binding cassette sub-family G member 2	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2610	doxorubicin	Multidrug resistance-associated protein 6	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2611	doxorubicin	Caspase-1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2612	doxorubicin	Tyrosine-protein kinase Lck	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2613	doxorubicin	Tyrosine-protein kinase Fyn	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2614	doxorubicin	Receptor tyrosine-protein kinase erbB-2	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2615	doxorubicin	72 kDa type IV collagenase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2616	doxorubicin	DNA topoisomerase 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2617	doxorubicin	Telomerase reverse transcriptase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2618	doxorubicin	DNA topoisomerase 2-beta	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2619	doxorubicin	Aurora kinase A	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2620	doxorubicin	Ribonuclease pancreatic	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2621	doxorubicin	Arachidonate 15-lipoxygenase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2622	doxorubicin	5-hydroxytryptamine receptor 1B	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2623	doxorubicin	Integrase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2624	doxorubicin	Reverse transcriptase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2625	doxorubicin	Type-2 restriction enzyme HindIII	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2626	doxorubicin	Type-2 restriction enzyme ScaI	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2627	doxorubicin	ORF 73	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2628	doxorubicin	UDP-galactopyranose mutase	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2629	doxorubicin	CDGSH iron-sulfur domain-containing protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO
2630	doxylamine	Histamine H1 receptor	CN(C)CCOC(C)(C1=CC=CC=C1)C1=NC=CC=C1
2631	drostanolone propionate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C
2632	droperidol	5-hydroxytryptamine receptor 4	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2633	droperidol	D(1A) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2634	droperidol	D(2) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2635	droperidol	Alpha-2A adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2636	droperidol	Potassium voltage-gated channel subfamily H member 2	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2637	droperidol	5-hydroxytryptamine receptor 1A	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2638	droperidol	5-hydroxytryptamine receptor 2A	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2639	droperidol	5-hydroxytryptamine receptor 2B	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2640	droperidol	5-hydroxytryptamine receptor 2C	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2641	droperidol	Alpha-2B adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2642	droperidol	D(3) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2643	droperidol	Histamine H1 receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2644	droperidol	Muscarinic acetylcholine receptor M4	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2645	droperidol	Muscarinic acetylcholine receptor M5	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2646	droperidol	Alpha-2C adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2647	droperidol	D(4) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2648	droperidol	Alpha-1D adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2649	droperidol	Alpha-1B adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2650	droperidol	Membrane-associated progesterone receptor component 1	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2651	droperidol	Alpha-1A adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2652	droperidol	Sodium channel alpha subunits; brain (Types I, II, III)	FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2
2653	drospirenone	Mineralocorticoid receptor	[H][C@@]12[C@@H]3C[C@@H]3[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H]2C[C@H]2C2=CC(=O)CC[C@]12C
2654	drospirenone	Androgen receptor	[H][C@@]12[C@@H]3C[C@@H]3[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H]2C[C@H]2C2=CC(=O)CC[C@]12C
2655	drospirenone	Progesterone receptor	[H][C@@]12[C@@H]3C[C@@H]3[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H]2C[C@H]2C2=CC(=O)CC[C@]12C
2656	droxidopa	Muscarinic acetylcholine receptor M1	N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
2657	droxidopa	Adrenergic receptor	N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
2658	duloxetine	Sodium-dependent serotonin transporter	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2659	duloxetine	Sodium-dependent noradrenaline transporter	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2660	duloxetine	5-hydroxytryptamine receptor 1A	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2661	duloxetine	5-hydroxytryptamine receptor 2A	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2662	duloxetine	5-hydroxytryptamine receptor 2B	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2663	duloxetine	5-hydroxytryptamine receptor 2C	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2664	duloxetine	5-hydroxytryptamine receptor 6	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2665	duloxetine	5-hydroxytryptamine receptor 7	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2666	duloxetine	Histamine H1 receptor	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2667	duloxetine	5-hydroxytryptamine receptor 1B	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2668	duloxetine	5-hydroxytryptamine receptor 1D	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2669	duloxetine	Sodium-dependent dopamine transporter	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2670	duloxetine	5-hydroxytryptamine receptor 1F	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2671	duloxetine	5-hydroxytryptamine receptor 1E	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2672	duloxetine	Transporter	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2673	duloxetine	Serine hydroxymethyltransferase, mitochondrial	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1
2674	dutasteride	Glycine receptor subunit alpha-1	[H][C@@]12CC[C@H](C(=O)NC3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
2675	dutasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 2	[H][C@@]12CC[C@H](C(=O)NC3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
2676	dutasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 1	[H][C@@]12CC[C@H](C(=O)NC3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
2677	dyclonine	Acetylcholinesterase	CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1
2678	dyclonine	Sodium channel protein type 10 subunit alpha	CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1
2679	dydrogesterone	Progesterone receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C
2680	dydrogesterone	Nuclear receptor subfamily 2 group E member 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C
2681	diprophylline	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
2682	diprophylline	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
2683	ebastine	D(1A) dopamine receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2684	ebastine	D(2) dopamine receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2685	ebastine	Alpha-2A adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2686	ebastine	Potassium voltage-gated channel subfamily H member 2	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2687	ebastine	Multidrug resistance protein 1	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2688	ebastine	Sodium-dependent serotonin transporter	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2689	ebastine	Sodium-dependent noradrenaline transporter	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2690	ebastine	5-hydroxytryptamine receptor 1A	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2691	ebastine	5-hydroxytryptamine receptor 2A	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2692	ebastine	5-hydroxytryptamine receptor 2B	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2693	ebastine	5-hydroxytryptamine receptor 2C	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2694	ebastine	5-hydroxytryptamine receptor 6	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2695	ebastine	Alpha-2B adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2696	ebastine	D(3) dopamine receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2697	ebastine	Histamine H2 receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2698	ebastine	Muscarinic acetylcholine receptor M1	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2699	ebastine	Muscarinic acetylcholine receptor M2	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2700	ebastine	Muscarinic acetylcholine receptor M3	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2701	ebastine	Muscarinic acetylcholine receptor M4	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2702	ebastine	Muscarinic acetylcholine receptor M5	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2703	ebastine	Beta-3 adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2704	ebastine	Alpha-2C adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2705	ebastine	Sodium-dependent dopamine transporter	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2706	ebastine	Adenosine receptor A3	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2707	ebastine	D(4) dopamine receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2708	ebastine	Alpha-1D adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2709	ebastine	Acetylcholinesterase	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2710	ebastine	Epidermal growth factor receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2711	ebastine	Tyrosine-protein kinase Fyn	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2712	ebastine	Receptor tyrosine-protein kinase erbB-2	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2713	ebastine	Substance-K receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2714	ebastine	Alpha-1B adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2715	ebastine	5-hydroxytryptamine receptor 1B	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2716	ebastine	Membrane-associated progesterone receptor component 1	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2717	ebastine	Alpha-1A adrenergic receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2718	ebastine	Histamine H1 receptor	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
2719	ebrotidine	Histamine H2 receptor	NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1
2720	echothiophate	Acetylcholinesterase	CCOP(=O)(OCC)SCC[N+](C)(C)C
2721	edatrexate	Dihydrofolate reductase	CCC(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2722	edatrexate	Folylpolyglutamate synthase, mitochondrial	CCC(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2723	edrophonium	Acetylcholinesterase	CC[N+](C)(C)C1=CC=CC(O)=C1
2724	eflornithine	Ornithine decarboxylase	NCCCC(N)(C(F)F)C(O)=O
2725	efonidipine	Voltage-dependent T-type calcium channel subunit alpha-1G	CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1
2726	efonidipine	Voltage-dependent T-type calcium channel subunit alpha-1H	CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1
2727	efonidipine	Voltage-gated L-type calcium channel	CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1
2728	eletriptan	5-hydroxytryptamine receptor 1A	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
2729	eletriptan	5-hydroxytryptamine receptor 1B	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
2730	eletriptan	5-hydroxytryptamine receptor 1D	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
2731	eletriptan	5-hydroxytryptamine receptor 1F	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
2732	eletriptan	5-hydroxytryptamine receptor 1E	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
2733	emedastine	Histamine H1 receptor	CCOCCN1C(=NC2=C1C=CC=C2)N1CCCN(C)CC1
2734	enalapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O
2735	enalaprilat	Angiotensin-converting enzyme	C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
2736	enalaprilat	Angiotensin-converting enzyme 2	C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
2737	enflurane	Glycine receptor subunit alpha-1	FC(F)OC(F)(F)C(F)Cl
2738	enflurane	Potassium channel subfamily K member 2	FC(F)OC(F)(F)C(F)Cl
2739	enflurane	Potassium channel subfamily K member 3	FC(F)OC(F)(F)C(F)Cl
2740	enflurane	Potassium channel subfamily K member 9	FC(F)OC(F)(F)C(F)Cl
2741	enflurane	Potassium channel subfamily K member 10	FC(F)OC(F)(F)C(F)Cl
2742	enflurane	Potassium channel subfamily K member 18	FC(F)OC(F)(F)C(F)Cl
2743	entacapone	Catechol O-methyltransferase	CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N
2744	entacapone	G-protein coupled receptor 35	CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N
2745	entacapone	Alpha-ketoglutarate-dependent dioxygenase FTO	CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N
2746	epalrestat	Alcohol dehydrogenase [NADP(+)]	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1
2747	epalrestat	Aldose reductase	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1
2748	epalrestat	Aldo-keto reductase family 1 member B10	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1
2749	epalrestat	Sorbitol dehydrogenase	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1
2750	epalrestat	Cytochrome P450 4A11	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1
2751	ephedrine	Beta-2 adrenergic receptor	CN[C@@H](C)[C@H](O)C1=CC=CC=C1
2752	epinastine	Alpha-2A adrenergic receptor	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2753	epinastine	Potassium voltage-gated channel subfamily H member 2	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2754	epinastine	Multidrug resistance protein 1	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2755	epinastine	5-hydroxytryptamine receptor 2A	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2756	epinastine	Alpha-1A adrenergic receptor	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2757	epinastine	Histamine H1 receptor	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2758	epinastine	Histamine H2 receptor	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2759	epinastine	Solute carrier family 22 member 2	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2760	epinastine	Multidrug and toxin extrusion protein 1	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2761	epinastine	Multidrug and toxin extrusion protein 2	[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1
2762	epinephrine	Beta-1 adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2763	epinephrine	Beta-2 adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2764	epinephrine	D(1A) dopamine receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2765	epinephrine	D(2) dopamine receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2766	epinephrine	Alpha-2A adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2767	epinephrine	Sodium-dependent noradrenaline transporter	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2768	epinephrine	Alpha-1A adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2769	epinephrine	Alpha-2B adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2770	epinephrine	Alpha-2C adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2771	epinephrine	Alpha-1D adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2772	epinephrine	Alpha-1B adrenergic receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2773	epinephrine	Arachidonate 15-lipoxygenase	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2774	epinephrine	Mu-type opioid receptor	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2775	epinephrine	Adrenergic receptor alpha-2	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2776	epinephrine	Adrenergic receptor beta	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2777	epinephrine	M18 aspartyl aminopeptidase	CNC[C@H](O)C1=CC=C(O)C(O)=C1
2778	eplerenone	Glucocorticoid receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC
2779	eplerenone	Mineralocorticoid receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC
2780	eplerenone	Progesterone receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC
2781	epoprostenol	Prostaglandin E2 receptor EP1 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
2782	epoprostenol	P2Y purinoceptor 12	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
2783	epoprostenol	Prostacyclin receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
2784	epoprostenol	Prostaglandin E2 receptor EP4 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
2785	eprosartan	Type-1 angiotensin II receptor	CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
2786	eprosartan	Type-1B angiotensin II receptor	CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
2787	eprosartan	Type-2 angiotensin II receptor	CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
2788	eprosartan	Angiotensin II receptor (AT-1) type-1	CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
2789	eprosartan	Angiotensin II receptor	CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
2790	eptifibatide	Integrin alpha-IIb/beta-3	NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O
2791	ergotamine	5-hydroxytryptamine receptor 4	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2792	ergotamine	Beta-1 adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2793	ergotamine	Beta-2 adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2794	ergotamine	D(1A) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2795	ergotamine	D(2) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2796	ergotamine	Alpha-2A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2797	ergotamine	Cytochrome P450 3A4	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2798	ergotamine	5-hydroxytryptamine receptor 1A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2799	ergotamine	5-hydroxytryptamine receptor 2A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2800	ergotamine	5-hydroxytryptamine receptor 2B	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2801	ergotamine	5-hydroxytryptamine receptor 2C	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2802	ergotamine	5-hydroxytryptamine receptor 6	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2803	ergotamine	Alpha-1A adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2804	ergotamine	Alpha-2B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2805	ergotamine	D(3) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2806	ergotamine	D(1B) dopamine receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2807	ergotamine	Muscarinic acetylcholine receptor M1	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2808	ergotamine	Muscarinic acetylcholine receptor M2	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2809	ergotamine	5-hydroxytryptamine receptor 1B	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2810	ergotamine	5-hydroxytryptamine receptor 1D	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2811	ergotamine	Alpha-2C adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2812	ergotamine	Alpha-1D adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2813	ergotamine	5-hydroxytryptamine receptor 5A	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2814	ergotamine	5-hydroxytryptamine receptor 1F	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2815	ergotamine	5-hydroxytryptamine receptor 1E	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2816	ergotamine	Tyrosine-protein kinase Lck	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2817	ergotamine	Tyrosine-protein kinase Fyn	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2818	ergotamine	Thromboxane-A synthase	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2819	ergotamine	Alpha-1B adrenergic receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2820	ergotamine	5-hydroxytryptamine receptor 7	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2821	ergotamine	Gastrin/cholecystokinin type B receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2822	ergotamine	Cholecystokinin A receptor	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2823	ergotamine	Adenylate cyclase	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
2824	erlotinib	Tyrosine-protein kinase JAK3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2825	erlotinib	Platelet-derived growth factor receptor beta	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2826	erlotinib	Tyrosine-protein kinase ABL1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2827	erlotinib	Mast/stem cell growth factor receptor Kit	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2828	erlotinib	Epidermal growth factor receptor	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2829	erlotinib	Proto-oncogene tyrosine-protein kinase Src	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2830	erlotinib	Tyrosine-protein kinase Lck	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2831	erlotinib	Tyrosine-protein kinase Yes	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2832	erlotinib	Serine/threonine-protein kinase B-raf	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2833	erlotinib	Receptor-type tyrosine-protein kinase FLT3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2834	erlotinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2835	erlotinib	Vascular endothelial growth factor receptor 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2836	erlotinib	Vascular endothelial growth factor receptor 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2837	erlotinib	Vascular endothelial growth factor receptor 3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2838	erlotinib	Platelet-derived growth factor receptor alpha	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2839	erlotinib	Receptor tyrosine-protein kinase erbB-2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2840	erlotinib	Death-associated protein kinase 3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2841	erlotinib	Focal adhesion kinase 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2842	erlotinib	Tyrosine-protein kinase HCK	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2843	erlotinib	Receptor tyrosine-protein kinase erbB-4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2844	erlotinib	Mitogen-activated protein kinase 10	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2845	erlotinib	Tyrosine-protein kinase JAK2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2846	erlotinib	Calcium/calmodulin-dependent protein kinase type II subunit delta	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2847	erlotinib	Myosin light chain kinase 2, skeletal/cardiac muscle	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2848	erlotinib	Tyrosine-protein kinase CSK	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2849	erlotinib	Ephrin type-A receptor 8	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2850	erlotinib	AP2-associated protein kinase 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2851	erlotinib	Hepatocyte growth factor receptor	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2852	erlotinib	Tyrosine-protein kinase Lyn	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2853	erlotinib	Serine/threonine-protein kinase 17B	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2854	erlotinib	Serine/threonine-protein kinase 10	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2855	erlotinib	Serine/threonine-protein kinase PLK4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2856	erlotinib	Aurora kinase C	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2857	erlotinib	Dual specificity protein kinase TTK	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2858	erlotinib	Abelson tyrosine-protein kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2859	erlotinib	Ephrin type-A receptor 5	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2860	erlotinib	Fibroblast growth factor receptor 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2861	erlotinib	Serine/threonine-protein kinase 17A	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2862	erlotinib	Ephrin type-A receptor 6	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2863	erlotinib	TRAF2 and NCK-interacting protein kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2864	erlotinib	Casein kinase I isoform epsilon	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2865	erlotinib	Tyrosine-protein kinase Fgr	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2866	erlotinib	Aurora kinase A	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2867	erlotinib	ALK tyrosine kinase receptor	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2868	erlotinib	Serine/threonine-protein kinase 36	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2869	erlotinib	Ephrin type-A receptor 3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2870	erlotinib	BMP-2-inducible protein kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2871	erlotinib	Tyrosine-protein kinase FRK	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2872	erlotinib	Cyclin-G-associated kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2873	erlotinib	Receptor-interacting serine/threonine-protein kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2874	erlotinib	Ephrin type-B receptor 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2875	erlotinib	Ephrin type-A receptor 7	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2876	erlotinib	STE20-like serine/threonine-protein kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2877	erlotinib	MAP kinase-interacting serine/threonine-protein kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2878	erlotinib	Mitogen-activated protein kinase 9	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2879	erlotinib	Epithelial discoidin domain-containing receptor 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2880	erlotinib	Solute carrier family 22 member 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2881	erlotinib	Ephrin type-B receptor 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2882	erlotinib	Serine/threonine-protein kinase ULK3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2883	erlotinib	Tyrosine-protein kinase receptor UFO	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2884	erlotinib	Tyrosine-protein kinase receptor TYRO3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2885	erlotinib	Non-receptor tyrosine-protein kinase TNK1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2886	erlotinib	Non-receptor tyrosine-protein kinase TYK2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2887	erlotinib	Casein kinase I isoform delta	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2888	erlotinib	Tyrosine-protein kinase receptor Tie-1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2889	erlotinib	Tyrosine-protein kinase TXK	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2890	erlotinib	MAP kinase-interacting serine/threonine-protein kinase 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2891	erlotinib	Eukaryotic translation initiation factor 2-alpha kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2892	erlotinib	Serine/threonine-protein kinase SIK2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2893	erlotinib	Serine/threonine-protein kinase TNNI3K	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2894	erlotinib	Myotonin-protein kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2895	erlotinib	Chaperone activity of bc1 complex-like, mitochondrial	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2896	erlotinib	Serine/threonine-protein kinase MRCK gamma	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2897	erlotinib	Leukocyte tyrosine kinase receptor	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2898	erlotinib	Aurora kinase B	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2899	erlotinib	Tyrosine-protein kinase Blk	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2900	erlotinib	Tyrosine-protein kinase Mer	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2901	erlotinib	Citron Rho-interacting kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2902	erlotinib	AarF domain-containing protein kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2903	erlotinib	Tubulin alpha-1A chain	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2904	erlotinib	Mitogen-activated protein kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2905	erlotinib	Interferon-induced, double-stranded RNA-activated protein kinase	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2906	erlotinib	Ribosomal protein S6 kinase alpha-4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2907	erlotinib	Misshapen-like kinase 1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2908	erlotinib	Serine/threonine-protein kinase TBK1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2909	erlotinib	Dual specificity tyrosine-phosphorylation-regulated kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2910	erlotinib	Ephrin type-B receptor 6	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2911	erlotinib	G protein-coupled receptor kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2912	erlotinib	Homeodomain-interacting protein kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2913	erlotinib	Mitogen-activated protein kinase kinase kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2914	erlotinib	Mitogen-activated protein kinase kinase kinase 3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2915	erlotinib	SRSF protein kinase 3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2916	erlotinib	Mitogen-activated protein kinase kinase kinase 19	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2917	erlotinib	Receptor-interacting serine/threonine-protein kinase 4	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2918	erlotinib	Receptor tyrosine-protein kinase erbB-3	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2919	erlotinib	Serine/threonine-protein kinase SBK1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2920	erlotinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2921	erlotinib	Dual specificity mitogen-activated protein kinase kinase 5	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2922	erlotinib	Leucine-rich repeat serine/threonine-protein kinase 2	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2923	erlotinib	Solute carrier organic anion transporter family member 2B1	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2
2924	escitalopram	Sodium-dependent serotonin transporter	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2925	escitalopram	Sodium-dependent noradrenaline transporter	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2926	escitalopram	5-hydroxytryptamine receptor 2C	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2927	escitalopram	Alpha-1A adrenergic receptor	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2928	escitalopram	Histamine H1 receptor	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2929	escitalopram	Muscarinic acetylcholine receptor M1	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2930	escitalopram	Sodium-dependent dopamine transporter	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2931	escitalopram	Transporter	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
2932	esmolol	Beta-1 adrenergic receptor	COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1
2933	esmolol	Beta-2 adrenergic receptor	COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1
2934	esomeprazole	Potassium-transporting ATPase	COC1=CC=C2N=C(NC2=C1)[S@@](=O)CC1=C(C)C(OC)=C(C)C=N1
2935	estazolam	GABA-A receptor alpha-1/beta-2/gamma-2	ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1
2936	estazolam	GABA-A receptor alpha-2/beta-3/gamma-2	ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1
2937	estazolam	GABA-A receptor alpha-3/beta-3/gamma-2	ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1
2938	estazolam	GABA-A receptor alpha-5/beta-3/gamma-2	ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1
2939	estradiol	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2940	estradiol	Aldehyde oxidase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2941	estradiol	Glucocorticoid receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2942	estradiol	Sodium-dependent dopamine transporter	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2943	estradiol	Estrogen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2944	estradiol	Androgen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2945	estradiol	Calcium-activated potassium channel subunit alpha-1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2946	estradiol	Estrogen receptor beta	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2947	estradiol	G-protein coupled estrogen receptor 1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2948	estradiol	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2949	estradiol	Steryl-sulfatase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2950	estradiol	Sex hormone-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2951	estradiol	Steroid hormone receptor ERR1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2952	estradiol	Steroid hormone receptor ERR2	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2953	estradiol	Arachidonate 15-lipoxygenase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2954	estradiol	Progesterone receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2955	estradiol	Cytochrome P450 1B1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2956	estradiol cypionate	Estrogen receptor	[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2957	estradiol valerate	Estrogen receptor	[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2958	estramustine phosphate	Estrogen receptor beta	[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3
2959	estramustine phosphate	Tyrosine-protein phosphatase non-receptor type 1	[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3
2960	estramustine phosphate	Tyrosine-protein phosphatase non-receptor type 11	[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3
2961	estramustine phosphate	Protein-tyrosine phosphatase 1C	[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3
2962	eszopiclone	Gamma-aminobutyric acid receptor subunit alpha-1	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2963	eszopiclone	Gamma-aminobutyric acid receptor subunit alpha-2	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2964	eszopiclone	Gamma-aminobutyric acid receptor subunit alpha-3	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2965	eszopiclone	Gamma-aminobutyric acid receptor subunit alpha-4	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2966	eszopiclone	GABA-A receptor alpha-1/beta-2/gamma-2	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2967	eszopiclone	GABA-A receptor alpha-1/beta-2/gamma-3	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2968	eszopiclone	GABA A receptor alpha-3/beta-2/gamma-2	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2969	eszopiclone	GABA A receptor alpha-3/beta-2/gamma-3	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2970	eszopiclone	GABA A receptor alpha-5/beta-2/gamma-2	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2971	eszopiclone	GABA A receptor alpha-5/beta-2/gamma-3	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1
2972	ethacrynic acid	Solute carrier family 12 member 1	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2973	ethacrynic acid	Glutathione S-transferase P	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2974	ethacrynic acid	Glutathione S-transferase A1	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2975	ethacrynic acid	Aldose reductase	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2976	ethacrynic acid	UDP-glucose 4-epimerase	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2977	ethacrynic acid	Glutathione S-transferase omega-1	CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
2978	ethchlorvynol	GABA-A receptor alpha-1/beta-3/gamma-2	CCC(O)(C=CCl)C#C
2979	ethinylestradiol	5-hydroxytryptamine receptor 4	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2980	ethinylestradiol	Nuclear receptor subfamily 1 group I member 3	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2981	ethinylestradiol	Mu-type opioid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2982	ethinylestradiol	Adenosine receptor A2a	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2983	ethinylestradiol	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2984	ethinylestradiol	Sodium-dependent noradrenaline transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2985	ethinylestradiol	Aldehyde oxidase	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2986	ethinylestradiol	Glucocorticoid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2987	ethinylestradiol	Sodium-dependent dopamine transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2988	ethinylestradiol	Adenosine receptor A3	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2989	ethinylestradiol	Kappa-type opioid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2990	ethinylestradiol	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2991	ethinylestradiol	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2992	ethinylestradiol	Estrogen receptor beta	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2993	ethinylestradiol	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2994	ethinylestradiol	Arachidonate 15-lipoxygenase	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2995	ethinylestradiol	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2996	ethinylestradiol	Solute carrier family 22 member 2	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2997	ethinylestradiol	Multidrug and toxin extrusion protein 1	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2998	ethinylestradiol	Multidrug and toxin extrusion protein 2	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
2999	profenamine	Muscarinic acetylcholine receptor M1	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3000	profenamine	Glutamate receptor ionotropic, NMDA 3A	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3001	profenamine	Acetylcholinesterase	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3002	profenamine	Cholinesterase	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3003	profenamine	Solute carrier family 22 member 1	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3004	profenamine	Muscarinic acetylcholine receptor M2	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3005	profenamine	Butyrylcholinesterase	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
3006	ethosuximide	Voltage-dependent T-type calcium channel subunit alpha-1G	CCC1(C)CC(=O)NC1=O
3007	ethotoin	Sodium channel alpha subunit	CCN1C(=O)NC(C1=O)C1=CC=CC=C1
3008	ethoxzolamide	Carbonic anhydrase 2	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3009	ethoxzolamide	Carbonic anhydrase 1	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3010	ethoxzolamide	Carbonic anhydrase 4	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3011	ethoxzolamide	Carbonic anhydrase 9	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3012	ethoxzolamide	Carbonic anhydrase 12	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3013	ethoxzolamide	Carbonic anhydrase 5A, mitochondrial	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3014	ethoxzolamide	Carbonic anhydrase 5B, mitochondrial	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3015	ethoxzolamide	Carbonic anhydrase 7	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3016	ethoxzolamide	Carbonic anhydrase	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3017	ethoxzolamide	Carbonic anhydrase 3	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3018	ethoxzolamide	Carbonic anhydrase 6	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3019	ethoxzolamide	Carbonic anhydrase 14	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3020	ethoxzolamide	Carbonic anhydrase 13	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3021	ethoxzolamide	Carbonic anhydrase 15	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3022	ethoxzolamide	Alpha carbonic anhydrase	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3023	ethoxzolamide	Astrosclerin-3	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3024	ethoxzolamide	Beta-carbonic anhydrase 1	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3025	ethoxzolamide	Delta carbonic anhydrase	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3026	ethoxzolamide	Carbonic anhydrase V	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3027	ethoxzolamide	Carbonic anhydrase, alpha family	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3028	ethoxzolamide	Carbonate dehydratase	CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
3029	ethylestrenol	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3030	ethylestrenol	Sodium-dependent noradrenaline transporter	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3031	ethylestrenol	Muscarinic acetylcholine receptor M2	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3032	ethylestrenol	Estrogen receptor	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3033	ethylestrenol	Androgen receptor	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3034	ethylestrenol	Acetylcholinesterase	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3035	ethylestrenol	Cytochrome P450 2C19	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3036	ethylestrenol	Progesterone receptor	[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
3037	etynodiol	Estrogen receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
3038	etynodiol	Progesterone receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
3039	etynodiol	Amine oxidase [flavin-containing] A	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
3040	etynodiol	Androgen receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
3041	etidocaine	Sodium channel protein type 5 subunit alpha	CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C
3042	etidocaine	Sodium channel protein type 2 subunit alpha	CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C
3043	etidocaine	Sodium channel protein type 4 subunit alpha	CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C
3044	etidocaine	Potassium channel subfamily K member 3	CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C
3045	etilefrine	Beta-1 adrenergic receptor	CCNCC(O)C1=CC(O)=CC=C1
3046	etodolac	Prostaglandin G/H synthase 2	CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(O)=O
3047	etodolac	Prostaglandin G/H synthase 1	CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(O)=O
3048	etomidate	Gamma-aminobutyric acid receptor subunit alpha-1	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3049	etomidate	Cytochrome P450 11B1, mitochondrial	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3050	etomidate	Cytochrome P450 11B2, mitochondrial	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3051	etomidate	Acetylcholine receptor subunit delta	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3052	etomidate	GABA-A receptor alpha-1/beta-2/gamma-2	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3053	etomidate	GABA A receptor alpha-2/beta-2/gamma-2	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
3054	etonogestrel	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
3055	etonogestrel	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
3056	etonogestrel	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
3057	etoposide	Multidrug resistance protein 1	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3058	etoposide	Canalicular multispecific organic anion transporter 1	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3059	etoposide	Nuclear receptor subfamily 1 group I member 2	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3060	etoposide	DNA topoisomerase 2-alpha	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3061	etoposide	Multidrug resistance-associated protein 1	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3062	etoposide	ATP-binding cassette sub-family G member 2	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3063	etoposide	Multidrug resistance-associated protein 6	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3064	etoposide	Canalicular multispecific organic anion transporter 2	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3065	etoposide	DNA topoisomerase 2-beta	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3066	etoposide	Arachidonate 15-lipoxygenase	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
3067	etoricoxib	Prostaglandin G/H synthase 2	CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
3068	etoricoxib	Prostaglandin G/H synthase 1	CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
3069	etoricoxib	Prostaglandin E2 receptor EP2 subtype	CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
3070	etoricoxib	Mitogen-activated protein kinase 14	CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
3071	etretinate	Retinoic acid receptor alpha	CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(C)=C(OC)C=C1C
3072	etretinate	Retinoic acid receptor RXR-gamma	CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(C)=C(OC)C=C1C
3073	everolimus	Multidrug resistance protein 1	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OCCO)[C@@H](C1)OC)[C@]1([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
3074	everolimus	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OCCO)[C@@H](C1)OC)[C@]1([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
3075	everolimus	Serine/threonine-protein kinase mTOR	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OCCO)[C@@H](C1)OC)[C@]1([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
3076	exemestane	Androgen receptor	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C
3077	exemestane	Aromatase	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C
3078	exenatide	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
3079	ezetimibe	Niemann-Pick C1-like protein 1	O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1=CC=C(F)C=C1)C1=CC=C(O)C=C1)C1=CC=C(F)C=C1
3080	fadrozole	Cytochrome P450 11B1, mitochondrial	N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12
3081	fadrozole	Cytochrome P450 11B2, mitochondrial	N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12
3082	fadrozole	Aromatase	N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12
3083	famotidine	Histamine H2 receptor	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3084	famotidine	Carbonic anhydrase 2	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3085	famotidine	Carbonic anhydrase 1	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3086	famotidine	Carbonic anhydrase 4	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3087	famotidine	Carbonic anhydrase 9	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3088	famotidine	Carbonic anhydrase 12	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3089	famotidine	Carbonic anhydrase 5A, mitochondrial	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3090	famotidine	Carbonic anhydrase 5B, mitochondrial	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3091	famotidine	Carbonic anhydrase 7	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3092	famotidine	Carbonic anhydrase 6	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3093	famotidine	Carbonic anhydrase 14	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3094	famotidine	Carbonic anhydrase 13	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3095	famotidine	Solute carrier family 22 member 2	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3096	famotidine	Multidrug and toxin extrusion protein 1	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3097	famotidine	Multidrug and toxin extrusion protein 2	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3098	famotidine	Heat shock protein HSP 90-alpha	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3099	famotidine	Solute carrier family 22 member 3	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1
3100	fasudil	Potassium voltage-gated channel subfamily H member 2	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3101	fasudil	Myosin light chain kinase, smooth muscle	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3102	fasudil	Protein kinase C epsilon type	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3103	fasudil	Serine/threonine-protein kinase N1	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3104	fasudil	Ribosomal protein S6 kinase alpha-5	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3105	fasudil	C-C motif chemokine 2	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3106	fasudil	Serine/threonine-protein kinase N2	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3107	fasudil	cAMP-dependent protein kinase catalytic subunit alpha	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3108	fasudil	Rho-associated protein kinase 2	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3109	fasudil	Rho-associated protein kinase 1	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
3110	febuxostat	Potassium voltage-gated channel subfamily H member 2	CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
3111	febuxostat	Xanthine dehydrogenase/oxidase	CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
3112	felbamate	Glutamate receptor ionotropic, NMDA 2A	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
3113	felbamate	Glutamate receptor ionotropic, NMDA 2B	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
3114	felbinac	Prostaglandin G/H synthase 2	OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1
3115	felbinac	Prostaglandin G/H synthase 1	OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1
3116	felodipine	Aldehyde oxidase	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3117	felodipine	Adenosine receptor A3	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3118	felodipine	Voltage-dependent L-type calcium channel subunit alpha-1C	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3119	felodipine	Voltage-dependent L-type calcium channel subunit alpha-1D	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3120	felodipine	Cytochrome P450 2C9	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3121	felodipine	Voltage-dependent T-type calcium channel subunit alpha-1H	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3122	felodipine	Bile acid receptor	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3123	felodipine	Cystic fibrosis transmembrane conductance regulator	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3124	felodipine	Sodium channel alpha subunits; brain (Types I, II, III)	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
3125	fenbufen	Prostaglandin G/H synthase 1	OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1
3126	fenbufen	Prostaglandin G/H synthase 2	OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1
3127	fenofibrate	Sodium-dependent noradrenaline transporter	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3128	fenofibrate	5-hydroxytryptamine receptor 2A	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3129	fenofibrate	5-hydroxytryptamine receptor 2C	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3130	fenofibrate	D(3) dopamine receptor	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3131	fenofibrate	Beta-3 adrenergic receptor	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3132	fenofibrate	Sodium-dependent dopamine transporter	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3133	fenofibrate	Adenosine receptor A3	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3134	fenofibrate	Acetylcholinesterase	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3135	fenofibrate	Peroxisome proliferator-activated receptor alpha	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3136	fenofibrate	Peroxisome proliferator-activated receptor gamma	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3137	fenofibrate	Fatty acid-binding protein, liver	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3138	fenofibrate	Cruzipain	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
3139	fenoldopam	D(1A) dopamine receptor	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3140	fenoldopam	D(2) dopamine receptor	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3141	fenoldopam	D(1B) dopamine receptor	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3142	fenoldopam	D(4) dopamine receptor	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3143	fenoldopam	Lysine-specific demethylase 4E	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3144	fenoldopam	Adrenergic receptor alpha-1	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3145	fenoldopam	Adenosine A2b receptor	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3146	fenoldopam	FAD-linked sulfhydryl oxidase ALR	OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
3147	fenoprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1
3148	fenoprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1
3149	fenoprofen	Cyclooxygenase	CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1
3150	fenoprofen	Sodium-coupled monocarboxylate transporter 1	CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1
3151	fenoterol	Beta-2 adrenergic receptor	CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1
3152	fentanyl	Mu-type opioid receptor	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3153	fentanyl	Sigma non-opioid intracellular receptor 1	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3154	fentanyl	Potassium voltage-gated channel subfamily H member 2	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3155	fentanyl	Kappa-type opioid receptor	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3156	fentanyl	Delta-type opioid receptor	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3157	fentanyl	Solute carrier family 22 member 1	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3158	fentanyl	Histamine H1 receptor	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3159	fentanyl	Opioid receptor	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3160	fentanyl	Monoamine oxidase	CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
3161	fexofenadine	Potassium voltage-gated channel subfamily H member 2	CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
3162	fexofenadine	Multidrug resistance protein 1	CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
3163	fexofenadine	Histamine H1 receptor	CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
3164	fexofenadine	Solute carrier organic anion transporter family member 1A2	CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
3165	finasteride	Cytochrome P450 2C9	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3166	finasteride	Cytochrome P450 2C19	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3167	finasteride	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3168	finasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 1	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3169	finasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 2	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3170	finasteride	Steroid 5-alpha-reductase	[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
3171	flavoxate	Potassium voltage-gated channel subfamily H member 2	CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1
3172	flavoxate	Phosphodiesterase 4	CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1
3173	flavoxate	Phosphodiesterase 7	CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1
3174	flavoxate	Phosphodiesterase 8	CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1
3175	flecainide	Sodium channel protein type 5 subunit alpha	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3176	flecainide	Potassium voltage-gated channel subfamily H member 2	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3177	flecainide	Sodium channel protein type 4 subunit alpha	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3178	flecainide	Potassium voltage-gated channel subfamily A member 5	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3179	flecainide	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3180	flecainide	Potassium voltage-gated channel subfamily A member 7	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3181	flecainide	Potassium voltage-gated channel subfamily D member 2	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3182	flecainide	Potassium voltage-gated channel subfamily C member 1	FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
3183	floctafenine	Prostaglandin G/H synthase 2	OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1
3184	floctafenine	Prostaglandin G/H synthase 1	OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1
3185	flopropione	Catechol O-methyltransferase	CCC(=O)C1=C(O)C=C(O)C=C1O
3186	floxuridine	Thymidylate synthase	OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O
3187	fludarabine phosphate	Ribonucleoside-diphosphate reductase large subunit	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3188	fludarabine phosphate	Ribonucleoside-diphosphate reductase subunit M2	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3189	fludarabine phosphate	Carbonic anhydrase 5A, mitochondrial	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3190	fludarabine phosphate	Adenosine receptor A1	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3191	fludarabine phosphate	Adenosine receptor A2a	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3192	fludarabine phosphate	Adenosine receptor A3	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3193	fludarabine phosphate	DNA polymerase alpha catalytic subunit	NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1
3194	fludrocortisone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3195	fludrocortisone acetate	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3196	fludrocortisone acetate	Mineralocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3197	flufenamic acid	Prostaglandin G/H synthase 2	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3198	flufenamic acid	Prostaglandin G/H synthase 1	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3199	flufenamic acid	Transthyretin	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3200	flufenamic acid	Androgen receptor	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3201	flufenamic acid	Aldose reductase	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3202	flufenamic acid	Aldo-keto reductase family 1 member C1	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3203	flufenamic acid	Aldo-keto reductase family 1 member C2	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3204	flufenamic acid	Aldo-keto reductase family 1 member C3	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3205	flufenamic acid	Potassium channel subfamily K member 2	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3206	flufenamic acid	Myeloperoxidase	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3207	flufenamic acid	Potassium channel subfamily T member 2	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3208	flufenamic acid	Transient receptor potential cation channel subfamily A member 1	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3209	flufenamic acid	Transient receptor potential cation channel subfamily M member 2	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3210	flufenamic acid	Transient receptor potential cation channel subfamily M member 4	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3211	flufenamic acid	Aldo-keto reductase family 1 member B10	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3212	flufenamic acid	Transient receptor potential cation channel subfamily M member 5	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3213	flufenamic acid	Transcriptional enhancer factor TEF-3	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3214	flufenamic acid	Nicotinate phosphoribosyltransferase	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3215	flufenamic acid	Taste receptor type 2 member 14	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1
3216	flumazenil	Gamma-aminobutyric acid receptor subunit alpha-1	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3217	flumazenil	Gamma-aminobutyric acid receptor subunit alpha-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3218	flumazenil	Gamma-aminobutyric acid receptor subunit alpha-3	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3219	flumazenil	Gamma-aminobutyric acid receptor subunit alpha-5	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3220	flumazenil	Gamma-aminobutyric acid receptor subunit alpha-4	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3221	flumazenil	GABA-A receptor alpha-2/beta-3/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3222	flumazenil	GABA-A receptor alpha-3/beta-3/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3223	flumazenil	GABA-A receptor alpha-5/beta-3/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3224	flumazenil	GABA-A receptor alpha-1/beta-3/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3225	flumazenil	GABA-A receptor; anion channel	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3226	flumazenil	GABA A receptor alpha-3/beta-2/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3227	flumazenil	GABA A receptor alpha-6/beta-2/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3228	flumazenil	GABA-A receptor; alpha-1/beta-2/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3229	flumazenil	GABA-A receptor alpha-6/beta-3/gamma-2	CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1
3230	flumetasone pivalate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
3231	flunarizine	Cannabinoid receptor 1	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3232	flunarizine	Mu-type opioid receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3233	flunarizine	D(1A) dopamine receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3234	flunarizine	D(2) dopamine receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3235	flunarizine	Alpha-2A adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3236	flunarizine	Sigma non-opioid intracellular receptor 1	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3237	flunarizine	Potassium voltage-gated channel subfamily H member 2	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3238	flunarizine	Sodium-dependent serotonin transporter	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3239	flunarizine	Sodium-dependent noradrenaline transporter	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3240	flunarizine	5-hydroxytryptamine receptor 1A	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3241	flunarizine	5-hydroxytryptamine receptor 2A	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3242	flunarizine	5-hydroxytryptamine receptor 2B	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3243	flunarizine	5-hydroxytryptamine receptor 2C	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3244	flunarizine	Alpha-2B adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3245	flunarizine	D(3) dopamine receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3246	flunarizine	Histamine H1 receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3247	flunarizine	Muscarinic acetylcholine receptor M1	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3248	flunarizine	Muscarinic acetylcholine receptor M3	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3249	flunarizine	Muscarinic acetylcholine receptor M4	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3250	flunarizine	Muscarinic acetylcholine receptor M5	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3251	flunarizine	Alpha-2C adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3252	flunarizine	Sodium channel protein type 1 subunit alpha	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3253	flunarizine	Sodium-dependent dopamine transporter	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3254	flunarizine	Adenosine receptor A3	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3255	flunarizine	Alpha-1D adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3256	flunarizine	Kappa-type opioid receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3257	flunarizine	Delta-type opioid receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3258	flunarizine	Voltage-dependent N-type calcium channel subunit alpha-1B	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3259	flunarizine	Alpha-1B adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3260	flunarizine	Membrane-associated progesterone receptor component 1	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3261	flunarizine	Alpha-1A adrenergic receptor	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3262	flunarizine	Sodium channel protein type 2 subunit alpha	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3263	flunarizine	Sodium channel alpha subunits; brain (Types I, II, III)	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3264	flunarizine	CAAX prenyl protease 2	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3265	flunarizine	Potassium channel subfamily K member 2	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3266	flunarizine	Voltage-dependent T-type calcium channel subunit alpha-1G	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3267	flunarizine	Voltage-dependent T-type calcium channel subunit alpha-1H	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3268	flunarizine	Voltage-dependent T-type calcium channel subunit alpha-1I	FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
3269	flunisolide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3270	flunisolide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3271	flunitrazepam	Gamma-aminobutyric acid receptor subunit alpha-1	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3272	flunitrazepam	Gamma-aminobutyric acid receptor subunit alpha-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3273	flunitrazepam	Gamma-aminobutyric acid receptor subunit alpha-3	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3274	flunitrazepam	Gamma-aminobutyric acid receptor subunit alpha-5	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3275	flunitrazepam	GABA-A receptor alpha-1/beta-2/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3276	flunitrazepam	GABA-A receptor alpha-2/beta-3/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3277	flunitrazepam	GABA-A receptor alpha-3/beta-3/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3278	flunitrazepam	GABA-A receptor alpha-5/beta-3/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3279	flunitrazepam	GABA-A receptor alpha-1/beta-2/gamma-3	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3280	flunitrazepam	GABA-A receptor alpha-1/beta-3/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3281	flunitrazepam	GABA-A receptor; anion channel	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3282	flunitrazepam	GABA A receptor alpha-3/beta-2/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3283	flunitrazepam	GABA A receptor alpha-3/beta-2/gamma-3	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3284	flunitrazepam	GABA A receptor alpha-5/beta-3/gamma-3	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3285	flunitrazepam	GABA A receptor alpha-5/beta-2/gamma-2	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3286	flunitrazepam	GABA A receptor alpha-5/beta-2/gamma-3	CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O
3287	fluocinolone acetonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3288	fluocinolone acetonide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3289	fluocinonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O
3290	fluocinonide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O
3291	fluorometholone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
3292	fluorometholone	Androgen receptor	[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
3293	fluorometholone	Progesterone receptor	[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
3294	fluoxetine	Beta-1 adrenergic receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3295	fluoxetine	Alpha-2A adrenergic receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3296	fluoxetine	Sigma non-opioid intracellular receptor 1	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3297	fluoxetine	Potassium voltage-gated channel subfamily H member 2	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3298	fluoxetine	Sodium-dependent serotonin transporter	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3299	fluoxetine	Sodium-dependent noradrenaline transporter	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3300	fluoxetine	5-hydroxytryptamine receptor 2A	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3301	fluoxetine	5-hydroxytryptamine receptor 2B	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3302	fluoxetine	5-hydroxytryptamine receptor 2C	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3303	fluoxetine	5-hydroxytryptamine receptor 6	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3304	fluoxetine	Alpha-1A adrenergic receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3305	fluoxetine	Alpha-2B adrenergic receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3306	fluoxetine	D(3) dopamine receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3307	fluoxetine	Histamine H1 receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3308	fluoxetine	Muscarinic acetylcholine receptor M1	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3309	fluoxetine	Muscarinic acetylcholine receptor M2	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3310	fluoxetine	Muscarinic acetylcholine receptor M3	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3311	fluoxetine	Muscarinic acetylcholine receptor M4	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3312	fluoxetine	Muscarinic acetylcholine receptor M5	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3313	fluoxetine	Sodium-dependent dopamine transporter	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3314	fluoxetine	Cytochrome P450 2D6	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3315	fluoxetine	Acetylcholinesterase	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3316	fluoxetine	Potassium channel subfamily K member 2	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3317	fluoxetine	Histamine H3 receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3318	fluoxetine	Transporter	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3319	fluoxetine	Serotonin 1 (5-HT1) receptor	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3320	fluoxetine	Adrenergic receptor alpha-2	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3321	fluoxetine	Adrenergic receptor alpha-1	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3322	fluoxetine	Equilibrative nucleoside transporter 4	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3323	fluoxetine	Potassium voltage-gated channel subfamily C member 1	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3324	fluoxetine	G protein-activated inward rectifier potassium channel 2	CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
3325	fluoxymesterone	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3326	flupentixol	D(1A) dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3327	flupentixol	D(2) dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3328	flupentixol	Sigma non-opioid intracellular receptor 1	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3329	flupentixol	5-hydroxytryptamine receptor 1A	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3330	flupentixol	5-hydroxytryptamine receptor 2A	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3331	flupentixol	Alpha-1A adrenergic receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3332	flupentixol	D(3) dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3333	flupentixol	D(1B) dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3334	flupentixol	Histamine H1 receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3335	flupentixol	D(4) dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3336	flupentixol	Potassium channel subfamily K member 2	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3337	flupentixol	Solute carrier family 22 member 1	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3338	flupentixol	Dopamine receptor	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3339	fluphenazine	Mu-type opioid receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3340	fluphenazine	D(1A) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3341	fluphenazine	D(2) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3342	fluphenazine	Alpha-2A adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3343	fluphenazine	Sigma non-opioid intracellular receptor 1	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3344	fluphenazine	Potassium voltage-gated channel subfamily H member 2	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3345	fluphenazine	Sodium-dependent serotonin transporter	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3346	fluphenazine	Sodium-dependent noradrenaline transporter	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3347	fluphenazine	5-hydroxytryptamine receptor 1A	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3348	fluphenazine	5-hydroxytryptamine receptor 2A	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3349	fluphenazine	5-hydroxytryptamine receptor 2B	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3350	fluphenazine	5-hydroxytryptamine receptor 2C	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3351	fluphenazine	5-hydroxytryptamine receptor 6	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3352	fluphenazine	5-hydroxytryptamine receptor 7	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3353	fluphenazine	Alpha-1A adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3354	fluphenazine	Alpha-2B adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3355	fluphenazine	D(3) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3356	fluphenazine	D(1B) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3357	fluphenazine	Histamine H1 receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3358	fluphenazine	Histamine H2 receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3359	fluphenazine	Muscarinic acetylcholine receptor M1	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3360	fluphenazine	Muscarinic acetylcholine receptor M2	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3361	fluphenazine	Muscarinic acetylcholine receptor M3	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3362	fluphenazine	Muscarinic acetylcholine receptor M4	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3363	fluphenazine	Muscarinic acetylcholine receptor M5	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3364	fluphenazine	Beta-3 adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3365	fluphenazine	5-hydroxytryptamine receptor 1B	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3366	fluphenazine	5-hydroxytryptamine receptor 1D	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3367	fluphenazine	Alpha-2C adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3368	fluphenazine	Sodium-dependent dopamine transporter	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3369	fluphenazine	Adenosine receptor A3	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3370	fluphenazine	D(4) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3371	fluphenazine	Alpha-1D adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3372	fluphenazine	Alpha-1B adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3373	fluphenazine	Kappa-type opioid receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3374	fluphenazine	Delta-type opioid receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3375	fluphenazine	5-hydroxytryptamine receptor 5A	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3376	fluphenazine	5-hydroxytryptamine receptor 1E	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3377	fluphenazine	Epidermal growth factor receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3378	fluphenazine	Potassium channel subfamily K member 2	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3379	fluphenazine	Tyrosine-protein kinase Fyn	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3380	fluphenazine	Receptor tyrosine-protein kinase erbB-2	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3381	fluphenazine	Substance-K receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3382	fluphenazine	Androgen receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3383	fluphenazine	Trypanothione reductase	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3384	fluphenazine	Melanocortin receptor 5	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3385	fluphenazine	Membrane-associated progesterone receptor component 1	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3386	fluphenazine	Pleiotropic ABC efflux transporter of multiple drugs	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3387	fluphenazine	Sodium channel alpha subunits; brain (Types I, II, III)	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3388	fluphenazine	Adenylate cyclase	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1
3389	fluphenazine decanoate	D(2) dopamine receptor	CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3390	fluphenazine enanthate	D(1A) dopamine receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3391	fluphenazine enanthate	D(2) dopamine receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3392	fluphenazine enanthate	Alpha-2A adrenergic receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3393	fluphenazine enanthate	Sodium-dependent serotonin transporter	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3394	fluphenazine enanthate	5-hydroxytryptamine receptor 1A	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3395	fluphenazine enanthate	5-hydroxytryptamine receptor 2A	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3396	fluphenazine enanthate	5-hydroxytryptamine receptor 2C	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3397	fluphenazine enanthate	5-hydroxytryptamine receptor 6	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3398	fluphenazine enanthate	5-hydroxytryptamine receptor 7	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3399	fluphenazine enanthate	Alpha-1A adrenergic receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3400	fluphenazine enanthate	Alpha-2B adrenergic receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3401	fluphenazine enanthate	D(3) dopamine receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3402	fluphenazine enanthate	D(1B) dopamine receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3403	fluphenazine enanthate	Histamine H1 receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3404	fluphenazine enanthate	Histamine H2 receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3405	fluphenazine enanthate	Muscarinic acetylcholine receptor M1	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3406	fluphenazine enanthate	Muscarinic acetylcholine receptor M2	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3407	fluphenazine enanthate	Muscarinic acetylcholine receptor M3	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3408	fluphenazine enanthate	Muscarinic acetylcholine receptor M4	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3409	fluphenazine enanthate	Muscarinic acetylcholine receptor M5	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3410	fluphenazine enanthate	5-hydroxytryptamine receptor 1B	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3411	fluphenazine enanthate	5-hydroxytryptamine receptor 1D	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3412	fluphenazine enanthate	Alpha-2C adrenergic receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3413	fluphenazine enanthate	D(4) dopamine receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3414	fluphenazine enanthate	Alpha-1B adrenergic receptor	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3415	fluphenazine enanthate	5-hydroxytryptamine receptor 5A	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3416	fluphenazine enanthate	5-hydroxytryptamine receptor 1E	CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
3417	fluprednisolone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
3418	fludroxycortide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3419	fludroxycortide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
3420	flurazepam	Solute carrier family 22 member 2	CCN(CC)CCN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=C(F)C=CC=C1
3421	flurazepam	GABA-A receptor alpha-1/beta-2/gamma-2	CCN(CC)CCN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=C(F)C=CC=C1
3422	flurbiprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3423	flurbiprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3424	flurbiprofen	Aldo-keto reductase family 1 member C2	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3425	flurbiprofen	Aldo-keto reductase family 1 member C3	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3426	flurbiprofen	Fatty acid-binding protein, intestinal	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3427	flurbiprofen	Fatty acid-binding protein, liver	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
3428	flutamide	5-hydroxytryptamine receptor 4	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3429	flutamide	5-hydroxytryptamine receptor 6	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3430	flutamide	Androgen receptor	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3431	flutamide	Cytochrome P450 1A2	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3432	flutamide	Bile salt export pump	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3433	fluticasone propionate	Glucocorticoid receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CC)C(=O)SCF
3434	fluticasone propionate	Mineralocorticoid receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CC)C(=O)SCF
3435	fluticasone propionate	Progesterone receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CC)C(=O)SCF
3436	fluticasone propionate	Cytosolic phospholipase A2	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CC)C(=O)SCF
3437	fluvastatin	Nuclear receptor subfamily 1 group I member 3	CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1
3438	fluvastatin	Cytochrome P450 2C9	CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1
3439	fluvastatin	Retinoic acid receptor RXR-alpha	CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1
3440	fluvastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1
3441	fluvastatin	Sodium/bile acid cotransporter	CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1
3442	fluvoxamine	Sigma non-opioid intracellular receptor 1	COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3443	fluvoxamine	Sodium-dependent serotonin transporter	COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3444	fluvoxamine	Sodium-dependent noradrenaline transporter	COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3445	fluvoxamine	Sodium-dependent dopamine transporter	COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3446	fluvoxamine	Cytochrome P450 1A2	COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3447	fomepizole	Alcohol dehydrogenase	CC1=CNN=C1
3448	fondaparinux	Antithrombin-III	[H][C@@]1(O[C@@H]2[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]3([H])[C@H](O)[C@@H](OS(O)(=O)=O)[C@H](O[C@@]4([H])[C@H](O)[C@@H](NS(O)(=O)=O)[C@@H](OC)O[C@@H]4COS(O)(=O)=O)O[C@H]3C(O)=O)[C@H](NS(O)(=O)=O)[C@H]2OS(O)(=O)=O)O[C@@H]([C@@H](O[C@@]2([H])O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]2NS(O)(=O)=O)[C@H](O)[C@H]1O)C(O)=O
3449	formoterol	Beta-1 adrenergic receptor	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3450	formoterol	Beta-2 adrenergic receptor	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3451	formoterol	D(2) dopamine receptor	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3452	formoterol	D(3) dopamine receptor	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3453	formoterol	Beta-3 adrenergic receptor	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3454	formoterol	Heat shock protein HSP 90-alpha	COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
3455	fosinopril	Angiotensin-converting enzyme	CCC(=O)O[C@@H](O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C
3456	fosphenytoin	Sodium channel protein type 5 subunit alpha	OP(O)(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
3457	frovatriptan	5-hydroxytryptamine receptor 1A	CN[C@@H]1CCC2=C(C1)C1=CC(=CC=C1N2)C(N)=O
3458	frovatriptan	5-hydroxytryptamine receptor 1B	CN[C@@H]1CCC2=C(C1)C1=CC(=CC=C1N2)C(N)=O
3459	frovatriptan	5-hydroxytryptamine receptor 1D	CN[C@@H]1CCC2=C(C1)C1=CC(=CC=C1N2)C(N)=O
3460	fulvestrant	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3461	fulvestrant	Beta-lactamase TEM	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3462	fulvestrant	Estrogen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3463	fulvestrant	Progesterone receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3464	fulvestrant	Estrogen receptor beta	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3465	fulvestrant	G-protein coupled estrogen receptor 1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3466	fulvestrant	Bile acid receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3467	fulvestrant	Steroid hormone receptor ERR1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3468	fulvestrant	Bifunctional epoxide hydrolase 2	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
3469	furosemide	Solute carrier family 12 member 1	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3470	furosemide	Sodium/potassium-transporting ATPase subunit alpha-1	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3471	furosemide	Carbonic anhydrase 2	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3472	furosemide	Carbonic anhydrase 1	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3473	furosemide	Carbonic anhydrase 4	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3474	furosemide	Carbonic anhydrase 9	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3475	furosemide	Carbonic anhydrase 12	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3476	furosemide	Carbonic anhydrase 5A, mitochondrial	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3477	furosemide	Carbonic anhydrase 5B, mitochondrial	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3478	furosemide	Carbonic anhydrase 7	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3479	furosemide	Carbonic anhydrase 6	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3480	furosemide	Carbonic anhydrase 14	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3481	furosemide	Corticosteroid 11-beta-dehydrogenase isozyme 1	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3482	furosemide	Solute carrier family 12 member 2	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3483	furosemide	Carbonic anhydrase 13	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3484	furosemide	G-protein coupled receptor 35	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3485	furosemide	Holo-[acyl-carrieir-protein] synthase	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3486	furosemide	CDGSH iron-sulfur domain-containing protein 1	NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
3487	gabapentin	Sodium channel protein type 5 subunit alpha	NCC1(CC(O)=O)CCCCC1
3488	gabapentin	Alpha-2A adrenergic receptor	NCC1(CC(O)=O)CCCCC1
3489	gabapentin	Adenosine receptor A1	NCC1(CC(O)=O)CCCCC1
3490	gabapentin	Gamma-aminobutyric acid type B receptor subunit 2	NCC1(CC(O)=O)CCCCC1
3491	gabapentin	Glutamate receptor ionotropic, NMDA 3A	NCC1(CC(O)=O)CCCCC1
3492	gabapentin	Large neutral amino acids transporter small subunit 1	NCC1(CC(O)=O)CCCCC1
3493	gabapentin	Voltage-dependent calcium channel subunit alpha-2/delta-1	NCC1(CC(O)=O)CCCCC1
3494	gabapentin	Potassium voltage-gated channel subfamily KQT member 3	NCC1(CC(O)=O)CCCCC1
3495	gabapentin	Potassium voltage-gated channel subfamily KQT member 5	NCC1(CC(O)=O)CCCCC1
3496	gabapentin	Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit	NCC1(CC(O)=O)CCCCC1
3497	gabapentin	Voltage-dependent calcium channel subunit alpha-2/delta-2	NCC1(CC(O)=O)CCCCC1
3498	galantamine	Acetylcholinesterase	[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13
3499	galantamine	Cholinesterase	[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13
3500	galantamine	Butyrylcholinesterase; Protein Bche	[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13
3501	galantamine	Butyrylcholinesterase	[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13
3502	gallamine	Muscarinic acetylcholine receptor M1	CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
3503	gallamine	Acetylcholinesterase	CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
3504	gallamine	Muscarinic acetylcholine receptor M2	CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
3505	gallamine	Acetylcholine receptor subunit alpha	CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
3506	ganirelix	Gonadotropin-releasing hormone receptor	CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
3507	gefitinib	ATP-binding cassette sub-family G member 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3508	gefitinib	Tyrosine-protein kinase ABL1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3509	gefitinib	Mast/stem cell growth factor receptor Kit	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3510	gefitinib	Epidermal growth factor receptor	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3511	gefitinib	Tyrosine-protein kinase Lck	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3512	gefitinib	Serine/threonine-protein kinase B-raf	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3513	gefitinib	Receptor-type tyrosine-protein kinase FLT3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3514	gefitinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3515	gefitinib	Vascular endothelial growth factor receptor 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3516	gefitinib	Receptor tyrosine-protein kinase erbB-2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3517	gefitinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3518	gefitinib	Death-associated protein kinase 3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3519	gefitinib	Tyrosine-protein kinase HCK	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3520	gefitinib	Receptor tyrosine-protein kinase erbB-4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3521	gefitinib	Mitogen-activated protein kinase 10	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3522	gefitinib	Myosin light chain kinase 2, skeletal/cardiac muscle	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3523	gefitinib	Ephrin type-A receptor 8	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3524	gefitinib	Hepatocyte growth factor receptor	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3525	gefitinib	Tyrosine-protein kinase Lyn	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3526	gefitinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3527	gefitinib	Serine/threonine-protein kinase 17B	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3528	gefitinib	Serine/threonine-protein kinase 10	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3529	gefitinib	Abelson tyrosine-protein kinase 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3530	gefitinib	Ephrin type-A receptor 5	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3531	gefitinib	Serine/threonine-protein kinase 17A	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3532	gefitinib	Ephrin type-A receptor 6	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3533	gefitinib	TRAF2 and NCK-interacting protein kinase	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3534	gefitinib	Casein kinase I isoform epsilon	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3535	gefitinib	Tyrosine-protein kinase Fgr	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3536	gefitinib	Serine/threonine-protein kinase 36	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3537	gefitinib	Ephrin type-A receptor 3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3538	gefitinib	Tyrosine-protein kinase FRK	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3539	gefitinib	Beta-secretase 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3540	gefitinib	Cyclin-G-associated kinase	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3541	gefitinib	Receptor-interacting serine/threonine-protein kinase 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3542	gefitinib	Ephrin type-B receptor 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3543	gefitinib	Activated CDC42 kinase 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3544	gefitinib	STE20-like serine/threonine-protein kinase	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3545	gefitinib	MAP kinase-interacting serine/threonine-protein kinase 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3546	gefitinib	Mitogen-activated protein kinase 9	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3547	gefitinib	Ephrin type-B receptor 4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3548	gefitinib	Serine/threonine-protein kinase ULK3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3549	gefitinib	Protein-tyrosine kinase 6	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3550	gefitinib	Tyrosine-protein kinase receptor UFO	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3551	gefitinib	Cyclin-dependent kinase 7	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3552	gefitinib	Serine/threonine-protein kinase D1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3553	gefitinib	Serine/threonine-protein kinase DCLK3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3554	gefitinib	NUAK family SNF1-like kinase 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3555	gefitinib	Casein kinase I isoform delta	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3556	gefitinib	Tyrosine-protein kinase TXK	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3557	gefitinib	MAP kinase-interacting serine/threonine-protein kinase 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3558	gefitinib	Serine/threonine-protein kinase NLK	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3559	gefitinib	Interleukin-1 receptor-associated kinase 3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3560	gefitinib	Serine/threonine-protein kinase SIK2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3561	gefitinib	Myotonin-protein kinase	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3562	gefitinib	Leukocyte tyrosine kinase receptor	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3563	gefitinib	Serine/threonine-protein kinase pim-3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3564	gefitinib	Tyrosine-protein kinase Blk	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3565	gefitinib	Citron Rho-interacting kinase	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3566	gefitinib	Ephrin type-A receptor 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3567	gefitinib	Tubulin alpha-1A chain	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3568	gefitinib	Mitogen-activated protein kinase 6	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3569	gefitinib	Mitogen-activated protein kinase 4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3570	gefitinib	Ribosomal protein S6 kinase alpha-4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3571	gefitinib	Cruzipain	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3572	gefitinib	Misshapen-like kinase 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3573	gefitinib	Interleukin-1 receptor-associated kinase 4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3574	gefitinib	Serine/threonine-protein kinase Chk2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3575	gefitinib	Ephrin type-B receptor 6	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3576	gefitinib	Homeodomain-interacting protein kinase 4	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3577	gefitinib	Interleukin-1 receptor-associated kinase 1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3578	gefitinib	Mitogen-activated protein kinase kinase kinase 2	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3579	gefitinib	Mitogen-activated protein kinase kinase kinase 3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3580	gefitinib	Mitogen-activated protein kinase kinase kinase 19	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3581	gefitinib	Receptor tyrosine-protein kinase erbB-3	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3582	gefitinib	Quinolone resistance protein NorA	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3583	gefitinib	Serine/threonine-protein kinase SBK1	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3584	gefitinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3585	gefitinib	Dual specificity mitogen-activated protein kinase kinase 5	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3586	gefitinib	Proto-oncogene tyrosine-protein kinase Src	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
3587	gemcitabine	Thymidylate synthase	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3588	gemcitabine	Deoxycytidine kinase	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3589	gemcitabine	Ribonucleoside-diphosphate reductase large subunit	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3590	gemcitabine	Ribonucleoside-diphosphate reductase subunit M2	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3591	gemcitabine	UMP-CMP kinase	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3592	gemcitabine	DNA polymerase (alpha/delta/epsilon)	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
3593	gemfibrozil	Lipoprotein lipase	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3594	gemfibrozil	Transthyretin	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3595	gemfibrozil	Cytochrome P450 2C8	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3596	gemfibrozil	Cytochrome P450 2C9	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3597	gemfibrozil	Peroxisome proliferator-activated receptor alpha	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3598	gemfibrozil	Fatty acid-binding protein, liver	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3599	gemfibrozil	CDGSH iron-sulfur domain-containing protein 1	CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3600	gimeracil	Dihydropyrimidine dehydrogenase [NADP(+)]	OC1=CC(=O)NC=C1Cl
3601	glibornuride	Sulfonylurea receptor 2, Kir6.2	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]1[C@H](O)[C@]2(C)CC[C@H]1C2(C)C
3602	glibornuride	Sulfonylurea receptor 1, Kir6.2	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]1[C@H](O)[C@]2(C)CC[C@H]1C2(C)C
3603	gliclazide	Sulfonylurea receptor 2, Kir6.2	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1
3604	gliclazide	Sulfonylurea receptor 1, Kir6.2	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1
3605	glimepiride	Sulfonylurea receptor 1, Kir6.2	CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O
3606	glimepiride	Sulfonylurea receptor 2, Kir6.2	CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O
3607	glipizide	Sulfonylurea receptor 1, Kir6.2	CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3608	gliquidone	Sulfonylurea receptor 1, Kir6.2	COC1=CC=C2C(=C1)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C
3609	glisoxepide	Sulfonylurea receptor 1, Kir6.2	CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
3610	glutethimide	GABA-A receptor alpha-1/beta-3/gamma-2	CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
3611	glibenclamide	Potassium voltage-gated channel subfamily H member 2	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3612	glibenclamide	Bile salt export pump	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3613	glibenclamide	Cytochrome P450 2C9	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3614	glibenclamide	Peroxisome proliferator-activated receptor gamma	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3615	glibenclamide	Cystic fibrosis transmembrane conductance regulator	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3616	glibenclamide	Sulfonylurea receptor 2, Kir6.2	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3617	glibenclamide	ATP-sensitive inward rectifier potassium channel 11	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3618	glibenclamide	NACHT, LRR and PYD domains-containing protein 3	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3619	glibenclamide	CDGSH iron-sulfur domain-containing protein 1	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3620	glibenclamide	Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3621	glibenclamide	Sulfonylurea receptor 1, Kir6.2	COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
3622	goserelin	Lutropin-choriogonadotropic hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O
3623	goserelin	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O
3624	granisetron	Potassium voltage-gated channel subfamily H member 2	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3625	granisetron	5-hydroxytryptamine receptor 3A	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3626	granisetron	Solute carrier family 22 member 2	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3627	granisetron	Multidrug and toxin extrusion protein 1	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3628	granisetron	Serotonin 3 (5-HT3) receptor	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3629	granisetron	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3630	granisetron	5-hydroxytryptamine receptor 3B	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3631	granisetron	Neuronal acetylcholine receptor subunit alpha-3	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2
3632	guanadrel	Sodium-dependent noradrenaline transporter	NC(=N)NCC1COC2(CCCCC2)O1
3633	guanadrel	Alpha-1A adrenergic receptor	NC(=N)NCC1COC2(CCCCC2)O1
3634	guanethidine	Alpha-2A adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3635	guanethidine	Sodium-dependent noradrenaline transporter	NC(=N)NCCN1CCCCCCC1
3636	guanethidine	Alpha-1A adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3637	guanethidine	Alpha-2B adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3638	guanethidine	Alpha-2C adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3639	guanethidine	Alpha-1D adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3640	guanethidine	Alpha-1B adrenergic receptor	NC(=N)NCCN1CCCCCCC1
3641	guanfacine	5-hydroxytryptamine receptor 2A	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3642	guanfacine	5-hydroxytryptamine receptor 2B	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3643	guanfacine	5-hydroxytryptamine receptor 2C	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3644	guanfacine	Alpha-2B adrenergic receptor	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3645	guanfacine	Alpha-2C adrenergic receptor	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3646	guanfacine	Alpha-1D adrenergic receptor	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3647	guanfacine	Nischarin	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3648	guanfacine	Alpha-1A adrenergic receptor	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3649	guanfacine	Alpha-2A adrenergic receptor	NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
3650	guanidine	Voltage-gated potassium channel	NC(N)=N
3651	halazepam	GABA-A receptor; anion channel	FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1
3652	ulobetasol propionate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
3653	haloperidol	Beta-2 adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3654	haloperidol	Mu-type opioid receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3655	haloperidol	D(1A) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3656	haloperidol	D(2) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3657	haloperidol	Alpha-2A adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3658	haloperidol	Sigma non-opioid intracellular receptor 1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3659	haloperidol	Potassium voltage-gated channel subfamily H member 2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3660	haloperidol	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3661	haloperidol	Multidrug resistance protein 1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3662	haloperidol	Sodium-dependent serotonin transporter	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3663	haloperidol	Sodium-dependent noradrenaline transporter	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3664	haloperidol	5-hydroxytryptamine receptor 1A	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3665	haloperidol	5-hydroxytryptamine receptor 2A	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3666	haloperidol	5-hydroxytryptamine receptor 2B	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3667	haloperidol	5-hydroxytryptamine receptor 2C	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3668	haloperidol	5-hydroxytryptamine receptor 6	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3669	haloperidol	5-hydroxytryptamine receptor 7	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3670	haloperidol	Alpha-1A adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3671	haloperidol	Alpha-2B adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3672	haloperidol	D(3) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3673	haloperidol	D(1B) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3674	haloperidol	Histamine H1 receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3675	haloperidol	Histamine H2 receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3676	haloperidol	Muscarinic acetylcholine receptor M1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3677	haloperidol	Muscarinic acetylcholine receptor M3	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3678	haloperidol	Muscarinic acetylcholine receptor M5	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3679	haloperidol	5-hydroxytryptamine receptor 1B	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3680	haloperidol	5-hydroxytryptamine receptor 1D	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3681	haloperidol	Alpha-2C adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3682	haloperidol	Alpha-1D adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3683	haloperidol	Alpha-1B adrenergic receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3684	haloperidol	Calmodulin	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3685	haloperidol	5-hydroxytryptamine receptor 5A	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3686	haloperidol	5-hydroxytryptamine receptor 1F	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3687	haloperidol	5-hydroxytryptamine receptor 1E	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3688	haloperidol	Potassium channel subfamily K member 2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3689	haloperidol	Potassium voltage-gated channel subfamily H member 1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3690	haloperidol	Membrane-associated progesterone receptor component 1	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3691	haloperidol	Pol polyprotein	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3692	haloperidol	Muscarinic acetylcholine receptor M2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3693	haloperidol	Protease	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3694	haloperidol	C-8 sterol isomerase	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3695	haloperidol	Transporter	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3696	haloperidol	Vesicular acetylcholine transporter	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3697	haloperidol	AP-2 complex subunit sigma	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3698	haloperidol	Muscarinic acetylcholine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3699	haloperidol	Opioid receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3700	haloperidol	Serotonin 1 (5-HT1) receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3701	haloperidol	Adrenergic receptor alpha-2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3702	haloperidol	Dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3703	haloperidol	Sodium channel alpha subunits; brain (Types I, II, III)	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3704	haloperidol	Serotonin 2 (5-HT2) receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3705	haloperidol	Adenylate cyclase	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3706	haloperidol	G protein-activated inward rectifier potassium channel 2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3707	haloperidol	Histone H1.0	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3708	haloperidol	Transmembrane protein 97	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3709	haloperidol	Sigma intracellular receptor 2	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3710	haloperidol	Zinc finger protein 664	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3711	haloperidol	D(4) dopamine receptor	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
3712	halopredone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@@H](F)C2=CC(=O)C(Br)=C[C@]12C
3713	halothane	Potassium channel subfamily K member 2	FC(F)(F)C(Cl)Br
3714	halothane	Potassium channel subfamily K member 3	FC(F)(F)C(Cl)Br
3715	halothane	Potassium channel subfamily K member 9	FC(F)(F)C(Cl)Br
3716	halothane	Potassium channel subfamily K member 10	FC(F)(F)C(Cl)Br
3717	halothane	Potassium channel subfamily K member 18	FC(F)(F)C(Cl)Br
3718	halothane	Glycine receptor (alpha-1/beta)	FC(F)(F)C(Cl)Br
3719	halothane	GABA-A receptor; anion channel	FC(F)(F)C(Cl)Br
3720	hexafluronium	Acetylcholinesterase	C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C2=C1C=CC=C2)C1C2=CC=CC=C2C2=C1C=CC=C2
3721	hexafluronium	Butyrylcholinesterase	C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C2=C1C=CC=C2)C1C2=CC=CC=C2C2=C1C=CC=C2
3722	hexocyclium	Muscarinic acetylcholine receptor M1	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
3723	hexocyclium	Muscarinic acetylcholine receptor M2	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
3724	hexocyclium	Muscarinic acetylcholine receptor M3	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
3725	hexocyclium	Muscarinic acetylcholine receptor M4	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
3726	hexocyclium	Muscarinic acetylcholine receptor M5	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
3727	hexylcaine	Sodium channel alpha subunits; brain (Types I, II, III)	CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1
3728	histamine	Histamine H1 receptor	NCCC1=CN=CN1
3729	histamine	Histamine H2 receptor	NCCC1=CN=CN1
3730	histamine	Histamine H4 receptor	NCCC1=CN=CN1
3731	histamine	Trace amine-associated receptor 1	NCCC1=CN=CN1
3732	histamine	Histamine H3 receptor	NCCC1=CN=CN1
3733	hydralazine	Aldehyde oxidase	NNC1=NN=CC2=CC=CC=C12
3734	hydralazine	Voltage-dependent L-type calcium channel subunit alpha-1C	NNC1=NN=CC2=CC=CC=C12
3735	hydralazine	DNA (cytosine-5)-methyltransferase 1	NNC1=NN=CC2=CC=CC=C12
3736	hydralazine	DNA (cytosine-5)-methyltransferase 3A	NNC1=NN=CC2=CC=CC=C12
3737	hydralazine	DNA (cytosine-5)-methyltransferase 3B	NNC1=NN=CC2=CC=CC=C12
3738	hydralazine	Myeloperoxidase	NNC1=NN=CC2=CC=CC=C12
3739	hydralazine	Arachidonate 15-lipoxygenase	NNC1=NN=CC2=CC=CC=C12
3740	hydralazine	Acetylcholinesterase	NNC1=NN=CC2=CC=CC=C12
3741	hydralazine	Cholinesterase	NNC1=NN=CC2=CC=CC=C12
3742	hydralazine	Lactoperoxidase	NNC1=NN=CC2=CC=CC=C12
3743	hydralazine	Ryanodine receptor 2	NNC1=NN=CC2=CC=CC=C12
3744	hydrochlorothiazide	Carbonic anhydrase 2	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3745	hydrochlorothiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3746	hydrochlorothiazide	Carbonic anhydrase 1	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3747	hydrochlorothiazide	Carbonic anhydrase 4	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3748	hydrochlorothiazide	Calcium-activated potassium channel subunit alpha-1	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3749	hydrochlorothiazide	Astrosclerin-3	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3750	hydrochlorothiazide	Delta carbonic anhydrase	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3751	hydrochlorothiazide	Carbonic anhydrase	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3752	hydrochlorothiazide	Carbonic anhydrase, alpha family	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3753	hydrochlorothiazide	Carbonate dehydratase	NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
3754	hydrocodone	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3OC
3755	hydrocodone	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3OC
3756	hydrocortamate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CN(CC)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3757	hydrocortisone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3758	hydrocortisone	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3759	hydrocortisone	Mineralocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3760	hydrocortisone	Nitric oxide synthase, inducible	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3761	hydrocortisone	Corticosteroid-binding globulin	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3762	hydrocortisone	Sex hormone-binding globulin	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3763	hydrocortisone cypionate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
3764	hydroflumethiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
3765	hydromorphone	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3O
3766	hydromorphone	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3O
3767	hydromorphone	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3O
3768	hydromorphone	Opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3O
3769	hydroxyamfetamine	Beta-secretase 1	CC(N)CC1=CC=C(O)C=C1
3770	hydroxyamfetamine	Trace amine-associated receptor 1	CC(N)CC1=CC=C(O)C=C1
3771	hydroxychloroquine	Alpha-2A adrenergic receptor	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3772	hydroxychloroquine	Sigma non-opioid intracellular receptor 1	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3773	hydroxychloroquine	Potassium voltage-gated channel subfamily H member 2	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3774	hydroxychloroquine	Alpha-2B adrenergic receptor	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3775	hydroxychloroquine	Muscarinic acetylcholine receptor M1	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3776	hydroxychloroquine	Muscarinic acetylcholine receptor M2	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3777	hydroxychloroquine	Muscarinic acetylcholine receptor M3	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3778	hydroxychloroquine	Muscarinic acetylcholine receptor M4	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3779	hydroxychloroquine	Muscarinic acetylcholine receptor M5	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3780	hydroxychloroquine	Alpha-2C adrenergic receptor	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3781	hydroxychloroquine	Hemoglobin subunit alpha	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3782	hydroxychloroquine	Alpha-1D adrenergic receptor	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3783	hydroxychloroquine	Toll-like receptor 7	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3784	hydroxychloroquine	Toll-like receptor 9	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3785	hydroxychloroquine	Transmembrane protein 97	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
3786	hydroxycarbamide	Carbonic anhydrase 2	NC(=O)NO
3787	hydroxycarbamide	Carbonic anhydrase 9	NC(=O)NO
3788	hydroxycarbamide	Ribonucleoside-diphosphate reductase large subunit	NC(=O)NO
3789	hydroxycarbamide	Ribonucleoside-diphosphate reductase subunit M2	NC(=O)NO
3790	hydroxycarbamide	Carbonic anhydrase 5A, mitochondrial	NC(=O)NO
3791	hydroxyzine	D(2) dopamine receptor	OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
3792	hydroxyzine	5-hydroxytryptamine receptor 2A	OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
3793	hydroxyzine	Histamine H1 receptor	OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
3794	hydroxyzine	Cytochrome P450 2D6	OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
3795	hydroxyzine	Envelope glycoprotein gp160	OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
3796	hyoscyamine	Muscarinic acetylcholine receptor M1	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
3797	hyoscyamine	Muscarinic acetylcholine receptor M2	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
3798	hyoscyamine	Muscarinic acetylcholine receptor M3	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
3799	hyoscyamine	Muscarinic acetylcholine receptor M4	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
3800	hyoscyamine	Muscarinic acetylcholine receptor M5	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
3801	ibandronic acid	Farnesyl pyrophosphate synthase	CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
3802	ibandronic acid	Geranylgeranyl pyrophosphate synthase	CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
3803	ibandronic acid	Squalene synthase	CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
3804	ibuprofen	Prostaglandin G/H synthase 2	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3805	ibuprofen	Prostaglandin G/H synthase 1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3806	ibuprofen	Cytochrome P450 2C9	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3807	ibuprofen	Aldo-keto reductase family 1 member C2	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3808	ibuprofen	Aldo-keto reductase family 1 member C3	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3809	ibuprofen	Arachidonate 5-lipoxygenase	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3810	ibuprofen	Fatty acid-binding protein, liver	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3811	ibuprofen	Interleukin-8	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3812	ibuprofen	Prostaglandin-H2 D-isomerase	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3813	ibuprofen	Serum albumin	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3814	ibuprofen	Solute carrier family 22 member 6	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3815	ibuprofen	Solute carrier family 22 member 20	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3816	ibuprofen	Cyclooxygenase	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3817	ibuprofen	Sodium-coupled monocarboxylate transporter 1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3818	ibuprofen	Dehydrogenase/reductase SDR family member 9	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3819	ibuprofen	Acid-sensing ion channel 1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
3820	icosapent ethyl	Diacylglycerol O-acyltransferase 1	CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC
3821	idarubicin	Multidrug resistance protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=CC=CC=C1C3=O)C(C)=O
3822	idarubicin	DNA topoisomerase 2-alpha	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=CC=CC=C1C3=O)C(C)=O
3823	idarubicin	Multidrug resistance-associated protein 1	[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=CC=CC=C1C3=O)C(C)=O
3824	iloprost	Prostaglandin E2 receptor EP1 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3825	iloprost	Prostaglandin E2 receptor EP3 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3826	iloprost	Prostacyclin receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3827	iloprost	Thromboxane A2 receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3828	iloprost	Prostaglandin E2 receptor EP2 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3829	iloprost	Prostaglandin E2 receptor EP4 subtype	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3830	iloprost	Prostaglandin D2 receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3831	iloprost	Prostaglandin F2-alpha receptor	[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
3832	imatinib	Multidrug resistance protein 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3833	imatinib	Sodium-dependent serotonin transporter	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3834	imatinib	5-hydroxytryptamine receptor 2A	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3835	imatinib	Histamine H2 receptor	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3836	imatinib	Carbonic anhydrase 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3837	imatinib	Multidrug resistance-associated protein 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3838	imatinib	ATP-binding cassette sub-family G member 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3839	imatinib	Carbonic anhydrase 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3840	imatinib	Carbonic anhydrase 4	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3841	imatinib	Ribosyldihydronicotinamide dehydrogenase [quinone]	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3842	imatinib	Carbonic anhydrase 9	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3843	imatinib	Carbonic anhydrase 12	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3844	imatinib	Platelet-derived growth factor receptor beta	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3845	imatinib	Tyrosine-protein kinase ABL1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3846	imatinib	Mast/stem cell growth factor receptor Kit	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3847	imatinib	Epidermal growth factor receptor	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3848	imatinib	Carbonic anhydrase 5A, mitochondrial	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3849	imatinib	Carbonic anhydrase 5B, mitochondrial	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3850	imatinib	Carbonic anhydrase 7	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3851	imatinib	Proto-oncogene tyrosine-protein kinase Src	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3852	imatinib	Tyrosine-protein kinase Lck	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3853	imatinib	Tyrosine-protein kinase Fyn	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3854	imatinib	RAF proto-oncogene serine/threonine-protein kinase	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3855	imatinib	Serine/threonine-protein kinase B-raf	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3856	imatinib	Receptor-type tyrosine-protein kinase FLT3	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3857	imatinib	Vascular endothelial growth factor receptor 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3858	imatinib	Macrophage colony-stimulating factor 1 receptor	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3859	imatinib	Platelet-derived growth factor receptor alpha	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3860	imatinib	Insulin receptor	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3861	imatinib	Thromboxane-A synthase	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3862	imatinib	Mitogen-activated protein kinase 8	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3863	imatinib	Carbonic anhydrase 3	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3864	imatinib	Carbonic anhydrase 6	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3865	imatinib	Mitogen-activated protein kinase 10	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3866	imatinib	Tyrosine-protein kinase JAK2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3867	imatinib	Tyrosine-protein kinase SYK	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3868	imatinib	Ephrin type-A receptor 8	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3869	imatinib	Tyrosine-protein kinase Lyn	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3870	imatinib	Cytoplasmic tyrosine-protein kinase BMX	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3871	imatinib	Carbonic anhydrase 14	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3872	imatinib	Fibroblast growth factor receptor 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3873	imatinib	Serine/threonine-protein kinase PLK4	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3874	imatinib	Abelson tyrosine-protein kinase 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3875	imatinib	Fibroblast growth factor receptor 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3876	imatinib	Serine/threonine-protein kinase 17A	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3877	imatinib	Tyrosine-protein kinase Fgr	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3878	imatinib	Mitogen-activated protein kinase 14	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3879	imatinib	Tyrosine-protein kinase FRK	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3880	imatinib	Dual specificity protein kinase CLK1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3881	imatinib	Cyclin-G-associated kinase	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3882	imatinib	Ephrin type-B receptor 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3883	imatinib	Dual specificity protein kinase CLK4	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3884	imatinib	Mitogen-activated protein kinase 9	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3885	imatinib	Epithelial discoidin domain-containing receptor 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3886	imatinib	Ephrin type-B receptor 4	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3887	imatinib	Lysine--tRNA ligase	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3888	imatinib	Carbonic anhydrase 13	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3889	imatinib	Carbonic anhydrase 15	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3890	imatinib	Non-receptor tyrosine-protein kinase TYK2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3891	imatinib	Mitogen-activated protein kinase kinase kinase MLT	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3892	imatinib	Maternal embryonic leucine zipper kinase	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3893	imatinib	Serine/threonine-protein kinase TNNI3K	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3894	imatinib	Discoidin domain-containing receptor 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3895	imatinib	Tyrosine-protein kinase Blk	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3896	imatinib	Cyclin-dependent kinase 19	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3897	imatinib	Homeodomain-interacting protein kinase 4	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3898	imatinib	Interleukin-1 receptor-associated kinase 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3899	imatinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3900	imatinib	Solute carrier family 22 member 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3901	imatinib	Multidrug and toxin extrusion protein 1	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3902	imatinib	Multidrug and toxin extrusion protein 2	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3903	imatinib	Solute carrier family 22 member 3	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3904	imatinib	Platelet-derived growth factor receptor	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3905	imatinib	Tyrosine-protein kinase ABL	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3906	imatinib	Bcr/Abl fusion protein	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
3907	imidapril	Angiotensin-converting enzyme	[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1[C@@H](CN(C)C1=O)C(O)=O
3908	imipramine	D(2) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3909	imipramine	Sigma non-opioid intracellular receptor 1	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3910	imipramine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3911	imipramine	Sodium-dependent serotonin transporter	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3912	imipramine	Sodium-dependent noradrenaline transporter	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3913	imipramine	5-hydroxytryptamine receptor 1A	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3914	imipramine	5-hydroxytryptamine receptor 2A	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3915	imipramine	5-hydroxytryptamine receptor 2C	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3916	imipramine	Alpha-1A adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3917	imipramine	Alpha-2B adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3918	imipramine	D(3) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3919	imipramine	Histamine H1 receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3920	imipramine	Muscarinic acetylcholine receptor M1	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3921	imipramine	Muscarinic acetylcholine receptor M2	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3922	imipramine	Muscarinic acetylcholine receptor M3	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3923	imipramine	Muscarinic acetylcholine receptor M4	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3924	imipramine	Muscarinic acetylcholine receptor M5	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3925	imipramine	Sodium-dependent dopamine transporter	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3926	imipramine	Adenosine receptor A3	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3927	imipramine	Major prion protein	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3928	imipramine	Solute carrier family 22 member 1	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3929	imipramine	Potassium voltage-gated channel subfamily H member 1	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3930	imipramine	Transporter	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3931	imipramine	Pleiotropic ABC efflux transporter of multiple drugs	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3932	imipramine	Solute carrier family 22 member 2	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3933	imipramine	Glutamate NMDA receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3934	imipramine	Muscarinic acetylcholine receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3935	imipramine	Serotonin (5-HT) receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3936	imipramine	Adrenergic receptor alpha-2	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3937	imipramine	Dopamine receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3938	imipramine	Adrenergic receptor alpha-1	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3939	imipramine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3940	imipramine	Serotonin 2 (5-HT2) receptor	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3941	imipramine	G protein-activated inward rectifier potassium channel 4	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3942	imipramine	G protein-activated inward rectifier potassium channel 2	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3943	imipramine	Sphingomyelin phosphodiesterase	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2
3944	imiquimod	Adenosine receptor A2a	CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
3945	imiquimod	Histamine H2 receptor	CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
3946	imiquimod	Alpha-1D adrenergic receptor	CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
3947	imiquimod	Toll-like receptor 7	CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
3948	incadronic acid	Farnesyl pyrophosphate synthase	OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O
3949	incadronic acid	Vacuolar-type proton translocating pyrophosphatase 1	OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O
3950	indapamide	Carbonic anhydrase 2	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3951	indapamide	Solute carrier family 12 member 3	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3952	indapamide	Carbonic anhydrase 1	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3953	indapamide	Carbonic anhydrase 4	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3954	indapamide	Carbonic anhydrase 9	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3955	indapamide	Carbonic anhydrase 12	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3956	indapamide	Potassium voltage-gated channel subfamily KQT member 1	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3957	indapamide	Carbonic anhydrase 5A, mitochondrial	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3958	indapamide	Carbonic anhydrase 5B, mitochondrial	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3959	indapamide	Carbonic anhydrase 7	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3960	indapamide	Carbonic anhydrase 6	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3961	indapamide	Carbonic anhydrase 14	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3962	indapamide	Arachidonate 15-lipoxygenase	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3963	indapamide	Carbonic anhydrase 13	[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
3964	indecainide	Sodium channel protein type 5 subunit alpha	CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=C1C=CC=C2
3965	indisetron	5-hydroxytryptamine receptor 3A	CN1C[C@@H]2C[C@@H](C[C@H](C1)N2C)NC(=O)C1=NNC2=C1C=CC=C2
3966	indomethacin	Prostaglandin G/H synthase 2	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3967	indomethacin	Prostaglandin G/H synthase 1	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3968	indomethacin	Multidrug resistance protein 1	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3969	indomethacin	Multidrug resistance-associated protein 1	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3970	indomethacin	Androgen receptor	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3971	indomethacin	Prostaglandin D2 receptor 2	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3972	indomethacin	Dehydrogenase/reductase SDR family member 9	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3973	indomethacin	Aldose reductase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3974	indomethacin	Aldo-keto reductase family 1 member C2	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3975	indomethacin	Aldo-keto reductase family 1 member C3	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3976	indomethacin	Peroxisome proliferator-activated receptor gamma	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3977	indomethacin	Prostaglandin E2 receptor EP2 subtype	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3978	indomethacin	Lactoylglutathione lyase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3979	indomethacin	Cytochrome c oxidase subunit 2	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3980	indomethacin	Interleukin-8	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3981	indomethacin	Potassium voltage-gated channel subfamily A member 7	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3982	indomethacin	Prostaglandin-H2 D-isomerase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3983	indomethacin	Cyclooxygenase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3984	indomethacin	Prostaglandin G/H synthase (cyclooxygenase)	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3985	indomethacin	Nitric oxide synthase, inducible	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3986	indomethacin	Prostaglandin E synthase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3987	indomethacin	Aldo-keto reductase family 1 member C4	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3988	indomethacin	Nicotinate phosphoribosyltransferase	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
3989	ipratropium	Muscarinic acetylcholine receptor M1	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3990	ipratropium	Muscarinic acetylcholine receptor M2	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3991	ipratropium	Muscarinic acetylcholine receptor M3	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3992	ipratropium	Muscarinic acetylcholine receptor M4	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3993	ipratropium	Muscarinic acetylcholine receptor M5	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3994	ipratropium	Solute carrier family 22 member 2	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
3995	iproniazid	Amine oxidase [flavin-containing] B	CC(C)NNC(=O)C1=CC=NC=C1
3996	iproniazid	Amine oxidase [flavin-containing] A	CC(C)NNC(=O)C1=CC=NC=C1
3997	irbesartan	Type-1 angiotensin II receptor	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
3998	irbesartan	Endothelin-1 receptor	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
3999	irbesartan	Type-1B angiotensin II receptor	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
4000	irbesartan	Angiotensin II receptor (AT-1) type-1	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
4001	irbesartan	Angiotensin II receptor	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
4002	irbesartan	Sodium/bile acid cotransporter	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
4003	irinotecan	Multidrug resistance protein 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4004	irinotecan	Muscarinic acetylcholine receptor M4	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4005	irinotecan	Canalicular multispecific organic anion transporter 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4006	irinotecan	Alpha-2C adrenergic receptor	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4007	irinotecan	Multidrug resistance-associated protein 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4008	irinotecan	ATP-binding cassette sub-family G member 2	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4009	irinotecan	Multidrug resistance-associated protein 4	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4010	irinotecan	Acetylcholinesterase	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4011	irinotecan	DNA topoisomerase 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4012	irinotecan	Interstitial collagenase	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4013	irinotecan	Solute carrier family 22 member 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4014	irinotecan	Solute carrier family 22 member 2	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4015	irinotecan	Multidrug and toxin extrusion protein 1	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4016	irinotecan	Multidrug and toxin extrusion protein 2	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4017	irinotecan	Solute carrier family 22 member 3	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
4018	isocarboxazid	Amine oxidase [flavin-containing] B	CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1
4019	isocarboxazid	Amine oxidase [flavin-containing] A	CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1
4020	isoetarine	Beta-2 adrenergic receptor	CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1
4021	isoflurane	5-hydroxytryptamine receptor 2B	FC(F)OC(Cl)C(F)(F)F
4022	isoflurane	Potassium channel subfamily K member 2	FC(F)OC(Cl)C(F)(F)F
4023	isoflurane	Potassium channel subfamily K member 3	FC(F)OC(Cl)C(F)(F)F
4024	isoflurane	Potassium channel subfamily K member 9	FC(F)OC(Cl)C(F)(F)F
4025	isoflurane	Potassium channel subfamily K member 10	FC(F)OC(Cl)C(F)(F)F
4026	isoflurane	Potassium channel subfamily K member 18	FC(F)OC(Cl)C(F)(F)F
4027	isoflurane	Glycine receptor (alpha-1/beta)	FC(F)OC(Cl)C(F)(F)F
4028	isoflurane	GABA-A receptor; anion channel	FC(F)OC(Cl)C(F)(F)F
4029	fluostigmine	Prostaglandin G/H synthase 2	CC(C)OP(F)(=O)OC(C)C
4030	fluostigmine	Acetylcholinesterase	CC(C)OP(F)(=O)OC(C)C
4031	fluostigmine	Lysosomal protective protein	CC(C)OP(F)(=O)OC(C)C
4032	fluostigmine	Liver carboxylesterase	CC(C)OP(F)(=O)OC(C)C
4033	isoprenaline	Beta-1 adrenergic receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4034	isoprenaline	Beta-2 adrenergic receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4035	isoprenaline	D(2) dopamine receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4036	isoprenaline	D(3) dopamine receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4037	isoprenaline	Beta-3 adrenergic receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4038	isoprenaline	D(4) dopamine receptor	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4039	isoprenaline	Arachidonate 15-lipoxygenase	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4040	isoprenaline	Taste receptor type 2 member 14	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4041	isoprenaline	Taste receptor type 2 member 46	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4042	isoprenaline	Taste receptor type 2 member 38	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4043	isoprenaline	Taste receptor type 2 member 39	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4044	isoprenaline	Taste receptor type 2 member 40	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4045	isoprenaline	Taste receptor type 2 member 41	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4046	isoprenaline	Taste receptor type 2 member 43	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4047	isoprenaline	Taste receptor type 2 member 31	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4048	isoprenaline	Taste receptor type 2 member 45	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4049	isoprenaline	Taste receptor type 2 member 30	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4050	isoprenaline	Taste receptor type 2 member 19	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4051	isoprenaline	Taste receptor type 2 member 20	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4052	isoprenaline	Taste receptor type 2 member 50	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4053	isoprenaline	Taste receptor type 2 member 60	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4054	isoprenaline	Taste receptor type 2 member 42	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4055	isoprenaline	Taste receptor type 2 member 16	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4056	isoprenaline	Taste receptor type 2 member 13	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4057	isoprenaline	Taste receptor type 2 member 10	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4058	isoprenaline	Taste receptor type 2 member 9	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4059	isoprenaline	Taste receptor type 2 member 8	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4060	isoprenaline	Taste receptor type 2 member 7	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4061	isoprenaline	Taste receptor type 2 member 5	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4062	isoprenaline	Taste receptor type 2 member 4	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4063	isoprenaline	Taste receptor type 2 member 3	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4064	isoprenaline	Taste receptor type 2 member 1	CC(C)NCC(O)C1=CC=C(O)C(O)=C1
4065	isopropamide	Muscarinic acetylcholine receptor M1	CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C
4066	isopropamide	Muscarinic acetylcholine receptor M3	CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C
4067	isosorbide dinitrate	Atrial natriuretic peptide receptor 1	[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
4068	isosorbide dinitrate	Soluble guanylate cyclase	[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
4069	isosorbide mononitrate	Atrial natriuretic peptide receptor 1	[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O
4070	isosorbide mononitrate	Soluble guanylate cyclase	[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O
4071	isotretinoin	5-hydroxytryptamine receptor 2B	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4072	isotretinoin	Alpha-2B adrenergic receptor	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4073	isotretinoin	Adenosine receptor A3	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4074	isotretinoin	Retinoic acid receptor alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4075	isotretinoin	Alcohol dehydrogenase 4	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4076	isotretinoin	Dehydrogenase/reductase SDR family member 9	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4077	isotretinoin	11-cis retinol dehydrogenase	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4078	isotretinoin	17-beta-hydroxysteroid dehydrogenase type 6	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4079	isotretinoin	Retinoic acid receptor beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4080	isotretinoin	Mitogen-activated protein kinase 14	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4081	isotretinoin	Mitogen-activated protein kinase 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4082	isotretinoin	Cellular retinoic acid-binding protein 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4083	isotretinoin	Olfactory receptor 51E2	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
4084	isradipine	Potassium voltage-gated channel subfamily H member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4085	isradipine	Nuclear receptor subfamily 1 group I member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4086	isradipine	Voltage-dependent L-type calcium channel subunit alpha-1C	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4087	isradipine	Voltage-dependent L-type calcium channel subunit alpha-1D	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4088	isradipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4089	isradipine	Voltage-dependent L-type calcium channel subunit alpha-1F	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
4090	ixabepilone	Tubulin beta	[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1
4091	ketamine	Acetylcholine receptor subunit alpha	CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1
4092	ketamine	Glutamate [NMDA] receptor	CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1
4093	ketamine	Glutamate NMDA receptor	CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1
4094	ketamine	Glutamate receptor ionotropic AMPA	CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1
4095	ketoconazole	Sodium/nucleoside cotransporter 1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4096	ketoconazole	Alpha-2A adrenergic receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4097	ketoconazole	Potassium voltage-gated channel subfamily H member 2	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4098	ketoconazole	Cytochrome P450 3A4	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4099	ketoconazole	Multidrug resistance protein 1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4100	ketoconazole	Sodium-dependent serotonin transporter	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4101	ketoconazole	Sodium-dependent noradrenaline transporter	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4102	ketoconazole	Alpha-2B adrenergic receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4103	ketoconazole	Histamine H2 receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4104	ketoconazole	Muscarinic acetylcholine receptor M2	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4105	ketoconazole	Aldehyde oxidase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4106	ketoconazole	Sodium-dependent dopamine transporter	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4107	ketoconazole	Nuclear receptor subfamily 1 group I member 2	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4108	ketoconazole	Alpha-1D adrenergic receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4109	ketoconazole	Lanosterol 14-alpha demethylase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4110	ketoconazole	Delta-type opioid receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4111	ketoconazole	Bile salt export pump	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4112	ketoconazole	Cytochrome P450 2C9	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4113	ketoconazole	Aromatase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4114	ketoconazole	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4115	ketoconazole	Potassium voltage-gated channel subfamily A member 10	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4116	ketoconazole	Cytochrome P450 2C19	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4117	ketoconazole	Thromboxane-A synthase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4118	ketoconazole	Indoleamine 2,3-dioxygenase 1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4119	ketoconazole	Solute carrier family 22 member 1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4120	ketoconazole	Substance-K receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4121	ketoconazole	Cytochrome P450 3A5	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4122	ketoconazole	Arachidonate 15-lipoxygenase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4123	ketoconazole	Alpha-1B adrenergic receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4124	ketoconazole	5-hydroxytryptamine receptor 1B	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4125	ketoconazole	Membrane-associated progesterone receptor component 1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4126	ketoconazole	Alpha-1A adrenergic receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4127	ketoconazole	Gonadotropin-releasing hormone receptor	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4128	ketoconazole	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4129	ketoconazole	Cytochrome P450 21	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4130	ketoconazole	Cytochrome P450 11B1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4131	ketoconazole	Cytochrome P450 11A1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4132	ketoconazole	Cytochrome P450 24A1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4133	ketoconazole	Cytochrome P450 7A1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4134	ketoconazole	Cytochrome P450 51	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4135	ketoconazole	Cytochrome P450 17A1	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4136	ketoconazole	Cytochrome P450 11B2, mitochondrial	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4137	ketoconazole	Steroid 17-alpha-hydroxylase/17,20 lyase	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4138	ketoconazole	Cytochrome P450 11B1, mitochondrial	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
4139	ketoprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
4140	ketoprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
4141	ketoprofen	Cyclooxygenase	CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
4142	ketorolac	Prostaglandin G/H synthase 2	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4143	ketorolac	Prostaglandin G/H synthase 1	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4144	ketorolac	Fatty acid-binding protein, liver	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4145	ketorolac	Aldose reductase	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4146	ketorolac	Prostaglandin-H2 D-isomerase	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4147	ketorolac	Serine/threonine-protein kinase PAK 1	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
4148	ketotifen	D(1A) dopamine receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4149	ketotifen	Alpha-2A adrenergic receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4150	ketotifen	Multidrug resistance protein 1	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4151	ketotifen	5-hydroxytryptamine receptor 1A	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4152	ketotifen	5-hydroxytryptamine receptor 2A	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4153	ketotifen	5-hydroxytryptamine receptor 2B	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4154	ketotifen	5-hydroxytryptamine receptor 2C	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4155	ketotifen	5-hydroxytryptamine receptor 6	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4156	ketotifen	Alpha-2B adrenergic receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4157	ketotifen	D(3) dopamine receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4158	ketotifen	Histamine H1 receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4159	ketotifen	Histamine H2 receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4160	ketotifen	Histamine H4 receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4161	ketotifen	Muscarinic acetylcholine receptor M1	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4162	ketotifen	Muscarinic acetylcholine receptor M2	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4163	ketotifen	Muscarinic acetylcholine receptor M3	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4164	ketotifen	Muscarinic acetylcholine receptor M4	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4165	ketotifen	Muscarinic acetylcholine receptor M5	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4166	ketotifen	Alpha-1D adrenergic receptor	CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2
4167	labetalol	Beta-1 adrenergic receptor	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4168	labetalol	Beta-2 adrenergic receptor	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4169	labetalol	Sigma non-opioid intracellular receptor 1	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4170	labetalol	Sodium-dependent noradrenaline transporter	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4171	labetalol	5-hydroxytryptamine receptor 1A	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4172	labetalol	5-hydroxytryptamine receptor 2B	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4173	labetalol	Sodium-dependent dopamine transporter	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4174	labetalol	Cytochrome P450 2D6	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4175	labetalol	Alpha-1D adrenergic receptor	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4176	labetalol	Alpha-1B adrenergic receptor	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4177	labetalol	Alpha-1A adrenergic receptor	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4178	labetalol	CAAX prenyl protease 1	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4179	labetalol	CAAX prenyl protease 2	CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
4180	lacidipine	Cytochrome P450 3A4	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4181	lacidipine	Sodium-dependent noradrenaline transporter	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4182	lacidipine	D(3) dopamine receptor	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4183	lacidipine	Adenosine receptor A3	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4184	lacidipine	Cytochrome P450 2C9	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4185	lacidipine	Cytochrome P450 2C19	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4186	lacidipine	Thromboxane-A synthase	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4187	lacidipine	Androgen receptor	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4188	lacidipine	Voltage-gated L-type calcium channel	CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC
4189	lamotrigine	Sodium channel protein type 5 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4190	lamotrigine	Sigma non-opioid intracellular receptor 1	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4191	lamotrigine	Sodium channel protein type 1 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4192	lamotrigine	Sodium channel protein type 2 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4193	lamotrigine	Sodium channel protein type 3 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4194	lamotrigine	Sodium channel protein type 4 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4195	lamotrigine	Sodium channel protein type 8 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4196	lamotrigine	Sodium channel protein type 9 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4197	lamotrigine	5-hydroxytryptamine receptor 3A	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4198	lamotrigine	Sodium channel protein type 10 subunit alpha	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4199	lamotrigine	Dihydrofolate reductase	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4200	lamotrigine	Sodium channel alpha subunits; brain (Types I, II, III)	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4201	lamotrigine	Sodium channel protein type X alpha subunit	NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1
4202	landiolol	Beta-1 adrenergic receptor	CC1(C)OC[C@@H](COC(=O)CCC2=CC=C(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)C=C2)O1
4203	lanreotide	Somatostatin receptor type 2	[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
4204	lanreotide	Somatostatin receptor type 3	[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
4205	lanreotide	Somatostatin receptor type 5	[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
4206	lanreotide	Somatostatin receptor type 4	[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
4207	lanreotide	Somatostatin receptor type 1	[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
4208	lansoprazole	Cytochrome P450 2D6	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4209	lansoprazole	Cytochrome P450 2C19	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4210	lansoprazole	Fatty acid synthase	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4211	lansoprazole	Phosphoethanolamine/phosphocholine phosphatase	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4212	lansoprazole	Microtubule-associated protein tau	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4213	lansoprazole	Indoleamine 2,3-dioxygenase 2	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4214	lansoprazole	Potassium-transporting ATPase	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4215	lansoprazole	Indoleamine 2,3-dioxygenase 1	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4216	lansoprazole	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4217	lansoprazole	Cytosolic endo-beta-N-acetylglucosaminidase	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4218	lapatinib	Multidrug resistance protein 1	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4219	lapatinib	ATP-binding cassette sub-family G member 2	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4220	lapatinib	Platelet-derived growth factor receptor beta	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4221	lapatinib	Tyrosine-protein kinase ABL1	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4222	lapatinib	Epidermal growth factor receptor	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4223	lapatinib	Receptor tyrosine-protein kinase erbB-2	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4224	lapatinib	Solute carrier organic anion transporter family member 1B1	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4225	lapatinib	Cyclin-dependent kinase 2	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4226	lapatinib	Insulin receptor	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4227	lapatinib	Receptor tyrosine-protein kinase erbB-4	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4228	lapatinib	Serine/threonine-protein kinase 10	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4229	lapatinib	Receptor-interacting serine/threonine-protein kinase 2	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4230	lapatinib	STE20-like serine/threonine-protein kinase	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4231	lapatinib	Dual specificity mitogen-activated protein kinase kinase 7	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4232	lapatinib	Tubulin alpha-1A chain	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4233	lapatinib	Receptor tyrosine-protein kinase erbB-3	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4234	lapatinib	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4235	lapatinib	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4236	lapatinib	Phosphatidylinositol 4-kinase beta	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4237	lapatinib	Dual specificity mitogen-activated protein kinase kinase 5	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1
4238	latanoprost	Prostaglandin E2 receptor EP1 subtype	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1
4239	latanoprost	Prostaglandin E2 receptor EP3 subtype	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1
4240	latanoprost	Prostaglandin F2-alpha receptor	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1
4241	leflunomide	Sodium/nucleoside cotransporter 1	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4242	leflunomide	Sodium-dependent noradrenaline transporter	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4243	leflunomide	Sodium-dependent dopamine transporter	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4244	leflunomide	Dihydroorotate dehydrogenase (quinone), mitochondrial	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4245	leflunomide	Cytochrome P450 1A2	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4246	leflunomide	Amine oxidase [flavin-containing] A	CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
4247	letrozole	Aromatase	N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N
4248	letrozole	Cytochrome P450 11B1, mitochondrial	N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N
4249	letrozole	Cytochrome P450 11B2, mitochondrial	N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N
4250	leuprorelin	Gonadotropin-releasing hormone receptor	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
4251	levallorphan	Mu-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2CC=C
4252	levallorphan	Acetylcholinesterase	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2CC=C
4253	levallorphan	Opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2CC=C
4254	levetiracetam	Sodium channel protein type 1 subunit alpha	CC[C@H](N1CCCC1=O)C(N)=O
4255	levetiracetam	Voltage-dependent T-type calcium channel subunit alpha-1G	CC[C@H](N1CCCC1=O)C(N)=O
4256	levetiracetam	Carbonic anhydrase 1	CC[C@H](N1CCCC1=O)C(N)=O
4257	levetiracetam	Synaptic vesicle glycoprotein 2A	CC[C@H](N1CCCC1=O)C(N)=O
4258	levocabastine	Multidrug resistance protein 1	[H][C@@]1(C)CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@@]1([H])CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
4259	levocabastine	Histamine H1 receptor	[H][C@@]1(C)CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@@]1([H])CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
4260	levocabastine	Neurotensin receptor type 2	[H][C@@]1(C)CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@@]1([H])CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
4261	levocabastine	Neurotensin receptor 2	[H][C@@]1(C)CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@@]1([H])CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
4262	levocetirizine	Histamine H1 receptor	OC(=O)COCCN1CCN(CC1)[C@H](C1=CC=CC=C1)C1=CC=C(Cl)C=C1
4263	levodopa	Large neutral amino acids transporter small subunit 1	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4264	levodopa	Epidermal growth factor receptor	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4265	levodopa	Tyrosine-protein kinase Lck	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4266	levodopa	Tyrosine-protein kinase Fyn	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4267	levodopa	Arachidonate 15-lipoxygenase	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4268	levodopa	D(1A) dopamine receptor	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4269	levodopa	D(2) dopamine receptor	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
4270	levomethadyl acetate	Mu-type opioid receptor	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4271	levomethadyl acetate	Potassium voltage-gated channel subfamily H member 2	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4272	levonorgestrel	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4273	levonorgestrel	Glucocorticoid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4274	levonorgestrel	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4275	levonorgestrel	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4276	levonorgestrel	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4277	levonorgestrel	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
4278	levorphanol	Mu-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4279	levorphanol	Kappa-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4280	levorphanol	Delta-type opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4281	levorphanol	Solute carrier family 22 member 1	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4282	levorphanol	Acetylcholinesterase	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4283	levorphanol	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4284	levorphanol	Glutamate [NMDA] receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4285	levorphanol	Glutamate NMDA receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4286	levorphanol	Opioid receptor	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4287	levorphanol	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C
4288	levosalbutamol	Beta-2 adrenergic receptor	CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1
4289	levosimendan	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
4290	levosimendan	ATP-sensitive inward rectifier potassium channel 11	C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
4291	levosimendan	ATP-sensitive inward rectifier potassium channel 8	C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
4292	levosimendan	Troponin C, slow skeletal and cardiac muscles	C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
4293	lidocaine	Sodium channel protein type 5 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4294	lidocaine	Sodium channel protein type 2 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4295	lidocaine	Sodium channel protein type 3 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4296	lidocaine	Sodium channel protein type 4 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4297	lidocaine	Sodium channel protein type 9 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4298	lidocaine	5-hydroxytryptamine receptor 3A	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4299	lidocaine	Sodium channel protein type 10 subunit alpha	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4300	lidocaine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4301	lidocaine	Acetylcholine receptor	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4302	lidocaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4303	lidocaine	Sodium channel protein type X alpha subunit	CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4304	limaprost	Prostaglandin E2 receptor EP1 subtype	CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O
4305	liothyronine	Thyroid hormone receptor alpha	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4306	liothyronine	Thyroid hormone receptor beta	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4307	liothyronine	Adenosine receptor A1	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4308	liothyronine	Cytochrome P450 2C9	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4309	liothyronine	Proliferating cell nuclear antigen	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4310	liothyronine	THAP domain-containing protein 1	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4311	liothyronine	GABA-A receptor; anion channel	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
4312	lisinopril	Angiotensin-converting enzyme	NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
4313	lisuride	Beta-1 adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4314	lisuride	Beta-2 adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4315	lisuride	D(1A) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4316	lisuride	D(2) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4317	lisuride	Alpha-2A adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4318	lisuride	5-hydroxytryptamine receptor 1A	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4319	lisuride	5-hydroxytryptamine receptor 2A	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4320	lisuride	5-hydroxytryptamine receptor 2C	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4321	lisuride	5-hydroxytryptamine receptor 6	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4322	lisuride	Alpha-1A adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4323	lisuride	Alpha-2B adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4324	lisuride	D(3) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4325	lisuride	D(1B) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4326	lisuride	Histamine H1 receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4327	lisuride	Histamine H2 receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4328	lisuride	5-hydroxytryptamine receptor 1B	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4329	lisuride	5-hydroxytryptamine receptor 1D	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4330	lisuride	Alpha-2C adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4331	lisuride	Cytochrome P450 2D6	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4332	lisuride	D(4) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4333	lisuride	Alpha-1D adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4334	lisuride	Alpha-1B adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4335	lisuride	5-hydroxytryptamine receptor 7	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4336	lisuride	5-hydroxytryptamine receptor 2B	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
4337	lofepramine	D(2) dopamine receptor	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4338	lofepramine	Sodium-dependent serotonin transporter	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4339	lofepramine	Sodium-dependent noradrenaline transporter	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4340	lofepramine	5-hydroxytryptamine receptor 1A	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4341	lofepramine	5-hydroxytryptamine receptor 2C	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4342	lofepramine	Alpha-1A adrenergic receptor	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4343	lofepramine	Histamine H1 receptor	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4344	lofepramine	Muscarinic acetylcholine receptor M1	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4345	lofepramine	Muscarinic acetylcholine receptor M2	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4346	lofepramine	Muscarinic acetylcholine receptor M3	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4347	lofepramine	Muscarinic acetylcholine receptor M4	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4348	lofepramine	Muscarinic acetylcholine receptor M5	CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1
4349	lofexidine	5-hydroxytryptamine receptor 1A	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4350	lofexidine	Alpha-2B adrenergic receptor	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4351	lofexidine	Alpha-2C adrenergic receptor	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4352	lofexidine	Nischarin	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4353	lofexidine	Adrenergic receptor alpha-2	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4354	lofexidine	Adrenergic receptor alpha-1	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4355	lofexidine	Alpha-2A adrenergic receptor	CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
4356	loperamide	Beta-2 adrenergic receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4357	loperamide	Sodium channel protein type 5 subunit alpha	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4358	loperamide	Mu-type opioid receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4359	loperamide	Glutamate receptor ionotropic, NMDA 2A	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4360	loperamide	Sigma non-opioid intracellular receptor 1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4361	loperamide	Sodium-dependent serotonin transporter	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4362	loperamide	5-hydroxytryptamine receptor 2B	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4363	loperamide	D(3) dopamine receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4364	loperamide	Histamine H1 receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4365	loperamide	Histamine H2 receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4366	loperamide	Aldehyde oxidase	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4367	loperamide	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4368	loperamide	Cytochrome P450 2D6	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4369	loperamide	Alpha-1D adrenergic receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4370	loperamide	Kappa-type opioid receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4371	loperamide	Calmodulin	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4372	loperamide	Delta-type opioid receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4373	loperamide	Somatostatin receptor type 5	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4374	loperamide	Glutamate receptor ionotropic, NMDA 2B	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4375	loperamide	Glutamate receptor ionotropic, NMDA 2C	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4376	loperamide	Glutamate receptor ionotropic, NMDA 2D	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4377	loperamide	Angiopoietin-1 receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4378	loperamide	Solute carrier family 22 member 1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4379	loperamide	Alpha-1B adrenergic receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4380	loperamide	Membrane-associated progesterone receptor component 1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4381	loperamide	Alpha-1A adrenergic receptor	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4382	loperamide	Cocaine esterase	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4383	loperamide	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4384	loperamide	Menin	CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
4385	loratadine	Potassium voltage-gated channel subfamily H member 2	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4386	loratadine	Multidrug resistance protein 1	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4387	loratadine	5-hydroxytryptamine receptor 2B	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4388	loratadine	Histamine H1 receptor	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4389	loratadine	Nuclear receptor subfamily 1 group I member 2	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4390	loratadine	Cytochrome P450 2C19	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4391	loratadine	Potassium channel subfamily K member 9	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4392	loratadine	Bile acid receptor	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4393	loratadine	Sodium-dependent neutral amino acid transporter B(0)AT2	CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2
4394	lorazepam	Fatty acid-binding protein, liver	OC1N=C(C2=CC(Cl)=CC=C2NC1=O)C1=C(Cl)C=CC=C1
4395	lorazepam	GABA-A receptor alpha-1/beta-3/gamma-2	OC1N=C(C2=CC(Cl)=CC=C2NC1=O)C1=C(Cl)C=CC=C1
4396	losartan	Multidrug resistance protein 1	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4397	losartan	Angiotensin-converting enzyme	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4398	losartan	Cytochrome P450 2C9	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4399	losartan	Type-1 angiotensin II receptor	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4400	losartan	Type-2 angiotensin II receptor	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4401	losartan	Type-1B angiotensin II receptor	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4402	losartan	Type-1A angiotensin II receptor	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4403	losartan	Phosphodiesterase 3	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4404	losartan	Phosphodiesterase 4	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4405	losartan	Angiotensin II receptor (AT-1) type-1	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4406	losartan	Angiotensin II receptor	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4407	losartan	Platelet glycoprotein VI	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
4408	loteprednol etabonate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
4409	lovastatin	Sodium-dependent noradrenaline transporter	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4410	lovastatin	Sodium-dependent dopamine transporter	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4411	lovastatin	Adenosine receptor A1	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4412	lovastatin	Nuclear receptor subfamily 1 group I member 2	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4413	lovastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4414	lovastatin	Hydroxycarboxylic acid receptor 2	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4415	lovastatin	Hydroxycarboxylic acid receptor 3	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4416	lovastatin	Histone deacetylase 2	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4417	lovastatin	Histone deacetylase 1	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4418	lovastatin	Histone deacetylase 6	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4419	lovastatin	Substance-K receptor	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4420	lovastatin	Androgen receptor	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4421	lovastatin	Acetylcholinesterase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4422	lovastatin	Cholinesterase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4423	lovastatin	Leukocyte adhesion glycoprotein LFA-1 alpha	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4424	lovastatin	Acyl-CoA:cholesterol acyltransferase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
4425	loxapine	D(1A) dopamine receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4426	loxapine	D(2) dopamine receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4427	loxapine	Alpha-2A adrenergic receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4428	loxapine	Sodium-dependent noradrenaline transporter	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4429	loxapine	5-hydroxytryptamine receptor 1A	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4430	loxapine	5-hydroxytryptamine receptor 2A	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4431	loxapine	5-hydroxytryptamine receptor 2C	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4432	loxapine	5-hydroxytryptamine receptor 6	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4433	loxapine	Alpha-1A adrenergic receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4434	loxapine	Alpha-2B adrenergic receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4435	loxapine	D(3) dopamine receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4436	loxapine	D(1B) dopamine receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4437	loxapine	Histamine H1 receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4438	loxapine	Histamine H2 receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4439	loxapine	Histamine H4 receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4440	loxapine	Muscarinic acetylcholine receptor M1	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4441	loxapine	Muscarinic acetylcholine receptor M2	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4442	loxapine	Muscarinic acetylcholine receptor M3	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4443	loxapine	Muscarinic acetylcholine receptor M4	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4444	loxapine	Muscarinic acetylcholine receptor M5	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4445	loxapine	5-hydroxytryptamine receptor 1B	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4446	loxapine	5-hydroxytryptamine receptor 1D	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4447	loxapine	Alpha-2C adrenergic receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4448	loxapine	D(4) dopamine receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4449	loxapine	5-hydroxytryptamine receptor 3A	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4450	loxapine	Alpha-1B adrenergic receptor	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4451	loxapine	5-hydroxytryptamine receptor 5A	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4452	loxapine	5-hydroxytryptamine receptor 1E	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4453	loxapine	Potassium channel subfamily K member 2	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4454	loxapine	Potassium channel subfamily T member 1	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4455	loxapine	5-hydroxytryptamine receptor 7	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4456	loxapine	Adrenergic receptor alpha-1	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2
4457	loxoprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1
4458	loxoprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1
4459	lumiracoxib	Prostaglandin G/H synthase 1	CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
4460	lumiracoxib	Prostaglandin G/H synthase 2	CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
4461	manidipine	Cruzipain	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
4462	manidipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
4463	maprotiline	D(1A) dopamine receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4464	maprotiline	D(2) dopamine receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4465	maprotiline	Alpha-2A adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4466	maprotiline	Cytochrome P450 3A4	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4467	maprotiline	Sodium-dependent serotonin transporter	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4468	maprotiline	Sodium-dependent noradrenaline transporter	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4469	maprotiline	5-hydroxytryptamine receptor 2A	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4470	maprotiline	5-hydroxytryptamine receptor 2B	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4471	maprotiline	5-hydroxytryptamine receptor 2C	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4472	maprotiline	5-hydroxytryptamine receptor 6	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4473	maprotiline	Alpha-1A adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4474	maprotiline	Alpha-2B adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4475	maprotiline	D(3) dopamine receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4476	maprotiline	D(1B) dopamine receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4477	maprotiline	Histamine H1 receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4478	maprotiline	Histamine H2 receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4479	maprotiline	Muscarinic acetylcholine receptor M1	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4480	maprotiline	Muscarinic acetylcholine receptor M2	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4481	maprotiline	Muscarinic acetylcholine receptor M3	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4482	maprotiline	Muscarinic acetylcholine receptor M4	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4483	maprotiline	Muscarinic acetylcholine receptor M5	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4484	maprotiline	Aldehyde oxidase	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4485	maprotiline	Alpha-2C adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4486	maprotiline	Sodium-dependent dopamine transporter	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4487	maprotiline	Alpha-1D adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4488	maprotiline	ATP-binding cassette sub-family G member 2	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4489	maprotiline	Alpha-1B adrenergic receptor	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4490	maprotiline	G protein-activated inward rectifier potassium channel 2	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4491	maprotiline	Transient receptor potential cation channel subfamily M member 3	CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1
4492	maraviroc	C-C chemokine receptor type 5	[H][C@]12CC[C@]([H])(C[C@@H](C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1
4493	maraviroc	Multidrug and toxin extrusion protein 1	[H][C@]12CC[C@]([H])(C[C@@H](C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1
4494	mazindol	Sigma non-opioid intracellular receptor 1	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4495	mazindol	Sodium-dependent serotonin transporter	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4496	mazindol	Sodium-dependent noradrenaline transporter	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4497	mazindol	Histamine H1 receptor	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4498	mazindol	Sodium-dependent dopamine transporter	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4499	mazindol	Transporter	OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
4500	mebhydrolin	Histamine H1 receptor	CN1CCC2=C(C1)C1=C(C=CC=C1)N2CC1=CC=CC=C1
4501	mebhydrolin	Histamine H4 receptor	CN1CCC2=C(C1)C1=C(C=CC=C1)N2CC1=CC=CC=C1
4502	mebhydrolin	Muscarinic acetylcholine receptor M1	CN1CCC2=C(C1)C1=C(C=CC=C1)N2CC1=CC=CC=C1
4503	mebhydrolin	5-hydroxytryptamine receptor 5A	CN1CCC2=C(C1)C1=C(C=CC=C1)N2CC1=CC=CC=C1
4504	mecamylamine	Neuronal acetylcholine receptor subunit alpha-7	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4505	mecamylamine	Acetylcholine receptor subunit alpha	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4506	mecamylamine	Neuronal acetylcholine receptor; alpha2/beta4	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4507	mecamylamine	Neuronal acetylcholine receptor; alpha4/beta2	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4508	mecamylamine	Neuronal acetylcholine receptor; alpha3/beta4	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4509	mecamylamine	Neuronal acetylcholine receptor; alpha3/beta2	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4510	mecamylamine	Neuronal acetylcholine receptor; alpha4/beta4	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4511	mecamylamine	Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4512	mecamylamine	Neuronal acetylcholine receptor subunit alpha-3	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4513	mecamylamine	Neuronal acetylcholine receptor subunit alpha-4	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4514	mecamylamine	Neuronal acetylcholine receptor subunit alpha-6	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C
4515	meclozine	Nuclear receptor subfamily 1 group I member 3	CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1
4516	meclozine	Histamine H1 receptor	CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1
4517	meclozine	Constitutive androstane receptor	CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1
4518	meclozine	Serine protease hepsin	CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1
4519	meclofenamic acid	Prostaglandin G/H synthase 2	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4520	meclofenamic acid	Prostaglandin G/H synthase 1	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4521	meclofenamic acid	Transthyretin	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4522	meclofenamic acid	Androgen receptor	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4523	meclofenamic acid	Aldo-keto reductase family 1 member C1	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4524	meclofenamic acid	Aldo-keto reductase family 1 member C2	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4525	meclofenamic acid	Aldo-keto reductase family 1 member C3	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4526	meclofenamic acid	Arachidonate 5-lipoxygenase	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4527	meclofenamic acid	Fatty acid-binding protein, intestinal	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4528	meclofenamic acid	Fatty acid-binding protein, liver	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4529	meclofenamic acid	Mitogen-activated protein kinase 1	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4530	meclofenamic acid	Cyclooxygenase	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
4531	medroxyprogesterone	Histamine H2 receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4532	medroxyprogesterone	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4533	medroxyprogesterone	Mineralocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4534	medroxyprogesterone	Androgen receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4535	medroxyprogesterone	Progesterone receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4536	medroxyprogesterone	Aldo-keto reductase family 1 member C1	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4537	medroxyprogesterone	Aldo-keto reductase family 1 member C2	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4538	medroxyprogesterone	Aldo-keto reductase family 1 member C3	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4539	medroxyprogesterone	Cytochrome P450 2C19	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4540	medroxyprogesterone	Sex hormone-binding globulin	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4541	medroxyprogesterone	Estrogen receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4542	medrysone	Glucocorticoid receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
4543	mefenamic acid	Prostaglandin G/H synthase 2	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4544	mefenamic acid	Prostaglandin G/H synthase 1	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4545	mefenamic acid	Cytochrome P450 2C9	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4546	mefenamic acid	Aldose reductase	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4547	mefenamic acid	Aldo-keto reductase family 1 member C1	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4548	mefenamic acid	Aldo-keto reductase family 1 member C2	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4549	mefenamic acid	Aldo-keto reductase family 1 member C3	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4550	mefenamic acid	Myeloperoxidase	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4551	mefenamic acid	Acetylcholinesterase	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4552	mefenamic acid	Transient receptor potential cation channel subfamily A member 1	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4553	mefenamic acid	Aldo-keto reductase family 1 member B10	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4554	mefenamic acid	Nicotinate phosphoribosyltransferase	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4555	megestrol acetate	Multidrug resistance protein 1	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
4556	megestrol acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
4557	megestrol acetate	Progesterone receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
4558	megestrol acetate	Cytochrome P450 2C9	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
4559	megestrol acetate	Androgen receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
4560	melatonin	5-hydroxytryptamine receptor 2B	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4561	melatonin	Ribosyldihydronicotinamide dehydrogenase [quinone]	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4562	melatonin	Melatonin receptor type 1A	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4563	melatonin	Melatonin receptor type 1B	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4564	melatonin	Nuclear receptor ROR-alpha	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4565	melatonin	Myeloperoxidase	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4566	melatonin	Histamine H3 receptor	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4567	melatonin	Cytochrome P450 1B1	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4568	melatonin	Melatonin receptor	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4569	meloxicam	Prostaglandin G/H synthase 2	CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=CC=CC=C2S1(=O)=O
4570	meloxicam	Prostaglandin G/H synthase 1	CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=CC=CC=C2S1(=O)=O
4571	memantine	5-hydroxytryptamine receptor 3A	CC12CC3CC(C)(C1)CC(N)(C3)C2
4572	memantine	Glutamate receptor ionotropic, NMDA 3A	CC12CC3CC(C)(C1)CC(N)(C3)C2
4573	memantine	Glutamate receptor ionotropic, NMDA 1	CC12CC3CC(C)(C1)CC(N)(C3)C2
4574	memantine	Solute carrier family 22 member 1	CC12CC3CC(C)(C1)CC(N)(C3)C2
4575	memantine	Glutamate receptor ionotropic, NMDA 2C	CC12CC3CC(C)(C1)CC(N)(C3)C2
4576	memantine	Glutamate NMDA receptor; GRIN1/GRIN2B	CC12CC3CC(C)(C1)CC(N)(C3)C2
4577	memantine	Glutamate NMDA receptor; GRIN1/GRIN2A	CC12CC3CC(C)(C1)CC(N)(C3)C2
4578	mepenzolate	Muscarinic acetylcholine receptor M1	C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
4579	mepenzolate	Muscarinic acetylcholine receptor M2	C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
4580	mepenzolate	Muscarinic acetylcholine receptor M3	C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
4581	mepenzolate	Solute carrier family 22 member 1	C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
4582	pethidine	Mu-type opioid receptor	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4583	pethidine	Potassium voltage-gated channel subfamily H member 2	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4584	pethidine	Sodium-dependent dopamine transporter	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4585	pethidine	Kappa-type opioid receptor	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4586	pethidine	Glutamate receptor ionotropic, NMDA 3A	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4587	pethidine	Solute carrier family 22 member 1	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4588	pethidine	Sodium-dependent serotonin transporter	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4589	pethidine	Opioid receptor	CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
4590	mephentermine	Alpha-1A adrenergic receptor	CNC(C)(C)CC1=CC=CC=C1
4591	mephenytoin	Sodium channel alpha subunit	CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1
4592	mepivacaine	Sodium channel protein type 5 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4593	mepivacaine	Sodium channel protein type 1 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4594	mepivacaine	Sodium channel protein type 2 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4595	mepivacaine	Sodium channel protein type 3 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4596	mepivacaine	Sodium channel protein type 4 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4597	mepivacaine	Sodium channel protein type 8 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4598	mepivacaine	Sodium channel protein type 9 subunit alpha	[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C
4599	meprednisone	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
4600	meprobamate	Multidrug resistance protein 1	CCCC(C)(COC(N)=O)COC(N)=O
4601	meprobamate	GABA-A receptor alpha-2/beta-3/gamma-2	CCCC(C)(COC(N)=O)COC(N)=O
4602	meprobamate	GABA-A receptor alpha-3/beta-3/gamma-2	CCCC(C)(COC(N)=O)COC(N)=O
4603	meprobamate	GABA-A receptor alpha-5/beta-3/gamma-2	CCCC(C)(COC(N)=O)COC(N)=O
4604	meprobamate	GABA-A receptor alpha-1/beta-3/gamma-2	CCCC(C)(COC(N)=O)COC(N)=O
4605	meptazinol	Solute carrier family 22 member 1	CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1
4606	meptazinol	Acetylcholinesterase	CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1
4607	meptazinol	Cholinesterase	CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1
4608	meptazinol	Mu-type opioid receptor	CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1
4609	mercaptopurine	Prostaglandin G/H synthase 1	S=C1N=CNC2=C1NC=N2
4610	mercaptopurine	Multidrug resistance-associated protein 5	S=C1N=CNC2=C1NC=N2
4611	mercaptopurine	Multidrug resistance-associated protein 4	S=C1N=CNC2=C1NC=N2
4612	mercaptopurine	Purine nucleoside phosphorylase	S=C1N=CNC2=C1NC=N2
4613	mercaptopurine	Amidophosphoribosyltransferase	S=C1N=CNC2=C1NC=N2
4614	mercaptopurine	Thiopurine S-methyltransferase	S=C1N=CNC2=C1NC=N2
4615	mesalazine	Prostaglandin G/H synthase 2	NC1=CC(C(O)=O)=C(O)C=C1
4616	mesalazine	Prostaglandin G/H synthase 1	NC1=CC(C(O)=O)=C(O)C=C1
4617	mesalazine	Arachidonate 5-lipoxygenase	NC1=CC(C(O)=O)=C(O)C=C1
4618	mesalazine	Peroxisome proliferator-activated receptor gamma	NC1=CC(C(O)=O)=C(O)C=C1
4619	mesalazine	Tumor necrosis factor	NC1=CC(C(O)=O)=C(O)C=C1
4620	mesalazine	Hydroxyacid oxidase 1	NC1=CC(C(O)=O)=C(O)C=C1
4621	mesoridazine	D(1A) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4622	mesoridazine	D(2) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4623	mesoridazine	Potassium voltage-gated channel subfamily H member 2	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4624	mesoridazine	5-hydroxytryptamine receptor 1A	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4625	mesoridazine	5-hydroxytryptamine receptor 2A	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4626	mesoridazine	5-hydroxytryptamine receptor 2C	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4627	mesoridazine	5-hydroxytryptamine receptor 6	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4628	mesoridazine	D(3) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4629	mesoridazine	Histamine H1 receptor	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4630	mesoridazine	Muscarinic acetylcholine receptor M1	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4631	mesoridazine	Muscarinic acetylcholine receptor M2	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4632	mesoridazine	Muscarinic acetylcholine receptor M3	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4633	mesoridazine	Muscarinic acetylcholine receptor M4	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4634	mesoridazine	Muscarinic acetylcholine receptor M5	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4635	mesoridazine	D(4) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C
4636	mestranol	Cannabinoid receptor 1	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4637	mestranol	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4638	mestranol	Sodium-dependent noradrenaline transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4639	mestranol	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4640	mestranol	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4641	mestranol	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
4642	orciprenaline	Beta-2 adrenergic receptor	CC(C)NCC(O)C1=CC(O)=CC(O)=C1
4643	metaraminol	Alpha-1A adrenergic receptor	C[C@H](N)[C@H](O)C1=CC(O)=CC=C1
4644	metformin	5'-AMP-activated protein kinase subunit beta-1	CN(C)C(=N)NC(N)=N
4645	metformin	Dipeptidyl peptidase 4	CN(C)C(=N)NC(N)=N
4646	metformin	Solute carrier family 22 member 1	CN(C)C(=N)NC(N)=N
4647	metformin	Solute carrier family 22 member 2	CN(C)C(=N)NC(N)=N
4648	metformin	Solute carrier family 22 member 3	CN(C)C(=N)NC(N)=N
4649	metformin	Mitochondrial complex I (NADH dehydrogenase)	CN(C)C(=N)NC(N)=N
4650	methacholine	Muscarinic acetylcholine receptor M1	CC(C[N+](C)(C)C)OC(C)=O
4651	methacholine	Muscarinic acetylcholine receptor M2	CC(C[N+](C)(C)C)OC(C)=O
4652	methacholine	Muscarinic acetylcholine receptor M3	CC(C[N+](C)(C)C)OC(C)=O
4653	methacholine	Muscarinic acetylcholine receptor M4	CC(C[N+](C)(C)C)OC(C)=O
4654	methadone	Mu-type opioid receptor	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4655	methadone	Potassium voltage-gated channel subfamily H member 2	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4656	methadone	Kappa-type opioid receptor	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4657	methadone	Glutamate receptor ionotropic, NMDA 3A	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4658	methadone	Neuronal acetylcholine receptor subunit alpha-10	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4659	methadone	Delta-type opioid receptor	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4660	methadone	Opioid receptor	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4661	acetylmethadol	Potassium voltage-gated channel subfamily H member 2	CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4662	acetylmethadol	Mu-type opioid receptor	CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
4663	methamphetamine	Alpha-2A adrenergic receptor	CN[C@@H](C)CC1=CC=CC=C1
4664	methamphetamine	Sigma non-opioid intracellular receptor 1	CN[C@@H](C)CC1=CC=CC=C1
4665	methamphetamine	Sodium-dependent serotonin transporter	CN[C@@H](C)CC1=CC=CC=C1
4666	methamphetamine	Sodium-dependent noradrenaline transporter	CN[C@@H](C)CC1=CC=CC=C1
4667	methamphetamine	5-hydroxytryptamine receptor 2B	CN[C@@H](C)CC1=CC=CC=C1
4668	methamphetamine	Alpha-2B adrenergic receptor	CN[C@@H](C)CC1=CC=CC=C1
4669	methamphetamine	Alpha-2C adrenergic receptor	CN[C@@H](C)CC1=CC=CC=C1
4670	methamphetamine	Sodium-dependent dopamine transporter	CN[C@@H](C)CC1=CC=CC=C1
4671	methamphetamine	Trace amine-associated receptor 1	CN[C@@H](C)CC1=CC=CC=C1
4672	methamphetamine	Synaptic vesicular amine transporter	CN[C@@H](C)CC1=CC=CC=C1
4673	methanthelinium	Muscarinic acetylcholine receptor	CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2
4674	metharbital	GABA-A receptor; anion channel	CCC1(CC)C(=O)NC(=O)N(C)C1=O
4675	methazolamide	Carbonic anhydrase 2	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4676	methazolamide	Carbonic anhydrase 1	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4677	methazolamide	Carbonic anhydrase 4	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4678	methazolamide	Carbonic anhydrase 9	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4679	methazolamide	Carbonic anhydrase 12	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4680	methazolamide	Carbonic anhydrase 5A, mitochondrial	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4681	methazolamide	Carbonic anhydrase 5B, mitochondrial	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4682	methazolamide	Carbonic anhydrase 7	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4683	methazolamide	Carbonic anhydrase	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4684	methazolamide	Carbonic anhydrase 3	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4685	methazolamide	Carbonic anhydrase 6	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4686	methazolamide	Carbonic anhydrase 14	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4687	methazolamide	Carbonic anhydrase 13	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4688	methazolamide	Carbonic anhydrase 15	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4689	methazolamide	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4690	methazolamide	Alpha carbonic anhydrase	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4691	methazolamide	Astrosclerin-3	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4692	methazolamide	Beta-carbonic anhydrase 1	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4693	methazolamide	Delta carbonic anhydrase	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4694	methazolamide	Carbonic anhydrase V	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4695	methazolamide	Carbonic anhydrase, alpha family	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4696	methazolamide	Carbonate dehydratase	CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
4697	methdilazine	Histamine H1 receptor	CN1CCC(CN2C3=CC=CC=C3SC3=C2C=CC=C3)C1
4698	thiamazole	Thyroid peroxidase	CN1C=CNC1=S
4699	thiamazole	Lactoperoxidase	CN1C=CNC1=S
4700	thiamazole	Dopamine beta-hydroxylase	CN1C=CNC1=S
4701	methocarbamol	Carbonic anhydrase 1	COC1=C(OCC(O)COC(N)=O)C=CC=C1
4702	methohexital	Glycine receptor subunit alpha-1	CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
4703	methohexital	GABA-A receptor alpha-1/beta-3/gamma-2	CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
4704	methohexital	Neuronal acetylcholine receptor; alpha2/beta2	CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
4705	methotrexate	Multidrug resistance protein 1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4706	methotrexate	Canalicular multispecific organic anion transporter 1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4707	methotrexate	Multidrug resistance-associated protein 1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4708	methotrexate	ATP-binding cassette sub-family G member 2	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4709	methotrexate	Thymidylate synthase	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4710	methotrexate	Multidrug resistance-associated protein 5	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4711	methotrexate	Folylpolyglutamate synthase, mitochondrial	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4712	methotrexate	Multidrug resistance-associated protein 4	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4713	methotrexate	Bifunctional dihydrofolate reductase-thymidylate synthase	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4714	methotrexate	Dihydrofolate reductase	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4715	methotrexate	Folate receptor beta	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4716	methotrexate	Proton-coupled folate transporter	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4717	methotrexate	Pteridine reductase 1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4718	methotrexate	Folate transporter 1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4719	methotrexate	Folate receptor alpha	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4720	methotrexate	High mobility group protein B1	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4721	methoxamine	Alpha-1A adrenergic receptor	COC1=CC(C(O)C(C)N)=C(OC)C=C1
4722	methoxamine	Alpha-1D adrenergic receptor	COC1=CC(C(O)C(C)N)=C(OC)C=C1
4723	methoxamine	Alpha-1B adrenergic receptor	COC1=CC(C(O)C(C)N)=C(OC)C=C1
4724	methoxamine	Adrenergic receptor alpha-2	COC1=CC(C(O)C(C)N)=C(OC)C=C1
4725	methoxyflurane	Glycine receptor subunit alpha-1	COC(F)(F)C(Cl)Cl
4726	methoxyflurane	GABA-A receptor; anion channel	COC(F)(F)C(Cl)Cl
4727	methscopolamine	Muscarinic acetylcholine receptor M1	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
4728	methscopolamine	Muscarinic acetylcholine receptor M2	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
4729	methscopolamine	Muscarinic acetylcholine receptor M3	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
4730	methscopolamine	Muscarinic acetylcholine receptor M4	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
4731	methscopolamine	Muscarinic acetylcholine receptor M5	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
4732	methsuximide	Voltage-gated T-type calcium channel	CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1
4733	methylclothiazide	Solute carrier family 12 member 3	CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
4734	methyldopa	Alpha-2A adrenergic receptor	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4735	methyldopa	Aromatic-L-amino-acid decarboxylase	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4736	methyldopa	Epidermal growth factor receptor	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4737	methyldopa	Tyrosine-protein kinase Fyn	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4738	methyldopa	Arachidonate 15-lipoxygenase	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4739	methyldopa	Lysine-specific demethylase 4E	C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4740	methylergometrine	D(1A) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4741	methylergometrine	D(2) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4742	methylergometrine	Alpha-2A adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4743	methylergometrine	5-hydroxytryptamine receptor 1A	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4744	methylergometrine	5-hydroxytryptamine receptor 2A	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4745	methylergometrine	5-hydroxytryptamine receptor 2B	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4746	methylergometrine	5-hydroxytryptamine receptor 2C	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4747	methylergometrine	5-hydroxytryptamine receptor 6	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4748	methylergometrine	Alpha-2B adrenergic receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4749	methylergometrine	D(3) dopamine receptor	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4750	methylergometrine	Cytochrome P450 2D6	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4751	methylergometrine	5-hydroxytryptamine receptor 1F	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4752	methylergometrine	5-hydroxytryptamine receptor 1E	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4753	methylergometrine	5-hydroxytryptamine receptor 1B	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4754	naltrexone	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4755	naltrexone	Cytochrome P450 2D6	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4756	naltrexone	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4757	naltrexone	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4758	naltrexone	Neuronal acetylcholine receptor subunit alpha-7	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4759	naltrexone	Neuronal acetylcholine receptor subunit alpha-4	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4760	naltrexone	Opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4761	naltrexone	Opioid receptors; mu and delta	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
4762	methylphenidate	Alpha-2A adrenergic receptor	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4763	methylphenidate	Sodium-dependent serotonin transporter	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4764	methylphenidate	Sodium-dependent noradrenaline transporter	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4765	methylphenidate	Alpha-2B adrenergic receptor	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4766	methylphenidate	Alpha-2C adrenergic receptor	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4767	methylphenidate	Sodium-dependent dopamine transporter	[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1
4768	methylprednisolone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4769	methylprednisolone	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4770	methylprednisolone	Androgen receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4771	methylprednisolone	Short transient receptor potential channel 5	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4772	methylprednisolone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4773	methylprednisolone succinate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
4774	methyprylon	GABA-A receptor alpha-1/beta-3/gamma-2	[H]C1(C)CNC(=O)C(CC)(CC)C1=O
4775	methysergide	D(1A) dopamine receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4776	methysergide	D(2) dopamine receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4777	methysergide	Alpha-2A adrenergic receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4778	methysergide	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4779	methysergide	5-hydroxytryptamine receptor 1A	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4780	methysergide	5-hydroxytryptamine receptor 6	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4781	methysergide	5-hydroxytryptamine receptor 7	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4782	methysergide	Alpha-2B adrenergic receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4783	methysergide	D(3) dopamine receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4784	methysergide	Histamine H1 receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4785	methysergide	Muscarinic acetylcholine receptor M1	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4786	methysergide	Muscarinic acetylcholine receptor M2	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4787	methysergide	Muscarinic acetylcholine receptor M3	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4788	methysergide	5-hydroxytryptamine receptor 1B	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4789	methysergide	5-hydroxytryptamine receptor 1D	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4790	methysergide	Alpha-2C adrenergic receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4791	methysergide	5-hydroxytryptamine receptor 5A	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4792	methysergide	5-hydroxytryptamine receptor 1F	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4793	methysergide	5-hydroxytryptamine receptor 1E	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4794	methysergide	Induced myeloid leukemia cell differentiation protein Mcl-1	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4795	methysergide	Bcl-2-like protein 1	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4796	methysergide	5-hydroxytryptamine receptor 2A	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4797	methysergide	Zinc finger protein mex-5	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4798	methysergide	Serotonin 2 (5-HT2) receptor	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4799	methysergide	Cytoplasmic zinc-finger protein	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4800	methysergide	5-hydroxytryptamine receptor 2B	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4801	methysergide	5-hydroxytryptamine receptor 2C	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
4802	metipranolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1
4803	metipranolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1
4804	metixene	5-hydroxytryptamine receptor 2C	CN1CCCC(CC2C3=CC=CC=C3SC3=C2C=CC=C3)C1
4805	metixene	Muscarinic acetylcholine receptor M1	CN1CCCC(CC2C3=CC=CC=C3SC3=C2C=CC=C3)C1
4806	metixene	Cholinesterase	CN1CCCC(CC2C3=CC=CC=C3SC3=C2C=CC=C3)C1
4807	metoclopramide	5-hydroxytryptamine receptor 4	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4808	metoclopramide	D(2) dopamine receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4809	metoclopramide	Alpha-2A adrenergic receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4810	metoclopramide	5-hydroxytryptamine receptor 2A	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4811	metoclopramide	5-hydroxytryptamine receptor 2B	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4812	metoclopramide	5-hydroxytryptamine receptor 2C	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4813	metoclopramide	D(3) dopamine receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4814	metoclopramide	Muscarinic acetylcholine receptor M1	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4815	metoclopramide	Aldehyde oxidase	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4816	metoclopramide	Cytochrome P450 2D6	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4817	metoclopramide	5-hydroxytryptamine receptor 3A	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4818	metoclopramide	Myeloperoxidase	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4819	metoclopramide	Solute carrier family 22 member 1	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4820	metoclopramide	Serotonin 3 (5-HT3) receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4821	metoclopramide	Serotonin 1 (5-HT1) receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4822	metoclopramide	Adrenergic receptor alpha-2	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4823	metoclopramide	Adrenergic receptor alpha-1	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4824	metoclopramide	Serotonin 2 (5-HT2) receptor	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4825	metoclopramide	Serotonin 3 receptor (5HT3)	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4826	metolazone	Solute carrier family 12 member 1	CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=C(C)C=CC=C1)S(N)(=O)=O
4827	metolazone	Solute carrier family 12 member 3	CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=C(C)C=CC=C1)S(N)(=O)=O
4828	metolazone	Carbonic anhydrase 7	CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=C(C)C=CC=C1)S(N)(=O)=O
4829	metoprolol	Beta-1 adrenergic receptor	COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
4830	metoprolol	Beta-2 adrenergic receptor	COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
4831	metoprolol	5-hydroxytryptamine receptor 1A	COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
4832	metoprolol	Adrenergic receptor beta	COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
4833	metyrapone	Cytochrome P450 3A4	CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1
4834	metyrapone	Cytochrome P450 11B2, mitochondrial	CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1
4835	metyrapone	Cytochrome P450 11B1	CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1
4836	metyrapone	Cytochrome P450 11B1, mitochondrial	CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1
4837	metirosine	Tyrosine 3-monooxygenase	C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O
4838	mexiletine	Sodium channel protein type 5 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4839	mexiletine	Sodium channel subunit beta-1	CC(N)COC1=C(C)C=CC=C1C
4840	mexiletine	Sodium channel subunit beta-2	CC(N)COC1=C(C)C=CC=C1C
4841	mexiletine	Sodium channel subunit beta-3	CC(N)COC1=C(C)C=CC=C1C
4842	mexiletine	Sodium channel subunit beta-4	CC(N)COC1=C(C)C=CC=C1C
4843	mexiletine	Potassium voltage-gated channel subfamily H member 2	CC(N)COC1=C(C)C=CC=C1C
4844	mexiletine	5-hydroxytryptamine receptor 2B	CC(N)COC1=C(C)C=CC=C1C
4845	mexiletine	Sodium channel protein type 1 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4846	mexiletine	Sodium channel protein type 2 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4847	mexiletine	Sodium channel protein type 4 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4848	mexiletine	Sodium channel protein type 9 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4849	mexiletine	Sodium channel protein type 10 subunit alpha	CC(N)COC1=C(C)C=CC=C1C
4850	mexiletine	Potassium channel subfamily K member 3	CC(N)COC1=C(C)C=CC=C1C
4851	mexiletine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CC(N)COC1=C(C)C=CC=C1C
4852	mexiletine	Solute carrier family 22 member 2	CC(N)COC1=C(C)C=CC=C1C
4853	mexiletine	Sodium channel protein type X alpha subunit	CC(N)COC1=C(C)C=CC=C1C
4854	mianserin	D(1A) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4855	mianserin	D(2) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4856	mianserin	Alpha-2A adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4857	mianserin	Sodium-dependent serotonin transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4858	mianserin	Sodium-dependent noradrenaline transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4859	mianserin	5-hydroxytryptamine receptor 1A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4860	mianserin	5-hydroxytryptamine receptor 2A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4861	mianserin	5-hydroxytryptamine receptor 2B	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4862	mianserin	5-hydroxytryptamine receptor 2C	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4863	mianserin	5-hydroxytryptamine receptor 6	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4864	mianserin	5-hydroxytryptamine receptor 7	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4865	mianserin	Alpha-1A adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4866	mianserin	Alpha-2B adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4867	mianserin	D(3) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4868	mianserin	Histamine H1 receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4869	mianserin	Histamine H2 receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4870	mianserin	Histamine H4 receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4871	mianserin	Muscarinic acetylcholine receptor M1	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4872	mianserin	Muscarinic acetylcholine receptor M2	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4873	mianserin	Muscarinic acetylcholine receptor M3	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4874	mianserin	Muscarinic acetylcholine receptor M4	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4875	mianserin	Muscarinic acetylcholine receptor M5	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4876	mianserin	5-hydroxytryptamine receptor 1B	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4877	mianserin	5-hydroxytryptamine receptor 1D	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4878	mianserin	Alpha-2C adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4879	mianserin	Sodium-dependent dopamine transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4880	mianserin	D(4) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4881	mianserin	Alpha-1D adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4882	mianserin	5-hydroxytryptamine receptor 3A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4883	mianserin	Alpha-1B adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4884	mianserin	5-hydroxytryptamine receptor 1F	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4885	mianserin	Transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4886	mianserin	Serotonin 3 (5-HT3) receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4887	mianserin	Serotonin 1 (5-HT1) receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4888	mianserin	Adrenergic receptor alpha-2	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4889	mianserin	Sodium channel alpha subunits; brain (Types I, II, III)	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4890	mianserin	Cerebral cortex alpha adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4891	mianserin	Serotonin 2 (5-HT2) receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4892	mianserin	Serotonin 3 receptor (5HT3)	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4893	mianserin	G-protein coupled receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1
4894	mibefradil	Sodium channel protein type 5 subunit alpha	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4895	mibefradil	Potassium voltage-gated channel subfamily H member 2	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4896	mibefradil	Cytochrome P450 3A4	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4897	mibefradil	Multidrug resistance protein 1	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4898	mibefradil	Sodium channel protein type 9 subunit alpha	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4899	mibefradil	Voltage-dependent L-type calcium channel subunit alpha-1C	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4900	mibefradil	Voltage-dependent T-type calcium channel subunit alpha-1G	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4901	mibefradil	Voltage-dependent T-type calcium channel subunit alpha-1I	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4902	mibefradil	Potassium channel subfamily K member 9	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4903	mibefradil	Voltage-dependent N-type calcium channel subunit alpha-1B	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4904	mibefradil	Sodium channel protein type 2 subunit alpha	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4905	mibefradil	Cation channel sperm-associated protein 1	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4906	mibefradil	Cation channel sperm-associated protein 2	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4907	mibefradil	Cation channel sperm-associated protein 3	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4908	mibefradil	Cation channel sperm-associated protein 4	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4909	mibefradil	Voltage-dependent R-type calcium channel subunit alpha-1E	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4910	mibefradil	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4911	mibefradil	Calcium release-activated calcium channel protein 1	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4912	mibefradil	Sodium channel protein type 4 subunit alpha	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4913	mibefradil	Voltage-dependent T-type calcium channel subunit alpha-1H	COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C
4914	midazolam	Cytochrome P450 3A4	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4915	midazolam	Multidrug resistance protein 1	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4916	midazolam	Translocator protein	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4917	midazolam	Thyrotropin-releasing hormone receptor	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4918	midazolam	GABA-A receptor alpha-1/beta-2/gamma-2	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4919	midazolam	GABA-A receptor alpha-5/beta-3/gamma-2	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4920	midazolam	GABA-A receptor alpha-1/beta-2/gamma-3	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4921	midazolam	GABA-A receptor; anion channel	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4922	midazolam	GABA A receptor alpha-3/beta-2/gamma-2	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4923	midazolam	GABA A receptor alpha-3/beta-2/gamma-3	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4924	midazolam	GABA A receptor alpha-5/beta-3/gamma-3	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4925	midazolam	GABA A receptor alpha-5/beta-2/gamma-2	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4926	midazolam	GABA A receptor alpha-5/beta-2/gamma-3	CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1
4927	midodrine	Alpha-1A adrenergic receptor	COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
4928	midodrine	Heat shock protein HSP 90-alpha	COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
4929	mifepristone	Mu-type opioid receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4930	mifepristone	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4931	mifepristone	Cytochrome P450 3A4	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4932	mifepristone	Alpha-2B adrenergic receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4933	mifepristone	Glucocorticoid receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4934	mifepristone	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4935	mifepristone	Kappa-type opioid receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4936	mifepristone	Mineralocorticoid receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4937	mifepristone	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4938	mifepristone	Androgen receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4939	mifepristone	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4940	mifepristone	Estrogen receptor beta	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4941	mifepristone	Tyrosine-protein kinase Fyn	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4942	mifepristone	Mitogen-activated protein kinase 14	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4943	mifepristone	Arachidonate 15-lipoxygenase	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4944	mifepristone	P-glycoprotein 3	[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
4945	miglitol	Maltase-glucoamylase, intestinal	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4946	miglitol	Pancreatic alpha-amylase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4947	miglitol	Glucosylceramidase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4948	miglitol	Lysosomal alpha-glucosidase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4949	miglitol	Sucrase-isomaltase, intestinal	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4950	miglitol	Glycogen debranching enzyme	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4951	miglitol	Lactase-phlorizin hydrolase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4952	miglitol	Beta-galactosidase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4953	miglitol	Alpha-mannosidase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4954	miglitol	Alpha-glucosidase	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4955	miglustat	Maltase-glucoamylase, intestinal	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4956	miglustat	Ceramide glucosyltransferase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4957	miglustat	Lysosomal alpha-glucosidase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4958	miglustat	Sucrase-isomaltase, intestinal	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4959	miglustat	Non-lysosomal glucosylceramidase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4960	miglustat	Glycogen debranching enzyme	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4961	miglustat	Sucrase-isomaltase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4962	miglustat	Putative alpha-glucosidase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4963	miglustat	Trehalase	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4964	miglustat	Uncharacterized protein	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
4965	milnacipran	Glutamate receptor ionotropic, NMDA 2A	CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
4966	milnacipran	Sodium-dependent serotonin transporter	CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
4967	milnacipran	Sodium-dependent noradrenaline transporter	CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
4968	milnacipran	Sodium-dependent dopamine transporter	CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
4969	milnacipran	Transporter	CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
4970	milrinone	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4971	milrinone	cGMP-specific 3',5'-cyclic phosphodiesterase	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4972	milrinone	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4973	milrinone	Cyclic nucleotide phosphodiesterase PDE3A	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4974	milrinone	Cyclic AMP-specific phosphodiesterase SSPDE4A1A	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4975	milrinone	Uncharacterized protein	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4976	milrinone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4977	milrinone	Phosphodiesterase 3	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4978	milrinone	Phosphodiesterase 4	CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
4979	minoxidil	ATP-sensitive inward rectifier potassium channel 1	NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
4980	minoxidil	Sulfonylurea receptor 2, Kir6.2	NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
4981	mirtazapine	D(1A) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4982	mirtazapine	D(2) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4983	mirtazapine	Alpha-2A adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4984	mirtazapine	Sodium-dependent noradrenaline transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4985	mirtazapine	5-hydroxytryptamine receptor 1A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4986	mirtazapine	5-hydroxytryptamine receptor 2A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4987	mirtazapine	5-hydroxytryptamine receptor 2C	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4988	mirtazapine	5-hydroxytryptamine receptor 7	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4989	mirtazapine	Alpha-1A adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4990	mirtazapine	Alpha-2B adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4991	mirtazapine	D(3) dopamine receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4992	mirtazapine	Histamine H1 receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4993	mirtazapine	Muscarinic acetylcholine receptor M1	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4994	mirtazapine	Muscarinic acetylcholine receptor M2	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4995	mirtazapine	Alpha-2C adrenergic receptor	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4996	mirtazapine	5-hydroxytryptamine receptor 3A	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4997	mirtazapine	Transporter	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4998	mirtazapine	Adrenergic receptor alpha-1	[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1
4999	misoprostol	Prostaglandin E2 receptor EP3 subtype	[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCC(=O)OC)[C@@]1([H])\C=C\CC(C)(O)CCCC
5000	misoprostol	Prostaglandin E2 receptor EP2 subtype	[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCC(=O)OC)[C@@]1([H])\C=C\CC(C)(O)CCCC
5001	misoprostol	Prostaglandin E2 receptor EP4 subtype	[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCC(=O)OC)[C@@]1([H])\C=C\CC(C)(O)CCCC
5002	misoprostol	Prostaglandin F2-alpha receptor	[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCC(=O)OC)[C@@]1([H])\C=C\CC(C)(O)CCCC
5003	mitiglinide	Sulfonylurea receptor 1, Kir6.2	[H][C@@]12CN(C[C@]1([H])CCCC2)C(=O)C[C@H](CC1=CC=CC=C1)C(O)=O
5004	mitotane	Alpha-2A adrenergic receptor	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5005	mitotane	Sodium-dependent serotonin transporter	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5006	mitotane	Sodium-dependent noradrenaline transporter	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5007	mitotane	5-hydroxytryptamine receptor 2B	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5008	mitotane	5-hydroxytryptamine receptor 6	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5009	mitotane	Sodium-dependent dopamine transporter	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5010	mitotane	Adenosine receptor A3	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5011	mitotane	Cytochrome P450 11B1, mitochondrial	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5012	mitotane	Adrenodoxin, mitochondrial	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5013	mitotane	Cholesterol side-chain cleavage enzyme, mitochondrial	ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1
5014	mitoxantrone	Potassium voltage-gated channel subfamily H member 2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5015	mitoxantrone	Multidrug resistance protein 1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5016	mitoxantrone	Sodium-dependent noradrenaline transporter	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5017	mitoxantrone	5-hydroxytryptamine receptor 2C	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5018	mitoxantrone	Muscarinic acetylcholine receptor M1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5019	mitoxantrone	Muscarinic acetylcholine receptor M2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5020	mitoxantrone	Muscarinic acetylcholine receptor M4	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5021	mitoxantrone	Canalicular multispecific organic anion transporter 1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5022	mitoxantrone	DNA topoisomerase 2-alpha	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5023	mitoxantrone	Multidrug resistance-associated protein 1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5024	mitoxantrone	ATP-binding cassette sub-family G member 2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5025	mitoxantrone	Epidermal growth factor receptor	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5026	mitoxantrone	Tyrosine-protein kinase Fyn	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5027	mitoxantrone	Receptor tyrosine-protein kinase erbB-2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5028	mitoxantrone	Serine/threonine-protein kinase pim-1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5029	mitoxantrone	Solute carrier family 22 member 1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5030	mitoxantrone	DNA-(apurinic or apyrimidinic site) lyase	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5031	mitoxantrone	Arachidonate 15-lipoxygenase	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5032	mitoxantrone	Integrase	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5033	mitoxantrone	Tyrosine-protein kinase BTK	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5034	mitoxantrone	Proto-oncogene tyrosine-protein kinase ROS	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5035	mitoxantrone	Solute carrier family 22 member 2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5036	mitoxantrone	Multidrug and toxin extrusion protein 1	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5037	mitoxantrone	Multidrug and toxin extrusion protein 2	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5038	mitoxantrone	Solute carrier family 22 member 3	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5039	mitoxantrone	DNA-3-methyladenine glycosylase	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5040	mitoxantrone	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
5041	mivacurium	Neuronal acetylcholine receptor subunit alpha-2	COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
5042	mivacurium	Acetylcholine receptor	COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
5043	mizolastine	Potassium voltage-gated channel subfamily H member 2	CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1
5044	mizolastine	Arachidonate 5-lipoxygenase	CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1
5045	mizolastine	Histamine H1 receptor	CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1
5046	moclobemide	Potassium voltage-gated channel subfamily H member 2	ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
5047	moclobemide	5-hydroxytryptamine receptor 1A	ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
5048	moclobemide	Amine oxidase [flavin-containing] B	ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
5049	moclobemide	Amine oxidase [flavin-containing] A	ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
5050	modafinil	D(2) dopamine receptor	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5051	modafinil	Sodium-dependent dopamine transporter	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5052	modafinil	Alpha-1B adrenergic receptor	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5053	modafinil	Cytochrome P450 1A2	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5054	modafinil	Cytochrome P450 2C19	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5055	modafinil	Transporter	NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
5056	moexipril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O
5057	molindone	D(2) dopamine receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5058	molindone	Alpha-2A adrenergic receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5059	molindone	Sigma non-opioid intracellular receptor 1	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5060	molindone	5-hydroxytryptamine receptor 1A	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5061	molindone	5-hydroxytryptamine receptor 2A	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5062	molindone	5-hydroxytryptamine receptor 2C	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5063	molindone	5-hydroxytryptamine receptor 6	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5064	molindone	5-hydroxytryptamine receptor 7	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5065	molindone	Alpha-1A adrenergic receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5066	molindone	Alpha-2B adrenergic receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5067	molindone	D(3) dopamine receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5068	molindone	Histamine H1 receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5069	molindone	Muscarinic acetylcholine receptor M3	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5070	molindone	Alpha-2C adrenergic receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5071	molindone	D(4) dopamine receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5072	molindone	D(1A) dopamine receptor	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
5073	mometasone furoate	Multidrug resistance protein 1	[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
5074	mometasone furoate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
5075	mometasone furoate	Progesterone receptor	[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
5076	monobenzone	Prostaglandin G/H synthase 2	OC1=CC=C(OCC2=CC=CC=C2)C=C1
5077	monobenzone	Prostaglandin G/H synthase 1	OC1=CC=C(OCC2=CC=CC=C2)C=C1
5078	monobenzone	Sodium-dependent noradrenaline transporter	OC1=CC=C(OCC2=CC=CC=C2)C=C1
5079	monobenzone	Tyrosinase	OC1=CC=C(OCC2=CC=CC=C2)C=C1
5080	monobenzone	Arachidonate 15-lipoxygenase	OC1=CC=C(OCC2=CC=CC=C2)C=C1
5081	montelukast	Beta-2 adrenergic receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5082	montelukast	Alpha-2A adrenergic receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5083	montelukast	Sodium-dependent noradrenaline transporter	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5084	montelukast	5-hydroxytryptamine receptor 2B	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5085	montelukast	D(3) dopamine receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5086	montelukast	Muscarinic acetylcholine receptor M1	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5087	montelukast	Muscarinic acetylcholine receptor M3	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5088	montelukast	Beta-3 adrenergic receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5089	montelukast	Alpha-2C adrenergic receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5090	montelukast	Sodium-dependent dopamine transporter	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5091	montelukast	Adenosine receptor A3	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5092	montelukast	Cytochrome P450 2C8	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5093	montelukast	Delta-type opioid receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5094	montelukast	Cysteinyl leukotriene receptor 1	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5095	montelukast	Arachidonate 5-lipoxygenase	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5096	montelukast	Epidermal growth factor receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5097	montelukast	Tyrosine-protein kinase Fyn	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5098	montelukast	Thromboxane-A synthase	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5099	montelukast	Cysteinyl leukotriene receptor 2	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5100	montelukast	Mitogen-activated protein kinase 14	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5101	montelukast	Substance-K receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5102	montelukast	Uracil nucleotide/cysteinyl leukotriene receptor	CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1
5103	moracizine	Sodium channel protein type 5 subunit alpha	CCOC(=O)NC1=CC=C2SC3=CC=CC=C3N(C(=O)CCN3CCOCC3)C2=C1
5104	morphine	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5105	morphine	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5106	morphine	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5107	morphine	Solute carrier family 22 member 1	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5108	morphine	Nociceptin receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5109	morphine	Opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5110	morphine	Dopamine receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5111	morphine	Mu opioid receptor-like OR2	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5112	morphine	Opioid receptor, delta 1b	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5113	morphine	Opioid receptor homologue	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
5114	mosapride	5-hydroxytryptamine receptor 4	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5115	mosapride	Alpha-2A adrenergic receptor	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5116	mosapride	Sigma non-opioid intracellular receptor 1	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5117	mosapride	Potassium voltage-gated channel subfamily H member 2	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5118	mosapride	Cytochrome P450 3A4	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5119	mosapride	Sodium-dependent serotonin transporter	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5120	mosapride	5-hydroxytryptamine receptor 2B	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5121	mosapride	5-hydroxytryptamine receptor 2C	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5122	mosapride	Alpha-2B adrenergic receptor	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5123	mosapride	5-hydroxytryptamine receptor 3A	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5124	mosapride	Cytochrome P450 2C9	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5125	mosapride	Cytochrome P450 1A2	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5126	mosapride	Cytochrome P450 2C19	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5127	mosapride	Serotonin 3 (5-HT3) receptor	CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1
5128	moxastine	Histamine H1 receptor	CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=C1
5129	moxonidine	Alpha-2A adrenergic receptor	COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
5130	moxonidine	5-hydroxytryptamine receptor 1A	COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
5131	moxonidine	Alpha-2C adrenergic receptor	COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
5132	moxonidine	Alpha-2B adrenergic receptor	COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
5133	moxonidine	Nischarin	COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
5134	mycophenolate mofetil	Inosine-5'-monophosphate dehydrogenase 1	COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1
5135	mycophenolate mofetil	Inosine-5'-monophosphate dehydrogenase 2	COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1
5136	mycophenolic acid	Inosine-5'-monophosphate dehydrogenase 1	COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
5137	mycophenolic acid	Inosine-5'-monophosphate dehydrogenase 2	COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
5138	mycophenolic acid	Inosine-5'-monophosphate dehydrogenase (IMPDH)	COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
5139	mycophenolic acid	Inosine-5'-monophosphate dehydrogenase	COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
5140	nabilone	Cannabinoid receptor 1	[H]C12CC(=O)CCC1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC
5141	nabilone	Cannabinoid receptor 2	[H]C12CC(=O)CCC1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC
5142	nabumetone	Prostaglandin G/H synthase 2	COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5143	nabumetone	Prostaglandin G/H synthase 1	COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5144	nabumetone	Sodium-dependent noradrenaline transporter	COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5145	nabumetone	Cytochrome P450 1A2	COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5146	nabumetone	Amine oxidase [flavin-containing] A	COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5147	nadolol	Beta-1 adrenergic receptor	CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2
5148	nadolol	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2
5149	nadolol	Beta-3 adrenergic receptor	CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2
5150	nafamostat	Plasminogen	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5151	nafamostat	Prothrombin	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5152	nafamostat	Trypsin-1	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5153	nafamostat	Kallikrein-1	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5154	nafamostat	Coagulation factor X	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5155	nafamostat	Suppressor of tumorigenicity 14 protein	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5156	nafamostat	Complement C1r subcomponent	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5157	nafamostat	Complement C1s subcomponent	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5158	nafamostat	Acid-sensing ion channel 2	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5159	nafamostat	Acid-sensing ion channel 1	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5160	nafamostat	Cationic trypsin	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5161	nafamostat	Acid-sensing ion channel 3	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5162	nafamostat	Tryptase alpha/beta-1	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5163	nafamostat	Serine protease hepsin	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5164	nafamostat	Hepatocyte growth factor activator	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5165	nafamostat	Transmembrane protease serine 2	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
5166	nafarelin	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
5167	naftopidil	Beta-2 adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5168	naftopidil	Adrenergic receptor alpha-2	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5169	naftopidil	Adrenergic receptor alpha-1	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5170	naftopidil	Alpha-1A adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5171	naftopidil	Alpha-1D adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5172	naftopidil	Alpha-1B adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
5173	nalbuphine	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O
5174	nalbuphine	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O
5175	nalbuphine	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O
5176	nalmefene	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
5177	nalmefene	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
5178	nalmefene	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
5179	naloxone	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5180	naloxone	Cytochrome P450 2D6	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5181	naloxone	Adenosine receptor A3	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5182	naloxone	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5183	naloxone	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5184	naloxone	C-C chemokine receptor type 5	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5185	naloxone	Opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O
5186	nandrolone	Androgen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5187	nandrolone	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5188	nandrolone	Sex hormone-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5189	nandrolone	Solute carrier family 22 member 1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5190	nandrolone	Progesterone receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5191	nandrolone decanoate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5192	nandrolone decanoate	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5193	nandrolone decanoate	Sex hormone-binding globulin	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5194	nandrolone decanoate	Solute carrier family 22 member 1	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5195	nandrolone decanoate	Progesterone receptor	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5196	nandrolone phenpropionate	Estrogen receptor	[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5197	nandrolone phenpropionate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5198	naproxen	Prostaglandin G/H synthase 2	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5199	naproxen	Prostaglandin G/H synthase 1	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5200	naproxen	Aldo-keto reductase family 1 member C2	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5201	naproxen	Aldo-keto reductase family 1 member C3	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5202	naproxen	Prostaglandin-H2 D-isomerase	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5203	naproxen	Hormone-sensitive lipase	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5204	naproxen	Cyclooxygenase	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5205	naratriptan	5-hydroxytryptamine receptor 1A	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1
5206	naratriptan	5-hydroxytryptamine receptor 1B	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1
5207	naratriptan	5-hydroxytryptamine receptor 1D	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1
5208	naratriptan	5-hydroxytryptamine receptor 1F	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1
5209	naratriptan	5-hydroxytryptamine receptor 1E	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1
5210	nateglinide	Solute carrier family 22 member 6	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
5211	nateglinide	Sulfonylurea receptor 1, Kir6.2	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
5212	nateglinide	Sulfonylurea receptor 2, Kir6.2	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
5213	nebivolol	Beta-1 adrenergic receptor	[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1
5214	nebivolol	Beta-2 adrenergic receptor	[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1
5215	nebivolol	5-hydroxytryptamine receptor 1A	[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1
5216	nebivolol	Beta-3 adrenergic receptor	[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1
5217	nefazodone	D(2) dopamine receptor	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5218	nefazodone	Cytochrome P450 3A4	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5219	nefazodone	Sodium-dependent serotonin transporter	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5220	nefazodone	Sodium-dependent noradrenaline transporter	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5221	nefazodone	5-hydroxytryptamine receptor 1A	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5222	nefazodone	5-hydroxytryptamine receptor 2A	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5223	nefazodone	5-hydroxytryptamine receptor 2C	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5224	nefazodone	Alpha-1A adrenergic receptor	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5225	nefazodone	Alpha-2B adrenergic receptor	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5226	nefazodone	Histamine H1 receptor	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5227	nefazodone	Sodium-dependent dopamine transporter	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5228	nefazodone	Acetylcholinesterase	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5229	nefazodone	Bile salt export pump	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5230	nefazodone	Transporter	CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
5231	neostigmine	Acetylcholinesterase	CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
5232	neostigmine	Cholinesterase	CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
5233	nepafenac	Prostaglandin G/H synthase 2	NC(=O)CC1=C(N)C(=CC=C1)C(=O)C1=CC=CC=C1
5234	nepafenac	Prostaglandin G/H synthase 1	NC(=O)CC1=C(N)C(=CC=C1)C(=O)C1=CC=CC=C1
5235	nepafenac	Cyclooxygenase	NC(=O)CC1=C(N)C(=CC=C1)C(=O)C1=CC=CC=C1
5236	nesiritide	Atrial natriuretic peptide receptor 1	[H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O
5237	nicardipine	Cytochrome P450 3A4	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5238	nicardipine	Multidrug resistance protein 1	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5239	nicardipine	Adenosine receptor A3	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5240	nicardipine	Nuclear receptor subfamily 1 group I member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5241	nicardipine	ATP-binding cassette sub-family G member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5242	nicardipine	Beta-lactamase	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5243	nicardipine	Cytochrome P450 2C9	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5244	nicardipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5245	nicardipine	Adenosine receptor A1	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5246	nicardipine	Adenosine receptor A2a	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5247	nicardipine	Equilibrative nucleoside transporter 1	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5248	nicardipine	Quinolone resistance protein NorA	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5249	nicardipine	Adrenergic receptor alpha-2	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5250	nicardipine	Adrenergic receptor alpha-1	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5251	nicardipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5252	nicardipine	Malate dehydrogenase cytoplasmic 	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5253	nicardipine	Potassium voltage-gated channel subfamily A member 4	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
5254	nicotine	Neuronal acetylcholine receptor subunit alpha-7	CN1CCC[C@H]1C1=CC=CN=C1
5255	nicotine	Potassium voltage-gated channel subfamily D member 3	CN1CCC[C@H]1C1=CC=CN=C1
5256	nicotine	Cytochrome P450 2A6	CN1CCC[C@H]1C1=CC=CN=C1
5257	nicotine	Acetylcholine-binding protein	CN1CCC[C@H]1C1=CC=CN=C1
5258	nicotine	Transient receptor potential cation channel subfamily A member 1	CN1CCC[C@H]1C1=CC=CN=C1
5259	nicotine	Acetylcholine receptor subunit delta	CN1CCC[C@H]1C1=CC=CN=C1
5260	nicotine	Neuronal acetylcholine receptor subunit alpha-4	CN1CCC[C@H]1C1=CC=CN=C1
5261	nicotine	Neuronal acetylcholine receptor subunit alpha-9	CN1CCC[C@H]1C1=CC=CN=C1
5262	nicotine	Neuronal acetylcholine receptor subunit beta-4	CN1CCC[C@H]1C1=CC=CN=C1
5263	nicotine	Neuronal acetylcholine receptor subunit alpha-3	CN1CCC[C@H]1C1=CC=CN=C1
5264	nicotine	Neuronal acetylcholine receptor subunit alpha-2	CN1CCC[C@H]1C1=CC=CN=C1
5265	nicotine	Soluble acetylcholine receptor	CN1CCC[C@H]1C1=CC=CN=C1
5266	nicotine	Acetylcholine receptor subunit alpha	CN1CCC[C@H]1C1=CC=CN=C1
5267	nicotine	Lycopene cyclase	CN1CCC[C@H]1C1=CC=CN=C1
5268	nicotine	Nicotinic acetylcholine receptor alpha 5 subunit	CN1CCC[C@H]1C1=CC=CN=C1
5269	nicotine	Acetylcholine receptor subunit beta-like 2	CN1CCC[C@H]1C1=CC=CN=C1
5270	nicotine	Neuronal acetylcholine receptor; alpha2/beta2	CN1CCC[C@H]1C1=CC=CN=C1
5271	nicotine	Neuronal acetylcholine receptor; alpha3/beta2	CN1CCC[C@H]1C1=CC=CN=C1
5272	nicotine	Neuronal acetylcholine receptor; alpha3/beta4	CN1CCC[C@H]1C1=CC=CN=C1
5273	nicotine	Neuronal acetylcholine receptor; alpha4/beta2	CN1CCC[C@H]1C1=CC=CN=C1
5274	nicotine	Neuronal acetylcholine receptor; alpha4/beta4	CN1CCC[C@H]1C1=CC=CN=C1
5275	nicotine	Neuronal acetylcholine receptor; alpha2/beta4	CN1CCC[C@H]1C1=CC=CN=C1
5276	nicotine	Neuronal acetylcholine receptor	CN1CCC[C@H]1C1=CC=CN=C1
5277	nicotine	Serotonin 3 (5-HT3) receptor	CN1CCC[C@H]1C1=CC=CN=C1
5278	nicotine	Acetylcholine receptor; alpha1/beta1/delta/gamma	CN1CCC[C@H]1C1=CC=CN=C1
5279	nicotine	Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3	CN1CCC[C@H]1C1=CC=CN=C1
5280	nicotine	Acetylcholine receptor	CN1CCC[C@H]1C1=CC=CN=C1
5281	nicotine	Muscarinic acetylcholine receptor	CN1CCC[C@H]1C1=CC=CN=C1
5282	nifedipine	Sodium/nucleoside cotransporter 1	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5283	nifedipine	Adenosine receptor A2a	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5284	nifedipine	Potassium voltage-gated channel subfamily H member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5285	nifedipine	Cytochrome P450 3A4	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5286	nifedipine	5-hydroxytryptamine receptor 2A	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5287	nifedipine	5-hydroxytryptamine receptor 2C	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5288	nifedipine	Adenosine receptor A1	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5289	nifedipine	Adenosine receptor A3	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5290	nifedipine	Glutathione reductase, mitochondrial	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5291	nifedipine	Transthyretin	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5292	nifedipine	Glycine receptor subunit alpha-1	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5293	nifedipine	Voltage-dependent L-type calcium channel subunit alpha-1D	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5294	nifedipine	Bile salt export pump	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5295	nifedipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5296	nifedipine	Cytochrome P450 1A2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5297	nifedipine	Potassium voltage-gated channel subfamily A member 1	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5298	nifedipine	Voltage-dependent L-type calcium channel subunit alpha-1S	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5299	nifedipine	Potassium voltage-gated channel subfamily A member 5	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5300	nifedipine	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5301	nifedipine	Glycine receptor subunit beta	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5302	nifedipine	Potassium voltage-gated channel subfamily A member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5303	nifedipine	Myosin light chain kinase, smooth muscle	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5304	nifedipine	Thromboxane-A synthase	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5305	nifedipine	C-C chemokine receptor type 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5306	nifedipine	Voltage-dependent L-type calcium channel subunit alpha-1F	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5307	nifedipine	Glycine receptor subunit alpha-3	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5308	nifedipine	Arachidonate 15-lipoxygenase	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5309	nifedipine	Acetylcholinesterase	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5310	nifedipine	Voltage-dependent L-type calcium channel subunit alpha-1C	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5311	nifedipine	Cholinesterase	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5312	nifedipine	Indoleamine 2,3-dioxygenase 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5313	nifedipine	Sodium channel alpha subunits; brain (Types I, II, III)	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5314	nifedipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5315	nifedipine	Indoleamine 2,3-dioxygenase 1	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5316	nifedipine	Potassium voltage-gated channel subfamily A member 7	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5317	nifedipine	Potassium channel subfamily K member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC
5318	nilotinib	Carbonic anhydrase 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5319	nilotinib	Carbonic anhydrase 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5320	nilotinib	Carbonic anhydrase 4	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5321	nilotinib	Ribosyldihydronicotinamide dehydrogenase [quinone]	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5322	nilotinib	Carbonic anhydrase 9	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5323	nilotinib	Carbonic anhydrase 12	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5324	nilotinib	Platelet-derived growth factor receptor beta	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5325	nilotinib	Tyrosine-protein kinase ABL1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5326	nilotinib	Mast/stem cell growth factor receptor Kit	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5327	nilotinib	Carbonic anhydrase 5A, mitochondrial	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5328	nilotinib	Carbonic anhydrase 5B, mitochondrial	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5329	nilotinib	Carbonic anhydrase 7	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5330	nilotinib	Proto-oncogene tyrosine-protein kinase Src	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5331	nilotinib	Tyrosine-protein kinase Lck	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5332	nilotinib	Tyrosine-protein kinase Yes	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5333	nilotinib	Tyrosine-protein kinase Fyn	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5334	nilotinib	Ephrin type-A receptor 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5335	nilotinib	RAF proto-oncogene serine/threonine-protein kinase	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5336	nilotinib	Serine/threonine-protein kinase B-raf	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5337	nilotinib	Receptor-type tyrosine-protein kinase FLT3	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5338	nilotinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5339	nilotinib	Macrophage colony-stimulating factor 1 receptor	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5340	nilotinib	Platelet-derived growth factor receptor alpha	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5341	nilotinib	Insulin receptor	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5342	nilotinib	Mitogen-activated protein kinase 8	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5343	nilotinib	Tyrosine-protein kinase HCK	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5344	nilotinib	Carbonic anhydrase 3	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5345	nilotinib	Carbonic anhydrase 6	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5346	nilotinib	Mitogen-activated protein kinase 10	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5347	nilotinib	Tyrosine-protein kinase JAK2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5348	nilotinib	Tyrosine-protein kinase CSK	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5349	nilotinib	Angiopoietin-1 receptor	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5350	nilotinib	Ephrin type-A receptor 8	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5351	nilotinib	Tyrosine-protein kinase Lyn	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5352	nilotinib	Cytoplasmic tyrosine-protein kinase BMX	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5353	nilotinib	Carbonic anhydrase 14	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5354	nilotinib	Fibroblast growth factor receptor 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5355	nilotinib	Serine/threonine-protein kinase 10	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5356	nilotinib	Abelson tyrosine-protein kinase 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5357	nilotinib	Mitogen-activated protein kinase 11	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5358	nilotinib	Ephrin type-A receptor 5	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5359	nilotinib	Ephrin type-A receptor 4	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5360	nilotinib	Fibroblast growth factor receptor 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5361	nilotinib	Ephrin type-A receptor 6	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5362	nilotinib	Tyrosine-protein kinase Fgr	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5363	nilotinib	Ephrin type-A receptor 3	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5364	nilotinib	Mitogen-activated protein kinase 14	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5365	nilotinib	Tyrosine-protein kinase FRK	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5366	nilotinib	Dual specificity protein kinase CLK1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5367	nilotinib	Ephrin type-B receptor 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5368	nilotinib	Dual specificity protein kinase CLK4	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5369	nilotinib	Mitogen-activated protein kinase 9	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5370	nilotinib	Epithelial discoidin domain-containing receptor 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5371	nilotinib	Ephrin type-B receptor 4	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5372	nilotinib	Carbonic anhydrase 13	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5373	nilotinib	Carbonic anhydrase 15	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5374	nilotinib	BDNF/NT-3 growth factors receptor	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5375	nilotinib	Ephrin type-B receptor 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5376	nilotinib	Mitogen-activated protein kinase kinase kinase MLT	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5377	nilotinib	Tyrosine-protein kinase receptor Tie-1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5378	nilotinib	NT-3 growth factor receptor	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5379	nilotinib	Serine/threonine-protein kinase TNNI3K	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5380	nilotinib	Discoidin domain-containing receptor 2	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5381	nilotinib	Mitogen-activated protein kinase kinase kinase kinase 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5382	nilotinib	Tyrosine-protein kinase Blk	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5383	nilotinib	Serine/threonine-protein kinase MRCK beta	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5384	nilotinib	Ephrin type-A receptor 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5385	nilotinib	Ephrin type-B receptor 3	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5386	nilotinib	Ephrin type-B receptor 6	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5387	nilotinib	Serine/threonine-protein kinase TAO1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5388	nilotinib	Serine/threonine-protein kinase TAO3	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5389	nilotinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5390	nilotinib	Dual specificity mitogen-activated protein kinase kinase 5	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5391	nilotinib	Calcium-dependent protein kinase 1	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5392	nilotinib	Bcr/Abl fusion protein	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F
5393	nilutamide	Androgen receptor	CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
5394	nilvadipine	Voltage-dependent calcium channel gamma-1 subunit	COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
5395	nilvadipine	Voltage-dependent L-type calcium channel subunit alpha-1C	COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
5396	nilvadipine	Voltage-dependent L-type calcium channel subunit alpha-1D	COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
5397	nilvadipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
5398	nimodipine	Sodium/nucleoside cotransporter 1	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5399	nimodipine	Cannabinoid receptor 1	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5400	nimodipine	Cytochrome P450 3A4	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5401	nimodipine	Adenosine receptor A3	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5402	nimodipine	Nuclear receptor subfamily 1 group I member 2	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5403	nimodipine	Voltage-dependent calcium channel gamma-1 subunit	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5404	nimodipine	Mineralocorticoid receptor	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5405	nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1C	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5406	nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1D	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5407	nimodipine	Cytochrome P450 2C9	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5408	nimodipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5409	nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1S	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5410	nimodipine	Cytochrome P450 2C19	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5411	nimodipine	Bile acid receptor	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5412	nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1F	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5413	nimodipine	Adenosine receptor A1	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5414	nimodipine	Adenosine receptor A2a	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
5415	nisoldipine	Adenosine receptor A2a	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5416	nisoldipine	Potassium voltage-gated channel subfamily H member 2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5417	nisoldipine	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5418	nisoldipine	Adenosine receptor A3	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5419	nisoldipine	Voltage-dependent L-type calcium channel subunit alpha-1C	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5420	nisoldipine	Voltage-dependent L-type calcium channel subunit alpha-1D	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5421	nisoldipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5422	nisoldipine	Cytochrome P450 1A2	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5423	nisoldipine	Sodium channel alpha subunits; brain (Types I, II, III)	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C
5424	nitisinone	4-hydroxyphenylpyruvate dioxygenase	[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O
5425	nitrazepam	GABA-A receptor alpha-1/beta-2/gamma-2	[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1
5426	nitrazepam	GABA-A receptor; anion channel	[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1
5427	nitrendipine	Potassium voltage-gated channel subfamily H member 2	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5428	nitrendipine	Adenosine receptor A3	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5429	nitrendipine	Intermediate conductance calcium-activated potassium channel protein 4	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5430	nitrendipine	Voltage-dependent calcium channel gamma-1 subunit	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5431	nitrendipine	Transthyretin	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5432	nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1D	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5433	nitrendipine	Cytochrome P450 2C9	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5434	nitrendipine	Voltage-dependent T-type calcium channel subunit alpha-1H	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5435	nitrendipine	Cytochrome P450 2C19	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5436	nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1F	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5437	nitrendipine	Adenosine receptor A1	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5438	nitrendipine	Adenosine receptor A2a	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5439	nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1C	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5440	nitrendipine	Voltage-dependent L-type calcium channel subunit alpha-1S	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5441	nitrendipine	Platelet-activating factor receptor	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5442	nitrendipine	Sodium channel alpha subunits; brain (Types I, II, III)	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
5443	glyceryl trinitrate	Atrial natriuretic peptide receptor 1	[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O
5444	glyceryl trinitrate	Soluble guanylate cyclase	[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O
5445	nizatidine	Histamine H2 receptor	CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O
5446	nizatidine	Acetylcholinesterase	CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O
5447	nomifensine	Sodium-dependent serotonin transporter	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5448	nomifensine	Sodium-dependent noradrenaline transporter	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5449	nomifensine	5-hydroxytryptamine receptor 1A	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5450	nomifensine	Histamine H1 receptor	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5451	nomifensine	Sodium-dependent dopamine transporter	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5452	nomifensine	Amine oxidase [flavin-containing] A	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5453	nomifensine	Myeloperoxidase	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5454	nomifensine	Transporter	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5455	nomifensine	Hemoglobin HbA	CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1
5456	norelgestromin	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
5457	norepinephrine	Beta-1 adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5458	norepinephrine	Beta-2 adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5459	norepinephrine	D(1A) dopamine receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5460	norepinephrine	D(2) dopamine receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5461	norepinephrine	Alpha-2A adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5462	norepinephrine	Alpha-1A adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5463	norepinephrine	Alpha-2B adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5464	norepinephrine	Beta-3 adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5465	norepinephrine	Alpha-2C adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5466	norepinephrine	Sodium-dependent dopamine transporter	NC[C@H](O)C1=CC(O)=C(O)C=C1
5467	norepinephrine	Alpha-1D adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5468	norepinephrine	Alpha-1B adrenergic receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5469	norepinephrine	Mu-type opioid receptor	NC[C@H](O)C1=CC(O)=C(O)C=C1
5470	norepinephrine	Adrenergic receptor alpha-2	NC[C@H](O)C1=CC(O)=C(O)C=C1
5471	norepinephrine	Adrenergic receptor alpha-1	NC[C@H](O)C1=CC(O)=C(O)C=C1
5472	norepinephrine	Adrenergic receptor alpha	NC[C@H](O)C1=CC(O)=C(O)C=C1
5473	norepinephrine	Adrenergic receptor beta	NC[C@H](O)C1=CC(O)=C(O)C=C1
5474	norethisterone	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5475	norethisterone	Glucocorticoid receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5476	norethisterone	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5477	norethisterone	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5478	norethisterone	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5479	norethisterone	Sex hormone-binding globulin	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5480	norethindrone acetate	Sodium-dependent serotonin transporter	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5481	norethindrone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5482	norethindrone acetate	Estrogen receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5483	norethindrone acetate	Androgen receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5484	norethindrone acetate	Progesterone receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5485	norethindrone acetate	Cytochrome P450 2C19	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5486	norethindrone acetate	Sex hormone-binding globulin	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
5487	norethynodrel	Progesterone receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
5488	norethynodrel	Androgen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
5489	norgestimate	Progesterone receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
5490	norgestimate	Short transient receptor potential channel 3	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
5491	norgestimate	Short transient receptor potential channel 6	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
5492	nortriptyline	D(1A) dopamine receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5493	nortriptyline	D(2) dopamine receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5494	nortriptyline	Alpha-2A adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5495	nortriptyline	Sodium-dependent serotonin transporter	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5496	nortriptyline	Sodium-dependent noradrenaline transporter	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5497	nortriptyline	5-hydroxytryptamine receptor 1A	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5498	nortriptyline	5-hydroxytryptamine receptor 2A	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5499	nortriptyline	5-hydroxytryptamine receptor 2B	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5500	nortriptyline	5-hydroxytryptamine receptor 2C	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5501	nortriptyline	5-hydroxytryptamine receptor 6	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5502	nortriptyline	Alpha-1A adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5503	nortriptyline	Alpha-2B adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5504	nortriptyline	D(3) dopamine receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5505	nortriptyline	Histamine H1 receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5506	nortriptyline	Histamine H2 receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5507	nortriptyline	Muscarinic acetylcholine receptor M1	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5508	nortriptyline	Muscarinic acetylcholine receptor M2	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5509	nortriptyline	Muscarinic acetylcholine receptor M3	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5510	nortriptyline	Muscarinic acetylcholine receptor M4	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5511	nortriptyline	Muscarinic acetylcholine receptor M5	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5512	nortriptyline	Aldehyde oxidase	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5513	nortriptyline	Alpha-2C adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5514	nortriptyline	Sodium-dependent dopamine transporter	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5515	nortriptyline	Cytochrome P450 2D6	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5516	nortriptyline	Alpha-1D adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5517	nortriptyline	Cytochrome P450 2C19	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5518	nortriptyline	Proto-oncogene tyrosine-protein kinase receptor Ret	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5519	nortriptyline	Alpha-1B adrenergic receptor	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5520	nortriptyline	5-hydroxytryptamine receptor 1B	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5521	nortriptyline	ATP-sensitive inward rectifier potassium channel 10	CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2
5522	octreotide	Mu-type opioid receptor	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5523	octreotide	Somatostatin receptor type 2	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5524	octreotide	Somatostatin receptor type 3	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5525	octreotide	Somatostatin receptor type 5	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5526	octreotide	Somatostatin receptor type 4	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5527	octreotide	Somatostatin receptor type 1	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O
5528	olanzapine	Beta-1 adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5529	olanzapine	Beta-2 adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5530	olanzapine	D(1A) dopamine receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5531	olanzapine	D(2) dopamine receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5532	olanzapine	Alpha-2A adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5533	olanzapine	Potassium voltage-gated channel subfamily H member 2	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5534	olanzapine	Sodium-dependent serotonin transporter	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5535	olanzapine	5-hydroxytryptamine receptor 1A	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5536	olanzapine	5-hydroxytryptamine receptor 2A	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5537	olanzapine	5-hydroxytryptamine receptor 2B	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5538	olanzapine	5-hydroxytryptamine receptor 2C	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5539	olanzapine	5-hydroxytryptamine receptor 6	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5540	olanzapine	5-hydroxytryptamine receptor 7	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5541	olanzapine	Alpha-1A adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5542	olanzapine	Alpha-2B adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5543	olanzapine	D(3) dopamine receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5544	olanzapine	D(1B) dopamine receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5545	olanzapine	Histamine H1 receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5546	olanzapine	Histamine H2 receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5547	olanzapine	Muscarinic acetylcholine receptor M1	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5548	olanzapine	Muscarinic acetylcholine receptor M2	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5549	olanzapine	Muscarinic acetylcholine receptor M3	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5550	olanzapine	Muscarinic acetylcholine receptor M4	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5551	olanzapine	Muscarinic acetylcholine receptor M5	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5552	olanzapine	Aldehyde oxidase	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5553	olanzapine	5-hydroxytryptamine receptor 1B	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5554	olanzapine	5-hydroxytryptamine receptor 1D	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5555	olanzapine	Alpha-2C adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5556	olanzapine	D(4) dopamine receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5557	olanzapine	Alpha-1D adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5558	olanzapine	5-hydroxytryptamine receptor 3A	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5559	olanzapine	Alpha-1B adrenergic receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5560	olanzapine	5-hydroxytryptamine receptor 5A	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5561	olanzapine	5-hydroxytryptamine receptor 1F	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5562	olanzapine	5-hydroxytryptamine receptor 1E	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5563	olanzapine	Arachidonate 15-lipoxygenase	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5564	olanzapine	Transporter	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5565	olanzapine	Adrenergic receptor alpha-2	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5566	olanzapine	Serotonin 2 (5-HT2) receptor	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5567	olanzapine	FAD-linked sulfhydryl oxidase ALR	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5568	olanzapine	Histone H1.0	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
5569	olmesartan medoxomil	Type-1 angiotensin II receptor	CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=O)OCC1=C(C)OC(=O)O1)C(C)(C)O
5570	olopatadine	Histamine H1 receptor	CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
5571	olprinone	Phosphodiesterase 3	CC1=C(C=C(C#N)C(=O)N1)C1=CN2C=CN=C2C=C1
5572	olsalazine	Arachidonate 5-lipoxygenase	OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1
5573	olsalazine	Peroxisome proliferator-activated receptor gamma	OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1
5574	olsalazine	Cyclooxygenase	OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1
5575	omeprazole	Cytochrome P450 3A4	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5576	omeprazole	Multidrug resistance protein 1	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5577	omeprazole	Cytochrome P450 2C9	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5578	omeprazole	Cytochrome P450 1A2	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5579	omeprazole	Cytochrome P450 2C19	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5580	omeprazole	Fatty acid synthase	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5581	omeprazole	Potassium-transporting ATPase	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5582	omeprazole	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5583	omeprazole	Glutathione S-transferase omega-1	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5584	omeprazole	Cytosolic endo-beta-N-acetylglucosaminidase	COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
5585	ondansetron	Potassium voltage-gated channel subfamily H member 2	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5586	ondansetron	5-hydroxytryptamine receptor 2B	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5587	ondansetron	Aldehyde oxidase	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5588	ondansetron	5-hydroxytryptamine receptor 3A	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5589	ondansetron	Solute carrier family 22 member 1	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5590	ondansetron	5-hydroxytryptamine receptor 1B	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5591	ondansetron	Mu-type opioid receptor	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5592	ondansetron	Muscarinic acetylcholine receptor M1	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5593	ondansetron	Gastrin/cholecystokinin type B receptor	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5594	ondansetron	Sigma non-opioid intracellular receptor 1	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5595	ondansetron	Neuronal acetylcholine receptor subunit alpha-7	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5596	ondansetron	5-hydroxytryptamine receptor 2C	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5597	ondansetron	5-hydroxytryptamine receptor 4	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5598	ondansetron	5-hydroxytryptamine receptor 1D	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5599	ondansetron	Solute carrier family 22 member 2	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5600	ondansetron	Multidrug and toxin extrusion protein 1	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5601	ondansetron	Multidrug and toxin extrusion protein 2	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5602	ondansetron	Solute carrier family 22 member 3	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5603	ondansetron	Serotonin 3 (5-HT3) receptor	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5604	ondansetron	Neuronal acetylcholine receptor; alpha4/beta2	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5605	ondansetron	Serotonin 2 (5-HT2) receptor	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5606	ondansetron	Serotonin 3 receptor (5HT3)	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5607	ondansetron	5-hydroxytryptamine receptor 3B	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
5608	orlistat	Cannabinoid receptor 1	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5609	orlistat	Lipoprotein lipase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5610	orlistat	Fatty acid synthase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5611	orlistat	Sn1-specific diacylglycerol lipase alpha	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5612	orlistat	Fatty-acid amide hydrolase 1	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5613	orlistat	Sn1-specific diacylglycerol lipase beta	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5614	orlistat	Abhydrolase domain-containing protein 16A	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5615	orlistat	Monoacylglycerol lipase ABHD12	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5616	orlistat	Platelet-activating factor acetylhydrolase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5617	orlistat	Pancreatic triacylglycerol lipase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5618	orlistat	Monoacylglycerol lipase ABHD6	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5619	orlistat	Hepatic triacylglycerol lipase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5620	orlistat	Endothelial lipase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5621	orlistat	Gastric triacylglycerol lipase	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
5622	orphenadrine	Sodium channel protein type 5 subunit alpha	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5623	orphenadrine	Alpha-2A adrenergic receptor	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5624	orphenadrine	Potassium voltage-gated channel subfamily H member 2	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5625	orphenadrine	Sodium-dependent serotonin transporter	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5626	orphenadrine	Sodium-dependent noradrenaline transporter	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5627	orphenadrine	5-hydroxytryptamine receptor 2A	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5628	orphenadrine	5-hydroxytryptamine receptor 2B	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5629	orphenadrine	5-hydroxytryptamine receptor 2C	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5630	orphenadrine	5-hydroxytryptamine receptor 6	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5631	orphenadrine	Alpha-2B adrenergic receptor	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5632	orphenadrine	Histamine H1 receptor	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5633	orphenadrine	Histamine H2 receptor	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5634	orphenadrine	Muscarinic acetylcholine receptor M1	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5635	orphenadrine	Muscarinic acetylcholine receptor M2	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5636	orphenadrine	Muscarinic acetylcholine receptor M3	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5637	orphenadrine	Muscarinic acetylcholine receptor M4	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5638	orphenadrine	Muscarinic acetylcholine receptor M5	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5639	orphenadrine	Sodium channel protein type 1 subunit alpha	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5640	orphenadrine	Sodium channel protein type 4 subunit alpha	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5641	orphenadrine	Sodium channel protein type 9 subunit alpha	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5642	orphenadrine	Cytochrome P450 2D6	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5643	orphenadrine	Sodium channel protein type 10 subunit alpha	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5644	orphenadrine	Solute carrier family 22 member 1	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5645	orphenadrine	Glutamate [NMDA] receptor	CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1
5646	oteracil	Uridine 5'-monophosphate synthase	OC(=O)C1=NC(=O)NC(=O)N1
5647	oxandrolone	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C
5648	oxaprozin	Prostaglandin G/H synthase 2	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5649	oxaprozin	Prostaglandin G/H synthase 1	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5650	oxaprozin	fMet-Leu-Phe receptor	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5651	oxaprozin	Bifunctional epoxide hydrolase 2	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5652	oxaprozin	Complement C5	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5653	oxaprozin	Serine hydroxymethyltransferase, mitochondrial	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
5654	oxatomide	5-hydroxytryptamine receptor 2A	O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
5655	oxatomide	5-hydroxytryptamine receptor 2B	O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
5656	oxatomide	D(3) dopamine receptor	O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
5657	oxatomide	Muscarinic acetylcholine receptor M1	O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
5658	oxatomide	Histamine H1 receptor	O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
5659	oxazepam	GABA-A receptor alpha-1/beta-3/gamma-2	OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O
5660	oxcarbazepine	Sodium channel protein type 5 subunit alpha	NC(=O)N1C2=CC=CC=C2C(=O)CC2=C1C=CC=C2
5661	oxyphencyclimine	Muscarinic acetylcholine receptor M1	CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5662	oxyphencyclimine	Muscarinic acetylcholine receptor M3	CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5663	oxprenolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1
5664	oxprenolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1
5665	oxprenolol	Solute carrier family 22 member 1	CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1
5666	oxprenolol	5-hydroxytryptamine receptor 1A	CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1
5667	oxybutynin	Sigma non-opioid intracellular receptor 1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5668	oxybutynin	Sodium-dependent noradrenaline transporter	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5669	oxybutynin	5-hydroxytryptamine receptor 2B	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5670	oxybutynin	D(3) dopamine receptor	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5671	oxybutynin	Muscarinic acetylcholine receptor M2	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5672	oxybutynin	Muscarinic acetylcholine receptor M4	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5673	oxybutynin	Muscarinic acetylcholine receptor M5	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5674	oxybutynin	Sodium-dependent dopamine transporter	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5675	oxybutynin	Cytochrome P450 2C19	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5676	oxybutynin	Membrane-associated progesterone receptor component 1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5677	oxybutynin	Muscarinic acetylcholine receptor M1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5678	oxybutynin	Muscarinic acetylcholine receptor M3	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5679	oxycodone	Mu-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3OC
5680	oxycodone	Kappa-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3OC
5681	oxycodone	Delta-type opioid receptor	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3OC
5682	oxycodone	Acetylcholinesterase	[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3OC
5683	oxymetazoline	Alpha-2A adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5684	oxymetazoline	5-hydroxytryptamine receptor 1A	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5685	oxymetazoline	5-hydroxytryptamine receptor 2A	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5686	oxymetazoline	5-hydroxytryptamine receptor 2B	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5687	oxymetazoline	5-hydroxytryptamine receptor 2C	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5688	oxymetazoline	5-hydroxytryptamine receptor 6	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5689	oxymetazoline	Muscarinic acetylcholine receptor M4	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5690	oxymetazoline	Muscarinic acetylcholine receptor M5	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5691	oxymetazoline	5-hydroxytryptamine receptor 1B	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5692	oxymetazoline	5-hydroxytryptamine receptor 1D	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5693	oxymetazoline	Alpha-2C adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5694	oxymetazoline	Cytochrome P450 2D6	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5695	oxymetazoline	Alpha-1D adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5696	oxymetazoline	Alpha-1B adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5697	oxymetazoline	5-hydroxytryptamine receptor 1E	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5698	oxymetazoline	Nischarin	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5699	oxymetazoline	Alpha-1A adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5700	oxymetazoline	Adrenergic receptor alpha-2	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5701	oxymetazoline	Alpha-2 adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5702	oxymetazoline	Alpha-2B adrenergic receptor	CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
5703	oxymetholone	Estrogen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O
5704	oxymetholone	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O
5705	oxymorphone	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O
5706	oxymorphone	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O
5707	oxymorphone	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O
5708	oxymorphone	Opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O
5709	oxymorphone	Opioid receptors; mu and delta	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O
5710	oxyphenbutazone	fMet-Leu-Phe receptor	CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
5711	oxyphenbutazone	Prostacyclin synthase	CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
5712	oxyphenbutazone	Cyclooxygenase	CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
5713	oxyphenbutazone	Nicotinate phosphoribosyltransferase	CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
5714	oxyphenonium	Muscarinic acetylcholine receptor M1	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5715	oxyphenonium	Muscarinic acetylcholine receptor M3	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5716	oxyphenonium	Muscarinic acetylcholine receptor M4	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5717	oxytocin	Vasopressin V1a receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
5718	oxytocin	Vasopressin V1b receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
5719	oxytocin	Vasopressin V2 receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
5720	oxytocin	Oxytocin receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
5721	oxytocin	Oxytocin-neurophysin 1	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
5722	paclitaxel	Multidrug resistance protein 1	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5723	paclitaxel	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5724	paclitaxel	Delta-type opioid receptor	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5725	paclitaxel	Bile salt export pump	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5726	paclitaxel	Multidrug resistance-associated protein 7	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5727	paclitaxel	Tubulin beta chain	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5728	paclitaxel	Tyrosine-protein kinase Fyn	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5729	paclitaxel	Receptor tyrosine-protein kinase erbB-2	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5730	paclitaxel	Cholecystokinin receptor type A	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5731	paclitaxel	Substance-K receptor	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5732	paclitaxel	Melanocortin receptor 5	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5733	paclitaxel	Botulinum neurotoxin type A	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5734	paclitaxel	Tyrosine-protein kinase Mer	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5735	paclitaxel	Tubulin beta-3 chain	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5736	paclitaxel	Nucleotide-binding oligomerization domain-containing protein 2	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5737	paclitaxel	Tubulin beta	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
5738	palonosetron	5-hydroxytryptamine receptor 3A	[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@]1([H])CN4CCC1CC4)=C23
5739	palonosetron	Serotonin 3 receptor (5HT3)	[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@]1([H])CN4CCC1CC4)=C23
5740	pamidronic acid	Farnesyl pyrophosphate synthase	NCCC(O)(P(O)(O)=O)P(O)(O)=O
5741	pamidronic acid	Hypoxanthine-guanine phosphoribosyltransferase	NCCC(O)(P(O)(O)=O)P(O)(O)=O
5742	aminosalicylic acid	2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	NC1=CC(O)=C(C=C1)C(O)=O
5743	aminosalicylic acid	Tyrosine-protein phosphatase non-receptor type 1	NC1=CC(O)=C(C=C1)C(O)=O
5744	aminosalicylic acid	Cyclooxygenase	NC1=CC(O)=C(C=C1)C(O)=O
5745	pancuronium	Acetylcholine receptor	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
5746	pancuronium	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
5747	pancuronium	Acetylcholine receptor; alpha1/beta1/delta/gamma	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
5748	pantoprazole	Sodium/potassium-transporting ATPase subunit alpha-1	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5749	pantoprazole	Fatty acid synthase	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5750	pantoprazole	Indoleamine 2,3-dioxygenase 2	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5751	pantoprazole	Solute carrier family 22 member 2	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5752	pantoprazole	Multidrug and toxin extrusion protein 1	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5753	pantoprazole	Multidrug and toxin extrusion protein 2	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5754	pantoprazole	Potassium-transporting ATPase	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5755	pantoprazole	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC
5756	paramethadione	Voltage-gated T-type calcium channel	CCC1(C)OC(=O)N(C)C1=O
5757	parecoxib	Prostaglandin G/H synthase 1	CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1
5758	parecoxib	Prostaglandin G/H synthase 2	CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1
5759	pargyline	Amine oxidase [flavin-containing] B	CN(CC#C)CC1=CC=CC=C1
5760	pargyline	Amine oxidase [flavin-containing] A	CN(CC#C)CC1=CC=CC=C1
5761	pargyline	Aldehyde dehydrogenase, mitochondrial	CN(CC#C)CC1=CC=CC=C1
5762	paricalcitol	Vitamin D3 receptor	C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1
5763	paroxetine	Beta-1 adrenergic receptor	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5764	paroxetine	Sigma non-opioid intracellular receptor 1	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5765	paroxetine	Potassium voltage-gated channel subfamily H member 2	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5766	paroxetine	Sodium-dependent serotonin transporter	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5767	paroxetine	Sodium-dependent noradrenaline transporter	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5768	paroxetine	5-hydroxytryptamine receptor 1A	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5769	paroxetine	D(3) dopamine receptor	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5770	paroxetine	Muscarinic acetylcholine receptor M1	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5771	paroxetine	Muscarinic acetylcholine receptor M2	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5772	paroxetine	Muscarinic acetylcholine receptor M3	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5773	paroxetine	Muscarinic acetylcholine receptor M4	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5774	paroxetine	Muscarinic acetylcholine receptor M5	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5775	paroxetine	Sodium-dependent dopamine transporter	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5776	paroxetine	Cytochrome P450 2D6	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5777	paroxetine	Cytochrome P450 1A2	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5778	paroxetine	Substance-P receptor	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5779	paroxetine	Myeloperoxidase	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5780	paroxetine	Beta-adrenergic receptor kinase 1	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5781	paroxetine	Transporter	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5782	paroxetine	Quinolone resistance protein NorA	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5783	paroxetine	P2X purinoceptor 4	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5784	paroxetine	Adrenergic receptor alpha-2	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5785	paroxetine	Adrenergic receptor alpha-1	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1
5786	pemetrexed	Thymidylate synthase	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5787	pemetrexed	Dihydrofolate reductase	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5788	pemetrexed	Folylpolyglutamate synthase, mitochondrial	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5789	pemetrexed	Bifunctional dihydrofolate reductase-thymidylate synthase	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5790	pemetrexed	Serine hydroxymethyltransferase, cytosolic	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5791	pemetrexed	Folate receptor beta	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5792	pemetrexed	Proton-coupled folate transporter	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5793	pemetrexed	Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5794	pemetrexed	Folate transporter 1	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5795	pemetrexed	Folate receptor alpha	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5796	pemetrexed	Trifunctional purine biosynthetic protein adenosine-3	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
5797	penbutolol	Beta-1 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1
5798	penbutolol	Beta-2 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1
5799	penbutolol	5-hydroxytryptamine receptor 1A	CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1
5800	penbutolol	Alpha-1-acid glycoprotein 1	CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1
5801	pentobarbital	Gamma-aminobutyric acid receptor subunit beta-3	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
5802	pentobarbital	Potassium voltage-gated channel subfamily H member 2	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
5803	pentobarbital	GABA-A receptor alpha-1/beta-2/gamma-2	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
5804	pentobarbital	GABA-A receptor; anion channel	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
5805	pentobarbital	GABA A receptor alpha-2/beta-2/gamma-2	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
5806	pentolonium	Neuronal acetylcholine receptor subunit alpha-10	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1
5807	pentolonium	Neuronal acetylcholine receptor; alpha3/beta4	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1
5808	pentostatin	Adenosine deaminase	OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1NC=NC[C@H]2O
5809	pentoxifylline	Adenosine receptor A2b	CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
5810	pentoxifylline	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
5811	pentoxifylline	Acetylcholinesterase	CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
5812	pentoxifylline	cGMP-specific 3',5'-cyclic phosphodiesterase	CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
5813	pergolide	Alpha-2A adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5814	pergolide	Potassium voltage-gated channel subfamily H member 2	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5815	pergolide	5-hydroxytryptamine receptor 1A	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5816	pergolide	5-hydroxytryptamine receptor 2A	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5817	pergolide	5-hydroxytryptamine receptor 2B	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5818	pergolide	5-hydroxytryptamine receptor 2C	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5819	pergolide	5-hydroxytryptamine receptor 6	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5820	pergolide	Alpha-1A adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5821	pergolide	Alpha-2B adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5822	pergolide	D(3) dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5823	pergolide	D(1B) dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5824	pergolide	5-hydroxytryptamine receptor 1B	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5825	pergolide	5-hydroxytryptamine receptor 1D	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5826	pergolide	Alpha-2C adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5827	pergolide	Cytochrome P450 2D6	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5828	pergolide	D(4) dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5829	pergolide	Alpha-1D adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5830	pergolide	Alpha-1B adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5831	pergolide	D(2) dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5832	pergolide	5-hydroxytryptamine receptor 7	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5833	pergolide	Adrenergic receptor alpha-2	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5834	pergolide	Dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5835	pergolide	Cerebral cortex alpha adrenergic receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5836	pergolide	D(1A) dopamine receptor	[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1
5837	perindopril	Angiotensin-converting enzyme	[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
5838	perospirone	D(2) dopamine receptor	[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
5839	perospirone	D(3) dopamine receptor	[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
5840	perospirone	D(4) dopamine receptor	[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
5841	perospirone	5-hydroxytryptamine receptor 2A	[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
5842	perphenazine	D(2) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5843	perphenazine	Alpha-2A adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5844	perphenazine	Potassium voltage-gated channel subfamily H member 2	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5845	perphenazine	5-hydroxytryptamine receptor 1A	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5846	perphenazine	5-hydroxytryptamine receptor 2A	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5847	perphenazine	5-hydroxytryptamine receptor 2C	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5848	perphenazine	5-hydroxytryptamine receptor 6	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5849	perphenazine	5-hydroxytryptamine receptor 7	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5850	perphenazine	Alpha-1A adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5851	perphenazine	Alpha-2B adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5852	perphenazine	D(3) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5853	perphenazine	Histamine H1 receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5854	perphenazine	Muscarinic acetylcholine receptor M3	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5855	perphenazine	Aldehyde oxidase	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5856	perphenazine	Alpha-2C adrenergic receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5857	perphenazine	D(4) dopamine receptor	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5858	perphenazine	Pleiotropic ABC efflux transporter of multiple drugs	OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
5859	phenazopyridine	Sodium channel alpha subunit	NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1
5860	phenazopyridine	Snake venom metalloproteinase Bap1	NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1
5861	phendimetrazine	Sodium-dependent noradrenaline transporter	[H][C@@]1(C)N(C)CCO[C@@]1([H])C1=CC=CC=C1
5862	phendimetrazine	5-hydroxytryptamine receptor 1A	[H][C@@]1(C)N(C)CCO[C@@]1([H])C1=CC=CC=C1
5863	phendimetrazine	Sodium-dependent dopamine transporter	[H][C@@]1(C)N(C)CCO[C@@]1([H])C1=CC=CC=C1
5864	phenelzine	Cytochrome P450 3A4	NNCCC1=CC=CC=C1
5865	phenelzine	Sodium-dependent dopamine transporter	NNCCC1=CC=CC=C1
5866	phenelzine	Cytochrome P450 2D6	NNCCC1=CC=CC=C1
5867	phenelzine	Cytochrome P450 2C8	NNCCC1=CC=CC=C1
5868	phenelzine	Cytochrome P450 2C9	NNCCC1=CC=CC=C1
5869	phenelzine	Amine oxidase [flavin-containing] B	NNCCC1=CC=CC=C1
5870	phenelzine	Amine oxidase [flavin-containing] A	NNCCC1=CC=CC=C1
5871	phenelzine	Cytochrome P450 2C19	NNCCC1=CC=CC=C1
5872	phenelzine	Membrane primary amine oxidase	NNCCC1=CC=CC=C1
5873	phenelzine	Indoleamine 2,3-dioxygenase 1	NNCCC1=CC=CC=C1
5874	phenelzine	Lysine-specific histone demethylase 1A	NNCCC1=CC=CC=C1
5875	phenelzine	FAD-linked sulfhydryl oxidase ALR	NNCCC1=CC=CC=C1
5876	phenindione	Vitamin K epoxide reductase complex subunit 1	O=C1C(C(=O)C2=C1C=CC=C2)C1=CC=CC=C1
5877	phenindione	Prothrombin	O=C1C(C(=O)C2=C1C=CC=C2)C1=CC=CC=C1
5878	phenindione	Arachidonate 5-lipoxygenase	O=C1C(C(=O)C2=C1C=CC=C2)C1=CC=CC=C1
5879	pheniprazine	Amine oxidase [flavin-containing] B	CC(CC1=CC=CC=C1)NN
5880	pheniprazine	Amine oxidase [flavin-containing] A	CC(CC1=CC=CC=C1)NN
5881	pheniramine	Histamine H1 receptor	[H]C(CCN(C)C)(C1=CC=CC=C1)C1=NC=CC=C1
5882	pheniramine	Histamine H4 receptor	[H]C(CCN(C)C)(C1=CC=CC=C1)C1=NC=CC=C1
5883	pheniramine	Sodium channel alpha subunits; brain (Types I, II, III)	[H]C(CCN(C)C)(C1=CC=CC=C1)C1=NC=CC=C1
5884	phenmetrazine	Sodium-dependent noradrenaline transporter	CC1NCCOC1C1=CC=CC=C1
5885	phenmetrazine	Sodium-dependent dopamine transporter	CC1NCCOC1C1=CC=CC=C1
5886	phenmetrazine	Amine oxidase [flavin-containing] A	CC1NCCOC1C1=CC=CC=C1
5887	phenoxybenzamine	Alpha-2A adrenergic receptor	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5888	phenoxybenzamine	Alpha-1A adrenergic receptor	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5889	phenoxybenzamine	Alpha-2B adrenergic receptor	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5890	phenoxybenzamine	Solute carrier family 22 member 1	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5891	phenoxybenzamine	Dopamine receptor	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5892	phenoxybenzamine	Adrenergic receptor alpha-1	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5893	phenoxybenzamine	Sodium channel alpha subunits; brain (Types I, II, III)	CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
5894	phenprocoumon	Pol polyprotein	CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
5895	phenprocoumon	Vitamin K epoxide reductase complex subunit 1	CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
5896	phensuximide	Voltage-gated T-type calcium channel	CN1C(=O)CC(C1=O)C1=CC=CC=C1
5897	phentermine	Sodium-dependent noradrenaline transporter	CC(C)(N)CC1=CC=CC=C1
5898	phentermine	Sodium-dependent dopamine transporter	CC(C)(N)CC1=CC=CC=C1
5899	phentolamine	Alpha-2A adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5900	phentolamine	Sigma non-opioid intracellular receptor 1	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5901	phentolamine	Potassium voltage-gated channel subfamily H member 2	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5902	phentolamine	5-hydroxytryptamine receptor 1A	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5903	phentolamine	5-hydroxytryptamine receptor 2A	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5904	phentolamine	5-hydroxytryptamine receptor 2B	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5905	phentolamine	5-hydroxytryptamine receptor 2C	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5906	phentolamine	Alpha-1A adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5907	phentolamine	Alpha-2B adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5908	phentolamine	Histamine H1 receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5909	phentolamine	Alpha-2C adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5910	phentolamine	Cytochrome P450 2D6	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5911	phentolamine	Alpha-1D adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5912	phentolamine	Alpha-1B adrenergic receptor	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5913	phentolamine	Nischarin	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5914	phentolamine	Adrenergic receptor alpha-2	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5915	phentolamine	Sodium channel alpha subunits; brain (Types I, II, III)	CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
5916	phenylbutazone	Prostaglandin G/H synthase 1	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5917	phenylbutazone	fMet-Leu-Phe receptor	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5918	phenylbutazone	Prostacyclin synthase	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5919	phenylbutazone	Cytochrome P450 2C9	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5920	phenylbutazone	Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5921	phenylbutazone	Cyclooxygenase	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5922	phenylbutazone	Nicotinate phosphoribosyltransferase	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
5923	phenylephrine	Alpha-1A adrenergic receptor	CNC[C@H](O)C1=CC(O)=CC=C1
5924	phenylephrine	Alpha-1D adrenergic receptor	CNC[C@H](O)C1=CC(O)=CC=C1
5925	phenylephrine	Alpha-1B adrenergic receptor	CNC[C@H](O)C1=CC(O)=CC=C1
5926	phenylephrine	Beta-1 adrenergic receptor	CNC[C@H](O)C1=CC(O)=CC=C1
5927	phenylephrine	Adrenergic receptor alpha-2	CNC[C@H](O)C1=CC(O)=CC=C1
5928	phenylephrine	Adrenergic receptor alpha-1	CNC[C@H](O)C1=CC(O)=CC=C1
5929	phenylpropanolamine	Alpha-2A adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5930	phenylpropanolamine	Potassium voltage-gated channel subfamily H member 2	CC(N)C(O)C1=CC=CC=C1
5931	phenylpropanolamine	Sodium-dependent noradrenaline transporter	CC(N)C(O)C1=CC=CC=C1
5932	phenylpropanolamine	5-hydroxytryptamine receptor 7	CC(N)C(O)C1=CC=CC=C1
5933	phenylpropanolamine	Alpha-1A adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5934	phenylpropanolamine	Alpha-2B adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5935	phenylpropanolamine	Muscarinic acetylcholine receptor M1	CC(N)C(O)C1=CC=CC=C1
5936	phenylpropanolamine	Alpha-2C adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5937	phenylpropanolamine	Sodium-dependent dopamine transporter	CC(N)C(O)C1=CC=CC=C1
5938	phenylpropanolamine	Alpha-1D adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5939	phenylpropanolamine	Alpha-1B adrenergic receptor	CC(N)C(O)C1=CC=CC=C1
5940	phenyltoloxamine	D(1A) dopamine receptor	CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1
5941	phenyltoloxamine	D(2) dopamine receptor	CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1
5942	phenyltoloxamine	D(1B) dopamine receptor	CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1
5943	phenyltoloxamine	D(4) dopamine receptor	CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1
5944	phenyltoloxamine	Histamine H1 receptor	CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1
5945	phenytoin	Nuclear receptor subfamily 1 group I member 3	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5946	phenytoin	Sodium channel protein type 5 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5947	phenytoin	Sodium channel protein type 1 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5948	phenytoin	Sodium channel protein type 2 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5949	phenytoin	Sodium channel protein type 3 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5950	phenytoin	Sodium channel protein type 4 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5951	phenytoin	Sodium channel protein type 8 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5952	phenytoin	Sodium channel protein type 9 subunit alpha	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5953	phenytoin	Sodium channel alpha subunits; brain (Types I, II, III)	O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
5954	physostigmine	Cytochrome P450 2D6	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5955	physostigmine	Acetylcholinesterase	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5956	physostigmine	Cholinesterase	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5957	physostigmine	Butyrylcholinesterase; Protein Bche	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5958	physostigmine	Muscarinic acetylcholine receptor M1	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5959	physostigmine	Butyrylcholinesterase	[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C
5960	piketoprofen	Prostaglandin G/H synthase 2	CC(C(=O)NC1=CC(C)=CC=N1)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
5961	piketoprofen	Prostaglandin G/H synthase 1	CC(C(=O)NC1=CC(C)=CC=N1)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1
5962	pilocarpine	Muscarinic acetylcholine receptor M2	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5963	pilocarpine	Muscarinic acetylcholine receptor M1	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5964	pilocarpine	Muscarinic acetylcholine receptor DM1	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5965	pilocarpine	Muscarinic acetylcholine receptor	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5966	pilocarpine	Muscarinic acetylcholine receptor M3	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5967	pilocarpine	Muscarinic acetylcholine receptor M4	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5968	pilocarpine	Muscarinic acetylcholine receptor M5	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
5969	pilsicainide	Potassium voltage-gated channel subfamily H member 2	CC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2
5970	pilsicainide	Sodium channel protein type 4 subunit alpha	CC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2
5971	pimecrolimus	Interleukin-5	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
5972	pimecrolimus	Interferon gamma	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
5973	pimecrolimus	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
5974	pimecrolimus	Interleukin-2	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
5975	pimecrolimus	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
5976	pimobendan	Type-1 angiotensin II receptor	COC1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NNC(=O)CC1C
5977	pimobendan	Phosphodiesterase 3	COC1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NNC(=O)CC1C
5978	pimozide	Mu-type opioid receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5979	pimozide	D(2) dopamine receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5980	pimozide	Alpha-2A adrenergic receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5981	pimozide	Sigma non-opioid intracellular receptor 1	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5982	pimozide	Potassium voltage-gated channel subfamily H member 2	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5983	pimozide	Multidrug resistance protein 1	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5984	pimozide	5-hydroxytryptamine receptor 1A	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5985	pimozide	5-hydroxytryptamine receptor 2A	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5986	pimozide	5-hydroxytryptamine receptor 2C	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5987	pimozide	5-hydroxytryptamine receptor 6	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5988	pimozide	5-hydroxytryptamine receptor 7	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5989	pimozide	Alpha-1A adrenergic receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5990	pimozide	Alpha-2B adrenergic receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5991	pimozide	D(3) dopamine receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5992	pimozide	Histamine H1 receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5993	pimozide	Histamine H4 receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5994	pimozide	Muscarinic acetylcholine receptor M3	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5995	pimozide	5-hydroxytryptamine receptor 1D	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5996	pimozide	Alpha-2C adrenergic receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5997	pimozide	D(4) dopamine receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5998	pimozide	Kappa-type opioid receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
5999	pimozide	Multidrug resistance-associated protein 1	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6000	pimozide	Glycine receptor subunit alpha-1	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6001	pimozide	Voltage-dependent T-type calcium channel subunit alpha-1G	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6002	pimozide	Calmodulin	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6003	pimozide	Delta-type opioid receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6004	pimozide	Voltage-dependent T-type calcium channel subunit alpha-1I	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6005	pimozide	Potassium channel subfamily K member 2	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6006	pimozide	Potassium voltage-gated channel subfamily A member 10	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6007	pimozide	Sodium channel protein type 2 subunit alpha	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6008	pimozide	Solute carrier family 22 member 2	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6009	pimozide	Dopamine receptor	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6010	pimozide	Ubiquitin carboxyl-terminal hydrolase 1	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6011	pimozide	Voltage-dependent T-type calcium channel subunit alpha-1H	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6012	pimozide	G protein-activated inward rectifier potassium channel 2	FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1
6013	pinacidil	ATP-binding cassette sub-family C member 9	CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C
6014	pinacidil	Calcium-activated potassium channel subunit alpha-1	CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C
6015	pinacidil	Sulfonylurea receptor 2, Kir6.2	CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C
6016	pindolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6017	pindolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6018	pindolol	5-hydroxytryptamine receptor 1A	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6019	pindolol	5-hydroxytryptamine receptor 2A	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6020	pindolol	5-hydroxytryptamine receptor 2B	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6021	pindolol	5-hydroxytryptamine receptor 2C	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6022	pindolol	Beta-3 adrenergic receptor	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6023	pindolol	5-hydroxytryptamine receptor 1B	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6024	pindolol	5-hydroxytryptamine receptor 1D	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6025	pindolol	Serotonin 1 (5-HT1) receptor	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6026	pindolol	Serotonin 2 (5-HT2) receptor	CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
6027	pioglitazone	Carbonic anhydrase 2	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6028	pioglitazone	Bile salt export pump	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6029	pioglitazone	Amine oxidase [flavin-containing] B	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6030	pioglitazone	Amine oxidase [flavin-containing] A	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6031	pioglitazone	Peroxisome proliferator-activated receptor alpha	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6032	pioglitazone	Peroxisome proliferator-activated receptor gamma	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6033	pioglitazone	Aldose reductase	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6034	pioglitazone	Enoyl-[acyl-carrier-protein] reductase [NADH]	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6035	pioglitazone	CDGSH iron-sulfur domain-containing protein 1	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6036	pioglitazone	CDGSH iron-sulfur domain-containing protein 2	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
6037	pipecuronium	Neuronal acetylcholine receptor; alpha2/beta4	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
6038	pipecuronium	Acetylcholine receptor	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
6039	pipecuronium	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
6040	pipecuronium	Neuronal acetylcholine receptor; alpha4/beta4	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
6041	pipotiazine palmitate	D(2) dopamine receptor	CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)S(=O)(=O)N(C)C)CC1
6042	pipotiazine palmitate	D(3) dopamine receptor	CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)S(=O)(=O)N(C)C)CC1
6043	pirbuterol	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1
6044	pirenzepine	Muscarinic acetylcholine receptor M1	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6045	pirenzepine	Muscarinic acetylcholine receptor M2	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6046	pirenzepine	Muscarinic acetylcholine receptor M3	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6047	pirenzepine	Muscarinic acetylcholine receptor M4	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6048	pirenzepine	Muscarinic acetylcholine receptor M5	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6049	pirenzepine	Adenosine receptor A3	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6050	pirenzepine	Muscarinic receptor M1	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6051	pirenzepine	Muscarinic acetylcholine receptor	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6052	pirenzepine	Muscarinic acetylcholine receptor DM1	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
6053	piretanide	Solute carrier family 12 member 1	NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O
6054	piretanide	Solute carrier family 12 member 2	NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O
6055	piribedil	Alpha-2A adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6056	piribedil	5-hydroxytryptamine receptor 1A	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6057	piribedil	5-hydroxytryptamine receptor 2B	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6058	piribedil	Alpha-1A adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6059	piribedil	Alpha-2B adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6060	piribedil	D(3) dopamine receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6061	piribedil	Alpha-2C adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6062	piribedil	D(4) dopamine receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6063	piribedil	Alpha-1D adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6064	piribedil	Alpha-1B adrenergic receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6065	piribedil	D(2) dopamine receptor	C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
6066	pirlindole	Transcriptional enhancer factor TEF-3	CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13
6067	pirlindole	Transcriptional enhancer factor TEF-1	CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13
6068	pirlindole	Transcriptional enhancer factor TEF-4	CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13
6069	pirlindole	Transcriptional enhancer factor TEF-5	CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13
6070	pirlindole	Amine oxidase [flavin-containing] A	CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13
6071	piroxicam	Prostaglandin G/H synthase 2	CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O
6072	piroxicam	Prostaglandin G/H synthase 1	CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O
6073	piroxicam	Cyclooxygenase	CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O
6074	pitavastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=C(C=CC=C2)N=C1C1CC1)CC(O)=O
6075	pitavastatin	Retinoic acid receptor RXR-alpha	O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=C(C=CC=C2)N=C1C1CC1)CC(O)=O
6076	polythiazide	Solute carrier family 12 member 3	CN1C(CSCC(F)(F)F)NC2=C(C=C(C(Cl)=C2)S(N)(=O)=O)S1(=O)=O
6077	pralidoxime	Acetylcholinesterase	C[N+]1=CC=CC=C1C=NO
6078	pralmorelin	Growth hormone secretagogue receptor type 1	C[C@@H](N)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O
6079	pramipexole	Beta-2 adrenergic receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6080	pramipexole	D(2) dopamine receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6081	pramipexole	Alpha-2A adrenergic receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6082	pramipexole	5-hydroxytryptamine receptor 1A	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6083	pramipexole	5-hydroxytryptamine receptor 2A	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6084	pramipexole	5-hydroxytryptamine receptor 7	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6085	pramipexole	Alpha-2B adrenergic receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6086	pramipexole	D(3) dopamine receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6087	pramipexole	Histamine H2 receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6088	pramipexole	5-hydroxytryptamine receptor 1B	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6089	pramipexole	5-hydroxytryptamine receptor 1D	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6090	pramipexole	Alpha-2C adrenergic receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6091	pramipexole	D(4) dopamine receptor	CCCN[C@H]1CCC2=C(C1)SC(N)=N2
6092	pramlintide	Amylin receptor AMY2	[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
6093	pramlintide	Amylin receptor AMY1	[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
6094	pramlintide	Amylin receptor AMY3	[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
6095	pranlukast	Bile acid receptor	O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
6096	pranlukast	Cysteinyl leukotriene receptor 2	O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
6097	pranlukast	Cysteinyl leukotriene receptor 1	O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
6098	pranlukast	Cruzipain	O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
6099	pranlukast	Uracil nucleotide/cysteinyl leukotriene receptor	O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
6100	pravastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC
6101	pravastatin	Solute carrier family 22 member 6	[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC
6102	prazepam	GABA-A receptor alpha-1/beta-2/gamma-2	ClC1=CC=C2N(CC3CC3)C(=O)CN=C(C3=CC=CC=C3)C2=C1
6103	prednicarbate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6104	prednisolone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6105	prednisolone	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6106	prednisolone	Mineralocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6107	prednisolone	Androgen receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6108	prednisolone	Progesterone receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6109	prednisolone	Corticosteroid-binding globulin	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6110	prednisolone	Interleukin-6	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6111	prednisolone	G-protein coupled bile acid receptor 1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6112	prednisolone	Fatty acid-binding protein, liver	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6113	prednisolone	Glutamine synthetase	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6114	prednisolone	Disintegrin and metalloproteinase domain-containing protein 17	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6115	prednisolone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6116	prednisolone tebutate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6117	prednisolone tebutate	Mineralocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6118	prednisolone tebutate	Androgen receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6119	prednisolone tebutate	Progesterone receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6120	prednisolone tebutate	Corticosteroid-binding globulin	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6121	prednisolone tebutate	Interleukin-6	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6122	prednisolone tebutate	G-protein coupled bile acid receptor 1	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6123	prednisolone tebutate	Fatty acid-binding protein, liver	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6124	prednisolone tebutate	Glutamine synthetase	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6125	prednisolone tebutate	Disintegrin and metalloproteinase domain-containing protein 17	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6126	prednisone	Sodium/nucleoside cotransporter 1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6127	prednisone	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6128	prednisone	Annexin A1	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6129	pregabalin	Large neutral amino acids transporter small subunit 1	CC(C)C[C@H](CN)CC(O)=O
6130	pregabalin	Voltage-dependent calcium channel subunit alpha-2/delta-1	CC(C)C[C@H](CN)CC(O)=O
6131	pregabalin	Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit	CC(C)C[C@H](CN)CC(O)=O
6132	pregabalin	Voltage-dependent calcium channel subunit alpha-2/delta-2	CC(C)C[C@H](CN)CC(O)=O
6133	prilocaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCNC(C)C(=O)NC1=C(C)C=CC=C1
6134	primidone	GABA-A receptor alpha-1/beta-2/gamma-2	CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
6135	primidone	Transient receptor potential cation channel subfamily M member 3	CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
6136	probenecid	Carbonic anhydrase 2	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6137	probenecid	Carbonic anhydrase 9	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6138	probenecid	Carbonic anhydrase 12	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6139	probenecid	Solute carrier family 22 member 6	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6140	probenecid	Solute carrier family 22 member 8	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6141	probenecid	Solute carrier family 22 member 11	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6142	probenecid	Solute carrier family 22 member 12	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6143	probenecid	Solute carrier family 22 member 20	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6144	probenecid	UDP-glucuronosyltransferase 1-7	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6145	probenecid	Transient receptor potential cation channel subfamily V member 2	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6146	probucol	Potassium voltage-gated channel subfamily H member 2	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
6147	probucol	Arachidonate 15-lipoxygenase	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
6148	probucol	ATP-binding cassette sub-family A member 1	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
6149	probucol	Serine protease hepsin	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
6150	probucol	Trypsin	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
6151	procainamide	Potassium voltage-gated channel subfamily H member 2	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6152	procainamide	Muscarinic acetylcholine receptor M2	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6153	procainamide	Acetylcholinesterase	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6154	procainamide	DNA (cytosine-5)-methyltransferase 1	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6155	procainamide	DNA (cytosine-5)-methyltransferase 3A	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6156	procainamide	DNA (cytosine-5)-methyltransferase 3B	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6157	procainamide	Sodium channel alpha subunit	CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6158	procaine	5-hydroxytryptamine receptor 3A	CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
6159	procaine	Glutamate receptor ionotropic, NMDA 3A	CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
6160	procaine	Sodium channel protein type 10 subunit alpha	CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
6161	procaine	Ryanodine receptor 1	CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
6162	procaine	Acetylcholine receptor	CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
6163	procaterol	Beta-2 adrenergic receptor	CC[C@@H](NC(C)C)[C@@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1
6164	procaterol	D(2) dopamine receptor	CC[C@@H](NC(C)C)[C@@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1
6165	prochlorperazine	5-hydroxytryptamine receptor 4	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6166	prochlorperazine	D(1A) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6167	prochlorperazine	D(2) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6168	prochlorperazine	Alpha-2A adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6169	prochlorperazine	Sigma non-opioid intracellular receptor 1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6170	prochlorperazine	Potassium voltage-gated channel subfamily H member 2	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6171	prochlorperazine	Sodium-dependent serotonin transporter	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6172	prochlorperazine	Sodium-dependent noradrenaline transporter	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6173	prochlorperazine	5-hydroxytryptamine receptor 1A	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6174	prochlorperazine	5-hydroxytryptamine receptor 2A	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6175	prochlorperazine	5-hydroxytryptamine receptor 2B	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6176	prochlorperazine	5-hydroxytryptamine receptor 2C	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6177	prochlorperazine	5-hydroxytryptamine receptor 6	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6178	prochlorperazine	Alpha-1A adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6179	prochlorperazine	Alpha-2B adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6180	prochlorperazine	D(3) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6181	prochlorperazine	Histamine H1 receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6182	prochlorperazine	Muscarinic acetylcholine receptor M1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6183	prochlorperazine	Muscarinic acetylcholine receptor M2	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6184	prochlorperazine	Muscarinic acetylcholine receptor M3	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6185	prochlorperazine	Muscarinic acetylcholine receptor M4	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6186	prochlorperazine	Muscarinic acetylcholine receptor M5	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6187	prochlorperazine	Alpha-2C adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6188	prochlorperazine	Sodium-dependent dopamine transporter	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6189	prochlorperazine	Cytochrome P450 2D6	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6190	prochlorperazine	D(4) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6191	prochlorperazine	Alpha-1D adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6192	prochlorperazine	Cytochrome P450 1A2	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6193	prochlorperazine	Tyrosine-protein kinase Fyn	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6194	prochlorperazine	Solute carrier family 22 member 1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6195	prochlorperazine	Alpha-1B adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6196	prochlorperazine	5-hydroxytryptamine receptor 1B	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6197	prochlorperazine	Membrane-associated progesterone receptor component 1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6198	prochlorperazine	Pleiotropic ABC efflux transporter of multiple drugs	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
6199	procyclidine	Muscarinic acetylcholine receptor M1	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6200	procyclidine	Muscarinic acetylcholine receptor M2	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6201	procyclidine	Muscarinic acetylcholine receptor M3	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6202	procyclidine	Muscarinic acetylcholine receptor M4	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6203	procyclidine	Muscarinic acetylcholine receptor M5	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6204	procyclidine	Histamine H1 receptor	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6205	procyclidine	Glutamate [NMDA] receptor	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
6206	progesterone	Sodium/nucleoside cotransporter 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6207	progesterone	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6208	progesterone	Multidrug resistance protein 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6209	progesterone	Glucocorticoid receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6210	progesterone	Mineralocorticoid receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6211	progesterone	Estrogen receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6212	progesterone	Androgen receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6213	progesterone	Progesterone receptor	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6214	progesterone	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6215	progesterone	Sex hormone-binding globulin	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6216	progesterone	Sterol O-acyltransferase 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6217	progesterone	Fatty acid-binding protein, intestinal	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6218	progesterone	Fatty acid-binding protein, liver	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6219	progesterone	C-8 sterol isomerase	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6220	progesterone	Steroid 5-alpha-reductase	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6221	progesterone	Cation channel sperm-associated protein 1	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6222	progesterone	Cation channel sperm-associated protein 2	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6223	progesterone	Cation channel sperm-associated protein 3	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6224	progesterone	Cation channel sperm-associated protein 4	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6225	progesterone	Short transient receptor potential channel 5	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6226	progesterone	P2X purinoceptor 3	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6227	proglumide	Histamine H2 receptor	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1
6228	proglumide	Gastrin/cholecystokinin type B receptor	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1
6229	promazine	D(1A) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6230	promazine	D(2) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6231	promazine	Alpha-2A adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6232	promazine	Sigma non-opioid intracellular receptor 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6233	promazine	Sodium-dependent serotonin transporter	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6234	promazine	Sodium-dependent noradrenaline transporter	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6235	promazine	5-hydroxytryptamine receptor 1A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6236	promazine	5-hydroxytryptamine receptor 2A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6237	promazine	5-hydroxytryptamine receptor 2B	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6238	promazine	5-hydroxytryptamine receptor 2C	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6239	promazine	5-hydroxytryptamine receptor 6	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6240	promazine	Alpha-1A adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6241	promazine	Alpha-2B adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6242	promazine	D(3) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6243	promazine	Histamine H1 receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6244	promazine	Histamine H2 receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6245	promazine	Muscarinic acetylcholine receptor M1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6246	promazine	Muscarinic acetylcholine receptor M2	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6247	promazine	Muscarinic acetylcholine receptor M3	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6248	promazine	Muscarinic acetylcholine receptor M4	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6249	promazine	Muscarinic acetylcholine receptor M5	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6250	promazine	Aldehyde oxidase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6251	promazine	Alpha-2C adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6252	promazine	Cytochrome P450 2D6	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6253	promazine	Alpha-1D adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6254	promazine	Major prion protein	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6255	promazine	Solute carrier family 22 member 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6256	promazine	Trypanothione reductase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6257	promazine	Alpha-1B adrenergic receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6258	promazine	Membrane-associated progesterone receptor component 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6259	promazine	Pleiotropic ABC efflux transporter of multiple drugs	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6260	promazine	Dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6261	promazine	Sodium channel alpha subunits; brain (Types I, II, III)	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6262	promazine	FAD-linked sulfhydryl oxidase ALR	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2
6263	promethazine	D(1A) dopamine receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6264	promethazine	D(2) dopamine receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6265	promethazine	Alpha-2A adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6266	promethazine	Sigma non-opioid intracellular receptor 1	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6267	promethazine	Sodium-dependent serotonin transporter	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6268	promethazine	Sodium-dependent noradrenaline transporter	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6269	promethazine	5-hydroxytryptamine receptor 1A	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6270	promethazine	5-hydroxytryptamine receptor 2A	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6271	promethazine	5-hydroxytryptamine receptor 2B	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6272	promethazine	5-hydroxytryptamine receptor 2C	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6273	promethazine	5-hydroxytryptamine receptor 6	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6274	promethazine	Alpha-1A adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6275	promethazine	Alpha-2B adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6276	promethazine	D(3) dopamine receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6277	promethazine	Histamine H1 receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6278	promethazine	Histamine H2 receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6279	promethazine	Histamine H4 receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6280	promethazine	Muscarinic acetylcholine receptor M1	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6281	promethazine	Muscarinic acetylcholine receptor M2	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6282	promethazine	Muscarinic acetylcholine receptor M3	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6283	promethazine	Muscarinic acetylcholine receptor M4	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6284	promethazine	Muscarinic acetylcholine receptor M5	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6285	promethazine	Aldehyde oxidase	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6286	promethazine	Alpha-2C adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6287	promethazine	Cytochrome P450 2D6	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6288	promethazine	Alpha-1D adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6289	promethazine	Cholinesterase	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6290	promethazine	Major prion protein	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6291	promethazine	Solute carrier family 22 member 1	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6292	promethazine	Alpha-1B adrenergic receptor	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6293	promethazine	Pleiotropic ABC efflux transporter of multiple drugs	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6294	promethazine	Sodium channel alpha subunits; brain (Types I, II, III)	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6295	promethazine	Chloroquine resistance transporter	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6296	promethazine	FAD-linked sulfhydryl oxidase ALR	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6297	promethazine	Calmodulin	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6298	promethazine	Calmodulin-1	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C
6299	propafenone	Beta-1 adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6300	propafenone	Beta-2 adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6301	propafenone	Sodium channel protein type 5 subunit alpha	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6302	propafenone	Sodium channel subunit beta-1	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6303	propafenone	Sodium channel subunit beta-2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6304	propafenone	Sodium channel subunit beta-3	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6305	propafenone	Sodium channel subunit beta-4	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6306	propafenone	Sigma non-opioid intracellular receptor 1	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6307	propafenone	Potassium voltage-gated channel subfamily H member 2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6308	propafenone	Multidrug resistance protein 1	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6309	propafenone	Sodium-dependent noradrenaline transporter	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6310	propafenone	5-hydroxytryptamine receptor 1A	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6311	propafenone	5-hydroxytryptamine receptor 2A	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6312	propafenone	5-hydroxytryptamine receptor 2B	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6313	propafenone	5-hydroxytryptamine receptor 2C	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6314	propafenone	5-hydroxytryptamine receptor 6	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6315	propafenone	Aldehyde oxidase	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6316	propafenone	Beta-3 adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6317	propafenone	Sodium-dependent dopamine transporter	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6318	propafenone	Cytochrome P450 2D6	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6319	propafenone	Alpha-1D adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6320	propafenone	Cytochrome P450 1A2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6321	propafenone	Potassium channel subfamily K member 2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6322	propafenone	Potassium voltage-gated channel subfamily A member 5	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6323	propafenone	Potassium channel subfamily K member 3	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6324	propafenone	Solute carrier family 22 member 1	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6325	propafenone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6326	propafenone	Alpha-1B adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6327	propafenone	Alpha-1A adrenergic receptor	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6328	propafenone	Solute carrier family 22 member 2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6329	propafenone	Sulfonylurea receptor 2, Kir6.2	CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
6330	propantheline	Muscarinic acetylcholine receptor M1	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C
6331	propantheline	Muscarinic acetylcholine receptor M2	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C
6332	propantheline	Muscarinic acetylcholine receptor M3	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C
6333	propantheline	Muscarinic acetylcholine receptor M4	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C
6334	proparacaine	Sigma non-opioid intracellular receptor 1	CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC
6335	proparacaine	Amine oxidase [flavin-containing] A	CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC
6336	proparacaine	Sodium channel protein type 10 subunit alpha	CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC
6337	proparacaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC
6338	propiomazine	D(1A) dopamine receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6339	propiomazine	D(2) dopamine receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6340	propiomazine	5-hydroxytryptamine receptor 2A	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6341	propiomazine	5-hydroxytryptamine receptor 2C	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6342	propiomazine	Histamine H1 receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6343	propiomazine	Muscarinic acetylcholine receptor M1	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6344	propiomazine	Muscarinic acetylcholine receptor M2	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6345	propiomazine	Muscarinic acetylcholine receptor M3	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6346	propiomazine	Muscarinic acetylcholine receptor M4	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6347	propiomazine	Muscarinic acetylcholine receptor M5	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6348	propiomazine	D(4) dopamine receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6349	propiomazine	Alpha-1B adrenergic receptor	CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1
6350	propiram	Mu-type opioid receptor	CCC(=O)N(C(C)CN1CCCCC1)C1=CC=CC=N1
6351	propofol	Fatty-acid amide hydrolase 1	CC(C)C1=CC=CC(C(C)C)=C1O
6352	propofol	Prostaglandin G/H synthase 1	CC(C)C1=CC=CC(C(C)C)=C1O
6353	propofol	Sodium-dependent noradrenaline transporter	CC(C)C1=CC=CC(C(C)C)=C1O
6354	propofol	5-hydroxytryptamine receptor 2B	CC(C)C1=CC=CC(C(C)C)=C1O
6355	propofol	5-hydroxytryptamine receptor 2C	CC(C)C1=CC=CC(C(C)C)=C1O
6356	propofol	Carbonic anhydrase 2	CC(C)C1=CC=CC(C(C)C)=C1O
6357	propofol	Carbonic anhydrase 1	CC(C)C1=CC=CC(C(C)C)=C1O
6358	propofol	Cytochrome P450 2C9	CC(C)C1=CC=CC(C(C)C)=C1O
6359	propofol	Arachidonate 15-lipoxygenase	CC(C)C1=CC=CC(C(C)C)=C1O
6360	propofol	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	CC(C)C1=CC=CC(C(C)C)=C1O
6361	propofol	GABA-A receptor alpha-1/beta-2/gamma-2	CC(C)C1=CC=CC(C(C)C)=C1O
6362	propofol	GABA-A receptor alpha-1/beta-3/gamma-2	CC(C)C1=CC=CC(C(C)C)=C1O
6363	propofol	GABA-A receptor; anion channel	CC(C)C1=CC=CC(C(C)C)=C1O
6364	propofol	GABA A receptor alpha-2/beta-2/gamma-2	CC(C)C1=CC=CC(C(C)C)=C1O
6365	propranolol	Sigma non-opioid intracellular receptor 1	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6366	propranolol	Multidrug resistance protein 1	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6367	propranolol	Sodium-dependent serotonin transporter	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6368	propranolol	5-hydroxytryptamine receptor 1A	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6369	propranolol	5-hydroxytryptamine receptor 2A	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6370	propranolol	5-hydroxytryptamine receptor 2B	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6371	propranolol	5-hydroxytryptamine receptor 2C	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6372	propranolol	5-hydroxytryptamine receptor 6	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6373	propranolol	Histamine H1 receptor	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6374	propranolol	Beta-3 adrenergic receptor	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6375	propranolol	5-hydroxytryptamine receptor 1B	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6376	propranolol	5-hydroxytryptamine receptor 1D	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6377	propranolol	Cytochrome P450 2D6	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6378	propranolol	Voltage-dependent L-type calcium channel subunit alpha-1C	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6379	propranolol	Cytochrome P450 1A2	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6380	propranolol	Solute carrier family 22 member 1	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6381	propranolol	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6382	propranolol	Membrane-associated progesterone receptor component 1	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6383	propranolol	D(2) dopamine receptor	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6384	propranolol	Beta-2 adrenergic receptor	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6385	propranolol	Beta-1 adrenergic receptor	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6386	propranolol	Adrenergic receptor beta	[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1
6387	propylthiouracil	Thyroid peroxidase	CCCC1=CC(=O)NC(=S)N1
6388	propylthiouracil	Myeloperoxidase	CCCC1=CC(=O)NC(=S)N1
6389	propylthiouracil	Type I iodothyronine deiodinase	CCCC1=CC(=O)NC(=S)N1
6390	propylthiouracil	Taste receptor type 2 member 38	CCCC1=CC(=O)NC(=S)N1
6391	propyphenazone	Transient receptor potential cation channel subfamily A member 1	CC(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
6392	protirelin	Thyrotropin-releasing hormone receptor	NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
6393	protirelin	Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2	NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
6394	protirelin	Thyrotropin-releasing hormone receptor 2	NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
6395	protokylol	Beta-2 adrenergic receptor	CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1
6396	protriptyline	Potassium voltage-gated channel subfamily H member 2	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6397	protriptyline	Sodium-dependent serotonin transporter	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6398	protriptyline	Sodium-dependent noradrenaline transporter	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6399	protriptyline	5-hydroxytryptamine receptor 2A	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6400	protriptyline	5-hydroxytryptamine receptor 2B	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6401	protriptyline	5-hydroxytryptamine receptor 2C	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6402	protriptyline	Histamine H1 receptor	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6403	protriptyline	Muscarinic acetylcholine receptor M1	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6404	protriptyline	Muscarinic acetylcholine receptor M2	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6405	protriptyline	Muscarinic acetylcholine receptor M3	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6406	protriptyline	Muscarinic acetylcholine receptor M4	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6407	protriptyline	Muscarinic acetylcholine receptor M5	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6408	protriptyline	Sodium-dependent dopamine transporter	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6409	protriptyline	Adenosine receptor A3	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2
6410	pseudoephedrine	Beta-2 adrenergic receptor	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
6411	pseudoephedrine	Alpha-2A adrenergic receptor	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
6412	pseudoephedrine	Sodium-dependent noradrenaline transporter	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
6413	pseudoephedrine	Alpha-1A adrenergic receptor	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
6414	pyridostigmine	Acetylcholinesterase	CN(C)C(=O)OC1=C[N+](C)=CC=C1
6415	pyridostigmine	Cholinesterase	CN(C)C(=O)OC1=C[N+](C)=CC=C1
6416	mepyramine	Alpha-2A adrenergic receptor	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6417	mepyramine	Sigma non-opioid intracellular receptor 1	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6418	mepyramine	Potassium voltage-gated channel subfamily H member 2	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6419	mepyramine	Sodium-dependent serotonin transporter	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6420	mepyramine	5-hydroxytryptamine receptor 2A	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6421	mepyramine	5-hydroxytryptamine receptor 2B	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6422	mepyramine	5-hydroxytryptamine receptor 2C	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6423	mepyramine	Histamine H1 receptor	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6424	mepyramine	Sodium-dependent dopamine transporter	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6425	mepyramine	Cytochrome P450 2D6	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6426	mepyramine	Adenosine receptor A3	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
6427	quazepam	GABA A receptor alpha-1/beta-1/gamma-2	FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12
6428	quazepam	GABA A receptor alpha-3/beta-1/gamma-2	FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12
6429	quazepam	GABA A receptor alpha-2/beta-1/gamma-2	FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12
6430	quetiapine	Beta-1 adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6431	quetiapine	Beta-2 adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6432	quetiapine	D(1A) dopamine receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6433	quetiapine	D(2) dopamine receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6434	quetiapine	Alpha-2A adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6435	quetiapine	Sigma non-opioid intracellular receptor 1	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6436	quetiapine	Potassium voltage-gated channel subfamily H member 2	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6437	quetiapine	Sodium-dependent noradrenaline transporter	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6438	quetiapine	5-hydroxytryptamine receptor 1A	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6439	quetiapine	5-hydroxytryptamine receptor 2A	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6440	quetiapine	5-hydroxytryptamine receptor 2B	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6441	quetiapine	5-hydroxytryptamine receptor 2C	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6442	quetiapine	5-hydroxytryptamine receptor 6	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6443	quetiapine	5-hydroxytryptamine receptor 7	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6444	quetiapine	Alpha-1A adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6445	quetiapine	Alpha-2B adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6446	quetiapine	D(3) dopamine receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6447	quetiapine	D(1B) dopamine receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6448	quetiapine	Histamine H1 receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6449	quetiapine	Muscarinic acetylcholine receptor M1	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6450	quetiapine	Muscarinic acetylcholine receptor M2	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6451	quetiapine	Muscarinic acetylcholine receptor M3	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6452	quetiapine	Muscarinic acetylcholine receptor M4	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6453	quetiapine	Muscarinic acetylcholine receptor M5	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6454	quetiapine	Aldehyde oxidase	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6455	quetiapine	5-hydroxytryptamine receptor 1B	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6456	quetiapine	5-hydroxytryptamine receptor 1D	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6457	quetiapine	Alpha-2C adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6458	quetiapine	D(4) dopamine receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6459	quetiapine	Alpha-1D adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6460	quetiapine	Alpha-1B adrenergic receptor	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6461	quetiapine	5-hydroxytryptamine receptor 5A	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6462	quetiapine	5-hydroxytryptamine receptor 1F	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6463	quetiapine	5-hydroxytryptamine receptor 1E	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6464	quetiapine	Membrane-associated progesterone receptor component 1	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6465	quetiapine	Transporter	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6466	quetiapine	Histone H1.0	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
6467	quinapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O
6468	quinestrol	Estrogen receptor	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3
6469	quinethazone	Solute carrier family 12 member 3	CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
6470	quingestanol acetate	Progesterone receptor	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(OC4CCCC4)=CC3=CC[C@@]21[H]
6471	quinidine	Sodium channel protein type 5 subunit alpha	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6472	quinidine	Sodium channel subunit beta-1	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6473	quinidine	Sodium channel subunit beta-2	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6474	quinidine	Sodium channel subunit beta-3	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6475	quinidine	Sodium channel subunit beta-4	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6476	quinidine	Potassium voltage-gated channel subfamily H member 2	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6477	quinidine	Multidrug resistance protein 1	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6478	quinidine	Muscarinic acetylcholine receptor M2	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6479	quinidine	Cholinesterase	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6480	quinidine	Potassium voltage-gated channel subfamily A member 5	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6481	quinidine	Potassium voltage-gated channel subfamily H member 1	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6482	quinidine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6483	quinidine	Potassium voltage-gated channel subfamily A member 7	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6484	quinidine	Solute carrier family 22 member 2	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6485	quinidine	Multidrug and toxin extrusion protein 1	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6486	quinidine	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6487	quinidine	Equilibrative nucleoside transporter 4	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6488	quinidine	Potassium voltage-gated channel subfamily D member 2	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6489	quinidine	Potassium channel subfamily T member 1	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6490	quinidine	Cytochrome P450 2D6	[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
6491	rabeprazole	Alpha-2B adrenergic receptor	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6492	rabeprazole	D(3) dopamine receptor	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6493	rabeprazole	5-hydroxytryptamine receptor 1D	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6494	rabeprazole	Sodium/potassium-transporting ATPase subunit alpha-1	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6495	rabeprazole	Adenosine receptor A3	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6496	rabeprazole	Fatty acid synthase	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6497	rabeprazole	Potassium-transporting ATPase	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6498	rabeprazole	Insulin-degrading enzyme	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6499	rabeprazole	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6500	rabeprazole	Cytosolic endo-beta-N-acetylglucosaminidase	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6501	rabeprazole	Sterile alpha and TIR motif-containing protein 1	COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C
6502	raloxifene	Mu-type opioid receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6503	raloxifene	D(1A) dopamine receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6504	raloxifene	D(2) dopamine receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6505	raloxifene	Adenosine receptor A2a	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6506	raloxifene	Alpha-2A adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6507	raloxifene	Sigma non-opioid intracellular receptor 1	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6508	raloxifene	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6509	raloxifene	Sodium-dependent serotonin transporter	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6510	raloxifene	Sodium-dependent noradrenaline transporter	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6511	raloxifene	5-hydroxytryptamine receptor 2A	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6512	raloxifene	5-hydroxytryptamine receptor 2B	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6513	raloxifene	5-hydroxytryptamine receptor 2C	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6514	raloxifene	5-hydroxytryptamine receptor 6	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6515	raloxifene	Alpha-2B adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6516	raloxifene	D(3) dopamine receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6517	raloxifene	Aldehyde oxidase	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6518	raloxifene	5-hydroxytryptamine receptor 1D	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6519	raloxifene	Alpha-2C adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6520	raloxifene	Sodium-dependent dopamine transporter	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6521	raloxifene	Nuclear receptor subfamily 1 group I member 2	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6522	raloxifene	Alpha-1D adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6523	raloxifene	Kappa-type opioid receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6524	raloxifene	Estrogen receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6525	raloxifene	Delta-type opioid receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6526	raloxifene	Acetylcholinesterase	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6527	raloxifene	Cytochrome P450 2C9	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6528	raloxifene	Estrogen receptor beta	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6529	raloxifene	G-protein coupled estrogen receptor 1	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6530	raloxifene	Interleukin-6	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6531	raloxifene	Tyrosine-protein kinase Fyn	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6532	raloxifene	Bile acid receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6533	raloxifene	Substance-K receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6534	raloxifene	Phospholipase D1	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6535	raloxifene	Phospholipase D2	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6536	raloxifene	Alpha-1B adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6537	raloxifene	5-hydroxytryptamine receptor 1B	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6538	raloxifene	Membrane-associated progesterone receptor component 1	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6539	raloxifene	Alpha-1A adrenergic receptor	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6540	raloxifene	C-8 sterol isomerase	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6541	raloxifene	Cruzipain	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6542	raloxifene	Complement C5	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6543	raloxifene	HLA class I histocompatibility antigen, A-3 alpha chain	OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
6544	ramatroban	Prostaglandin D2 receptor 2	OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12
6545	ramatroban	Thromboxane A2 receptor	OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12
6546	ramatroban	Prostaglandin D2 receptor	OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12
6547	ramelteon	Melatonin receptor type 1A	CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2
6548	ramelteon	Melatonin receptor type 1B	CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2
6549	ramipril	Angiotensin-converting enzyme	[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC
6550	ramosetron	5-hydroxytryptamine receptor 3A	CN1C=C(C(=O)[C@@H]2CCC3=C(C2)NC=N3)C2=CC=CC=C12
6551	ranitidine	Histamine H2 receptor	CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
6552	ranitidine	Acetylcholinesterase	CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
6553	ranitidine	Multidrug and toxin extrusion protein 1	CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
6554	ranolazine	Sodium channel protein type 5 subunit alpha	COC1=C(OCC(O)CN2CCN(CC(=O)NC3=C(C)C=CC=C3C)CC2)C=CC=C1
6555	ranolazine	Potassium voltage-gated channel subfamily H member 2	COC1=C(OCC(O)CN2CCN(CC(=O)NC3=C(C)C=CC=C3C)CC2)C=CC=C1
6556	ranolazine	Multidrug resistance protein 1	COC1=C(OCC(O)CN2CCN(CC(=O)NC3=C(C)C=CC=C3C)CC2)C=CC=C1
6557	ranolazine	Voltage-gated sodium channel Nav1.5 cardiac isoform	COC1=C(OCC(O)CN2CCN(CC(=O)NC3=C(C)C=CC=C3C)CC2)C=CC=C1
6558	regadenoson	Adenosine receptor A2a	CNC(=O)C1=CN(N=C1)C1=NC(N)=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=N1
6559	regadenoson	Adenosine receptor A1	CNC(=O)C1=CN(N=C1)C1=NC(N)=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=N1
6560	regadenoson	Adenosine receptor A2b	CNC(=O)C1=CN(N=C1)C1=NC(N)=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=N1
6561	regadenoson	Adenosine receptor A3	CNC(=O)C1=CN(N=C1)C1=NC(N)=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=N1
6562	remifentanil	Mu-type opioid receptor	CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC
6563	remoxipride	D(2) dopamine receptor	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6564	remoxipride	Sigma non-opioid intracellular receptor 1	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6565	remoxipride	5-hydroxytryptamine receptor 1A	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6566	remoxipride	5-hydroxytryptamine receptor 2A	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6567	remoxipride	D(3) dopamine receptor	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6568	remoxipride	D(4) dopamine receptor	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6569	remoxipride	Dopamine receptor	CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC
6570	repaglinide	ATP-binding cassette sub-family C member 8	CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
6571	repaglinide	Solute carrier organic anion transporter family member 1B1	CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
6572	repaglinide	Solute carrier family 22 member 1	CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
6573	repaglinide	Sulfonylurea receptor 1, Kir6.2	CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
6574	repaglinide	Sulfonylurea receptor 2, Kir6.2	CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
6575	reproterol	Beta-2 adrenergic receptor	CN1C2=C(N(CCCNCC(O)C3=CC(O)=CC(O)=C3)C=N2)C(=O)N(C)C1=O
6576	rescinnamine	Synaptic vesicular amine transporter	[H][C@]12C[C@@H](OC(=O)\C=C\C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6577	reserpine	Mu-type opioid receptor	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6578	reserpine	D(1A) dopamine receptor	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6579	reserpine	D(2) dopamine receptor	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6580	reserpine	Multidrug resistance protein 1	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6581	reserpine	5-hydroxytryptamine receptor 1A	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6582	reserpine	D(3) dopamine receptor	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6583	reserpine	ATP-binding cassette sub-family G member 2	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6584	reserpine	Synaptic vesicular amine transporter	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6585	reserpine	Quinolone resistance protein NorA	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6586	reserpine	Chromaffin granule amine transporter	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6587	reserpine	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6588	reserpine	Sodium-dependent serotonin transporter	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
6589	ribavirin	Adenosine receptor A1	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6590	ribavirin	Adenosine kinase	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6591	ribavirin	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6592	ribavirin	Cytosolic purine 5'-nucleotidase	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6593	ribavirin	Inosine-5'-monophosphate dehydrogenase 1	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6594	ribavirin	Inosine-5'-monophosphate dehydrogenase 2	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6595	ribavirin	DNA topoisomerase 1	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6596	ribavirin	NS5B protein	NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
6597	riluzole	Sodium channel protein type 5 subunit alpha	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6598	riluzole	Potassium voltage-gated channel subfamily H member 2	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6599	riluzole	Sodium-dependent noradrenaline transporter	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6600	riluzole	Intermediate conductance calcium-activated potassium channel protein 4	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6601	riluzole	Glutamate receptor ionotropic, NMDA 3A	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6602	riluzole	Small conductance calcium-activated potassium channel protein 3	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6603	riluzole	Pteridine reductase 1	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6604	riluzole	Small conductance calcium-activated potassium channel protein 1	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6605	riluzole	Short transient receptor potential channel 5	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6606	riluzole	Small conductance calcium-activated potassium channel protein 2	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6607	rimexolone	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
6608	risedronic acid	Farnesyl pyrophosphate synthase	OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O
6609	risedronic acid	Farnesyl diphosphate synthase	OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O
6610	risperidone	Beta-1 adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6611	risperidone	Beta-2 adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6612	risperidone	D(1A) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6613	risperidone	D(2) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6614	risperidone	Alpha-2A adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6615	risperidone	Sigma non-opioid intracellular receptor 1	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6616	risperidone	Potassium voltage-gated channel subfamily H member 2	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6617	risperidone	Sodium-dependent serotonin transporter	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6618	risperidone	5-hydroxytryptamine receptor 1A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6619	risperidone	5-hydroxytryptamine receptor 2A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6620	risperidone	5-hydroxytryptamine receptor 2B	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6621	risperidone	5-hydroxytryptamine receptor 2C	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6622	risperidone	5-hydroxytryptamine receptor 6	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6623	risperidone	5-hydroxytryptamine receptor 7	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6624	risperidone	Alpha-1A adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6625	risperidone	Alpha-2B adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6626	risperidone	D(3) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6627	risperidone	D(1B) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6628	risperidone	Histamine H1 receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6629	risperidone	Histamine H2 receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6630	risperidone	Muscarinic acetylcholine receptor M1	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6631	risperidone	Muscarinic acetylcholine receptor M2	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6632	risperidone	Muscarinic acetylcholine receptor M3	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6633	risperidone	Muscarinic acetylcholine receptor M4	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6634	risperidone	5-hydroxytryptamine receptor 1B	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6635	risperidone	5-hydroxytryptamine receptor 1D	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6636	risperidone	Alpha-2C adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6637	risperidone	Cytochrome P450 2D6	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6638	risperidone	D(4) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6639	risperidone	Alpha-1D adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6640	risperidone	Alpha-1B adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6641	risperidone	Glycine receptor subunit alpha-1	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6642	risperidone	5-hydroxytryptamine receptor 5A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6643	risperidone	5-hydroxytryptamine receptor 1F	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6644	risperidone	5-hydroxytryptamine receptor 1E	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6645	risperidone	Transporter	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6646	risperidone	Solute carrier family 22 member 2	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6647	risperidone	Multidrug and toxin extrusion protein 1	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6648	risperidone	Serotonin 1 (5-HT1) receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6649	risperidone	Serotonin 2 (5-HT2) receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6650	risperidone	Histone H1.0	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
6651	ritodrine	Beta-2 adrenergic receptor	C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1
6652	ritodrine	Beta-3 adrenergic receptor	C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1
6653	rivastigmine	Acetylcholinesterase	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
6654	rivastigmine	Cholinesterase	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
6655	rivastigmine	Butyrylcholinesterase; Protein Bche	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
6656	rivastigmine	Butyrylcholinesterase	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
6657	rizatriptan	5-hydroxytryptamine receptor 1A	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6658	rizatriptan	5-hydroxytryptamine receptor 2A	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6659	rizatriptan	5-hydroxytryptamine receptor 2C	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6660	rizatriptan	5-hydroxytryptamine receptor 1B	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6661	rizatriptan	5-hydroxytryptamine receptor 1D	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6662	rizatriptan	Cytochrome P450 2D6	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6663	rizatriptan	5-hydroxytryptamine receptor 1F	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6664	rizatriptan	5-hydroxytryptamine receptor 1E	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6665	rizatriptan	Serotonin 3 (5-HT3) receptor	CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
6666	rocuronium	Acetylcholine receptor	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1
6667	rocuronium	Acetylcholine receptor; alpha1/beta1/delta/gamma	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1
6668	rofecoxib	Prostaglandin G/H synthase 2	CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
6669	rofecoxib	Prostaglandin G/H synthase 1	CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
6670	rofecoxib	Prostaglandin E2 receptor EP2 subtype	CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
6671	rofecoxib	Cytochrome c oxidase subunit 2	CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
6672	ropinirole	D(1A) dopamine receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6673	ropinirole	D(2) dopamine receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6674	ropinirole	Alpha-2A adrenergic receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6675	ropinirole	5-hydroxytryptamine receptor 1A	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6676	ropinirole	5-hydroxytryptamine receptor 2A	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6677	ropinirole	5-hydroxytryptamine receptor 2B	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6678	ropinirole	5-hydroxytryptamine receptor 7	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6679	ropinirole	Alpha-2B adrenergic receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6680	ropinirole	D(3) dopamine receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6681	ropinirole	D(1B) dopamine receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6682	ropinirole	5-hydroxytryptamine receptor 1D	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6683	ropinirole	Alpha-2C adrenergic receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6684	ropinirole	D(4) dopamine receptor	CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6685	ropivacaine	Sodium channel protein type 5 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6686	ropivacaine	Sodium channel protein type 1 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6687	ropivacaine	Sodium channel protein type 2 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6688	ropivacaine	Sodium channel protein type 3 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6689	ropivacaine	Sodium channel protein type 4 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6690	ropivacaine	Sodium channel protein type 8 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6691	ropivacaine	Sodium channel protein type 9 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6692	ropivacaine	Sodium channel protein type 10 subunit alpha	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6693	ropivacaine	Potassium channel subfamily K member 3	CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
6694	rosiglitazone	Potassium voltage-gated channel subfamily H member 2	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6695	rosiglitazone	Carbonic anhydrase 2	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6696	rosiglitazone	Bile salt export pump	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6697	rosiglitazone	Amine oxidase [flavin-containing] B	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6698	rosiglitazone	Amine oxidase [flavin-containing] A	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6699	rosiglitazone	Peroxisome proliferator-activated receptor alpha	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6700	rosiglitazone	Peroxisome proliferator-activated receptor gamma	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6701	rosiglitazone	Retinoic acid receptor RXR-alpha	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6702	rosiglitazone	Retinoic acid receptor gamma	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6703	rosiglitazone	Thromboxane-A synthase	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6704	rosiglitazone	Peroxisome proliferator-activated receptor delta	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6705	rosiglitazone	Free fatty acid receptor 1	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6706	rosiglitazone	Type-1A angiotensin II receptor	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6707	rosiglitazone	Short transient receptor potential channel 5	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6708	rosiglitazone	Sodium/bile acid cotransporter	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6709	rosiglitazone	CDGSH iron-sulfur domain-containing protein 1	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6710	rosiglitazone	CDGSH iron-sulfur domain-containing protein 2	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
6711	rosuvastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1
6712	rosuvastatin	Phosphodiesterase 6D	CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1
6713	rotigotine	D(1A) dopamine receptor	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
6714	rotigotine	D(2) dopamine receptor	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
6715	rotigotine	D(3) dopamine receptor	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
6716	rotigotine	D(1B) dopamine receptor	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
6717	rotigotine	D(4) dopamine receptor	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
6718	roxatidine acetate	Histamine H2 receptor	CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
6719	rupatadine	Histamine H1 receptor	CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1
6720	rupatadine	Platelet-activating factor receptor	CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1
6721	salmeterol	Beta-1 adrenergic receptor	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6722	salmeterol	Beta-2 adrenergic receptor	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6723	salmeterol	D(2) dopamine receptor	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6724	salmeterol	D(3) dopamine receptor	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6725	salmeterol	Aldehyde oxidase	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6726	salmeterol	Beta-3 adrenergic receptor	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
6727	scopolamine	Muscarinic acetylcholine receptor M1	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6728	scopolamine	Muscarinic acetylcholine receptor M2	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6729	scopolamine	Muscarinic acetylcholine receptor M3	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6730	scopolamine	Muscarinic acetylcholine receptor M4	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6731	scopolamine	Muscarinic acetylcholine receptor M5	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6732	scopolamine	Muscarinic receptor M1	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6733	scopolamine	Muscarinic acetylcholine receptor DM1	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6734	scopolamine	Muscarinic acetylcholine receptor	CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
6735	secobarbital	Matrix metalloproteinase-9	CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
6736	secobarbital	GABA-A receptor alpha-1/beta-2/gamma-2	CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
6737	selegiline	Alpha-2A adrenergic receptor	C[C@H](CC1=CC=CC=C1)N(C)CC#C
6738	selegiline	Alpha-2B adrenergic receptor	C[C@H](CC1=CC=CC=C1)N(C)CC#C
6739	selegiline	Amine oxidase [flavin-containing] B	C[C@H](CC1=CC=CC=C1)N(C)CC#C
6740	selegiline	Amine oxidase [flavin-containing] A	C[C@H](CC1=CC=CC=C1)N(C)CC#C
6741	selegiline	Monoamine oxidase	C[C@H](CC1=CC=CC=C1)N(C)CC#C
6742	sermorelin	Growth hormone-releasing hormone receptor	[H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O
6743	sertindole	Beta-1 adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6744	sertindole	Beta-2 adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6745	sertindole	D(1A) dopamine receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6746	sertindole	Alpha-2A adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6747	sertindole	Potassium voltage-gated channel subfamily H member 2	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6748	sertindole	Multidrug resistance protein 1	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6749	sertindole	5-hydroxytryptamine receptor 1A	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6750	sertindole	5-hydroxytryptamine receptor 6	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6751	sertindole	5-hydroxytryptamine receptor 7	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6752	sertindole	Alpha-1A adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6753	sertindole	Alpha-2B adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6754	sertindole	D(3) dopamine receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6755	sertindole	Histamine H1 receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6756	sertindole	Muscarinic acetylcholine receptor M3	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6757	sertindole	5-hydroxytryptamine receptor 1B	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6758	sertindole	5-hydroxytryptamine receptor 1D	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6759	sertindole	Alpha-2C adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6760	sertindole	D(4) dopamine receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6761	sertindole	5-hydroxytryptamine receptor 1F	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6762	sertindole	5-hydroxytryptamine receptor 1E	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6763	sertindole	Alpha-1D adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6764	sertindole	D(2) dopamine receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6765	sertindole	5-hydroxytryptamine receptor 2A	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6766	sertindole	5-hydroxytryptamine receptor 2C	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6767	sertindole	Alpha-1B adrenergic receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6768	sertindole	Adrenergic receptor alpha-1	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6769	sertindole	Serotonin 2 (5-HT2) receptor	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
6770	sertraline	Alpha-2A adrenergic receptor	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6771	sertraline	Sigma non-opioid intracellular receptor 1	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6772	sertraline	Potassium voltage-gated channel subfamily H member 2	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6773	sertraline	Sodium-dependent serotonin transporter	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6774	sertraline	Sodium-dependent noradrenaline transporter	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6775	sertraline	5-hydroxytryptamine receptor 2A	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6776	sertraline	5-hydroxytryptamine receptor 2B	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6777	sertraline	5-hydroxytryptamine receptor 2C	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6778	sertraline	Alpha-1A adrenergic receptor	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6779	sertraline	Alpha-2B adrenergic receptor	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6780	sertraline	Muscarinic acetylcholine receptor M1	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6781	sertraline	Muscarinic acetylcholine receptor M2	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6782	sertraline	Muscarinic acetylcholine receptor M3	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6783	sertraline	Muscarinic acetylcholine receptor M4	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6784	sertraline	Muscarinic acetylcholine receptor M5	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6785	sertraline	Alpha-2C adrenergic receptor	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6786	sertraline	Sodium-dependent dopamine transporter	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6787	sertraline	Cytochrome P450 2C19	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6788	sertraline	Alpha-1B adrenergic receptor	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6789	sertraline	Melanocortin receptor 5	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6790	sertraline	Membrane-associated progesterone receptor component 1	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6791	sertraline	Transporter	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6792	sertraline	Transcriptional activator protein luxR	CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
6793	setastine	Histamine H1 receptor	CC(OCCN1CCCCCC1)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
6794	sevoflurane	Glycine receptor subunit alpha-1	FCOC(C(F)(F)F)C(F)(F)F
6795	sevoflurane	Potassium channel subfamily K member 2	FCOC(C(F)(F)F)C(F)(F)F
6796	sevoflurane	Potassium channel subfamily K member 3	FCOC(C(F)(F)F)C(F)(F)F
6797	sevoflurane	Potassium channel subfamily K member 9	FCOC(C(F)(F)F)C(F)(F)F
6798	sevoflurane	Potassium channel subfamily K member 10	FCOC(C(F)(F)F)C(F)(F)F
6799	sevoflurane	Potassium channel subfamily K member 18	FCOC(C(F)(F)F)C(F)(F)F
6800	sevoflurane	GABA-A receptor; anion channel	FCOC(C(F)(F)F)C(F)(F)F
6801	sibutramine	Sodium-dependent serotonin transporter	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6802	sibutramine	Sodium-dependent noradrenaline transporter	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6803	sibutramine	Alpha-2B adrenergic receptor	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6804	sibutramine	Alpha-2C adrenergic receptor	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6805	sibutramine	Sodium-dependent dopamine transporter	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6806	sibutramine	Potassium voltage-gated channel subfamily D member 3	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6807	sibutramine	Cytochrome P450 2B6	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6808	sibutramine	Solute carrier family 22 member 2	CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
6809	sildenafil	Adenosine receptor A2a	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6810	sildenafil	Potassium voltage-gated channel subfamily H member 2	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6811	sildenafil	Adenosine receptor A1	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6812	sildenafil	Multidrug resistance-associated protein 5	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6813	sildenafil	cGMP-specific 3',5'-cyclic phosphodiesterase	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6814	sildenafil	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6815	sildenafil	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6816	sildenafil	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6817	sildenafil	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6818	sildenafil	cGMP-dependent 3',5'-cyclic phosphodiesterase	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6819	sildenafil	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6820	sildenafil	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6821	sildenafil	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6822	sildenafil	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6823	sildenafil	Alpha-1B adrenergic receptor	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6824	sildenafil	Uncharacterized protein	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6825	sildenafil	Indoleamine 2,3-dioxygenase 2	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6826	sildenafil	Phosphodiesterase 3	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6827	sildenafil	Phosphodiesterase 4	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6828	sildenafil	Phosphodiesterase 1	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6829	sildenafil	Phosphodiesterase 6	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6830	sildenafil	Solute carrier organic anion transporter family member 1B3	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6831	sildenafil	Phosphodiesterase 2A	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
6832	simvastatin	Nuclear receptor subfamily 1 group I member 3	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
6833	simvastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
6834	simvastatin	Acetylcholinesterase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
6835	simvastatin	Cholinesterase	[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
6836	sirolimus	Sodium/nucleoside cotransporter 1	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6837	sirolimus	Cytochrome P450 3A4	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6838	sirolimus	Multidrug resistance protein 1	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6839	sirolimus	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6840	sirolimus	Cytochrome P450 2C9	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6841	sirolimus	Serine/threonine-protein kinase mTOR	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6842	sirolimus	Peptidyl-prolyl cis-trans isomerase FKBP3	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6843	sirolimus	Cytochrome P450 2C19	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6844	sirolimus	Peptidyl-prolyl cis-trans isomerase FKBP1B	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6845	sirolimus	Peptidyl-prolyl cis-trans isomerase FKBP5	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6846	sirolimus	Programmed cell death protein 4	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6847	sirolimus	Eukaryotic translation initiation factor 4E	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
6848	sitagliptin	Dipeptidyl peptidase 4	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6849	sitagliptin	Angiotensin-converting enzyme	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6850	sitagliptin	Prolyl endopeptidase FAP	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6851	sitagliptin	Dipeptidyl peptidase 8	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6852	sitagliptin	Dipeptidyl peptidase 9	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6853	sitagliptin	Dipeptidyl peptidase 2	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6854	sitagliptin	Dipeptidyl peptidase IV	N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
6855	sivelestat	Neutrophil elastase	CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O
6856	sivelestat	Myeloblastin	CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O
6857	solifenacin	Muscarinic acetylcholine receptor M1	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
6858	solifenacin	Muscarinic acetylcholine receptor M2	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
6859	solifenacin	Muscarinic acetylcholine receptor M3	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
6860	solifenacin	Muscarinic acetylcholine receptor M4	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
6861	solifenacin	Muscarinic acetylcholine receptor M5	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
6862	sorafenib	Tyrosine-protein kinase JAK3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6863	sorafenib	5-hydroxytryptamine receptor 1A	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6864	sorafenib	5-hydroxytryptamine receptor 2A	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6865	sorafenib	5-hydroxytryptamine receptor 2B	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6866	sorafenib	5-hydroxytryptamine receptor 2C	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6867	sorafenib	5-hydroxytryptamine receptor 6	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6868	sorafenib	5-hydroxytryptamine receptor 7	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6869	sorafenib	5-hydroxytryptamine receptor 5A	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6870	sorafenib	Platelet-derived growth factor receptor beta	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6871	sorafenib	Tyrosine-protein kinase ABL1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6872	sorafenib	Mast/stem cell growth factor receptor Kit	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6873	sorafenib	Epidermal growth factor receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6874	sorafenib	Carbonic anhydrase 7	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6875	sorafenib	Proto-oncogene tyrosine-protein kinase Src	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6876	sorafenib	Tyrosine-protein kinase Lck	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6877	sorafenib	Tyrosine-protein kinase Fyn	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6878	sorafenib	Ephrin type-A receptor 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6879	sorafenib	RAF proto-oncogene serine/threonine-protein kinase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6880	sorafenib	Serine/threonine-protein kinase B-raf	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6881	sorafenib	Receptor-type tyrosine-protein kinase FLT3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6882	sorafenib	Proto-oncogene tyrosine-protein kinase receptor Ret	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6883	sorafenib	Vascular endothelial growth factor receptor 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6884	sorafenib	Vascular endothelial growth factor receptor 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6885	sorafenib	Vascular endothelial growth factor receptor 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6886	sorafenib	Macrophage colony-stimulating factor 1 receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6887	sorafenib	Platelet-derived growth factor receptor alpha	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6888	sorafenib	Cyclin-dependent kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6889	sorafenib	Insulin receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6890	sorafenib	Fibroblast growth factor receptor 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6891	sorafenib	Tyrosine-protein kinase HCK	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6892	sorafenib	High affinity nerve growth factor receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6893	sorafenib	Myosin light chain kinase 2, skeletal/cardiac muscle	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6894	sorafenib	Tyrosine-protein kinase CSK	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6895	sorafenib	Angiopoietin-1 receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6896	sorafenib	Ephrin type-A receptor 8	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6897	sorafenib	Hepatocyte growth factor receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6898	sorafenib	Tyrosine-protein kinase Lyn	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6899	sorafenib	LIM domain kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6900	sorafenib	Fibroblast growth factor receptor 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6901	sorafenib	Cyclin-dependent-like kinase 5	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6902	sorafenib	Serine/threonine-protein kinase 10	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6903	sorafenib	Serine/threonine-protein kinase PLK4	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6904	sorafenib	Aurora kinase C	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6905	sorafenib	Dual specificity protein kinase TTK	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6906	sorafenib	Abelson tyrosine-protein kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6907	sorafenib	Mitogen-activated protein kinase 11	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6908	sorafenib	Ephrin type-A receptor 5	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6909	sorafenib	Ephrin type-A receptor 4	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6910	sorafenib	Fibroblast growth factor receptor 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6911	sorafenib	Mitogen-activated protein kinase 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6912	sorafenib	Ephrin type-A receptor 6	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6913	sorafenib	TRAF2 and NCK-interacting protein kinase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6914	sorafenib	Mitogen-activated protein kinase 12	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6915	sorafenib	Tyrosine-protein kinase Fgr	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6916	sorafenib	Aurora kinase A	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6917	sorafenib	Serine/threonine-protein kinase 36	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6918	sorafenib	Ephrin type-A receptor 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6919	sorafenib	Mitogen-activated protein kinase 14	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6920	sorafenib	Tyrosine-protein kinase FRK	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6921	sorafenib	Dual specificity protein kinase CLK1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6922	sorafenib	Mitogen-activated protein kinase kinase kinase kinase 5	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6923	sorafenib	Receptor-interacting serine/threonine-protein kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6924	sorafenib	Ephrin type-B receptor 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6925	sorafenib	Ephrin type-A receptor 7	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6926	sorafenib	STE20-like serine/threonine-protein kinase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6927	sorafenib	MAP kinase-interacting serine/threonine-protein kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6928	sorafenib	Mitogen-activated protein kinase 9	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6929	sorafenib	Epithelial discoidin domain-containing receptor 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6930	sorafenib	Ephrin type-B receptor 4	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6931	sorafenib	Cyclin-dependent kinase 15	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6932	sorafenib	Bifunctional epoxide hydrolase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6933	sorafenib	TGF-beta receptor type-2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6934	sorafenib	Mitogen-activated protein kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6935	sorafenib	Tyrosine-protein kinase receptor UFO	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6936	sorafenib	BDNF/NT-3 growth factors receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6937	sorafenib	Ephrin type-B receptor 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6938	sorafenib	Cyclin-dependent kinase 7	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6939	sorafenib	Ribosomal protein S6 kinase alpha-6	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6940	sorafenib	Non-receptor tyrosine-protein kinase TNK1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6941	sorafenib	Mitogen-activated protein kinase 13	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6942	sorafenib	Cyclin-dependent kinase 17	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6943	sorafenib	Cyclin-dependent kinase 14	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6944	sorafenib	Mitogen-activated protein kinase kinase kinase MLT	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6945	sorafenib	Tyrosine-protein kinase receptor Tie-1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6946	sorafenib	NT-3 growth factor receptor	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6947	sorafenib	LIM domain kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6948	sorafenib	MAP kinase-interacting serine/threonine-protein kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6949	sorafenib	Serine/threonine-protein kinase NLK	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6950	sorafenib	Serine/threonine-protein kinase 33	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6951	sorafenib	Serine/threonine-protein kinase TNNI3K	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6952	sorafenib	Discoidin domain-containing receptor 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6953	sorafenib	Mitogen-activated protein kinase kinase kinase kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6954	sorafenib	Aurora kinase B	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6955	sorafenib	Mitogen-activated protein kinase kinase kinase kinase 4	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6956	sorafenib	Tyrosine-protein kinase Mer	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6957	sorafenib	Cyclin-dependent kinase 19	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6958	sorafenib	Cyclin-dependent kinase 8	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6959	sorafenib	Muscle, skeletal receptor tyrosine-protein kinase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6960	sorafenib	Citron Rho-interacting kinase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6961	sorafenib	Myosin-IIIb	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6962	sorafenib	Cyclin-dependent kinase 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6963	sorafenib	Tyrosine-protein kinase Srms	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6964	sorafenib	Ephrin type-A receptor 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6965	sorafenib	Mitogen-activated protein kinase 15	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6966	sorafenib	Receptor-interacting serine/threonine-protein kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6967	sorafenib	Casein kinase I isoform alpha	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6968	sorafenib	Cyclin-dependent kinase-like 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6969	sorafenib	Cyclin-dependent kinase-like 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6970	sorafenib	Ephrin type-B receptor 6	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6971	sorafenib	Homeodomain-interacting protein kinase 2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6972	sorafenib	Homeodomain-interacting protein kinase 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6973	sorafenib	Homeodomain-interacting protein kinase 4	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6974	sorafenib	Mitogen-activated protein kinase kinase kinase 7	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6975	sorafenib	Serine/threonine-protein kinase TAO1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6976	sorafenib	Serine/threonine-protein kinase TAO3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6977	sorafenib	Mitogen-activated protein kinase kinase kinase 19	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6978	sorafenib	Homeodomain-interacting protein kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6979	sorafenib	Serine/threonine-protein kinase TAO2	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6980	sorafenib	Dual specificity mitogen-activated protein kinase kinase 5	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6981	sorafenib	Myosin light chain kinase 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6982	sorafenib	Calcium-dependent protein kinase 1	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6983	sorafenib	Serine/threonine-protein kinase A-Raf	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6984	sorafenib	Purine nucleoside phosphorylase	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6985	sorafenib	Receptor-interacting serine/threonine-protein kinase 3	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
6986	sotalol	Beta-1 adrenergic receptor	CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
6987	sotalol	Beta-2 adrenergic receptor	CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
6988	sotalol	Potassium voltage-gated channel subfamily H member 2	CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
6989	spiperone	D(1A) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6990	spiperone	D(2) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6991	spiperone	Sigma non-opioid intracellular receptor 1	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6992	spiperone	5-hydroxytryptamine receptor 1A	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6993	spiperone	5-hydroxytryptamine receptor 2A	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6994	spiperone	5-hydroxytryptamine receptor 2B	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6995	spiperone	5-hydroxytryptamine receptor 2C	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6996	spiperone	5-hydroxytryptamine receptor 6	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6997	spiperone	5-hydroxytryptamine receptor 7	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6998	spiperone	Alpha-1A adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
6999	spiperone	D(3) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7000	spiperone	D(1B) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7001	spiperone	Histamine H1 receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7002	spiperone	5-hydroxytryptamine receptor 1D	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7003	spiperone	D(4) dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7004	spiperone	Alpha-1D adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7005	spiperone	Alpha-1B adrenergic receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7006	spiperone	5-hydroxytryptamine receptor 5A	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7007	spiperone	5-hydroxytryptamine receptor 1F	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7008	spiperone	5-hydroxytryptamine receptor 1E	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7009	spiperone	5-hydroxytryptamine receptor 1B	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7010	spiperone	Vesicular acetylcholine transporter	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7011	spiperone	Muscarinic acetylcholine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7012	spiperone	Serotonin 1 (5-HT1) receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7013	spiperone	Dopamine receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7014	spiperone	Sodium channel alpha subunits; brain (Types I, II, III)	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7015	spiperone	Serotonin 2 (5-HT2) receptor	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7016	spiperone	Beta-casein	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7017	spiperone	HLA class I histocompatibility antigen, A-3 alpha chain	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1
7018	spirapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2
7019	spironolactone	Glucocorticoid receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7020	spironolactone	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7021	spironolactone	Mineralocorticoid receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7022	spironolactone	Androgen receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7023	spironolactone	Progesterone receptor	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7024	spironolactone	Estrogen receptor beta	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7025	spironolactone	Cytochrome P450 2C19	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7026	spironolactone	Multidrug and toxin extrusion protein 1	[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O
7027	stanozolol	Cytochrome P450 2D6	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7028	stanozolol	Adenosine receptor A3	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7029	stanozolol	Estrogen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7030	stanozolol	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7031	stanozolol	Cytochrome P450 2C9	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7032	stanozolol	Cytochrome P450 2C19	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7033	stanozolol	Progesterone receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3
7034	suxamethonium	Acetylcholinesterase	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
7035	suxamethonium	Muscle-type nicotinic acetylcholine receptor	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
7036	sufentanil	Mu-type opioid receptor	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7037	sufentanil	Kappa-type opioid receptor	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7038	sufentanil	Delta-type opioid receptor	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7039	sufentanil	Solute carrier family 22 member 1	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7040	sufentanil	Sigma non-opioid intracellular receptor 1	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7041	sufentanil	Opioid receptor	CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
7042	sulfasalazine	Carbonic anhydrase 2	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7043	sulfasalazine	Carbonic anhydrase 1	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7044	sulfasalazine	Acetyl-CoA acetyltransferase, mitochondrial	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7045	sulfasalazine	Arachidonate 5-lipoxygenase	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7046	sulfasalazine	Cystine/glutamate transporter	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7047	sulfasalazine	Caspase-1	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7048	sulfasalazine	Thromboxane-A synthase	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7049	sulfasalazine	Interstitial collagenase	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7050	sulfasalazine	Androgen receptor	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7051	sulfasalazine	Proton-coupled folate transporter	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7052	sulfasalazine	Aldose reductase	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7053	sulfasalazine	Mitogen-activated protein kinase 1	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7054	sulfasalazine	Cyclooxygenase	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7055	sulfasalazine	Sodium/bile acid cotransporter	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
7056	sulfinpyrazone	Multidrug resistance-associated protein 1	O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
7057	sulfinpyrazone	fMet-Leu-Phe receptor	O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
7058	sulfinpyrazone	Solute carrier family 22 member 12	O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
7059	sulfinpyrazone	Nicotinate phosphoribosyltransferase	O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
7060	sulindac	Prostaglandin G/H synthase 2	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7061	sulindac	Prostaglandin G/H synthase 1	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7062	sulindac	Glycine receptor subunit alpha-1	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7063	sulindac	Aldose reductase	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7064	sulindac	Retinoic acid receptor RXR-alpha	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7065	sulindac	72 kDa type IV collagenase	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7066	sulindac	Lactoylglutathione lyase	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7067	sulindac	Prostaglandin E synthase	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7068	sulindac	Complement C5	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7069	sulindac	Bile salt export pump	CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O
7070	sulpiride	D(2) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7071	sulpiride	Alpha-2A adrenergic receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7072	sulpiride	D(3) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7073	sulpiride	D(4) dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7074	sulpiride	Carbonic anhydrase 2	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7075	sulpiride	Carbonic anhydrase 1	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7076	sulpiride	Carbonic anhydrase 9	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7077	sulpiride	Carbonic anhydrase 12	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7078	sulpiride	Carbonic anhydrase 5A, mitochondrial	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7079	sulpiride	Carbonic anhydrase 5B, mitochondrial	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7080	sulpiride	Carbonic anhydrase 7	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7081	sulpiride	Carbonic anhydrase	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7082	sulpiride	Carbonic anhydrase 3	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7083	sulpiride	Carbonic anhydrase 6	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7084	sulpiride	Carbonic anhydrase 15	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7085	sulpiride	Alpha carbonic anhydrase	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7086	sulpiride	Astrosclerin-3	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7087	sulpiride	Beta-carbonic anhydrase 1	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7088	sulpiride	Delta carbonic anhydrase	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7089	sulpiride	Dopamine receptor	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7090	sulpiride	Carbonic anhydrase, alpha family	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7091	sulpiride	Carbonate dehydratase	CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
7092	sumatriptan	5-hydroxytryptamine receptor 1A	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7093	sumatriptan	5-hydroxytryptamine receptor 2A	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7094	sumatriptan	5-hydroxytryptamine receptor 2C	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7095	sumatriptan	5-hydroxytryptamine receptor 6	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7096	sumatriptan	5-hydroxytryptamine receptor 7	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7097	sumatriptan	5-hydroxytryptamine receptor 1B	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7098	sumatriptan	5-hydroxytryptamine receptor 1D	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7099	sumatriptan	5-hydroxytryptamine receptor 3A	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7100	sumatriptan	5-hydroxytryptamine receptor 5A	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7101	sumatriptan	5-hydroxytryptamine receptor 1F	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7102	sumatriptan	5-hydroxytryptamine receptor 1E	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7103	sumatriptan	Multidrug and toxin extrusion protein 1	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7104	sumatriptan	5-hydroxytryptamine 1D receptor	CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
7105	sunitinib	Tyrosine-protein kinase JAK3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7106	sunitinib	Potassium voltage-gated channel subfamily H member 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7107	sunitinib	Acetylcholinesterase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7108	sunitinib	Platelet-derived growth factor receptor beta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7109	sunitinib	Tyrosine-protein kinase ABL1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7110	sunitinib	Mast/stem cell growth factor receptor Kit	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7111	sunitinib	Epidermal growth factor receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7112	sunitinib	Proto-oncogene tyrosine-protein kinase Src	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7113	sunitinib	Tyrosine-protein kinase Lck	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7114	sunitinib	Tyrosine-protein kinase Yes	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7115	sunitinib	Tyrosine-protein kinase Fyn	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7116	sunitinib	Receptor-type tyrosine-protein kinase FLT3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7117	sunitinib	Vascular endothelial growth factor receptor 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7118	sunitinib	Vascular endothelial growth factor receptor 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7119	sunitinib	Macrophage colony-stimulating factor 1 receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7120	sunitinib	Ribosomal protein S6 kinase alpha-3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7121	sunitinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7122	sunitinib	Insulin-like growth factor 1 receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7123	sunitinib	Myosin light chain kinase, smooth muscle	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7124	sunitinib	Insulin receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7125	sunitinib	Death-associated protein kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7126	sunitinib	Calcium/calmodulin-dependent protein kinase type 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7127	sunitinib	Fibroblast growth factor receptor 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7128	sunitinib	Rho-associated protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7129	sunitinib	Focal adhesion kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7130	sunitinib	Tyrosine-protein kinase HCK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7131	sunitinib	Tyrosine-protein kinase JAK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7132	sunitinib	Mitogen-activated protein kinase 10	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7133	sunitinib	Death-associated protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7134	sunitinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7135	sunitinib	High affinity nerve growth factor receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7136	sunitinib	Tyrosine-protein kinase JAK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7137	sunitinib	Rho-associated protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7138	sunitinib	Protein kinase C alpha type	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7139	sunitinib	Calcium/calmodulin-dependent protein kinase type II subunit delta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7140	sunitinib	Myosin light chain kinase 2, skeletal/cardiac muscle	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7141	sunitinib	Calcium/calmodulin-dependent protein kinase type II subunit gamma	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7142	sunitinib	AP2-associated protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7143	sunitinib	Serine/threonine-protein kinase MARK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7144	sunitinib	Hepatocyte growth factor receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7145	sunitinib	Tyrosine-protein kinase Lyn	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7146	sunitinib	Serine/threonine-protein kinase Nek2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7147	sunitinib	Ribosomal protein S6 kinase alpha-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7148	sunitinib	5'-AMP-activated protein kinase catalytic subunit alpha-1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7149	sunitinib	Calcium/calmodulin-dependent protein kinase type II subunit beta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7150	sunitinib	Fibroblast growth factor receptor 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7151	sunitinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7152	sunitinib	Cyclin-dependent-like kinase 5	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7153	sunitinib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7154	sunitinib	Serine/threonine-protein kinase 17B	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7155	sunitinib	Serine/threonine-protein kinase 10	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7156	sunitinib	Tyrosine-protein kinase Fer	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7157	sunitinib	Serine/threonine-protein kinase PLK4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7158	sunitinib	Aurora kinase C	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7159	sunitinib	Serine/threonine-protein kinase 16	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7160	sunitinib	Dual specificity protein kinase TTK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7161	sunitinib	Abelson tyrosine-protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7162	sunitinib	Ephrin type-A receptor 5	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7163	sunitinib	Fibroblast growth factor receptor 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7164	sunitinib	Serine/threonine-protein kinase N1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7165	sunitinib	Protein kinase C theta type	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7166	sunitinib	Serine/threonine-protein kinase 17A	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7167	sunitinib	Ephrin type-A receptor 6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7168	sunitinib	TRAF2 and NCK-interacting protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7169	sunitinib	Casein kinase I isoform epsilon	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7170	sunitinib	Tyrosine-protein kinase Fgr	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7171	sunitinib	Aurora kinase A	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7172	sunitinib	ALK tyrosine kinase receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7173	sunitinib	Ephrin type-A receptor 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7174	sunitinib	BMP-2-inducible protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7175	sunitinib	Serine/threonine-protein kinase pim-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7176	sunitinib	Tyrosine-protein kinase FRK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7177	sunitinib	Dual specificity protein kinase CLK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7178	sunitinib	Dual specificity protein kinase CLK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7179	sunitinib	Serine/threonine-protein kinase 38-like	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7180	sunitinib	Mitogen-activated protein kinase kinase kinase kinase 5	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7181	sunitinib	Mitogen-activated protein kinase kinase kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7182	sunitinib	Cyclin-G-associated kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7183	sunitinib	Ephrin type-B receptor 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7184	sunitinib	Calcium/calmodulin-dependent protein kinase type 1D	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7185	sunitinib	Cyclin-dependent kinase 16	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7186	sunitinib	Serine/threonine-protein kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7187	sunitinib	Activated CDC42 kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7188	sunitinib	Ribosomal protein S6 kinase alpha-5	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7189	sunitinib	STE20-like serine/threonine-protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7190	sunitinib	Dual specificity protein kinase CLK4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7191	sunitinib	MAP kinase-interacting serine/threonine-protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7192	sunitinib	Mitogen-activated protein kinase 9	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7193	sunitinib	Calcium/calmodulin-dependent protein kinase kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7194	sunitinib	MAP/microtubule affinity-regulating kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7195	sunitinib	Calcium/calmodulin-dependent protein kinase kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7196	sunitinib	Calcium/calmodulin-dependent protein kinase type 1G	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7197	sunitinib	Epithelial discoidin domain-containing receptor 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7198	sunitinib	Solute carrier family 22 member 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7199	sunitinib	Testis-specific serine/threonine-protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7200	sunitinib	3-phosphoinositide-dependent protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7201	sunitinib	Dual specificity mitogen-activated protein kinase kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7202	sunitinib	Dual specificity mitogen-activated protein kinase kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7203	sunitinib	Tyrosine-protein kinase ITK/TSK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7204	sunitinib	Serine/threonine-protein kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7205	sunitinib	Serine/threonine-protein kinase ULK3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7206	sunitinib	Protein-tyrosine kinase 6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7207	sunitinib	Tyrosine-protein kinase BTK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7208	sunitinib	Tyrosine-protein kinase receptor UFO	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7209	sunitinib	BDNF/NT-3 growth factors receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7210	sunitinib	Tyrosine-protein kinase receptor TYRO3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7211	sunitinib	Cyclin-dependent kinase 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7212	sunitinib	Serine/threonine-protein kinase D1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7213	sunitinib	Ribosomal protein S6 kinase beta-1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7214	sunitinib	Serine/threonine-protein kinase N2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7215	sunitinib	RAC-beta serine/threonine-protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7216	sunitinib	Serine/threonine-protein kinase DCLK3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7217	sunitinib	Ribosomal protein S6 kinase alpha-6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7218	sunitinib	NUAK family SNF1-like kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7219	sunitinib	Non-receptor tyrosine-protein kinase TNK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7220	sunitinib	Non-receptor tyrosine-protein kinase TYK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7221	sunitinib	Serine/threonine-protein kinase Chk1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7222	sunitinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7223	sunitinib	Serine/threonine-protein kinase PAK 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7224	sunitinib	Cyclin-dependent kinase 17	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7225	sunitinib	Cyclin-dependent kinase 18	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7226	sunitinib	Cyclin-dependent kinase 14	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7227	sunitinib	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7228	sunitinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7229	sunitinib	Myosin light chain kinase family member 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7230	sunitinib	Wee1-like protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7231	sunitinib	Serine/threonine-protein kinase 25	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7232	sunitinib	Protein-tyrosine kinase 2-beta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7233	sunitinib	Serine/threonine-protein kinase RIO1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7234	sunitinib	Casein kinase I isoform alpha-like	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7235	sunitinib	Casein kinase I isoform delta	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7236	sunitinib	Casein kinase I isoform gamma-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7237	sunitinib	Casein kinase I isoform gamma-3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7238	sunitinib	Tyrosine-protein kinase receptor Tie-1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7239	sunitinib	Serine/threonine-protein kinase tousled-like 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7240	sunitinib	Serine/threonine-protein kinase tousled-like 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7241	sunitinib	NT-3 growth factor receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7242	sunitinib	Casein kinase II subunit alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7243	sunitinib	Casein kinase II subunit alpha'	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7244	sunitinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7245	sunitinib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7246	sunitinib	Serine/threonine-protein kinase STK11	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7247	sunitinib	Dual specificity mitogen-activated protein kinase kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7248	sunitinib	Maternal embryonic leucine zipper kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7249	sunitinib	MAP kinase-interacting serine/threonine-protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7250	sunitinib	Serine/threonine-protein kinase 26	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7251	sunitinib	Serine/threonine-protein kinase Nek7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7252	sunitinib	Eukaryotic translation initiation factor 2-alpha kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7253	sunitinib	Insulin receptor-related protein	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7254	sunitinib	Interleukin-1 receptor-associated kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7255	sunitinib	Serine/threonine-protein kinase RIO3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7256	sunitinib	Serine/threonine-protein kinase SIK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7257	sunitinib	SRSF protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7258	sunitinib	SRSF protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7259	sunitinib	Serine/threonine-protein kinase 33	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7260	sunitinib	5'-AMP-activated protein kinase catalytic subunit alpha-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7261	sunitinib	Ankyrin repeat and protein kinase domain-containing protein 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7262	sunitinib	Discoidin domain-containing receptor 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7263	sunitinib	Serine/threonine-protein kinase LATS1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7264	sunitinib	Serine/threonine-protein kinase LATS2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7265	sunitinib	Leukocyte tyrosine kinase receptor	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7266	sunitinib	Mitogen-activated protein kinase kinase kinase kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7267	sunitinib	Serine/threonine-protein kinase PAK 6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7268	sunitinib	Serine/threonine-protein kinase PAK 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7269	sunitinib	NUAK family SNF1-like kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7270	sunitinib	Serine/threonine-protein kinase pim-3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7271	sunitinib	Mitogen-activated protein kinase kinase kinase kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7272	sunitinib	Aurora kinase B	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7273	sunitinib	Tyrosine-protein kinase Blk	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7274	sunitinib	Bone morphogenetic protein receptor type-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7275	sunitinib	Serine/threonine-protein kinase BRSK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7276	sunitinib	Mitogen-activated protein kinase kinase kinase kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7277	sunitinib	Serine/threonine-protein kinase MARK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7278	sunitinib	MAP/microtubule affinity-regulating kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7279	sunitinib	Dual specificity mitogen-activated protein kinase kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7280	sunitinib	Dual specificity mitogen-activated protein kinase kinase 6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7281	sunitinib	Tyrosine-protein kinase Mer	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7282	sunitinib	Calcium/calmodulin-dependent protein kinase type IV	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7283	sunitinib	Mitogen-activated protein kinase kinase kinase 9	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7284	sunitinib	Mitogen-activated protein kinase kinase kinase 11	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7285	sunitinib	Serine/threonine-protein kinase 24	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7286	sunitinib	Muscle, skeletal receptor tyrosine-protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7287	sunitinib	Citron Rho-interacting kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7288	sunitinib	Casein kinase I isoform gamma-1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7289	sunitinib	Death-associated protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7290	sunitinib	Serine/threonine-protein kinase DCLK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7291	sunitinib	Serine/threonine-protein kinase DCLK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7292	sunitinib	Myosin-IIIa	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7293	sunitinib	Myosin-IIIb	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7294	sunitinib	Serine/threonine-protein kinase PAK 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7295	sunitinib	Serine/threonine-protein kinase BRSK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7296	sunitinib	Serine/threonine-protein kinase SIK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7297	sunitinib	Mitogen-activated protein kinase 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7298	sunitinib	Serine/threonine-protein kinase D2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7299	sunitinib	Serine/threonine-protein kinase D3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7300	sunitinib	Interferon-induced, double-stranded RNA-activated protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7301	sunitinib	Receptor-interacting serine/threonine-protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7302	sunitinib	Tyrosine-protein kinase Fes/Fps	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7303	sunitinib	Fibroblast growth factor receptor 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7304	sunitinib	Ribosomal protein S6 kinase alpha-1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7305	sunitinib	Ribosomal protein S6 kinase alpha-4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7306	sunitinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7307	sunitinib	Casein kinase I isoform alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7308	sunitinib	Mitogen-activated protein kinase kinase kinase kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7309	sunitinib	Misshapen-like kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7310	sunitinib	Serine/threonine-protein kinase TBK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7311	sunitinib	Interleukin-1 receptor-associated kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7312	sunitinib	Cyclin-dependent kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7313	sunitinib	Cyclin-dependent kinase-like 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7314	sunitinib	Serine/threonine-protein kinase Chk2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7315	sunitinib	Protein delta homolog 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7316	sunitinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7317	sunitinib	Dual specificity tyrosine-phosphorylation-regulated kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7318	sunitinib	Ephrin type-B receptor 6	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7319	sunitinib	Serine/threonine-protein kinase/endoribonuclease IRE1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7320	sunitinib	Rhodopsin kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7321	sunitinib	G protein-coupled receptor kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7322	sunitinib	G protein-coupled receptor kinase 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7323	sunitinib	Homeodomain-interacting protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7324	sunitinib	Homeodomain-interacting protein kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7325	sunitinib	Homeodomain-interacting protein kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7326	sunitinib	Hormonally up-regulated neu tumor-associated kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7327	sunitinib	Serine/threonine-protein kinase ICK	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7328	sunitinib	Inhibitor of nuclear factor kappa-B kinase subunit alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7329	sunitinib	Interleukin-1 receptor-associated kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7330	sunitinib	Mitogen-activated protein kinase kinase kinase 13	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7331	sunitinib	Mitogen-activated protein kinase kinase kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7332	sunitinib	Mitogen-activated protein kinase kinase kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7333	sunitinib	Microtubule-associated serine/threonine-protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7334	sunitinib	Serine/threonine-protein kinase 38	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7335	sunitinib	Serine/threonine-protein kinase NIM1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7336	sunitinib	Serine/threonine-protein kinase OSR1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7337	sunitinib	U4/U6 small nuclear ribonucleoprotein Prp4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7338	sunitinib	Serine/threonine-protein kinase RIO2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7339	sunitinib	SRSF protein kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7340	sunitinib	STE20/SPS1-related proline-alanine-rich protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7341	sunitinib	Mitogen-activated protein kinase kinase kinase 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7342	sunitinib	Serine/threonine-protein kinase TAO1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7343	sunitinib	Serine/threonine-protein kinase TAO3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7344	sunitinib	Serine/threonine-protein kinase ULK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7345	sunitinib	Serine/threonine-protein kinase ULK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7346	sunitinib	Mitogen-activated protein kinase kinase kinase 19	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7347	sunitinib	Homeodomain-interacting protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7348	sunitinib	Mitogen-activated protein kinase kinase kinase 15	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7349	sunitinib	Serine/threonine-protein kinase PLK2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7350	sunitinib	Receptor-interacting serine/threonine-protein kinase 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7351	sunitinib	Uncharacterized serine/threonine-protein kinase SBK3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7352	sunitinib	Serine/threonine-protein kinase 35	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7353	sunitinib	Tankyrase-2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7354	sunitinib	Megakaryocyte-associated tyrosine-protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7355	sunitinib	Bone morphogenetic protein receptor type-1B	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7356	sunitinib	Serine/threonine-protein kinase SBK1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7357	sunitinib	Serine/threonine-protein kinase PRP4 homolog	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7358	sunitinib	Mitogen-activated protein kinase kinase kinase 12	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7359	sunitinib	Serine/threonine-protein kinase Sgk3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7360	sunitinib	SNF-related serine/threonine-protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7361	sunitinib	Dual specificity mitogen-activated protein kinase kinase 5	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7362	sunitinib	Myosin light chain kinase 3	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7363	sunitinib	Leucine-rich repeat serine/threonine-protein kinase 2	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7364	sunitinib	Dual serine/threonine and tyrosine protein kinase	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7365	sunitinib	Calcium-dependent protein kinase 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7366	sunitinib	Serine/threonine-protein kinase PknB	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7367	sunitinib	Bromodomain-containing protein 9	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7368	sunitinib	Ephrin type-A receptor 7	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7369	sunitinib	Ephrin type-B receptor 4	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7370	sunitinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7371	sunitinib	Vascular endothelial growth factor receptor 1	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7372	sunitinib	Platelet-derived growth factor receptor alpha	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
7373	suprofen	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
7374	suprofen	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
7375	suprofen	Cytochrome P450 2C9	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
7376	secretin human	Secretin receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O
7377	tacrine	Sodium-dependent noradrenaline transporter	NC1=C2CCCCC2=NC2=CC=CC=C12
7378	tacrine	Aldehyde oxidase	NC1=C2CCCCC2=NC2=CC=CC=C12
7379	tacrine	Cytochrome P450 2D6	NC1=C2CCCCC2=NC2=CC=CC=C12
7380	tacrine	Alpha-1D adrenergic receptor	NC1=C2CCCCC2=NC2=CC=CC=C12
7381	tacrine	Acetylcholinesterase	NC1=C2CCCCC2=NC2=CC=CC=C12
7382	tacrine	Acetylcholine receptor subunit epsilon	NC1=C2CCCCC2=NC2=CC=CC=C12
7383	tacrine	Solute carrier family 22 member 1	NC1=C2CCCCC2=NC2=CC=CC=C12
7384	tacrine	Alpha-1A adrenergic receptor	NC1=C2CCCCC2=NC2=CC=CC=C12
7385	tacrine	Muscarinic acetylcholine receptor M2	NC1=C2CCCCC2=NC2=CC=CC=C12
7386	tacrine	Butyrylcholinesterase; Protein Bche	NC1=C2CCCCC2=NC2=CC=CC=C12
7387	tacrine	Choline O-acetyltransferase	NC1=C2CCCCC2=NC2=CC=CC=C12
7388	tacrine	Muscarinic acetylcholine receptor M1	NC1=C2CCCCC2=NC2=CC=CC=C12
7389	tacrine	Amine oxidase [flavin-containing] A	NC1=C2CCCCC2=NC2=CC=CC=C12
7390	tacrine	Cholinesterase	NC1=C2CCCCC2=NC2=CC=CC=C12
7391	tacrine	Histamine N-methyltransferase	NC1=C2CCCCC2=NC2=CC=CC=C12
7392	tacrine	Butyrylcholinesterase	NC1=C2CCCCC2=NC2=CC=CC=C12
7393	tacrine	Glutamate NMDA receptor; GRIN1/GRIN2B	NC1=C2CCCCC2=NC2=CC=CC=C12
7394	tacrine	Glutamate NMDA receptor; GRIN1/GRIN2A	NC1=C2CCCCC2=NC2=CC=CC=C12
7395	tacrine	Muscarinic acetylcholine receptor	NC1=C2CCCCC2=NC2=CC=CC=C12
7396	tacrine	Amyloid beta A4 protein	NC1=C2CCCCC2=NC2=CC=CC=C12
7397	tacrolimus	Potassium voltage-gated channel subfamily H member 2	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7398	tacrolimus	Cytochrome P450 3A4	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7399	tacrolimus	Interleukin-5	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7400	tacrolimus	Interferon gamma	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7401	tacrolimus	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7402	tacrolimus	Interleukin-2	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7403	tacrolimus	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7404	tacrolimus	Serine/threonine-protein kinase mTOR	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7405	tacrolimus	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7406	tacrolimus	Peptidyl-prolyl cis-trans isomerase FKBP1B	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7407	tacrolimus	Peptidyl-prolyl cis-trans isomerase FKBP5	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7408	tacrolimus	Splicing factor 3B subunit 3	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7409	tacrolimus	Peptidyl-prolyl cis-trans isomerase FKBP10	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC
7410	tadalafil	Potassium voltage-gated channel subfamily H member 2	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7411	tadalafil	cGMP-specific 3',5'-cyclic phosphodiesterase	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7412	tadalafil	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7413	tadalafil	Acetylcholinesterase	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7414	tadalafil	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7415	tadalafil	Phosphodiesterase 6	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1
7416	talbutal	GABA-A receptor; anion channel	CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
7417	taltirelin	Thyrotropin-releasing hormone receptor	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCCC1C(N)=O
7418	tamoxifen	Sodium/potassium-transporting ATPase subunit alpha-2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7419	tamoxifen	Beta-1 adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7420	tamoxifen	Prostaglandin G/H synthase 2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7421	tamoxifen	Prostaglandin G/H synthase 1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7422	tamoxifen	Mu-type opioid receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7423	tamoxifen	D(1A) dopamine receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7424	tamoxifen	D(2) dopamine receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7425	tamoxifen	Adenosine receptor A2a	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7426	tamoxifen	Alpha-2A adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7427	tamoxifen	Sigma non-opioid intracellular receptor 1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7428	tamoxifen	Potassium voltage-gated channel subfamily H member 2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7429	tamoxifen	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7430	tamoxifen	Multidrug resistance protein 1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7431	tamoxifen	Sodium-dependent serotonin transporter	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7432	tamoxifen	Sodium-dependent noradrenaline transporter	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7433	tamoxifen	5-hydroxytryptamine receptor 1A	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7434	tamoxifen	5-hydroxytryptamine receptor 2A	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7435	tamoxifen	5-hydroxytryptamine receptor 2B	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7436	tamoxifen	5-hydroxytryptamine receptor 2C	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7437	tamoxifen	5-hydroxytryptamine receptor 6	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7438	tamoxifen	Alpha-2B adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7439	tamoxifen	D(3) dopamine receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7440	tamoxifen	Histamine H2 receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7441	tamoxifen	Muscarinic acetylcholine receptor M1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7442	tamoxifen	Muscarinic acetylcholine receptor M2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7443	tamoxifen	Muscarinic acetylcholine receptor M3	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7444	tamoxifen	Muscarinic acetylcholine receptor M4	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7445	tamoxifen	Muscarinic acetylcholine receptor M5	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7446	tamoxifen	Aldehyde oxidase	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7447	tamoxifen	Beta-3 adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7448	tamoxifen	Sodium-dependent dopamine transporter	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7449	tamoxifen	Adenosine receptor A1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7450	tamoxifen	Adenosine receptor A3	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7451	tamoxifen	Nuclear receptor subfamily 1 group I member 2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7452	tamoxifen	D(4) dopamine receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7453	tamoxifen	Alpha-1D adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7454	tamoxifen	Kappa-type opioid receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7455	tamoxifen	Estrogen receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7456	tamoxifen	Progesterone receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7457	tamoxifen	Delta-type opioid receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7458	tamoxifen	Estrogen receptor beta	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7459	tamoxifen	G-protein coupled estrogen receptor 1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7460	tamoxifen	Estrogen-related receptor gamma	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7461	tamoxifen	Epidermal growth factor receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7462	tamoxifen	Substance-P receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7463	tamoxifen	Tyrosine-protein kinase Lck	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7464	tamoxifen	Tyrosine-protein kinase Fyn	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7465	tamoxifen	Receptor tyrosine-protein kinase erbB-2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7466	tamoxifen	Thromboxane-A synthase	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7467	tamoxifen	Steroid hormone receptor ERR1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7468	tamoxifen	Substance-K receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7469	tamoxifen	Androgen receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7470	tamoxifen	B2 bradykinin receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7471	tamoxifen	Melanocortin receptor 4	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7472	tamoxifen	Melanocortin receptor 5	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7473	tamoxifen	Melanocortin receptor 3	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7474	tamoxifen	Membrane-associated progesterone receptor component 1	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7475	tamoxifen	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7476	tamoxifen	Alpha-1A adrenergic receptor	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7477	tamoxifen	C-8 sterol isomerase	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7478	tamoxifen	Solute carrier family 22 member 2	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7479	tamoxifen	Emopamil-binding protein-like	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7480	tamoxifen	Anti-estrogen binding site (AEBS)	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7481	tamoxifen	Transcriptional activator protein luxR	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
7482	tazarotene	Retinoic acid receptor alpha	CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1
7483	tazarotene	Retinoic acid receptor beta	CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1
7484	tazarotene	Retinoic acid receptor gamma	CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1
7485	tegaserod	5-hydroxytryptamine receptor 4	CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
7486	tegaserod	5-hydroxytryptamine receptor 1A	CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
7487	tegaserod	5-hydroxytryptamine receptor 2B	CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
7488	tegaserod	5-hydroxytryptamine receptor 1D	CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
7489	tegaserod	5-hydroxytryptamine receptor 3A	CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
7490	teicoplanin aglycone	Cathepsin L1	[H][C@@]12CC3=CC=C(OC4=C(O)C5=CC(=C4)[C@@]([H])(NC(=O)[C@@]([H])(NC1=O)C1=CC(O)=CC(OC4=C(O)C=CC(=C4)[C@@H](N)C(=O)N2)=C1)C(=O)N[C@]1([H])C2=CC(=C(O)C=C2)C2=C(O)C=C(O)C=C2[C@]([H])(NC(=O)[C@@]([H])(NC1=O)[C@H](O)C1=CC(Cl)=C(O5)C=C1)C(O)=O)C(Cl)=C3
7491	telmisartan	Angiotensin-converting enzyme	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7492	telmisartan	Glycine receptor subunit alpha-1	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7493	telmisartan	Type-1 angiotensin II receptor	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7494	telmisartan	Peroxisome proliferator-activated receptor gamma	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7495	telmisartan	Type-2 angiotensin II receptor	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7496	telmisartan	Type-1B angiotensin II receptor	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7497	telmisartan	Type-1A angiotensin II receptor	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7498	telmisartan	Multidrug and toxin extrusion protein 1	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O
7499	temazepam	Nuclear receptor subfamily 1 group I member 3	CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=CC=CC=C1
7500	temazepam	GABA-A receptor alpha-1/beta-2/gamma-2	CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=CC=CC=C1
7501	temocapril	Angiotensin-converting enzyme	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)C1=CC=CS1
7502	teniposide	Multidrug resistance protein 1	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1
7503	teniposide	DNA topoisomerase 2-alpha	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1
7504	teniposide	ATP-binding cassette sub-family G member 2	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1
7505	teniposide	Multidrug resistance-associated protein 6	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1
7506	teniposide	Canalicular multispecific organic anion transporter 2	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1
7507	terbutaline	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1
7508	terfenadine	D(1A) dopamine receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7509	terfenadine	D(2) dopamine receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7510	terfenadine	Potassium voltage-gated channel subfamily H member 2	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7511	terfenadine	Multidrug resistance protein 1	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7512	terfenadine	Sodium-dependent noradrenaline transporter	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7513	terfenadine	5-hydroxytryptamine receptor 2A	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7514	terfenadine	5-hydroxytryptamine receptor 2B	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7515	terfenadine	5-hydroxytryptamine receptor 2C	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7516	terfenadine	5-hydroxytryptamine receptor 6	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7517	terfenadine	D(3) dopamine receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7518	terfenadine	Histamine H1 receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7519	terfenadine	Muscarinic acetylcholine receptor M1	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7520	terfenadine	Alpha-2C adrenergic receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7521	terfenadine	Sodium-dependent dopamine transporter	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7522	terfenadine	Epidermal growth factor receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7523	terfenadine	C-C chemokine receptor type 5	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7524	terfenadine	Tyrosine-protein kinase Fyn	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7525	terfenadine	Cytochrome P450 2J2	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7526	terfenadine	Substance-K receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7527	terfenadine	Potassium voltage-gated channel subfamily H member 1	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7528	terfenadine	Alpha-1B adrenergic receptor	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7529	terfenadine	Heat shock protein HSP 90-alpha	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7530	terfenadine	Adrenergic receptor alpha-1	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7531	terfenadine	Transcriptional activator protein luxR	[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C
7532	terguride	Beta-1 adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7533	terguride	Beta-2 adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7534	terguride	D(1A) dopamine receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7535	terguride	D(2) dopamine receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7536	terguride	Alpha-2A adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7537	terguride	5-hydroxytryptamine receptor 1A	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7538	terguride	5-hydroxytryptamine receptor 2C	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7539	terguride	Alpha-1A adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7540	terguride	Alpha-2B adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7541	terguride	D(3) dopamine receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7542	terguride	D(1B) dopamine receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7543	terguride	5-hydroxytryptamine receptor 1B	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7544	terguride	5-hydroxytryptamine receptor 1D	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7545	terguride	Alpha-2C adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7546	terguride	D(4) dopamine receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7547	terguride	Alpha-1D adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7548	terguride	Alpha-1B adrenergic receptor	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7549	terguride	5-hydroxytryptamine receptor 2A	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7550	terguride	5-hydroxytryptamine receptor 2B	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC
7551	testolactone	Aromatase	[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H]
7552	testosterone	Sigma non-opioid intracellular receptor 1	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7553	testosterone	Glucocorticoid receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7554	testosterone	Androgen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7555	testosterone	Aromatase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7556	testosterone	Corticosteroid-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7557	testosterone	Sex hormone-binding globulin	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7558	testosterone	Lanosterol 14-alpha demethylase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7559	testosterone	Progesterone receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7560	testosterone	C-8 sterol isomerase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7561	testosterone	Steroid 5-alpha-reductase	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7562	testosterone	Constitutive androstane receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7563	testosterone undecanoate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
7564	tetrabenazine	D(2) dopamine receptor	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7565	tetrabenazine	Alpha-2A adrenergic receptor	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7566	tetrabenazine	Alpha-2C adrenergic receptor	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7567	tetrabenazine	Synaptic vesicular amine transporter	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7568	tetrabenazine	Chromaffin granule amine transporter	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7569	tetrabenazine	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
7570	tetracaine	Sodium channel protein type 5 subunit alpha	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7571	tetracaine	Sigma non-opioid intracellular receptor 1	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7572	tetracaine	5-hydroxytryptamine receptor 2A	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7573	tetracaine	5-hydroxytryptamine receptor 2C	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7574	tetracaine	Sodium channel protein type 2 subunit alpha	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7575	tetracaine	Sodium channel protein type 8 subunit alpha	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7576	tetracaine	Sodium channel protein type 9 subunit alpha	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7577	tetracaine	Amine oxidase [flavin-containing] A	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7578	tetracaine	cGMP-gated cation channel alpha-1	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7579	tetracaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
7580	sapropterin	Nitric oxide synthase, brain	C[C@H](O)[C@H](O)[C@H]1CNC2=C(N1)C(=O)NC(N)=N2
7581	sapropterin	Phenylalanine-4-hydroxylase	C[C@H](O)[C@H](O)[C@H]1CNC2=C(N1)C(=O)NC(N)=N2
7582	thalidomide	Prostaglandin G/H synthase 2	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
7583	thalidomide	Prostaglandin G/H synthase 1	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
7584	thalidomide	Tumor necrosis factor	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
7585	thalidomide	Cereblon isoform 4	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
7586	thalidomide	Protein cereblon	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
7587	theophylline	Adenosine receptor A2a	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7588	theophylline	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7589	theophylline	Adenosine receptor A1	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7590	theophylline	Adenosine receptor A2b	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7591	theophylline	Adenosine receptor A3	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7592	theophylline	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7593	theophylline	Alkaline phosphatase, tissue-nonspecific isozyme	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7594	theophylline	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7595	theophylline	Uncharacterized protein	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7596	theophylline	Adenosine A2 receptor	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7597	theophylline	Adenosine A2b receptor	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7598	theophylline	Adenosine receptor	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7599	theophylline	Heart phosphodiesterase	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7600	theophylline	Adenosine A2a receptor	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7601	theophylline	Transmembrane domain-containing protein TMIGD3	CN1C2=C(N=CN2)C(=O)N(C)C1=O
7602	thiamylal	GABA-A receptor; anion channel	CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O
7603	thiethylperazine	D(1A) dopamine receptor	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7604	thiethylperazine	D(2) dopamine receptor	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7605	thiethylperazine	Sigma non-opioid intracellular receptor 1	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7606	thiethylperazine	5-hydroxytryptamine receptor 1A	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7607	thiethylperazine	5-hydroxytryptamine receptor 2A	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7608	thiethylperazine	5-hydroxytryptamine receptor 2B	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7609	thiethylperazine	5-hydroxytryptamine receptor 2C	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7610	thiethylperazine	Alpha-1A adrenergic receptor	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7611	thiethylperazine	D(3) dopamine receptor	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7612	thiethylperazine	Histamine H1 receptor	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7613	thiethylperazine	Muscarinic acetylcholine receptor M1	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7614	thiethylperazine	Muscarinic acetylcholine receptor M2	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7615	thiethylperazine	Muscarinic acetylcholine receptor M3	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7616	thiethylperazine	Muscarinic acetylcholine receptor M4	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7617	thiethylperazine	Muscarinic acetylcholine receptor M5	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7618	thiethylperazine	Pleiotropic ABC efflux transporter of multiple drugs	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7619	thiethylperazine	FAD-linked sulfhydryl oxidase ALR	CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1
7620	thioguanine	Prostaglandin G/H synthase 1	NC1=NC2=C(NC=N2)C(=S)N1
7621	thioguanine	Adenosine receptor A3	NC1=NC2=C(NC=N2)C(=S)N1
7622	thioguanine	Multidrug resistance-associated protein 5	NC1=NC2=C(NC=N2)C(=S)N1
7623	thioguanine	Multidrug resistance-associated protein 4	NC1=NC2=C(NC=N2)C(=S)N1
7624	thioguanine	Inosine-5'-monophosphate dehydrogenase 1	NC1=NC2=C(NC=N2)C(=S)N1
7625	thioguanine	Xanthine dehydrogenase/oxidase	NC1=NC2=C(NC=N2)C(=S)N1
7626	thioguanine	Inosine-5'-monophosphate dehydrogenase 2	NC1=NC2=C(NC=N2)C(=S)N1
7627	thioguanine	Hypoxanthine-guanine phosphoribosyltransferase	NC1=NC2=C(NC=N2)C(=S)N1
7628	thioguanine	Mitogen-activated protein kinase 3	NC1=NC2=C(NC=N2)C(=S)N1
7629	thioguanine	Arachidonate 15-lipoxygenase	NC1=NC2=C(NC=N2)C(=S)N1
7630	thioguanine	2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	NC1=NC2=C(NC=N2)C(=S)N1
7631	thiopental	GABA-A receptor alpha-1/beta-2/gamma-2	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
7632	thiopental	GABA-A receptor; anion channel	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
7633	thiopental	Potassium voltage-gated channel subfamily C member 4	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
7634	thioridazine	Nuclear receptor subfamily 1 group I member 3	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7635	thioridazine	D(1A) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7636	thioridazine	D(2) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7637	thioridazine	Alpha-2A adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7638	thioridazine	Sigma non-opioid intracellular receptor 1	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7639	thioridazine	Potassium voltage-gated channel subfamily H member 2	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7640	thioridazine	Sodium-dependent serotonin transporter	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7641	thioridazine	Sodium-dependent noradrenaline transporter	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7642	thioridazine	5-hydroxytryptamine receptor 1A	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7643	thioridazine	5-hydroxytryptamine receptor 2A	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7644	thioridazine	5-hydroxytryptamine receptor 2B	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7645	thioridazine	5-hydroxytryptamine receptor 2C	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7646	thioridazine	5-hydroxytryptamine receptor 6	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7647	thioridazine	5-hydroxytryptamine receptor 7	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7648	thioridazine	Alpha-1A adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7649	thioridazine	Alpha-2B adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7650	thioridazine	D(3) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7651	thioridazine	D(1B) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7652	thioridazine	Histamine H1 receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7653	thioridazine	Histamine H2 receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7654	thioridazine	Histamine H4 receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7655	thioridazine	Muscarinic acetylcholine receptor M1	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7656	thioridazine	Muscarinic acetylcholine receptor M2	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7657	thioridazine	Muscarinic acetylcholine receptor M3	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7658	thioridazine	Muscarinic acetylcholine receptor M4	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7659	thioridazine	Muscarinic acetylcholine receptor M5	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7660	thioridazine	Aldehyde oxidase	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7661	thioridazine	5-hydroxytryptamine receptor 1B	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7662	thioridazine	5-hydroxytryptamine receptor 1D	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7663	thioridazine	Alpha-2C adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7664	thioridazine	Sodium-dependent dopamine transporter	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7665	thioridazine	Cytochrome P450 2D6	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7666	thioridazine	D(4) dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7667	thioridazine	Alpha-1D adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7668	thioridazine	Alpha-1B adrenergic receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7669	thioridazine	Kappa-type opioid receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7670	thioridazine	5-hydroxytryptamine receptor 5A	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7671	thioridazine	Cytochrome P450 1A2	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7672	thioridazine	5-hydroxytryptamine receptor 1E	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7673	thioridazine	Epidermal growth factor receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7674	thioridazine	Cytochrome P450 2C19	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7675	thioridazine	Tyrosine-protein kinase Fyn	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7676	thioridazine	Serine/threonine-protein kinase pim-1	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7677	thioridazine	Membrane-associated progesterone receptor component 1	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7678	thioridazine	Pleiotropic ABC efflux transporter of multiple drugs	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7679	thioridazine	Muscarinic acetylcholine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7680	thioridazine	Serotonin 1 (5-HT1) receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7681	thioridazine	Adrenergic receptor alpha-2	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7682	thioridazine	Dopamine receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7683	thioridazine	Sodium channel alpha subunits; brain (Types I, II, III)	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7684	thioridazine	Serotonin 2 (5-HT2) receptor	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7685	thioridazine	G protein-activated inward rectifier potassium channel 2	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C
7686	thiothixene	D(1A) dopamine receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7687	thiothixene	D(2) dopamine receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7688	thiothixene	Alpha-2A adrenergic receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7689	thiothixene	Sodium-dependent serotonin transporter	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7690	thiothixene	5-hydroxytryptamine receptor 1A	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7691	thiothixene	5-hydroxytryptamine receptor 2A	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7692	thiothixene	5-hydroxytryptamine receptor 2C	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7693	thiothixene	5-hydroxytryptamine receptor 6	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7694	thiothixene	5-hydroxytryptamine receptor 7	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7695	thiothixene	Alpha-1A adrenergic receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7696	thiothixene	Alpha-2B adrenergic receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7697	thiothixene	D(3) dopamine receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7698	thiothixene	D(1B) dopamine receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7699	thiothixene	Histamine H1 receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7700	thiothixene	Histamine H2 receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7701	thiothixene	Muscarinic acetylcholine receptor M1	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7702	thiothixene	Muscarinic acetylcholine receptor M2	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7703	thiothixene	Muscarinic acetylcholine receptor M3	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7704	thiothixene	Muscarinic acetylcholine receptor M4	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7705	thiothixene	Muscarinic acetylcholine receptor M5	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7706	thiothixene	5-hydroxytryptamine receptor 1B	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7707	thiothixene	5-hydroxytryptamine receptor 1D	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7708	thiothixene	Alpha-2C adrenergic receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7709	thiothixene	D(4) dopamine receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7710	thiothixene	5-hydroxytryptamine receptor 3A	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7711	thiothixene	Alpha-1B adrenergic receptor	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7712	thiothixene	5-hydroxytryptamine receptor 5A	CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
7713	levothyroxine	Thyroid hormone receptor alpha	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7714	levothyroxine	Thyroid hormone receptor beta	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7715	levothyroxine	Transthyretin	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7716	levothyroxine	Bile acid receptor	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7717	levothyroxine	THAP domain-containing protein 1	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7718	levothyroxine	Macrophage migration inhibitory factor	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7719	levothyroxine	Malate dehydrogenase, mitochondrial	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
7720	tiagabine	Sodium- and chloride-dependent GABA transporter 1	CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1
7721	tiagabine	Sodium- and chloride-dependent betaine transporter	CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1
7722	tiaprofenic acid	Prostaglandin G/H synthase 2	CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1
7723	tiaprofenic acid	Prostaglandin G/H synthase 1	CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1
7724	ticlopidine	Prostaglandin G/H synthase 2	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7725	ticlopidine	Prostaglandin G/H synthase 1	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7726	ticlopidine	Alpha-2A adrenergic receptor	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7727	ticlopidine	Sigma non-opioid intracellular receptor 1	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7728	ticlopidine	Alpha-2B adrenergic receptor	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7729	ticlopidine	Alpha-2C adrenergic receptor	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7730	ticlopidine	Cytochrome P450 2D6	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7731	ticlopidine	Cytochrome P450 2A6	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7732	ticlopidine	Bile salt export pump	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7733	ticlopidine	P2Y purinoceptor 12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7734	ticlopidine	Cytochrome P450 2C19	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7735	ticlopidine	Cytochrome P450 2B6	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7736	ticlopidine	Membrane-associated progesterone receptor component 1	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7737	tilidine	Mu-type opioid receptor	[H]C1(C=CCCC1(C(=O)OCC)C1=CC=CC=C1)N(C)C
7738	tiotropium bromide	Muscarinic acetylcholine receptor M1	[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
7739	tiotropium bromide	Muscarinic acetylcholine receptor M2	[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
7740	tiotropium bromide	Muscarinic acetylcholine receptor M3	[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
7741	tiotropium bromide	Muscarinic acetylcholine receptor M4	[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
7742	tiotropium bromide	Muscarinic acetylcholine receptor M5	[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
7743	tirofiban	Integrin alpha-IIb/beta-3	CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O
7744	tizanidine	Alpha-2A adrenergic receptor	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7745	tizanidine	Alpha-2B adrenergic receptor	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7746	tizanidine	Alpha-2C adrenergic receptor	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7747	tizanidine	Nischarin	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7748	tizanidine	Alpha-1A adrenergic receptor	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7749	tizanidine	Alpha-1B adrenergic receptor	ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
7750	tocainide	Sodium channel alpha subunit	CC(N)C(=O)NC1=C(C)C=CC=C1C
7751	tolazamide	Arachidonate 15-lipoxygenase	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
7752	tolazamide	Sulfonylurea receptor 1, Kir6.2	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
7753	tolazoline	Alpha-2A adrenergic receptor	C(C1=NCCN1)C1=CC=CC=C1
7754	tolazoline	Alpha-1A adrenergic receptor	C(C1=NCCN1)C1=CC=CC=C1
7755	tolazoline	Alpha-2B adrenergic receptor	C(C1=NCCN1)C1=CC=CC=C1
7756	tolazoline	Alpha-2C adrenergic receptor	C(C1=NCCN1)C1=CC=CC=C1
7757	tolazoline	Trace amine-associated receptor 1	C(C1=NCCN1)C1=CC=CC=C1
7758	tolazoline	Adrenergic receptor alpha-2	C(C1=NCCN1)C1=CC=CC=C1
7759	tolazoline	Adrenergic receptor alpha-1	C(C1=NCCN1)C1=CC=CC=C1
7760	tolbutamide	Solute carrier family 22 member 6	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
7761	tolbutamide	ATP-sensitive inward rectifier potassium channel 11	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
7762	tolbutamide	Sulfonylurea receptor 1, Kir6.2	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
7763	tolcapone	Transthyretin	CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
7764	tolcapone	Catechol O-methyltransferase	CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
7765	tolcapone	G-protein coupled receptor 35	CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
7766	tolcapone	Krueppel-like factor 10	CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
7767	tolcapone	Bile salt export pump	CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
7768	tolmetin	Prostaglandin G/H synthase 2	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
7769	tolmetin	Prostaglandin G/H synthase 1	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
7770	tolmetin	Aldose reductase	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
7771	tolmetin	Lactoylglutathione lyase	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
7772	tolmetin	Interleukin-8	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
7773	toloxatone	Amine oxidase [flavin-containing] B	CC1=CC=CC(=C1)N1CC(CO)OC1=O
7774	toloxatone	Amine oxidase [flavin-containing] A	CC1=CC=CC(=C1)N1CC(CO)OC1=O
7775	tolrestat	Alcohol dehydrogenase [NADP(+)]	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O
7776	tolrestat	Aldose reductase	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O
7777	tolrestat	Aldo-keto reductase family 1 member C21	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O
7778	tolrestat	Aldo-keto reductase family 1 member B10	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O
7779	tolterodine	Potassium voltage-gated channel subfamily H member 2	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7780	tolterodine	Muscarinic acetylcholine receptor M1	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7781	tolterodine	Muscarinic acetylcholine receptor M2	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7782	tolterodine	Muscarinic acetylcholine receptor M3	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7783	tolterodine	Muscarinic acetylcholine receptor M4	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7784	tolterodine	Muscarinic acetylcholine receptor M5	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
7785	topiramate	Sodium channel protein type 5 subunit alpha	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7786	topiramate	Sodium channel protein type 1 subunit alpha	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7787	topiramate	Nuclear receptor subfamily 1 group I member 2	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7788	topiramate	Carbonic anhydrase 2	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7789	topiramate	Carbonic anhydrase 1	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7790	topiramate	Carbonic anhydrase 4	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7791	topiramate	Carbonic anhydrase 9	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7792	topiramate	Carbonic anhydrase 12	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7793	topiramate	Carbonic anhydrase 5A, mitochondrial	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7794	topiramate	Carbonic anhydrase 5B, mitochondrial	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7795	topiramate	Carbonic anhydrase 7	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7796	topiramate	Carbonic anhydrase	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7797	topiramate	Carbonic anhydrase 6	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7798	topiramate	Carbonic anhydrase 14	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7799	topiramate	Carbonic anhydrase 13	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7800	topiramate	Sodium channel protein type 2 subunit alpha	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7801	topiramate	Carbonic anhydrase 15	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7802	topiramate	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7803	topiramate	Alpha carbonic anhydrase	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7804	topiramate	Astrosclerin-3	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7805	topiramate	Beta-carbonic anhydrase 1	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7806	topiramate	Delta carbonic anhydrase	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7807	topiramate	GABA-A receptor alpha-1/beta-2/gamma-2	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7808	topiramate	Carbonic anhydrase V	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7809	topiramate	Glutamate receptor ionotropic kainate	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7810	topiramate	Glutamate receptor ionotropic AMPA	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7811	topiramate	Carbonic anhydrase, alpha family	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7812	topiramate	Carbonate dehydratase	[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
7813	topotecan	Cytochrome P450 3A4	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7814	topotecan	Multidrug resistance protein 1	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7815	topotecan	Canalicular multispecific organic anion transporter 1	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7816	topotecan	Nuclear receptor subfamily 1 group I member 2	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7817	topotecan	ATP-binding cassette sub-family G member 2	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7818	topotecan	Multidrug resistance-associated protein 4	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7819	topotecan	DNA topoisomerase I, mitochondrial	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7820	topotecan	DNA topoisomerase 1	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7821	topotecan	Hypoxia-inducible factor 1-alpha	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7822	topotecan	Solute carrier family 22 member 2	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7823	topotecan	Multidrug and toxin extrusion protein 1	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7824	topotecan	Multidrug and toxin extrusion protein 2	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7825	topotecan	DNA topoisomerase I	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7826	topotecan	ORF 73	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7827	topotecan	UDP-galactopyranose mutase	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O
7828	torsemide	Solute carrier family 12 member 1	CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC(C)=CC=C1
7829	toremifene	5-hydroxytryptamine receptor 6	CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
7830	toremifene	Estrogen receptor	CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
7831	toremifene	Estrogen-related receptor gamma	CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
7832	toremifene	Envelope glycoprotein	CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
7833	tramadol	Mu-type opioid receptor	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7834	tramadol	Sodium-dependent serotonin transporter	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7835	tramadol	Sodium-dependent noradrenaline transporter	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7836	tramadol	Kappa-type opioid receptor	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7837	tramadol	Delta-type opioid receptor	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7838	tramadol	Solute carrier family 22 member 1	COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
7839	trandolapril	Angiotensin-converting enzyme	[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
7840	tranexamic acid	Plasminogen	NC[C@H]1CC[C@@H](CC1)C(O)=O
7841	tranylcypromine	Sodium-dependent noradrenaline transporter	N[C@@H]1C[C@H]1C1=CC=CC=C1
7842	tranylcypromine	5-hydroxytryptamine receptor 1A	N[C@@H]1C[C@H]1C1=CC=CC=C1
7843	tranylcypromine	Sodium-dependent dopamine transporter	N[C@@H]1C[C@H]1C1=CC=CC=C1
7844	tranylcypromine	Cytochrome P450 2A6	N[C@@H]1C[C@H]1C1=CC=CC=C1
7845	tranylcypromine	Amine oxidase [flavin-containing] B	N[C@@H]1C[C@H]1C1=CC=CC=C1
7846	tranylcypromine	Amine oxidase [flavin-containing] A	N[C@@H]1C[C@H]1C1=CC=CC=C1
7847	tranylcypromine	Cytochrome P450 2C19	N[C@@H]1C[C@H]1C1=CC=CC=C1
7848	tranylcypromine	Cytochrome P450 2B6	N[C@@H]1C[C@H]1C1=CC=CC=C1
7849	tranylcypromine	Cationic trypsin	N[C@@H]1C[C@H]1C1=CC=CC=C1
7850	tranylcypromine	D(2) dopamine receptor	N[C@@H]1C[C@H]1C1=CC=CC=C1
7851	tranylcypromine	D(3) dopamine receptor	N[C@@H]1C[C@H]1C1=CC=CC=C1
7852	tranylcypromine	Lysine-specific histone demethylase 1A	N[C@@H]1C[C@H]1C1=CC=CC=C1
7853	tranylcypromine	Lysine-specific histone demethylase 1B	N[C@@H]1C[C@H]1C1=CC=CC=C1
7854	tranylcypromine	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	N[C@@H]1C[C@H]1C1=CC=CC=C1
7855	travoprost	Prostaglandin E2 receptor EP3 subtype	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC(=CC=C1)C(F)(F)F
7856	travoprost	Prostaglandin F2-alpha receptor	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC(=CC=C1)C(F)(F)F
7857	trazodone	D(1A) dopamine receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7858	trazodone	D(2) dopamine receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7859	trazodone	Alpha-2A adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7860	trazodone	Sigma non-opioid intracellular receptor 1	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7861	trazodone	Potassium voltage-gated channel subfamily H member 2	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7862	trazodone	Sodium-dependent serotonin transporter	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7863	trazodone	Sodium-dependent noradrenaline transporter	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7864	trazodone	5-hydroxytryptamine receptor 1A	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7865	trazodone	5-hydroxytryptamine receptor 2A	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7866	trazodone	5-hydroxytryptamine receptor 2B	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7867	trazodone	5-hydroxytryptamine receptor 2C	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7868	trazodone	5-hydroxytryptamine receptor 7	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7869	trazodone	Alpha-1A adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7870	trazodone	Alpha-2B adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7871	trazodone	D(3) dopamine receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7872	trazodone	Histamine H1 receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7873	trazodone	Histamine H2 receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7874	trazodone	5-hydroxytryptamine receptor 1D	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7875	trazodone	Alpha-2C adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7876	trazodone	Sodium-dependent dopamine transporter	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7877	trazodone	D(4) dopamine receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7878	trazodone	Alpha-1D adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7879	trazodone	Alpha-1B adrenergic receptor	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7880	trazodone	5-hydroxytryptamine receptor 1B	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7881	trazodone	Membrane-associated progesterone receptor component 1	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7882	trazodone	HLA class I histocompatibility antigen, A-3 alpha chain	ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
7883	treprostinil	Prostaglandin E2 receptor EP1 subtype	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7884	treprostinil	Prostaglandin E2 receptor EP3 subtype	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7885	treprostinil	Prostacyclin receptor	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7886	treprostinil	Prostaglandin E2 receptor EP2 subtype	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7887	treprostinil	Prostaglandin E2 receptor EP4 subtype	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7888	treprostinil	Prostaglandin D2 receptor	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2
7889	tretinoin	5-hydroxytryptamine receptor 2B	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7890	tretinoin	Adenosine receptor A3	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7891	tretinoin	Retinoic acid receptor alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7892	tretinoin	11-cis retinol dehydrogenase	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7893	tretinoin	Nuclear receptor ROR-alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7894	tretinoin	Retinoic acid receptor RXR-alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7895	tretinoin	Retinoic acid receptor RXR-beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7896	tretinoin	Retinoic acid receptor RXR-gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7897	tretinoin	Retinoic acid receptor beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7898	tretinoin	Retinoic acid receptor gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7899	tretinoin	Peroxisome proliferator-activated receptor delta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7900	tretinoin	Nuclear receptor ROR-beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7901	tretinoin	Nuclear receptor ROR-gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7902	tretinoin	Mitogen-activated protein kinase 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7903	tretinoin	Cellular retinoic acid-binding protein 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7904	tretinoin	Cellular retinoic acid-binding protein 2	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7905	tretinoin	Indoleamine 2,3-dioxygenase 2	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7906	tretinoin	Nuclear receptor subfamily 2 group E member 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7907	tretinoin	Nuclear receptor subfamily 2 group C member 2	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7908	tretinoin	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
7909	triamcinolone	Glucocorticoid receptor	[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
7910	triamcinolone	Annexin A1	[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
7911	triamcinolone	Progesterone receptor	[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
7912	triamcinolone acetonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
7913	triamcinolone acetonide	Annexin A1	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
7914	triamcinolone acetonide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
7915	triamcinolone diacetate	Glucocorticoid receptor	[H][C@@]12C[C@@H](OC(C)=O)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
7916	triamterene	Solute carrier family 12 member 1	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7917	triamterene	Cytochrome P450 2D6	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7918	triamterene	Caspase-1	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7919	triamterene	Cathepsin G	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7920	triamterene	Pteridine reductase 1	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7921	triamterene	Amiloride-sensitive sodium channel, ENaC	NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1
7922	triazolam	Cytochrome P450 3A4	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7923	triazolam	Platelet-activating factor receptor	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7924	triazolam	Cholecystokinin receptor type A	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7925	triazolam	GABA-A receptor alpha-1/beta-2/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7926	triazolam	GABA-A receptor alpha-2/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7927	triazolam	GABA-A receptor alpha-3/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7928	triazolam	GABA-A receptor alpha-5/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7929	triazolam	GABA-A receptor alpha-1/beta-2/gamma-3	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7930	triazolam	GABA-A receptor alpha-1/beta-3/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7931	triazolam	GABA-A receptor; anion channel	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7932	triazolam	GABA-A receptor	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7933	triazolam	GABA A receptor alpha-3/beta-2/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7934	triazolam	GABA A receptor alpha-3/beta-2/gamma-3	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7935	triazolam	GABA A receptor alpha-5/beta-3/gamma-3	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7936	triazolam	GABA A receptor alpha-5/beta-2/gamma-2	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7937	triazolam	GABA A receptor alpha-5/beta-2/gamma-3	CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1
7938	trichlormethiazide	Carbonic anhydrase 2	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7939	trichlormethiazide	Solute carrier family 12 member 3	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7940	trichlormethiazide	Carbonic anhydrase 1	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7941	trichlormethiazide	Carbonic anhydrase 4	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7942	trichlormethiazide	Carbonic anhydrase 9	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7943	trichlormethiazide	Carbonic anhydrase 12	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7944	trichlormethiazide	Carbonic anhydrase 5A, mitochondrial	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7945	trichlormethiazide	Carbonic anhydrase 5B, mitochondrial	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7946	trichlormethiazide	Carbonic anhydrase 7	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7947	trichlormethiazide	Carbonic anhydrase 6	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7948	trichlormethiazide	Carbonic anhydrase 14	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7949	trichlormethiazide	Carbonic anhydrase 13	NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl
7950	triclofos	GABA-A receptor; anion channel	OP(O)(=O)OCC(Cl)(Cl)Cl
7951	tridihexethyl	Muscarinic acetylcholine receptor M1	CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
7952	tridihexethyl	Muscarinic acetylcholine receptor M3	CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
7953	trifluoperazine	D(2) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7954	trifluoperazine	Alpha-2A adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7955	trifluoperazine	Sigma non-opioid intracellular receptor 1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7956	trifluoperazine	Potassium voltage-gated channel subfamily H member 2	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7957	trifluoperazine	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7958	trifluoperazine	Multidrug resistance protein 1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7959	trifluoperazine	5-hydroxytryptamine receptor 1A	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7960	trifluoperazine	5-hydroxytryptamine receptor 2A	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7961	trifluoperazine	5-hydroxytryptamine receptor 2C	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7962	trifluoperazine	5-hydroxytryptamine receptor 6	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7963	trifluoperazine	5-hydroxytryptamine receptor 7	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7964	trifluoperazine	Alpha-1A adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7965	trifluoperazine	Alpha-2B adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7966	trifluoperazine	D(3) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7967	trifluoperazine	Histamine H1 receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7968	trifluoperazine	Muscarinic acetylcholine receptor M3	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7969	trifluoperazine	Alpha-2C adrenergic receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7970	trifluoperazine	D(4) dopamine receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7971	trifluoperazine	Calmodulin	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7972	trifluoperazine	Trypanothione reductase	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7973	trifluoperazine	DNA-dependent protein kinase catalytic subunit	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7974	trifluoperazine	NS3	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7975	trifluoperazine	Beta-glucuronidase	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7976	trifluoperazine	Lysozyme C-1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7977	trifluoperazine	C-8 sterol isomerase	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7978	trifluoperazine	Pleiotropic ABC efflux transporter of multiple drugs	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7979	trifluoperazine	Emopamil-binding protein-like	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7980	trifluoperazine	Adrenergic receptor alpha-1	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7981	trifluoperazine	Sodium channel alpha subunits; brain (Types I, II, III)	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7982	trifluoperazine	Serotonin 2 (5-HT2) receptor	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
7983	triflupromazine	D(2) dopamine receptor	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7984	triflupromazine	Multidrug resistance protein 1	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7985	triflupromazine	5-hydroxytryptamine receptor 2A	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7986	triflupromazine	Trypanothione reductase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7987	triflupromazine	Cholinesterase	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7988	triflupromazine	Pleiotropic ABC efflux transporter of multiple drugs	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
7989	trihexyphenidyl	Sigma non-opioid intracellular receptor 1	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7990	trihexyphenidyl	Muscarinic acetylcholine receptor M1	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7991	trihexyphenidyl	Muscarinic acetylcholine receptor M2	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7992	trihexyphenidyl	Muscarinic acetylcholine receptor M3	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7993	trihexyphenidyl	Muscarinic acetylcholine receptor M4	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7994	trihexyphenidyl	Muscarinic acetylcholine receptor M5	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7995	trihexyphenidyl	Cytochrome P450 2D6	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
7996	trilostane	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N
7997	alimemazine	Histamine H1 receptor	CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
7998	alimemazine	FAD-linked sulfhydryl oxidase ALR	CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=CC=C2
7999	trimethadione	Voltage-dependent T-type calcium channel subunit alpha-1G	CN1C(=O)OC(C)(C)C1=O
8000	trimetaphan	Neuronal acetylcholine receptor subunit alpha-10	O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
8001	trimetaphan	Neuronal acetylcholine receptor subunit alpha-7	O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
8002	trimetaphan	Acetylcholine receptor subunit alpha	O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
8003	trimetaphan	Nicotinic acetylcholine receptor alpha 5 subunit	O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
8004	trimetaphan	Neuronal acetylcholine receptor; alpha3/beta4	O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
8005	trimipramine	Sodium-dependent serotonin transporter	CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2
8006	trimipramine	Sodium-dependent noradrenaline transporter	CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2
8007	trimipramine	Histamine H1 receptor	CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2
8008	trimipramine	Sodium-dependent dopamine transporter	CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2
8009	trimipramine	Solute carrier family 22 member 1	CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2
8010	tripelennamine	Histamine H1 receptor	CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1
8011	triprolidine	Histamine H1 receptor	CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC=N1
8012	troglitazone	Cytochrome P450 3A4	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8013	troglitazone	5-hydroxytryptamine receptor 2B	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8014	troglitazone	Adenosine receptor A3	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8015	troglitazone	Carbonic anhydrase 2	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8016	troglitazone	Bile salt export pump	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8017	troglitazone	Cytochrome P450 2C9	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8018	troglitazone	Amine oxidase [flavin-containing] B	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8019	troglitazone	Amine oxidase [flavin-containing] A	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8020	troglitazone	Aldose reductase	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8021	troglitazone	Peroxisome proliferator-activated receptor gamma	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8022	troglitazone	Tyrosine-protein phosphatase non-receptor type 1	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8023	troglitazone	Glycogen [starch] synthase, liver	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8024	troglitazone	Thromboxane-A synthase	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8025	troglitazone	Mitogen-activated protein kinase 1	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8026	troglitazone	Indoleamine 2,3-dioxygenase 2	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8027	troglitazone	UDP-glucuronosyltransferase 1-6	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8028	troglitazone	Indoleamine 2,3-dioxygenase 1	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8029	troglitazone	Polyunsaturated fatty acid lipoxygenase ALOX15	[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
8030	tropicamide	Muscarinic acetylcholine receptor M1	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8031	tropicamide	Muscarinic acetylcholine receptor M2	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8032	tropicamide	Muscarinic acetylcholine receptor M3	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8033	tropicamide	Muscarinic acetylcholine receptor M4	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8034	tropicamide	Muscarinic acetylcholine receptor M5	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8035	tropicamide	Cytochrome P450 2C9	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8036	tropicamide	Cytochrome P450 2C19	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
8037	tropisetron	5-hydroxytryptamine receptor 4	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8038	tropisetron	Sodium-dependent serotonin transporter	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8039	tropisetron	5-hydroxytryptamine receptor 1A	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8040	tropisetron	Muscarinic acetylcholine receptor M5	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8041	tropisetron	5-hydroxytryptamine receptor 3A	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8042	tropisetron	Glycine receptor subunit alpha-1	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8043	tropisetron	Glycine receptor subunit alpha-2	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8044	tropisetron	Neuronal acetylcholine receptor subunit alpha-7	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8045	tropisetron	Glycine receptor subunit beta	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8046	tropisetron	Serotonin 3 (5-HT3) receptor	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8047	tropisetron	Neuronal acetylcholine receptor; alpha4/beta2	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8048	tropisetron	Acetylcholine receptor; alpha1/beta1/delta/gamma	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8049	tropisetron	Serotonin 3 receptor (5HT3)	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8050	tropisetron	5-hydroxytryptamine receptor 3B	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8051	tropisetron	Neuronal acetylcholine receptor subunit alpha-3	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2
8052	trospium	Muscarinic acetylcholine receptor M1	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
8053	trospium	Muscarinic acetylcholine receptor M2	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
8054	trospium	Muscarinic acetylcholine receptor M3	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
8055	trospium	Muscarinic acetylcholine receptor M5	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
8056	tubocurarine	Muscarinic acetylcholine receptor M2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8057	tubocurarine	5-hydroxytryptamine receptor 3A	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8058	tubocurarine	Neuronal acetylcholine receptor subunit alpha-7	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8059	tubocurarine	Small conductance calcium-activated potassium channel protein 3	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8060	tubocurarine	Small conductance calcium-activated potassium channel protein 2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8061	tubocurarine	Zinc-activated ligand-gated ion channel	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8062	tubocurarine	Solute carrier family 22 member 2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8063	tubocurarine	Multidrug and toxin extrusion protein 1	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8064	tubocurarine	Multidrug and toxin extrusion protein 2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8065	tubocurarine	Acetylcholine receptor subunit alpha	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8066	tubocurarine	Nicotinic acetylcholine receptor alpha 5 subunit	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8067	tubocurarine	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8068	tubocurarine	Acetylcholine receptor	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8069	tubocurarine	Neuronal acetylcholine receptor; alpha2/beta2	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8070	tubocurarine	Neuronal acetylcholine receptor; alpha3/beta4	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8071	tubocurarine	Neuronal acetylcholine receptor; alpha4/beta4	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8072	tubocurarine	Acetylcholine receptor; alpha1/beta1/delta/gamma	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8073	tubocurarine	Serotonin 3 receptor (5HT3)	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8074	tubocurarine	Small conductance calcium-activated potassium channel protein 1	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8075	tubocurarine	GABA-A receptor; anion channel	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3
8076	tulobuterol	Beta-2 adrenergic receptor	CC(C)(C)NCC(O)C1=C(Cl)C=CC=C1
8077	tyramine	5-hydroxytryptamine receptor 3A	NCCC1=CC=C(O)C=C1
8078	tyramine	Beta-secretase 1	NCCC1=CC=C(O)C=C1
8079	tyramine	Trace amine-associated receptor 1	NCCC1=CC=C(O)C=C1
8080	tyramine	TyR1	NCCC1=CC=C(O)C=C1
8081	tyramine	Serotonin (5-HT) receptor	NCCC1=CC=C(O)C=C1
8082	urapidil	5-hydroxytryptamine receptor 1A	COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
8083	urapidil	Alpha-1A adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
8084	urapidil	Alpha-1D adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
8085	urapidil	Alpha-1B adrenergic receptor	COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
8086	ursodiol	Aldo-keto reductase family 1 member C2	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
8087	ursodiol	Bile acid receptor	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
8088	ursodiol	G-protein coupled bile acid receptor 1	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
8089	ursodiol	M1-family alanyl aminopeptidase	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
8090	ursodiol	CDGSH iron-sulfur domain-containing protein 1	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
8091	valdecoxib	Prostaglandin G/H synthase 2	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8092	valdecoxib	Prostaglandin G/H synthase 1	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8093	valdecoxib	Sodium-dependent noradrenaline transporter	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8094	valdecoxib	5-hydroxytryptamine receptor 2B	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8095	valdecoxib	Carbonic anhydrase 2	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8096	valdecoxib	Carbonic anhydrase 1	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8097	valdecoxib	Carbonic anhydrase 4	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8098	valdecoxib	Carbonic anhydrase 9	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8099	valdecoxib	Carbonic anhydrase 12	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8100	valdecoxib	Carbonic anhydrase 5A, mitochondrial	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8101	valdecoxib	Carbonic anhydrase 5B, mitochondrial	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8102	valdecoxib	Carbonic anhydrase 7	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8103	valdecoxib	Carbonic anhydrase 3	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8104	valdecoxib	Carbonic anhydrase 6	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8105	valdecoxib	Carbonic anhydrase 14	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8106	valdecoxib	Cytochrome c oxidase subunit 2	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8107	valdecoxib	Carbonic anhydrase 13	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8108	valdecoxib	Carbonic anhydrase	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8109	valdecoxib	Carbonic anhydrase 15	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8110	valdecoxib	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8111	valdecoxib	Alpha carbonic anhydrase	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8112	valdecoxib	Astrosclerin-3	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8113	valdecoxib	Beta-carbonic anhydrase 1	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8114	valdecoxib	Delta carbonic anhydrase	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8115	valdecoxib	Cytochrome c oxidase subunit 1	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8116	valdecoxib	Carbonic anhydrase, alpha family	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8117	valdecoxib	Carbonate dehydratase	CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
8118	valproic acid	Succinate-semialdehyde dehydrogenase, mitochondrial	CCCC(CCC)C(O)=O
8119	valproic acid	Histone deacetylase 2	CCCC(CCC)C(O)=O
8120	valproic acid	Histone deacetylase 1	CCCC(CCC)C(O)=O
8121	valproic acid	Alcohol dehydrogenase [NADP(+)]	CCCC(CCC)C(O)=O
8122	valproic acid	Aldose reductase	CCCC(CCC)C(O)=O
8123	valproic acid	UDP-glucuronosyltransferase 1-5	CCCC(CCC)C(O)=O
8124	valproic acid	Aldose reductase-related protein 1	CCCC(CCC)C(O)=O
8125	valrubicin	DNA topoisomerase 2-alpha	[H][C@@]1(C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=C(OC)C=CC=C3C(=O)C1=C2O)C(=O)COC(=O)CCCC
8126	valsartan	Type-1 angiotensin II receptor	CCCCC(=O)N(CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)[C@@H](C(C)C)C(O)=O
8127	valsartan	Type-1B angiotensin II receptor	CCCCC(=O)N(CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)[C@@H](C(C)C)C(O)=O
8128	valsartan	Type-1A angiotensin II receptor	CCCCC(=O)N(CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)[C@@H](C(C)C)C(O)=O
8129	valsartan	Angiotensin II receptor (AT-1) type-1	CCCCC(=O)N(CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)[C@@H](C(C)C)C(O)=O
8130	varenicline	Neuronal acetylcholine receptor subunit alpha-7	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8131	varenicline	Neuronal acetylcholine receptor; alpha2/beta2	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8132	varenicline	Neuronal acetylcholine receptor; alpha3/beta2	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8133	varenicline	Neuronal acetylcholine receptor; alpha3/beta4	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8134	varenicline	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8135	varenicline	Neuronal acetylcholine receptor; alpha4/beta4	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8136	varenicline	Acetylcholine receptor; alpha1/beta1/delta/gamma	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8137	varenicline	Neuronal acetylcholine receptor; alpha2/beta4	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8138	varenicline	Acetylcholine receptor	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1
8139	vardenafil	cGMP-specific 3',5'-cyclic phosphodiesterase	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8140	vardenafil	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8141	vardenafil	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8142	vardenafil	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8143	vardenafil	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8144	vardenafil	cGMP-dependent 3',5'-cyclic phosphodiesterase	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8145	vardenafil	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8146	vardenafil	Phosphodiesterase 3	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8147	vardenafil	Phosphodiesterase 4	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8148	vardenafil	Phosphodiesterase 1	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
8149	vasopressin	Vasopressin V1a receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
8150	vasopressin	Vasopressin V1b receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
8151	vasopressin	Vasopressin V2 receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
8152	vasopressin	Oxytocin receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
8153	vasopressin	Vasopressin V1 receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
8154	vecuronium	Solute carrier family 22 member 2	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8155	vecuronium	Multidrug and toxin extrusion protein 1	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8156	vecuronium	Multidrug and toxin extrusion protein 2	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8157	vecuronium	Neuronal acetylcholine receptor; alpha2/beta4	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8158	vecuronium	Acetylcholine receptor	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8159	vecuronium	Neuronal acetylcholine receptor; alpha4/beta2	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8160	vecuronium	Neuronal acetylcholine receptor; alpha4/beta4	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8161	vecuronium	Acetylcholine receptor; alpha1/beta1/delta/gamma	[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
8162	venlafaxine	Sodium-dependent serotonin transporter	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8163	venlafaxine	Sodium-dependent noradrenaline transporter	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8164	venlafaxine	5-hydroxytryptamine receptor 2A	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8165	venlafaxine	5-hydroxytryptamine receptor 2C	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8166	venlafaxine	5-hydroxytryptamine receptor 6	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8167	venlafaxine	Sodium-dependent dopamine transporter	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8168	venlafaxine	Alpha-1A adrenergic receptor	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8169	venlafaxine	Transporter	COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
8170	verapamil	Sodium channel protein type 5 subunit alpha	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8171	verapamil	Alpha-2A adrenergic receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8172	verapamil	Potassium voltage-gated channel subfamily H member 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8173	verapamil	Cytochrome P450 3A4	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8174	verapamil	Multidrug resistance protein 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8175	verapamil	Sodium-dependent serotonin transporter	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8176	verapamil	5-hydroxytryptamine receptor 1A	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8177	verapamil	5-hydroxytryptamine receptor 2A	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8178	verapamil	5-hydroxytryptamine receptor 2B	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8179	verapamil	5-hydroxytryptamine receptor 2C	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8180	verapamil	D(3) dopamine receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8181	verapamil	Histamine H2 receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8182	verapamil	Aldehyde oxidase	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8183	verapamil	Alpha-1D adrenergic receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8184	verapamil	Voltage-dependent L-type calcium channel subunit alpha-1C	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8185	verapamil	Multidrug resistance-associated protein 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8186	verapamil	ATP-binding cassette sub-family G member 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8187	verapamil	Carbonic anhydrase 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8188	verapamil	G protein-activated inward rectifier potassium channel 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8189	verapamil	Voltage-dependent T-type calcium channel subunit alpha-1H	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8190	verapamil	Voltage-dependent L-type calcium channel subunit alpha-1S	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8191	verapamil	Potassium voltage-gated channel subfamily A member 10	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8192	verapamil	Potassium voltage-gated channel subfamily A member 3	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8193	verapamil	Potassium voltage-gated channel subfamily C member 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8194	verapamil	Solute carrier family 22 member 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8195	verapamil	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8196	verapamil	Potassium voltage-gated channel subfamily A member 7	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8197	verapamil	Alpha-1B adrenergic receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8198	verapamil	Membrane-associated progesterone receptor component 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8199	verapamil	Alpha-1A adrenergic receptor	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8200	verapamil	Translocator protein	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8201	verapamil	Muscarinic acetylcholine receptor M2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8202	verapamil	Solute carrier family 22 member 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8203	verapamil	Sodium channel alpha subunits; brain (Types I, II, III)	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8204	verapamil	Voltage-gated L-type calcium channel	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8205	verapamil	Equilibrative nucleoside transporter 4	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8206	verapamil	Chloroquine resistance transporter	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8207	verapamil	Two pore calcium channel protein 1	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8208	verapamil	Two pore calcium channel protein 2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8209	vigabatrin	4-aminobutyrate aminotransferase, mitochondrial	NC(CCC(O)=O)C=C
8210	vigabatrin	Gamma-amino-N-butyrate transaminase	NC(CCC(O)=O)C=C
8211	viloxazine	Sodium-dependent serotonin transporter	CCOC1=CC=CC=C1OCC1CNCCO1
8212	viloxazine	Sodium-dependent dopamine transporter	CCOC1=CC=CC=C1OCC1CNCCO1
8213	viloxazine	Transporter	CCOC1=CC=CC=C1OCC1CNCCO1
8214	viloxazine	Sodium-dependent noradrenaline transporter	CCOC1=CC=CC=C1OCC1CNCCO1
8215	vinblastine	Multidrug resistance protein 1	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8216	vinblastine	Canalicular multispecific organic anion transporter 1	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8217	vinblastine	Multidrug resistance-associated protein 1	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8218	vinblastine	Multidrug resistance-associated protein 7	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8219	vinblastine	Thromboxane-A synthase	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8220	vinblastine	Arachidonate 15-lipoxygenase	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8221	vinblastine	Amine oxidase [flavin-containing] B	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8222	vinblastine	Tubulin beta	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8223	vincristine	Multidrug resistance protein 1	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8224	vincristine	Canalicular multispecific organic anion transporter 1	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8225	vincristine	Multidrug resistance-associated protein 1	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8226	vincristine	Multidrug resistance-associated protein 7	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8227	vincristine	Tubulin	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8228	vincristine	Tubulin beta	[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
8229	vinorelbine	Cytochrome P450 3A4	[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H]
8230	vinorelbine	Substance-K receptor	[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H]
8231	vinorelbine	Tubulin beta	[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H]
8232	nicotinic acid	Hydroxycarboxylic acid receptor 3	OC(=O)C1=CN=CC=C1
8233	nicotinic acid	Nicotinamide N-methyltransferase	OC(=O)C1=CN=CC=C1
8234	nicotinic acid	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	OC(=O)C1=CN=CC=C1
8235	nicotinic acid	Nicotinamide phosphoribosyltransferase	OC(=O)C1=CN=CC=C1
8236	nicotinic acid	Hydroxycarboxylic acid receptor 2	OC(=O)C1=CN=CC=C1
8237	nicotinic acid	Amyloid beta A4 protein	OC(=O)C1=CN=CC=C1
8238	ergocalciferol	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
8239	ergocalciferol	Vitamin D3 receptor	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
8240	ergocalciferol	Vitamin D 25-hydroxylase	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
8241	colecalciferol	Glycine receptor subunit alpha-1	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C
8242	colecalciferol	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C
8243	colecalciferol	Vitamin D3 receptor	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C
8244	colecalciferol	Vitamin D 25-hydroxylase	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C
8245	colecalciferol	Sterol 26-hydroxylase, mitochondrial	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C
8246	voglibose	Maltase-glucoamylase, intestinal	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
8247	voglibose	Sucrase-isomaltase, intestinal	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
8248	voglibose	Lysosomal alpha-glucosidase	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
8249	voglibose	Glycogen debranching enzyme	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
8250	warfarin	Cytochrome P450 3A4	CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
8251	warfarin	Cytochrome P450 2C9	CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
8252	warfarin	Vitamin K epoxide reductase complex subunit 1	CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
8253	warfarin	Proprotein convertase subtilisin/kexin type 7	CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
8254	warfarin	Vitamin K epoxide reductase complex subunit 1-like protein 1	CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
8255	ximelagatran	Urokinase-type plasminogen activator	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8256	ximelagatran	Plasminogen	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8257	ximelagatran	Coagulation factor X	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8258	ximelagatran	Tissue-type plasminogen activator	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8259	ximelagatran	Coagulation factor VII	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8260	ximelagatran	Vitamin K-dependent protein C	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8261	ximelagatran	Cationic trypsin	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8262	ximelagatran	Coagulation factor XI	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8263	ximelagatran	Prothrombin	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO
8264	zafirlukast	Cytochrome P450 3A4	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8265	zafirlukast	Adenosine receptor A3	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8266	zafirlukast	Cytochrome P450 2C9	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8267	zafirlukast	Cysteinyl leukotriene receptor 1	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8268	zafirlukast	Cytosolic phospholipase A2	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8269	zafirlukast	Epidermal growth factor receptor	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8270	zafirlukast	Peroxisome proliferator-activated receptor gamma	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8271	zafirlukast	Thromboxane-A synthase	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8272	zafirlukast	Mitogen-activated protein kinase 3	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8273	zafirlukast	Cysteinyl leukotriene receptor 2	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8274	zafirlukast	Mitogen-activated protein kinase 14	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8275	zafirlukast	Leukotriene B4 receptor 1	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8276	zafirlukast	Bifunctional epoxide hydrolase 2	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8277	zafirlukast	Mitogen-activated protein kinase 1	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8278	zafirlukast	Solute carrier family 22 member 2	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8279	zafirlukast	Multidrug and toxin extrusion protein 1	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8280	zafirlukast	Multidrug and toxin extrusion protein 2	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8281	zafirlukast	Sodium/bile acid cotransporter	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8282	zafirlukast	Prostaglandin E synthase	COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1
8283	zaleplon	GABA-A receptor alpha-2/beta-3/gamma-2	CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N
8284	zaleplon	GABA-A receptor alpha-1/beta-2/gamma-2	CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N
8285	zileuton	Arachidonate 5-lipoxygenase	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8286	zileuton	Arachidonate 15-lipoxygenase	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8287	zileuton	Cysteinyl leukotriene receptor 2	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8288	zileuton	Leukotriene A-4 hydrolase	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8289	zileuton	Leukotriene B4 receptor 1	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8290	zileuton	Arachidonate 5-lipoxygenase-activating protein	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8291	zileuton	Bifunctional epoxide hydrolase 2	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8292	zileuton	Prostaglandin E synthase	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
8293	ziprasidone	Beta-1 adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8294	ziprasidone	Beta-2 adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8295	ziprasidone	D(1A) dopamine receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8296	ziprasidone	D(2) dopamine receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8297	ziprasidone	Alpha-2A adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8298	ziprasidone	Potassium voltage-gated channel subfamily H member 2	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8299	ziprasidone	Sodium-dependent serotonin transporter	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8300	ziprasidone	Sodium-dependent noradrenaline transporter	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8301	ziprasidone	5-hydroxytryptamine receptor 1A	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8302	ziprasidone	5-hydroxytryptamine receptor 2A	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8303	ziprasidone	5-hydroxytryptamine receptor 2B	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8304	ziprasidone	5-hydroxytryptamine receptor 2C	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8305	ziprasidone	5-hydroxytryptamine receptor 6	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8306	ziprasidone	5-hydroxytryptamine receptor 7	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8307	ziprasidone	Alpha-1A adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8308	ziprasidone	Alpha-2B adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8309	ziprasidone	D(3) dopamine receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8310	ziprasidone	D(1B) dopamine receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8311	ziprasidone	Histamine H1 receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8312	ziprasidone	Histamine H2 receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8313	ziprasidone	Muscarinic acetylcholine receptor M1	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8314	ziprasidone	Muscarinic acetylcholine receptor M2	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8315	ziprasidone	Muscarinic acetylcholine receptor M3	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8316	ziprasidone	Muscarinic acetylcholine receptor M4	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8317	ziprasidone	Muscarinic acetylcholine receptor M5	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8318	ziprasidone	5-hydroxytryptamine receptor 1B	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8319	ziprasidone	5-hydroxytryptamine receptor 1D	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8320	ziprasidone	Alpha-2C adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8321	ziprasidone	Sodium-dependent dopamine transporter	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8322	ziprasidone	D(4) dopamine receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8323	ziprasidone	5-hydroxytryptamine receptor 3A	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8324	ziprasidone	Alpha-1B adrenergic receptor	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8325	ziprasidone	5-hydroxytryptamine receptor 5A	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8326	ziprasidone	5-hydroxytryptamine receptor 1E	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8327	ziprasidone	Transporter	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8328	ziprasidone	Adrenergic receptor alpha-1	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8329	ziprasidone	Histone H1.0	ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2
8330	zofenopril	Angiotensin-converting enzyme	C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1
8331	zoledronic acid	Carbonic anhydrase 2	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8332	zoledronic acid	Carbonic anhydrase 9	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8333	zoledronic acid	Carbonic anhydrase 12	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8334	zoledronic acid	Farnesyl pyrophosphate synthase	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8335	zoledronic acid	72 kDa type IV collagenase	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8336	zoledronic acid	Carbonic anhydrase 14	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8337	zoledronic acid	Matrix metalloproteinase-14	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8338	zoledronic acid	Matrix metalloproteinase-9	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8339	zoledronic acid	Neutrophil collagenase	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8340	zoledronic acid	Geranylgeranyl pyrophosphate synthase	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8341	zoledronic acid	Farnesyl diphosphate synthase	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8342	zoledronic acid	Butyrophilin subfamily 3 member A1	OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
8343	zolmitriptan	5-hydroxytryptamine receptor 1A	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8344	zolmitriptan	5-hydroxytryptamine receptor 1B	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8345	zolmitriptan	5-hydroxytryptamine receptor 1D	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8346	zolmitriptan	5-hydroxytryptamine receptor 1F	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8347	zolmitriptan	5-hydroxytryptamine receptor 1E	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8348	zolmitriptan	D(2) dopamine receptor	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8349	zolmitriptan	D(1A) dopamine receptor	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8350	zolmitriptan	Adrenergic receptor alpha-2	CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2
8351	zolpidem	Gamma-aminobutyric acid receptor subunit alpha-1	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8352	zolpidem	Gamma-aminobutyric acid receptor subunit alpha-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8353	zolpidem	Gamma-aminobutyric acid receptor subunit alpha-3	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8354	zolpidem	Multidrug resistance protein 1	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8355	zolpidem	Translocator protein	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8356	zolpidem	Gamma-aminobutyric acid receptor subunit alpha-5	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8357	zolpidem	GABA-A receptor alpha-1/beta-2/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8358	zolpidem	GABA-A receptor alpha-2/beta-3/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8359	zolpidem	GABA-A receptor alpha-3/beta-3/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8360	zolpidem	GABA-A receptor alpha-1/beta-3/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8361	zolpidem	GABA-A receptor; anion channel	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8362	zolpidem	GABA A receptor alpha-3/beta-2/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8363	zolpidem	GABA A receptor alpha-6/beta-2/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8364	zolpidem	GABA-A receptor; alpha-1/beta-2/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8365	zolpidem	GABA A receptor alpha-2/beta-2/gamma-2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8366	zolpidem	CAAX prenyl protease 2	CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
8367	zonisamide	Sodium channel protein type 1 subunit alpha	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8368	zonisamide	Carbonic anhydrase 2	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8369	zonisamide	Voltage-dependent T-type calcium channel subunit alpha-1G	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8370	zonisamide	Carbonic anhydrase 1	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8371	zonisamide	Carbonic anhydrase 4	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8372	zonisamide	Amine oxidase [flavin-containing] B	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8373	zonisamide	Carbonic anhydrase 9	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8374	zonisamide	Carbonic anhydrase 12	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8375	zonisamide	Carbonic anhydrase 5A, mitochondrial	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8376	zonisamide	Carbonic anhydrase 5B, mitochondrial	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8377	zonisamide	Carbonic anhydrase 7	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8378	zonisamide	Carbonic anhydrase	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8379	zonisamide	Carbonic anhydrase 6	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8380	zonisamide	Carbonic anhydrase 14	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8381	zonisamide	Carbonic anhydrase 13	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8382	zonisamide	Carbonic anhydrase 15	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8383	zonisamide	Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8384	zonisamide	Alpha carbonic anhydrase	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8385	zonisamide	Astrosclerin-3	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8386	zonisamide	Beta-carbonic anhydrase 1	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8387	zonisamide	Delta carbonic anhydrase	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8388	zonisamide	Carbonic anhydrase V	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8389	zonisamide	Carbonic anhydrase 3	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8390	zonisamide	Amine oxidase [flavin-containing]	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8391	zonisamide	Carbonic anhydrase, alpha family	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8392	zonisamide	Carbonate dehydratase	NS(=O)(=O)CC1=NOC2=CC=CC=C12
8393	zopiclone	GABA-A receptor; anion channel	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8394	zopiclone	GABA-A receptor alpha-1/beta-2/gamma-2	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8395	zopiclone	GABA-A receptor alpha-5/beta-3/gamma-2	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8396	zopiclone	GABA-A receptor alpha-1/beta-2/gamma-3	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8397	zopiclone	GABA A receptor alpha-3/beta-2/gamma-2	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8398	zopiclone	GABA A receptor alpha-3/beta-2/gamma-3	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8399	zopiclone	GABA A receptor alpha-5/beta-3/gamma-3	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8400	zopiclone	GABA A receptor alpha-5/beta-2/gamma-2	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8401	zopiclone	GABA A receptor alpha-5/beta-2/gamma-3	CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1
8402	zuclopenthixol	5-hydroxytryptamine receptor 2A	OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
8403	zuclopenthixol	5-hydroxytryptamine receptor 6	OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
8404	zuclopenthixol	Alpha-1A adrenergic receptor	OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
8405	zuclopenthixol	D(1A) dopamine receptor	OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
8406	zuclopenthixol	D(2) dopamine receptor	OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1
8407	ziconotide	Voltage-dependent N-type calcium channel subunit alpha-1B	[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(N)=O
8408	ziconotide	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(N)=O
8409	gonadorelin	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
8410	gonadorelin	Lutropin-choriogonadotropic hormone receptor	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
8411	lypressin	Vasopressin receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O
8412	mifamurtide	Nucleotide-binding oligomerization domain-containing protein 2	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC
8413	triptorelin	Gonadotropin-releasing hormone receptor	CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
8414	doxacurium	Muscarinic acetylcholine receptor M2	[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1
8415	doxacurium	Neuronal acetylcholine receptor subunit alpha-2	[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1
8416	doxacurium	Acetylcholine receptor	[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1
8417	histrelin	Gonadotropin-releasing hormone receptor	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CN(CC2=CC=CC=C2)C=N1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1
8418	calcitonin (salmon synthetic)	Amylin receptor AMY1	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O
8419	calcitonin (salmon synthetic)	Amylin receptor AMY2	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O
8420	calcitonin (salmon synthetic)	Amylin receptor AMY3	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O
8421	calcitonin (salmon synthetic)	Calcitonin receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O
8422	desirudin	Prothrombin	[H]N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C
8423	glucagon	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
8424	glucagon	Glucagon receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
8425	glucagon	Adenylate cyclase	[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
8426	lepirudin	Prothrombin	[H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C
8427	somatostatin	Mu-type opioid receptor	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8428	somatostatin	Delta-type opioid receptor	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8429	somatostatin	Somatostatin receptor type 2	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8430	somatostatin	Somatostatin receptor type 3	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8431	somatostatin	Somatostatin receptor type 5	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8432	somatostatin	Somatostatin receptor	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8433	somatostatin	Somatostatin receptor type 4	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8434	somatostatin	Somatostatin receptor type 1	[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O
8435	atosiban	Vasopressin V1a receptor	[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
8436	atosiban	Vasopressin V1b receptor	[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
8437	atosiban	Vasopressin V2 receptor	[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
8438	atosiban	Oxytocin receptor	[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
8439	oxybuprocaine	Sodium channel protein type 10 subunit alpha	CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC
8440	oxybuprocaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC
8441	capsaicin	Transient receptor potential cation channel subfamily V member 1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8442	capsaicin	Prostaglandin G/H synthase 1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8443	capsaicin	Cytochrome P450 1A2	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8444	capsaicin	Arachidonate 5-lipoxygenase	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8445	capsaicin	Potassium voltage-gated channel subfamily A member 1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8446	capsaicin	Tyrosine--tRNA ligase, cytoplasmic	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8447	capsaicin	NADH-ubiquinone oxidoreductase chain 1 	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8448	capsaicin	Transient receptor potential cation channel subfamily M member 8	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8449	capsaicin	Potassium voltage-gated channel subfamily A member 7	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8450	capsaicin	Potassium voltage-gated channel subfamily A member 2	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
8451	carglumic acid	Carbamoyl-phosphate synthase [ammonia], mitochondrial	NC(=O)N[C@@H](CCC(O)=O)C(O)=O
8452	articaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC
8453	desonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
8454	difluprednate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
8455	estriol	Sodium-dependent serotonin transporter	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8456	estriol	Glucocorticoid receptor	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8457	estriol	Estrogen receptor	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8458	estriol	Estrogen receptor beta	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8459	estriol	Corticosteroid-binding globulin	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8460	estriol	Sex hormone-binding globulin	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8461	estriol	Arachidonate 15-lipoxygenase	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8462	estriol	Lanosterol 14-alpha demethylase	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8463	estriol	Olfactory receptor 51E2	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8464	estrone	Sodium-dependent serotonin transporter	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8465	estrone	5-hydroxytryptamine receptor 2B	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8466	estrone	Estrogen receptor	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8467	estrone	Estrogen receptor beta	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8468	estrone	Aromatase	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8469	estrone	Corticosteroid-binding globulin	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8470	estrone	Steryl-sulfatase	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8471	estrone	Sex hormone-binding globulin	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8472	estrone	Estradiol 17-beta-dehydrogenase 1	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8473	estrone	Androgen receptor	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8474	estrone	Arachidonate 15-lipoxygenase	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8475	estrone	Progesterone receptor	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
8476	fosfestrol	Estrogen receptor	CC\C(=C(\CC)C1=CC=C(OP(O)(O)=O)C=C1)C1=CC=C(OP(O)(O)=O)C=C1
8477	fospropofol	GABA-A receptor	CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O
8478	iloperidone	D(1A) dopamine receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8479	iloperidone	D(2) dopamine receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8480	iloperidone	Alpha-2A adrenergic receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8481	iloperidone	Sigma non-opioid intracellular receptor 1	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8482	iloperidone	Sodium-dependent noradrenaline transporter	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8483	iloperidone	5-hydroxytryptamine receptor 1A	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8484	iloperidone	5-hydroxytryptamine receptor 2A	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8485	iloperidone	5-hydroxytryptamine receptor 2C	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8486	iloperidone	5-hydroxytryptamine receptor 6	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8487	iloperidone	5-hydroxytryptamine receptor 7	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8488	iloperidone	Alpha-1A adrenergic receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8489	iloperidone	Alpha-2B adrenergic receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8490	iloperidone	D(3) dopamine receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8491	iloperidone	D(1B) dopamine receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8492	iloperidone	Histamine H1 receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8493	iloperidone	Muscarinic acetylcholine receptor M1	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8494	iloperidone	Muscarinic acetylcholine receptor M2	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8495	iloperidone	Muscarinic acetylcholine receptor M4	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8496	iloperidone	5-hydroxytryptamine receptor 1B	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8497	iloperidone	5-hydroxytryptamine receptor 1D	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8498	iloperidone	Alpha-2C adrenergic receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8499	iloperidone	Sodium-dependent dopamine transporter	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8500	iloperidone	D(4) dopamine receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8501	iloperidone	Gastrin/cholecystokinin type B receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8502	iloperidone	Serotonin 2 (5-HT2) receptor	COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O
8503	ivabradine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
8504	ivabradine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
8505	ivabradine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
8506	ivabradine	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
8507	lenalidomide	Tumor necrosis factor	NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
8508	lenalidomide	Cereblon isoform 4	NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
8509	lenalidomide	Protein cereblon	NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
8510	mestanolone	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
8511	mestanolone	Sex hormone-binding globulin	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
8512	methyltestosterone	Glucocorticoid receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8513	methyltestosterone	Androgen receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8514	methyltestosterone	Sex hormone-binding globulin	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8515	methyltestosterone	Progesterone receptor	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8516	naphazoline	Alpha-2A adrenergic receptor	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8517	naphazoline	Alpha-2B adrenergic receptor	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8518	naphazoline	Alpha-2C adrenergic receptor	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8519	naphazoline	Nischarin	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8520	naphazoline	Adrenergic receptor alpha-2	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8521	naphazoline	Adrenergic receptor alpha-1	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8522	naphazoline	Adrenergic receptor alpha	C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
8523	pentazocine	Mu-type opioid receptor	[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C
8524	pentazocine	Sigma non-opioid intracellular receptor 1	[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C
8525	pentazocine	Kappa-type opioid receptor	[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C
8526	pentazocine	Delta-type opioid receptor	[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C
8527	pentazocine	Opioid receptor	[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C
8528	practolol	Beta-1 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1
8529	practolol	Beta-2 adrenergic receptor	CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1
8530	propoxycaine	Sodium channel alpha subunits; brain (Types I, II, III)	CCCOC1=C(C=CC(N)=C1)C(=O)OCCN(CC)CC
8531	prucalopride	D(4) dopamine receptor	COCCCN1CCC(CC1)NC(=O)C1=CC(Cl)=C(N)C2=C1OCC2
8532	prucalopride	5-hydroxytryptamine receptor 3A	COCCCN1CCC(CC1)NC(=O)C1=CC(Cl)=C(N)C2=C1OCC2
8533	prucalopride	5-hydroxytryptamine receptor 4	COCCCN1CCC(CC1)NC(=O)C1=CC(Cl)=C(N)C2=C1OCC2
8534	rapacuronium	Muscle-type nicotinic acetylcholine receptor	[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1
8535	rasagiline	Acetylcholinesterase	C#CCN[C@@H]1CCC2=C1C=CC=C2
8536	rasagiline	Amine oxidase [flavin-containing] B	C#CCN[C@@H]1CCC2=C1C=CC=C2
8537	rasagiline	Cholinesterase	C#CCN[C@@H]1CCC2=C1C=CC=C2
8538	rasagiline	Amine oxidase [flavin-containing] A	C#CCN[C@@H]1CCC2=C1C=CC=C2
8539	revaprazan	Potassium-transporting ATPase	CC1N(CCC2=CC=CC=C12)C1=C(C)C(C)=NC(NC2=CC=C(F)C=C2)=N1
8540	rioprostil	Prostaglandin E2 receptor EP2 subtype	[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCCO)[C@@]1([H])\C=C\CC(C)(O)CCCC
8541	roflumilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
8542	roflumilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
8543	roflumilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
8544	roflumilast	Phosphodiesterase 4	FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
8545	roflumilast	Phosphodiesterase	FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
8546	rufinamide	Carbonic anhydrase 5A, mitochondrial	NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
8547	rufinamide	Sodium channel alpha subunit	NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
8548	saralasin	Type-1 angiotensin II receptor	CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O
8549	saralasin	Type-2 angiotensin II receptor	CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O
8550	saralasin	Type-1B angiotensin II receptor	CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O
8551	saralasin	Angiotensin II receptor (AT-1) type-1	CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O
8552	sitaxentan	Endothelin-1 receptor	CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl
8553	sitaxentan	Endothelin B receptor	CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl
8554	talastine	Histamine H1 receptor	CN(C)CCN1N=C(CC2=CC=CC=C2)C2=C(C=CC=C2)C1=O
8555	terazosin	Alpha-2A adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8556	terazosin	Potassium voltage-gated channel subfamily H member 2	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8557	terazosin	5-hydroxytryptamine receptor 2A	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8558	terazosin	Alpha-1A adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8559	terazosin	Alpha-2B adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8560	terazosin	Alpha-2C adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8561	terazosin	Alpha-1D adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8562	terazosin	Alpha-1B adrenergic receptor	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8563	terazosin	Ribosyldihydronicotinamide dehydrogenase [quinone]	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8564	terazosin	Solute carrier family 22 member 1	COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1
8565	tetryzoline	Adrenergic receptor alpha-2	[H]C1(CCCC2=CC=CC=C12)C1=NCCN1
8566	tetryzoline	Adrenergic receptor alpha-1	[H]C1(CCCC2=CC=CC=C12)C1=NCCN1
8567	tetryzoline	Adrenergic receptor alpha	[H]C1(CCCC2=CC=CC=C12)C1=NCCN1
8568	vildagliptin	Prolyl endopeptidase FAP	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
8569	vildagliptin	Dipeptidyl peptidase 8	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
8570	vildagliptin	Dipeptidyl peptidase 9	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
8571	vildagliptin	Dipeptidyl peptidase IV	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
8572	vildagliptin	Dipeptidyl peptidase 4	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
8573	vinflunine	Tubulin beta	[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC
8574	vorozole	Aromatase	CN1N=NC2=C1C=C(C=C2)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1
8575	xylometazoline	Alpha-2A adrenergic receptor	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8576	xylometazoline	Alpha-1A adrenergic receptor	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8577	xylometazoline	5-hydroxytryptamine receptor 1B	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8578	xylometazoline	5-hydroxytryptamine receptor 1D	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8579	xylometazoline	Alpha-2C adrenergic receptor	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8580	xylometazoline	Adrenergic receptor alpha-2	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8581	xylometazoline	Adrenergic receptor alpha-1	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8582	xylometazoline	Adrenergic receptor alpha	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8583	xylometazoline	Alpha-2B adrenergic receptor	CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
8584	yohimbine	D(2) dopamine receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8585	yohimbine	Alpha-2A adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8586	yohimbine	5-hydroxytryptamine receptor 1A	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8587	yohimbine	5-hydroxytryptamine receptor 2B	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8588	yohimbine	5-hydroxytryptamine receptor 6	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8589	yohimbine	5-hydroxytryptamine receptor 7	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8590	yohimbine	Alpha-1A adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8591	yohimbine	Alpha-2B adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8592	yohimbine	D(3) dopamine receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8593	yohimbine	5-hydroxytryptamine receptor 1B	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8594	yohimbine	5-hydroxytryptamine receptor 1D	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8595	yohimbine	Alpha-2C adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8596	yohimbine	Cytochrome P450 2D6	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8597	yohimbine	Adenosine receptor A3	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8598	yohimbine	Alpha-1D adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8599	yohimbine	Alpha-1B adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8600	yohimbine	5-hydroxytryptamine receptor 5A	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8601	yohimbine	5-hydroxytryptamine receptor 1F	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8602	yohimbine	5-hydroxytryptamine receptor 1E	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8603	yohimbine	DNA topoisomerase 1	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8604	yohimbine	5-hydroxytryptamine receptor 2A	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8605	yohimbine	Voltage-dependent L-type calcium channel subunit alpha-1C	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8606	yohimbine	Adrenergic receptor alpha-2	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8607	yohimbine	Dopamine receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8608	yohimbine	Sodium channel alpha subunits; brain (Types I, II, III)	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8609	yohimbine	Alpha-2 adrenergic receptor	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8610	yohimbine	Dual specificity phosphatase Cdc25A	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2
8611	ciramadol	Mu-type opioid receptor	[H][C@@]1(CCCC[C@H]1O)[C@@H](N(C)C)C1=CC(O)=CC=C1
8612	tasosartan	Angiotensin II receptor (AT-1) type-1	CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=C(C=CC=C3)C3=NN=NN3)C2=N1
8613	tasosartan	Type-1 angiotensin II receptor	CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=C(C=CC=C3)C3=NN=NN3)C2=N1
8614	alitretinoin	Retinoic acid receptor alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8615	alitretinoin	Retinoic acid receptor RXR-alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8616	alitretinoin	Retinoic acid receptor RXR-beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8617	alitretinoin	Retinoic acid receptor RXR-gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8618	alitretinoin	Retinoic acid receptor beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8619	alitretinoin	Retinoic acid receptor gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8620	alitretinoin	Nuclear receptor ROR-gamma	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8621	alitretinoin	Nuclear receptor subfamily 4 group A member 1	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8622	alitretinoin	Oxysterols receptor LXR-beta	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8623	alitretinoin	Oxysterols receptor LXR-alpha	C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
8624	benidipine	Voltage-dependent T-type calcium channel subunit alpha-1H	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
8625	benidipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
8626	clobetasone butyrate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CCC)(C(=O)CCl)[C@@]1(C)CC(=O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8627	dexamethasone phosphate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8628	dexamethasone phosphate	Mineralocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8629	dexamethasone phosphate	Androgen receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8630	dexamethasone phosphate	Progesterone receptor	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8631	dexamethasone phosphate	Fatty acid-binding protein, liver	[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
8632	dolasetron	Potassium voltage-gated channel subfamily H member 2	[H][C@]12C[C@@H](C[C@]3([H])CC(C1)C(=O)CN23)OC(=O)C1=CNC2=C1C=CC=C2
8633	dolasetron	5-hydroxytryptamine receptor 3A	[H][C@]12C[C@@H](C[C@]3([H])CC(C1)C(=O)CN23)OC(=O)C1=CNC2=C1C=CC=C2
8634	etoposide phosphate	DNA topoisomerase 2-alpha	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OP(O)(O)=O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
8635	guanabenz	Alpha-2A adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8636	guanabenz	5-hydroxytryptamine receptor 1A	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8637	guanabenz	5-hydroxytryptamine receptor 2A	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8638	guanabenz	5-hydroxytryptamine receptor 2B	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8639	guanabenz	5-hydroxytryptamine receptor 2C	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8640	guanabenz	Alpha-2B adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8641	guanabenz	Alpha-2C adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8642	guanabenz	Alpha-1D adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8643	guanabenz	Amine oxidase [flavin-containing] A	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8644	guanabenz	Trace amine-associated receptor 1	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8645	guanabenz	Nischarin	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8646	guanabenz	Solute carrier family 22 member 1	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8647	guanabenz	Alpha-1B adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8648	guanabenz	Alpha-1A adrenergic receptor	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8649	guanabenz	Adrenergic receptor alpha-2	NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl
8650	hydrocortisone butyrate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8651	ilaprazole	Potassium-transporting ATPase	COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC(=C3)N2C=CC=C2)=C1C
8652	niperotidine	Histamine H2 receptor	CN(C)CC1=CC=C(CSCCNC(NCC2=CC3=C(OCO3)C=C2)=C[N+]([O-])=O)O1
8653	mozavaptan	Vasopressin V1a receptor	CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12
8654	mozavaptan	Vasopressin V1b receptor	CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12
8655	mozavaptan	Oxytocin receptor	CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12
8656	mozavaptan	Vasopressin V2 receptor	CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12
8657	mozavaptan	Vasopressin V1 receptor	CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12
8658	timolol	Beta-1 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1
8659	timolol	Beta-2 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1
8660	timolol	5-hydroxytryptamine receptor 1A	CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1
8661	timolol	Beta-3 adrenergic receptor	CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1
8662	levamlodipine	Voltage-gated L-type calcium channel	CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=C(Cl)C=CC=C1)C(=O)OC
8663	dronabinol	Cannabinoid receptor 1	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8664	dronabinol	D(3) dopamine receptor	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8665	dronabinol	Glycine receptor subunit alpha-1	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8666	dronabinol	Glycine receptor subunit alpha-2	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8667	dronabinol	Cannabinoid receptor 2	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8668	dronabinol	Glycine receptor subunit alpha-3	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8669	dronabinol	N-arachidonyl glycine receptor	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8670	dronabinol	Transient receptor potential cation channel subfamily A member 1	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8671	dronabinol	G-protein coupled receptor 55	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8672	dronabinol	Cannabinoid receptor	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8673	dronabinol	Transient receptor potential cation channel subfamily V member 2	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21
8674	tolvaptan	Vasopressin V1a receptor	CC1=C(C=CC=C1)C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCCC(O)C2=CC(Cl)=CC=C12
8675	tolvaptan	Vasopressin V2 receptor	CC1=C(C=CC=C1)C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCCC(O)C2=CC(Cl)=CC=C12
8676	dronedarone	Thyroid hormone receptor alpha	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8677	dronedarone	Potassium voltage-gated channel subfamily H member 2	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8678	dronedarone	Voltage-dependent calcium channel gamma-1 subunit	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8679	dronedarone	Potassium voltage-gated channel subfamily KQT member 2	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8680	dronedarone	Potassium voltage-gated channel subfamily A member 5	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8681	dronedarone	THAP domain-containing protein 1	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8682	dronedarone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8683	dronedarone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8684	dronedarone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8685	dronedarone	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
8686	prasugrel	P2Y purinoceptor 12	[H]C(N1CCC2=C(C1)C=C(OC(C)=O)S2)(C(=O)C1CC1)C1=C(F)C=CC=C1
8687	saxagliptin	Cytochrome P450 3A4	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2
8688	saxagliptin	Multidrug resistance protein 1	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2
8689	saxagliptin	Dipeptidyl peptidase 4	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2
8690	saxagliptin	Dipeptidyl peptidase 8	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2
8691	saxagliptin	Dipeptidyl peptidase 9	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2
8692	asenapine	Beta-1 adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8693	asenapine	Beta-2 adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8694	asenapine	D(1A) dopamine receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8695	asenapine	D(2) dopamine receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8696	asenapine	Alpha-2A adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8697	asenapine	5-hydroxytryptamine receptor 1A	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8698	asenapine	5-hydroxytryptamine receptor 2A	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8699	asenapine	5-hydroxytryptamine receptor 2B	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8700	asenapine	5-hydroxytryptamine receptor 2C	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8701	asenapine	5-hydroxytryptamine receptor 6	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8702	asenapine	5-hydroxytryptamine receptor 7	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8703	asenapine	Alpha-1A adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8704	asenapine	Alpha-2B adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8705	asenapine	D(3) dopamine receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8706	asenapine	D(1B) dopamine receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8707	asenapine	Histamine H1 receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8708	asenapine	Histamine H2 receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8709	asenapine	Muscarinic acetylcholine receptor M1	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8710	asenapine	Muscarinic acetylcholine receptor M2	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8711	asenapine	Muscarinic acetylcholine receptor M3	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8712	asenapine	Muscarinic acetylcholine receptor M5	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8713	asenapine	5-hydroxytryptamine receptor 1B	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8714	asenapine	5-hydroxytryptamine receptor 1D	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8715	asenapine	Alpha-2C adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8716	asenapine	Sodium-dependent dopamine transporter	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8717	asenapine	D(4) dopamine receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8718	asenapine	5-hydroxytryptamine receptor 3A	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8719	asenapine	Alpha-1B adrenergic receptor	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8720	asenapine	5-hydroxytryptamine receptor 5A	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8721	asenapine	5-hydroxytryptamine receptor 1E	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1
8722	pralatrexate	Dihydrofolate reductase	NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
8723	pralatrexate	Proton-coupled folate transporter	NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
8724	pralatrexate	Folate transporter 1	NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
8725	pralatrexate	Folate receptor alpha	NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
8726	pazopanib	Tyrosine-protein kinase JAK3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8727	pazopanib	Acetylcholinesterase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8728	pazopanib	Platelet-derived growth factor receptor beta	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8729	pazopanib	Tyrosine-protein kinase ABL1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8730	pazopanib	Mast/stem cell growth factor receptor Kit	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8731	pazopanib	Proto-oncogene tyrosine-protein kinase Src	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8732	pazopanib	Tyrosine-protein kinase Lck	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8733	pazopanib	Tyrosine-protein kinase Yes	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8734	pazopanib	Tyrosine-protein kinase Fyn	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8735	pazopanib	RAF proto-oncogene serine/threonine-protein kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8736	pazopanib	Serine/threonine-protein kinase B-raf	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8737	pazopanib	Receptor-type tyrosine-protein kinase FLT3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8738	pazopanib	Proto-oncogene tyrosine-protein kinase receptor Ret	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8739	pazopanib	Vascular endothelial growth factor receptor 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8740	pazopanib	Vascular endothelial growth factor receptor 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8741	pazopanib	Vascular endothelial growth factor receptor 3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8742	pazopanib	Macrophage colony-stimulating factor 1 receptor	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8743	pazopanib	Platelet-derived growth factor receptor alpha	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8744	pazopanib	Calcium/calmodulin-dependent protein kinase type 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8745	pazopanib	Mitogen-activated protein kinase 8	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8746	pazopanib	Fibroblast growth factor receptor 3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8747	pazopanib	Tyrosine-protein kinase HCK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8748	pazopanib	Mitogen-activated protein kinase 10	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8749	pazopanib	Tyrosine-protein kinase JAK2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8750	pazopanib	Tyrosine-protein kinase SYK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8751	pazopanib	Myosin light chain kinase 2, skeletal/cardiac muscle	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8752	pazopanib	Angiopoietin-1 receptor	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8753	pazopanib	AP2-associated protein kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8754	pazopanib	Hepatocyte growth factor receptor	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8755	pazopanib	Tyrosine-protein kinase Lyn	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8756	pazopanib	Serine/threonine-protein kinase Nek2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8757	pazopanib	LIM domain kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8758	pazopanib	Fibroblast growth factor receptor 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8759	pazopanib	Serine/threonine-protein kinase 10	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8760	pazopanib	Tyrosine-protein kinase Fer	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8761	pazopanib	Serine/threonine-protein kinase PLK4	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8762	pazopanib	Aurora kinase C	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8763	pazopanib	Serine/threonine-protein kinase 16	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8764	pazopanib	Dual specificity protein kinase TTK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8765	pazopanib	Abelson tyrosine-protein kinase 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8766	pazopanib	Fibroblast growth factor receptor 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8767	pazopanib	TRAF2 and NCK-interacting protein kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8768	pazopanib	Tyrosine-protein kinase Fgr	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8769	pazopanib	Aurora kinase A	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8770	pazopanib	ALK tyrosine kinase receptor	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8771	pazopanib	Serine/threonine-protein kinase 36	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8772	pazopanib	BMP-2-inducible protein kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8773	pazopanib	Tyrosine-protein kinase FRK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8774	pazopanib	Mitogen-activated protein kinase kinase kinase kinase 5	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8775	pazopanib	Cyclin-G-associated kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8776	pazopanib	Receptor-interacting serine/threonine-protein kinase 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8777	pazopanib	Cyclin-dependent kinase 16	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8778	pazopanib	STE20-like serine/threonine-protein kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8779	pazopanib	MAP/microtubule affinity-regulating kinase 3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8780	pazopanib	Calcium/calmodulin-dependent protein kinase type 1G	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8781	pazopanib	Epithelial discoidin domain-containing receptor 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8782	pazopanib	TGF-beta receptor type-2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8783	pazopanib	Tyrosine-protein kinase ITK/TSK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8784	pazopanib	Protein-tyrosine kinase 6	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8785	pazopanib	Non-receptor tyrosine-protein kinase TNK1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8786	pazopanib	Non-receptor tyrosine-protein kinase TYK2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8787	pazopanib	Tyrosine-protein kinase receptor Tie-1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8788	pazopanib	Tyrosine-protein kinase TXK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8789	pazopanib	LIM domain kinase 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8790	pazopanib	Serine/threonine-protein kinase NLK	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8791	pazopanib	Interleukin-1 receptor-associated kinase 3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8792	pazopanib	Serine/threonine-protein kinase SIK2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8793	pazopanib	Activin receptor type-2B	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8794	pazopanib	Discoidin domain-containing receptor 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8795	pazopanib	Leukocyte tyrosine kinase receptor	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8796	pazopanib	Mitogen-activated protein kinase kinase kinase kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8797	pazopanib	Mitogen-activated protein kinase kinase kinase kinase 3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8798	pazopanib	Tyrosine-protein kinase Blk	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8799	pazopanib	Mitogen-activated protein kinase kinase kinase kinase 4	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8800	pazopanib	Dual specificity mitogen-activated protein kinase kinase 4	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8801	pazopanib	Dual specificity mitogen-activated protein kinase kinase 6	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8802	pazopanib	Tyrosine-protein kinase Mer	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8803	pazopanib	Cyclin-dependent kinase 11B	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8804	pazopanib	Cyclin-dependent kinase 11A	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8805	pazopanib	Mitogen-activated protein kinase kinase kinase 9	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8806	pazopanib	Mitogen-activated protein kinase kinase kinase 10	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8807	pazopanib	Mitogen-activated protein kinase kinase kinase 11	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8808	pazopanib	Serine/threonine-protein kinase Nek5	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8809	pazopanib	Serine/threonine-protein kinase SIK1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8810	pazopanib	Tyrosine-protein kinase Srms	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8811	pazopanib	Interferon-induced, double-stranded RNA-activated protein kinase	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8812	pazopanib	Receptor-interacting serine/threonine-protein kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8813	pazopanib	Tyrosine-protein kinase Fes/Fps	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8814	pazopanib	Fibroblast growth factor receptor 4	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8815	pazopanib	Proto-oncogene tyrosine-protein kinase ROS	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8816	pazopanib	Mitogen-activated protein kinase kinase kinase kinase 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8817	pazopanib	Ephrin type-B receptor 6	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8818	pazopanib	Interleukin-1 receptor-associated kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8819	pazopanib	Mitogen-activated protein kinase kinase kinase 2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8820	pazopanib	Serine/threonine-protein kinase RIO2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8821	pazopanib	Serine/threonine-protein kinase TAO1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8822	pazopanib	Serine/threonine-protein kinase TAO3	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8823	pazopanib	Mitogen-activated protein kinase kinase kinase 19	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8824	pazopanib	Mitogen-activated protein kinase kinase kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8825	pazopanib	Phosphatidylinositol 4-kinase beta	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8826	pazopanib	Bone morphogenetic protein receptor type-1B	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8827	pazopanib	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8828	pazopanib	Serine/threonine-protein kinase TAO2	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8829	pazopanib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8830	pazopanib	Dual specificity mitogen-activated protein kinase kinase 5	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8831	pazopanib	Calcium-dependent protein kinase 1	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1
8832	romidepsin	Histone deacetylase 5	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8833	romidepsin	Histone deacetylase 2	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8834	romidepsin	Histone deacetylase 1	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8835	romidepsin	Histone deacetylase 3	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8836	romidepsin	Histone deacetylase 6	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8837	romidepsin	Histone deacetylase 7	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8838	romidepsin	Histone deacetylase 8	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8839	romidepsin	Histone deacetylase 4	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8840	romidepsin	Histone deacetylase 9	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8841	romidepsin	Bromodomain-containing protein 4	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8842	romidepsin	Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8843	romidepsin	Histone deacetylase 3/NCoR1	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8844	romidepsin	Histone deacetylase	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2
8845	lubiprostone	Chloride channel protein 2	[H][C@@]12CC(=O)[C@]([H])(CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC
8846	vorinostat	Histone deacetylase 5	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8847	vorinostat	Histone deacetylase 2	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8848	vorinostat	Histone deacetylase 1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8849	vorinostat	Histone deacetylase 3	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8850	vorinostat	Histone deacetylase 6	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8851	vorinostat	Histone deacetylase 7	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8852	vorinostat	Histone deacetylase 8	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8853	vorinostat	Histone deacetylase 4	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8854	vorinostat	Histone deacetylase 9	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8855	vorinostat	Leukotriene A-4 hydrolase	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8856	vorinostat	Histone deacetylase 10	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8857	vorinostat	HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8858	vorinostat	Histone deacetylase	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8859	vorinostat	Histone deacetylase-like amidohydrolase	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8860	vorinostat	Histone deacetylase 11	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8861	vorinostat	Lysine-specific demethylase 4E	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8862	vorinostat	Bromodomain-containing protein 4	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8863	vorinostat	Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8864	vorinostat	Histone deacetylase 3/NCoR1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8865	vorinostat	Histone deacetylase 1/3/5/8	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8866	vorinostat	Histone deacetylase (HDAC1 and HDAC2)	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
8867	lisdexamfetamine	Sodium-dependent noradrenaline transporter	C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN
8868	lisdexamfetamine	Sodium-dependent dopamine transporter	C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN
8869	lisdexamfetamine	Synaptic vesicular amine transporter	C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN
8870	paliperidone	Beta-1 adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8871	paliperidone	Beta-2 adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8872	paliperidone	D(1A) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8873	paliperidone	Alpha-2A adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8874	paliperidone	Potassium voltage-gated channel subfamily H member 2	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8875	paliperidone	Sodium-dependent serotonin transporter	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8876	paliperidone	5-hydroxytryptamine receptor 1A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8877	paliperidone	5-hydroxytryptamine receptor 2B	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8878	paliperidone	5-hydroxytryptamine receptor 2C	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8879	paliperidone	5-hydroxytryptamine receptor 6	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8880	paliperidone	5-hydroxytryptamine receptor 7	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8881	paliperidone	Alpha-1A adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8882	paliperidone	Alpha-2B adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8883	paliperidone	D(3) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8884	paliperidone	D(1B) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8885	paliperidone	Histamine H1 receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8886	paliperidone	Histamine H2 receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8887	paliperidone	Histamine H4 receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8888	paliperidone	5-hydroxytryptamine receptor 1B	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8889	paliperidone	5-hydroxytryptamine receptor 1D	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8890	paliperidone	Alpha-2C adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8891	paliperidone	D(4) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8892	paliperidone	Alpha-1B adrenergic receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8893	paliperidone	5-hydroxytryptamine receptor 5A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8894	paliperidone	5-hydroxytryptamine receptor 1E	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8895	paliperidone	Prostaglandin E2 receptor EP3 subtype	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8896	paliperidone	D(2) dopamine receptor	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8897	paliperidone	5-hydroxytryptamine receptor 2A	CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
8898	udenafil	Multidrug resistance protein 1	CCCOC1=CC=C(C=C1C1=NC(=O)C2=C(N1)C(CCC)=NN2C)S(=O)(=O)NCCC1CCCN1C
8899	udenafil	cGMP-specific 3',5'-cyclic phosphodiesterase	CCCOC1=CC=C(C=C1C1=NC(=O)C2=C(N1)C(CCC)=NN2C)S(=O)(=O)NCCC1CCCN1C
8900	testosterone propionate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8901	testosterone propionate	Steroid 17-alpha-hydroxylase/17,20 lyase	[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
8902	rimonabant	Potassium voltage-gated channel subfamily H member 2	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8903	rimonabant	Acetylcholinesterase	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8904	rimonabant	Cannabinoid receptor 2	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8905	rimonabant	N-arachidonyl glycine receptor	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8906	rimonabant	Cannabinoid receptor 1	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8907	rimonabant	G-protein coupled receptor 55	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1
8908	silodosin	Potassium voltage-gated channel subfamily H member 2	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
8909	silodosin	Multidrug resistance protein 1	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
8910	silodosin	Alpha-1A adrenergic receptor	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
8911	silodosin	Alpha-1D adrenergic receptor	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
8912	silodosin	Alpha-1B adrenergic receptor	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
8913	cabazitaxel	Tubulin beta	[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1
8914	lercanidipine	Voltage-gated L-type calcium channel	COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1
8915	temsirolimus	Multidrug resistance protein 1	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OC(=O)C(C)(CO)CO)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
8916	temsirolimus	Peptidyl-prolyl cis-trans isomerase FKBP1A	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OC(=O)C(C)(CO)CO)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
8917	temsirolimus	Serine/threonine-protein kinase mTOR	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OC(=O)C(C)(CO)CO)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
8918	temsirolimus	Peptidyl-prolyl cis-trans isomerase FKBP3	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OC(=O)C(C)(CO)CO)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC
8919	dexlansoprazole	Potassium-transporting ATPase	CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=C(N1)C=CC=C2
8920	dexlansoprazole	Cytosolic endo-beta-N-acetylglucosaminidase	CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=C(N1)C=CC=C2
8921	dexlansoprazole	Sterile alpha and TIR motif-containing protein 1	CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=C(N1)C=CC=C2
8922	fampridine	Voltage-gated potassium channel	NC1=CC=NC=C1
8923	fampridine	Potassium voltage-gated channel subfamily C member 1	NC1=CC=NC=C1
8924	fampridine	Potassium voltage-gated channel subfamily C member 2	NC1=CC=NC=C1
8925	liraglutide	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
8926	alcaftadine	Histamine H1 receptor	CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=C1C=CC=C2
8927	ulipristal	Progesterone receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
8928	fingolimod	Sphingosine-1-phosphate lyase 1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8929	fingolimod	Sphingosine 1-phosphate receptor 1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8930	fingolimod	Sphingosine 1-phosphate receptor 5	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8931	fingolimod	Sphingosine 1-phosphate receptor 4	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8932	fingolimod	Sphingosine 1-phosphate receptor 3	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8933	fingolimod	Transient receptor potential cation channel subfamily M member 7	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
8934	lurasidone	Alpha-2A adrenergic receptor	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8935	lurasidone	5-hydroxytryptamine receptor 1A	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8936	lurasidone	5-hydroxytryptamine receptor 7	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8937	lurasidone	Alpha-2C adrenergic receptor	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8938	lurasidone	D(2) dopamine receptor	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8939	lurasidone	5-hydroxytryptamine receptor 2A	[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O
8940	tesamorelin	Growth hormone-releasing hormone receptor	[H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O
8941	eribulin	Tubulin beta	[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
8942	linagliptin	Muscarinic acetylcholine receptor M1	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
8943	linagliptin	Dipeptidyl peptidase 4	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
8944	linagliptin	Prolyl endopeptidase FAP	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
8945	linagliptin	Dipeptidyl peptidase 9	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
8946	linagliptin	Dipeptidyl peptidase IV	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
8947	abiraterone acetate	Cytochrome P450 3A4	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8948	abiraterone acetate	Androgen receptor	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8949	abiraterone acetate	Steroid 17-alpha-hydroxylase/17,20 lyase	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8950	abiraterone acetate	Cytochrome P450 11B1, mitochondrial	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8951	abiraterone acetate	Cytochrome P450 11B2, mitochondrial	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8952	abiraterone acetate	Cytochrome P450 17A1	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O
8953	gabapentin enacarbil	Voltage-dependent calcium channel subunit alpha-2/delta-1	[H]C(C)(OC(=O)NCC1(CC(O)=O)CCCCC1)OC(=O)C(C)C
8954	gabapentin enacarbil	Voltage-dependent calcium channel subunit alpha-2/delta-2	[H]C(C)(OC(=O)NCC1(CC(O)=O)CCCCC1)OC(=O)C(C)C
8955	vandetanib	Macrophage-stimulating protein receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8956	vandetanib	Platelet-derived growth factor receptor beta	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8957	vandetanib	Tyrosine-protein kinase ABL1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8958	vandetanib	Mast/stem cell growth factor receptor Kit	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8959	vandetanib	Epidermal growth factor receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8960	vandetanib	Proto-oncogene tyrosine-protein kinase Src	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8961	vandetanib	Tyrosine-protein kinase Lck	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8962	vandetanib	Tyrosine-protein kinase Yes	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8963	vandetanib	Tyrosine-protein kinase Fyn	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8964	vandetanib	Ephrin type-A receptor 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8965	vandetanib	Receptor-type tyrosine-protein kinase FLT3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8966	vandetanib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8967	vandetanib	Vascular endothelial growth factor receptor 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8968	vandetanib	Vascular endothelial growth factor receptor 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8969	vandetanib	Vascular endothelial growth factor receptor 3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8970	vandetanib	Macrophage colony-stimulating factor 1 receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8971	vandetanib	Platelet-derived growth factor receptor alpha	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8972	vandetanib	Receptor tyrosine-protein kinase erbB-2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8973	vandetanib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8974	vandetanib	Fibroblast growth factor receptor 3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8975	vandetanib	Tyrosine-protein kinase HCK	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8976	vandetanib	Receptor tyrosine-protein kinase erbB-4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8977	vandetanib	Rho-associated protein kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8978	vandetanib	Tyrosine-protein kinase CSK	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8979	vandetanib	Angiopoietin-1 receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8980	vandetanib	Ephrin type-A receptor 8	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8981	vandetanib	Hepatocyte growth factor receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8982	vandetanib	Tyrosine-protein kinase Lyn	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8983	vandetanib	5'-AMP-activated protein kinase catalytic subunit alpha-1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8984	vandetanib	Fibroblast growth factor receptor 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8985	vandetanib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8986	vandetanib	Serine/threonine-protein kinase 10	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8987	vandetanib	Serine/threonine-protein kinase PLK4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8988	vandetanib	Aurora kinase C	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8989	vandetanib	Abelson tyrosine-protein kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8990	vandetanib	Ephrin type-A receptor 5	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8991	vandetanib	Ephrin type-A receptor 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8992	vandetanib	Fibroblast growth factor receptor 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8993	vandetanib	Ephrin type-A receptor 6	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8994	vandetanib	TRAF2 and NCK-interacting protein kinase	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8995	vandetanib	Casein kinase I isoform epsilon	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8996	vandetanib	Tyrosine-protein kinase Fgr	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8997	vandetanib	ALK tyrosine kinase receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8998	vandetanib	Ephrin type-A receptor 3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
8999	vandetanib	Tyrosine-protein kinase FRK	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9000	vandetanib	Mitogen-activated protein kinase kinase kinase kinase 5	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9001	vandetanib	Mitogen-activated protein kinase kinase kinase 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9002	vandetanib	Cyclin-G-associated kinase	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9003	vandetanib	Receptor-interacting serine/threonine-protein kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9004	vandetanib	Ephrin type-B receptor 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9005	vandetanib	Ephrin type-A receptor 7	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9006	vandetanib	STE20-like serine/threonine-protein kinase	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9007	vandetanib	MAP kinase-interacting serine/threonine-protein kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9008	vandetanib	Epithelial discoidin domain-containing receptor 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9009	vandetanib	Ephrin type-B receptor 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9010	vandetanib	Serine/threonine-protein kinase receptor R3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9011	vandetanib	Activin receptor type-1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9012	vandetanib	Dual specificity mitogen-activated protein kinase kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9013	vandetanib	Dual specificity mitogen-activated protein kinase kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9014	vandetanib	Protein-tyrosine kinase 6	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9015	vandetanib	Tyrosine-protein kinase BTK	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9016	vandetanib	Tyrosine-protein kinase receptor UFO	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9017	vandetanib	Tyrosine-protein kinase receptor TYRO3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9018	vandetanib	Ephrin type-B receptor 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9019	vandetanib	Cyclin-dependent kinase 7	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9020	vandetanib	Ribosomal protein S6 kinase beta-1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9021	vandetanib	Ribosomal protein S6 kinase alpha-6	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9022	vandetanib	Mitogen-activated protein kinase kinase kinase MLT	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9023	vandetanib	Tyrosine-protein kinase receptor Tie-1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9024	vandetanib	Tyrosine-protein kinase TXK	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9025	vandetanib	MAP kinase-interacting serine/threonine-protein kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9026	vandetanib	Serine/threonine-protein kinase SIK2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9027	vandetanib	Serine/threonine-protein kinase 33	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9028	vandetanib	Serine/threonine-protein kinase TNNI3K	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9029	vandetanib	Discoidin domain-containing receptor 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9030	vandetanib	Chaperone activity of bc1 complex-like, mitochondrial	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9031	vandetanib	Serine/threonine-protein kinase MRCK gamma	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9032	vandetanib	Leukocyte tyrosine kinase receptor	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9033	vandetanib	Mitogen-activated protein kinase kinase kinase kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9034	vandetanib	Mitogen-activated protein kinase kinase kinase kinase 3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9035	vandetanib	Tyrosine-protein kinase Blk	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9036	vandetanib	Mitogen-activated protein kinase kinase kinase kinase 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9037	vandetanib	Tyrosine-protein kinase Mer	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9038	vandetanib	Serine/threonine-protein kinase MRCK alpha	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9039	vandetanib	Serine/threonine-protein kinase MRCK beta	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9040	vandetanib	Citron Rho-interacting kinase	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9041	vandetanib	AarF domain-containing protein kinase 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9042	vandetanib	Serine/threonine-protein kinase SIK1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9043	vandetanib	Tyrosine-protein kinase Srms	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9044	vandetanib	Dual specificity testis-specific protein kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9045	vandetanib	Ephrin type-A receptor 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9046	vandetanib	Tubulin alpha-1A chain	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9047	vandetanib	Mitogen-activated protein kinase 6	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9048	vandetanib	Fibroblast growth factor receptor 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9049	vandetanib	Ribosomal protein S6 kinase alpha-1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9050	vandetanib	Mitogen-activated protein kinase kinase kinase kinase 2	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9051	vandetanib	Misshapen-like kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9052	vandetanib	Interleukin-1 receptor-associated kinase 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9053	vandetanib	Ephrin type-B receptor 6	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9054	vandetanib	Hormonally up-regulated neu tumor-associated kinase	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9055	vandetanib	Interleukin-1 receptor-associated kinase 1	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9056	vandetanib	Serine/threonine-protein kinase ULK3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9057	vandetanib	Mitogen-activated protein kinase kinase kinase 19	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9058	vandetanib	Receptor-interacting serine/threonine-protein kinase 4	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9059	vandetanib	Serine/threonine-protein kinase 35	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9060	vandetanib	Receptor tyrosine-protein kinase erbB-3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9061	vandetanib	Serine/threonine-protein kinase SIK3	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9062	vandetanib	Bone morphogenetic protein receptor type-1B	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9063	vandetanib	Serine/threonine-protein kinase 32A	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9064	vandetanib	Dual specificity mitogen-activated protein kinase kinase 5	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
9065	retigabine	Potassium voltage-gated channel subfamily KQT member 2	CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
9066	retigabine	Potassium voltage-gated channel subfamily KQT member 3	CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
9067	retigabine	Potassium voltage-gated channel subfamily KQT member 5	CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
9068	retigabine	Potassium voltage-gated channel subfamily KQT member 4	CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
9069	rivaroxaban	Coagulation factor X	ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O
9070	rivaroxaban	Suppressor of tumorigenicity 14 protein	ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O
9071	indacaterol	Beta-1 adrenergic receptor	CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2
9072	indacaterol	Beta-2 adrenergic receptor	CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2
9073	indacaterol	D(2) dopamine receptor	CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2
9074	indacaterol	D(3) dopamine receptor	CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2
9075	ticagrelor	P2Y purinoceptor 12	CCCSC1=NC(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=C2N=NN([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1
9076	ticagrelor	Equilibrative nucleoside transporter 1	CCCSC1=NC(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=C2N=NN([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1
9077	vemurafenib	RAF proto-oncogene serine/threonine-protein kinase	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9078	vemurafenib	Serine/threonine-protein kinase B-raf	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9079	vemurafenib	Vascular endothelial growth factor receptor 2	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9080	vemurafenib	Mitogen-activated protein kinase kinase kinase MLT	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9081	vemurafenib	Serine/threonine-protein kinase A-Raf	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9082	vemurafenib	GTPase KRas	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9083	vemurafenib	Ferrochelatase, mitochondrial	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F
9084	icatibant	B2 bradykinin receptor	[H]N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@]([H])(O)C[C@@]1([H])C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@@H](C[C@]3([H])CCCC[C@]13[H])C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2
9085	icatibant	B1 bradykinin receptor	[H]N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@]([H])(O)C[C@@]1([H])C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@@H](C[C@]3([H])CCCC[C@]13[H])C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2
9086	crizotinib	Tyrosine-protein kinase JAK3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9087	crizotinib	Macrophage-stimulating protein receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9088	crizotinib	Tyrosine-protein kinase ABL1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9089	crizotinib	Mast/stem cell growth factor receptor Kit	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9090	crizotinib	Epidermal growth factor receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9091	crizotinib	Proto-oncogene tyrosine-protein kinase Src	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9092	crizotinib	Tyrosine-protein kinase Lck	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9093	crizotinib	Tyrosine-protein kinase Yes	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9094	crizotinib	Tyrosine-protein kinase Fyn	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9095	crizotinib	Ephrin type-A receptor 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9096	crizotinib	Receptor-type tyrosine-protein kinase FLT3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9097	crizotinib	Proto-oncogene tyrosine-protein kinase receptor Ret	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9098	crizotinib	Vascular endothelial growth factor receptor 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9099	crizotinib	Macrophage colony-stimulating factor 1 receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9100	crizotinib	Insulin-like growth factor 1 receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9101	crizotinib	Insulin receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9102	crizotinib	Fibroblast growth factor receptor 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9103	crizotinib	Rho-associated protein kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9104	crizotinib	Focal adhesion kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9105	crizotinib	Tyrosine-protein kinase JAK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9106	crizotinib	High affinity nerve growth factor receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9107	crizotinib	Tyrosine-protein kinase JAK2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9108	crizotinib	Rho-associated protein kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9109	crizotinib	Tyrosine-protein kinase SYK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9110	crizotinib	Angiopoietin-1 receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9111	crizotinib	Ephrin type-A receptor 8	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9112	crizotinib	AP2-associated protein kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9113	crizotinib	Hepatocyte growth factor receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9114	crizotinib	Tyrosine-protein kinase Lyn	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9115	crizotinib	Cytoplasmic tyrosine-protein kinase BMX	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9116	crizotinib	LIM domain kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9117	crizotinib	5'-AMP-activated protein kinase catalytic subunit alpha-1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9118	crizotinib	Serine/threonine-protein kinase 10	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9119	crizotinib	Tyrosine-protein kinase Fer	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9120	crizotinib	Serine/threonine-protein kinase PLK4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9121	crizotinib	Aurora kinase C	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9122	crizotinib	Abelson tyrosine-protein kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9123	crizotinib	Ephrin type-A receptor 5	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9124	crizotinib	Ephrin type-A receptor 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9125	crizotinib	Ephrin type-A receptor 6	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9126	crizotinib	Tyrosine-protein kinase Fgr	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9127	crizotinib	Aurora kinase A	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9128	crizotinib	ALK tyrosine kinase receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9129	crizotinib	Ephrin type-A receptor 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9130	crizotinib	BMP-2-inducible protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9131	crizotinib	Tyrosine-protein kinase FRK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9132	crizotinib	Mitogen-activated protein kinase kinase kinase kinase 5	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9133	crizotinib	Receptor-interacting serine/threonine-protein kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9134	crizotinib	Ephrin type-B receptor 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9135	crizotinib	Serine/threonine-protein kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9136	crizotinib	Activated CDC42 kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9137	crizotinib	Ephrin type-A receptor 7	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9138	crizotinib	STE20-like serine/threonine-protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9139	crizotinib	Calcium/calmodulin-dependent protein kinase kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9140	crizotinib	Epithelial discoidin domain-containing receptor 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9141	crizotinib	Ephrin type-B receptor 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9142	crizotinib	Activin receptor type-1B	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9143	crizotinib	Activin receptor type-1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9144	crizotinib	Inhibitor of nuclear factor kappa-B kinase subunit beta	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9145	crizotinib	Tyrosine-protein kinase ITK/TSK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9146	crizotinib	Tyrosine-protein kinase ZAP-70	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9147	crizotinib	Tyrosine-protein kinase BTK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9148	crizotinib	Tyrosine-protein kinase receptor UFO	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9149	crizotinib	BDNF/NT-3 growth factors receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9150	crizotinib	Tyrosine-protein kinase receptor TYRO3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9151	crizotinib	Cyclin-dependent kinase 7	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9152	crizotinib	Serine/threonine-protein kinase D1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9153	crizotinib	Ribosomal protein S6 kinase beta-1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9154	crizotinib	Serine/threonine-protein kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9155	crizotinib	NUAK family SNF1-like kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9156	crizotinib	Non-receptor tyrosine-protein kinase TNK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9157	crizotinib	Non-receptor tyrosine-protein kinase TYK2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9158	crizotinib	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9159	crizotinib	Protein-tyrosine kinase 2-beta	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9160	crizotinib	Serine/threonine-protein kinase RIO1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9161	crizotinib	Tyrosine-protein kinase receptor Tie-1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9162	crizotinib	NT-3 growth factor receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9163	crizotinib	Tyrosine-protein kinase TXK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9164	crizotinib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9165	crizotinib	LIM domain kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9166	crizotinib	Dual specificity mitogen-activated protein kinase kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9167	crizotinib	Serine/threonine-protein kinase 26	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9168	crizotinib	Serine/threonine-protein kinase Nek7	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9169	crizotinib	Insulin receptor-related protein	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9170	crizotinib	Interleukin-1 receptor-associated kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9171	crizotinib	Serine/threonine-protein kinase RIO3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9172	crizotinib	Serine/threonine-protein kinase SIK2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9173	crizotinib	SRSF protein kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9174	crizotinib	Serine/threonine-protein kinase TNNI3K	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9175	crizotinib	Ankyrin repeat and protein kinase domain-containing protein 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9176	crizotinib	Myotonin-protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9177	crizotinib	Leukocyte tyrosine kinase receptor	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9178	crizotinib	Mitogen-activated protein kinase kinase kinase kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9179	crizotinib	Mitogen-activated protein kinase kinase kinase kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9180	crizotinib	Aurora kinase B	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9181	crizotinib	Tyrosine-protein kinase Blk	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9182	crizotinib	Tyrosine-protein kinase Mer	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9183	crizotinib	Cyclin-dependent kinase 11B	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9184	crizotinib	Cyclin-dependent kinase 11A	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9185	crizotinib	Muscle, skeletal receptor tyrosine-protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9186	crizotinib	Serine/threonine-protein kinase DCLK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9187	crizotinib	Serine/threonine-protein kinase DCLK2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9188	crizotinib	Serine/threonine-protein kinase Nek9	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9189	crizotinib	AarF domain-containing protein kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9190	crizotinib	Dual specificity testis-specific protein kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9191	crizotinib	TGF-beta receptor type-1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9192	crizotinib	Ephrin type-A receptor 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9193	crizotinib	Mitogen-activated protein kinase 7	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9194	crizotinib	Serine/threonine-protein kinase D3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9195	crizotinib	Interferon-induced, double-stranded RNA-activated protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9196	crizotinib	Receptor-interacting serine/threonine-protein kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9197	crizotinib	Tyrosine-protein kinase Fes/Fps	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9198	crizotinib	Proto-oncogene tyrosine-protein kinase ROS	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9199	crizotinib	Mitogen-activated protein kinase kinase kinase kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9200	crizotinib	Misshapen-like kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9201	crizotinib	Serine/threonine-protein kinase TBK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9202	crizotinib	Interleukin-1 receptor-associated kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9203	crizotinib	Cyclin-dependent kinase-like 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9204	crizotinib	Dual specificity tyrosine-phosphorylation-regulated kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9205	crizotinib	Ephrin type-B receptor 6	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9206	crizotinib	G protein-coupled receptor kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9207	crizotinib	Homeodomain-interacting protein kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9208	crizotinib	Interleukin-1 receptor-associated kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9209	crizotinib	Mitogen-activated protein kinase kinase kinase 13	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9210	crizotinib	Mitogen-activated protein kinase kinase kinase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9211	crizotinib	Mitogen-activated protein kinase kinase kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9212	crizotinib	Serine/threonine-protein kinase NIM1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9213	crizotinib	SRSF protein kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9214	crizotinib	Mitogen-activated protein kinase kinase kinase 7	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9215	crizotinib	Serine/threonine-protein kinase TAO1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9216	crizotinib	Serine/threonine-protein kinase TAO3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9217	crizotinib	Serine/threonine-protein kinase ULK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9218	crizotinib	Serine/threonine-protein kinase ULK2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9219	crizotinib	Serine/threonine-protein kinase ULK3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9220	crizotinib	Mitogen-activated protein kinase kinase kinase 19	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9221	crizotinib	Mitogen-activated protein kinase kinase kinase 15	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9222	crizotinib	Receptor-interacting serine/threonine-protein kinase 4	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9223	crizotinib	Uncharacterized serine/threonine-protein kinase SBK3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9224	crizotinib	Serine/threonine-protein kinase 35	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9225	crizotinib	Mitogen-activated protein kinase kinase kinase 1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9226	crizotinib	Bone morphogenetic protein receptor type-1B	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9227	crizotinib	Serine/threonine-protein kinase SBK1	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9228	crizotinib	Peripheral plasma membrane protein CASK	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9229	crizotinib	Mitogen-activated protein kinase kinase kinase 12	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9230	crizotinib	Serine/threonine-protein kinase TAO2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9231	crizotinib	Dual serine/threonine and tyrosine protein kinase	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9232	crizotinib	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9233	crizotinib	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9234	crizotinib	Receptor-interacting serine/threonine-protein kinase 3	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9235	crizotinib	Mixed lineage kinase domain-like protein	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
9236	hydroxyprogesterone caproate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9237	hydroxyprogesterone caproate	Sodium-dependent dopamine transporter	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9238	hydroxyprogesterone caproate	Adenosine receptor A3	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9239	hydroxyprogesterone caproate	Corticosteroid-binding globulin	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9240	hydroxyprogesterone caproate	Sex hormone-binding globulin	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9241	hydroxyprogesterone caproate	Mitogen-activated protein kinase 3	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9242	hydroxyprogesterone caproate	Androgen receptor	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9243	hydroxyprogesterone caproate	Progesterone receptor	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9244	ruxolitinib	Tyrosine-protein kinase JAK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9245	ruxolitinib	Tyrosine-protein kinase ABL1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9246	ruxolitinib	Mast/stem cell growth factor receptor Kit	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9247	ruxolitinib	Serine/threonine-protein kinase B-raf	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9248	ruxolitinib	Proto-oncogene tyrosine-protein kinase receptor Ret	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9249	ruxolitinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9250	ruxolitinib	Myosin light chain kinase, smooth muscle	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9251	ruxolitinib	Death-associated protein kinase 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9252	ruxolitinib	Histone deacetylase 6	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9253	ruxolitinib	Calcium/calmodulin-dependent protein kinase type 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9254	ruxolitinib	Mitogen-activated protein kinase 8	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9255	ruxolitinib	Rho-associated protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9256	ruxolitinib	Tyrosine-protein kinase JAK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9257	ruxolitinib	Serine/threonine-protein kinase PLK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9258	ruxolitinib	Death-associated protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9259	ruxolitinib	High affinity nerve growth factor receptor	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9260	ruxolitinib	Tyrosine-protein kinase JAK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9261	ruxolitinib	Rho-associated protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9262	ruxolitinib	Calcium/calmodulin-dependent protein kinase type II subunit delta	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9263	ruxolitinib	Calcium/calmodulin-dependent protein kinase type II subunit gamma	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9264	ruxolitinib	AP2-associated protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9265	ruxolitinib	Serine/threonine-protein kinase MARK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9266	ruxolitinib	Ribosomal protein S6 kinase alpha-2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9267	ruxolitinib	Calcium/calmodulin-dependent protein kinase type II subunit beta	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9268	ruxolitinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9269	ruxolitinib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9270	ruxolitinib	Serine/threonine-protein kinase 17B	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9271	ruxolitinib	Protein kinase C epsilon type	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9272	ruxolitinib	Serine/threonine-protein kinase PLK4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9273	ruxolitinib	Aurora kinase C	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9274	ruxolitinib	Serine/threonine-protein kinase 16	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9275	ruxolitinib	Dual specificity protein kinase TTK	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9276	ruxolitinib	Serine/threonine-protein kinase 17A	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9277	ruxolitinib	ALK tyrosine kinase receptor	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9278	ruxolitinib	Ephrin type-A receptor 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9279	ruxolitinib	BMP-2-inducible protein kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9280	ruxolitinib	Dual specificity protein kinase CLK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9281	ruxolitinib	Cyclin-G-associated kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9282	ruxolitinib	Calcium/calmodulin-dependent protein kinase type 1D	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9283	ruxolitinib	Activated CDC42 kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9284	ruxolitinib	Ribosomal protein S6 kinase alpha-5	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9285	ruxolitinib	Dual specificity protein kinase CLK4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9286	ruxolitinib	MAP kinase-interacting serine/threonine-protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9287	ruxolitinib	Calcium/calmodulin-dependent protein kinase type 1G	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9288	ruxolitinib	Inhibitor of nuclear factor kappa-B kinase subunit beta	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9289	ruxolitinib	Dual specificity mitogen-activated protein kinase kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9290	ruxolitinib	Dual specificity mitogen-activated protein kinase kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9291	ruxolitinib	BDNF/NT-3 growth factors receptor	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9292	ruxolitinib	Cyclin-dependent kinase 7	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9293	ruxolitinib	Serine/threonine-protein kinase DCLK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9294	ruxolitinib	Ribosomal protein S6 kinase alpha-6	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9295	ruxolitinib	NUAK family SNF1-like kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9296	ruxolitinib	Non-receptor tyrosine-protein kinase TYK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9297	ruxolitinib	Serine/threonine-protein kinase 25	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9298	ruxolitinib	Serine/threonine-protein kinase RIO1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9299	ruxolitinib	NT-3 growth factor receptor	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9300	ruxolitinib	Casein kinase II subunit alpha	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9301	ruxolitinib	Casein kinase II subunit alpha'	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9302	ruxolitinib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9303	ruxolitinib	Dual specificity mitogen-activated protein kinase kinase 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9304	ruxolitinib	Maternal embryonic leucine zipper kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9305	ruxolitinib	Serine/threonine-protein kinase 26	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9306	ruxolitinib	Serine/threonine-protein kinase Nek7	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9307	ruxolitinib	Serine/threonine-protein kinase RIO3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9308	ruxolitinib	SRSF protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9309	ruxolitinib	Ankyrin repeat and protein kinase domain-containing protein 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9310	ruxolitinib	Myotonin-protein kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9311	ruxolitinib	Leukocyte tyrosine kinase receptor	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9312	ruxolitinib	Serine/threonine-protein kinase PAK 6	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9313	ruxolitinib	Serine/threonine-protein kinase PAK 7	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9314	ruxolitinib	Bone morphogenetic protein receptor type-2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9315	ruxolitinib	Dual specificity mitogen-activated protein kinase kinase 4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9316	ruxolitinib	Death-associated protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9317	ruxolitinib	Serine/threonine-protein kinase DCLK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9318	ruxolitinib	Serine/threonine-protein kinase DCLK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9319	ruxolitinib	Serine/threonine-protein kinase PAK 4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9320	ruxolitinib	Serine/threonine-protein kinase PLK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9321	ruxolitinib	cGMP-dependent protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9322	ruxolitinib	Ribosomal protein S6 kinase alpha-1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9323	ruxolitinib	Ribosomal protein S6 kinase alpha-4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9324	ruxolitinib	Casein kinase I isoform alpha	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9325	ruxolitinib	Mitogen-activated protein kinase kinase kinase kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9326	ruxolitinib	Serine/threonine-protein kinase TBK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9327	ruxolitinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9328	ruxolitinib	Dual specificity tyrosine-phosphorylation-regulated kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9329	ruxolitinib	Ephrin type-B receptor 6	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9330	ruxolitinib	Serine/threonine-protein kinase/endoribonuclease IRE1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9331	ruxolitinib	Rhodopsin kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9332	ruxolitinib	G protein-coupled receptor kinase 4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9333	ruxolitinib	G protein-coupled receptor kinase 7	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9334	ruxolitinib	Homeodomain-interacting protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9335	ruxolitinib	Homeodomain-interacting protein kinase 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9336	ruxolitinib	Interleukin-1 receptor-associated kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9337	ruxolitinib	Mitogen-activated protein kinase kinase kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9338	ruxolitinib	Mitogen-activated protein kinase kinase kinase 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9339	ruxolitinib	Microtubule-associated serine/threonine-protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9340	ruxolitinib	Serine/threonine-protein kinase OSR1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9341	ruxolitinib	Serine/threonine-protein kinase RIO2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9342	ruxolitinib	SRSF protein kinase 3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9343	ruxolitinib	STE20/SPS1-related proline-alanine-rich protein kinase	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9344	ruxolitinib	Mitogen-activated protein kinase kinase kinase 7	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9345	ruxolitinib	Serine/threonine-protein kinase TAO1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9346	ruxolitinib	Serine/threonine-protein kinase TAO3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9347	ruxolitinib	Serine/threonine-protein kinase ULK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9348	ruxolitinib	Serine/threonine-protein kinase ULK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9349	ruxolitinib	Serine/threonine-protein kinase ULK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9350	ruxolitinib	Mitogen-activated protein kinase kinase kinase 19	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9351	ruxolitinib	Homeodomain-interacting protein kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9352	ruxolitinib	Mitogen-activated protein kinase kinase kinase 15	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9353	ruxolitinib	Serine/threonine-protein kinase PLK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9354	ruxolitinib	Receptor-interacting serine/threonine-protein kinase 4	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9355	ruxolitinib	Uncharacterized serine/threonine-protein kinase SBK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9356	ruxolitinib	Mitogen-activated protein kinase kinase kinase 1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9357	ruxolitinib	Phosphatidylinositol 4-kinase beta	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9358	ruxolitinib	Serine/threonine-protein kinase SIK3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9359	ruxolitinib	Bone morphogenetic protein receptor type-1B	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9360	ruxolitinib	Serine/threonine-protein kinase SBK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9361	ruxolitinib	Serine/threonine-protein kinase Nek3	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9362	ruxolitinib	Peripheral plasma membrane protein CASK	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9363	ruxolitinib	Serine/threonine-protein kinase VRK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9364	ruxolitinib	Serine/threonine-protein kinase TAO2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9365	ruxolitinib	Leucine-rich repeat serine/threonine-protein kinase 2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9366	ruxolitinib	Serine/threonine-protein kinase PknB	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9367	ruxolitinib	JAK2/JAK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9368	ruxolitinib	JAK3/JAK1	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9369	ruxolitinib	JAK1/TYK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9370	ruxolitinib	JAK1/JAK2/TYK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9371	ruxolitinib	JAK2/TYK2	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9372	ruxolitinib	Oxysterols receptor LXR-beta	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
9373	fesoterodine	Muscarinic acetylcholine receptor M1	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
9374	fesoterodine	Muscarinic acetylcholine receptor M2	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
9375	fesoterodine	Muscarinic acetylcholine receptor M3	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
9376	fesoterodine	Muscarinic acetylcholine receptor M4	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
9377	fesoterodine	Muscarinic acetylcholine receptor M5	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
9378	tafamidis	ATP-binding cassette sub-family G member 2	OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1
9379	tafamidis	Solute carrier family 22 member 6	OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1
9380	tafamidis	Solute carrier family 22 member 8	OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1
9381	tafamidis	Transthyretin	OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1
9382	prazosin	Alpha-2A adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9383	prazosin	Potassium voltage-gated channel subfamily H member 2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9384	prazosin	5-hydroxytryptamine receptor 2A	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9385	prazosin	5-hydroxytryptamine receptor 2B	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9386	prazosin	Alpha-1A adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9387	prazosin	Alpha-2B adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9388	prazosin	5-hydroxytryptamine receptor 1D	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9389	prazosin	Alpha-2C adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9390	prazosin	Adenosine receptor A3	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9391	prazosin	D(4) dopamine receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9392	prazosin	Alpha-1D adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9393	prazosin	Alpha-1B adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9394	prazosin	Ribosyldihydronicotinamide dehydrogenase [quinone]	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9395	prazosin	Matrix metalloproteinase-9	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9396	prazosin	Interstitial collagenase	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9397	prazosin	Solute carrier family 22 member 1	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9398	prazosin	Mu-type opioid receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9399	prazosin	D(2) dopamine receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9400	prazosin	5-hydroxytryptamine receptor 1A	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9401	prazosin	Solute carrier family 22 member 2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9402	prazosin	Multidrug and toxin extrusion protein 1	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9403	prazosin	Multidrug and toxin extrusion protein 2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9404	prazosin	Adrenergic receptor alpha-2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9405	prazosin	Adrenergic receptor alpha-1	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9406	prazosin	Sodium channel alpha subunits; brain (Types I, II, III)	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9407	prazosin	Serotonin 2 (5-HT2) receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9408	prazosin	Alpha-2 adrenergic receptor	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9409	prazosin	Beta-casein	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
9410	hydrocortisone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9411	hydrocortisone acetate	Corticosteroid-binding globulin	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9412	methyldopate	Adrenergic receptor alpha-2	CCOC(=O)[C@@](C)(N)CC1=CC(O)=C(O)C=C1
9413	mequinol	Tyrosinase	COC1=CC=C(O)C=C1
9414	vilazodone	D(2) dopamine receptor	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9415	vilazodone	Sodium-dependent serotonin transporter	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9416	vilazodone	5-hydroxytryptamine receptor 1A	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9417	vilazodone	5-hydroxytryptamine receptor 7	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9418	vilazodone	D(3) dopamine receptor	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9419	vilazodone	Histamine H1 receptor	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9420	vilazodone	5-hydroxytryptamine receptor 4	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9421	vilazodone	5-hydroxytryptamine receptor 1B	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9422	vilazodone	5-hydroxytryptamine receptor 2A	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9423	vilazodone	Acetylcholinesterase	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9424	vilazodone	5-hydroxytryptamine receptor 2C	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9425	vilazodone	5-hydroxytryptamine receptor 1D	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9426	vilazodone	D(4) dopamine receptor	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9427	vilazodone	5-hydroxytryptamine receptor 6	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9428	vilazodone	Serotonin 3 (5-HT3) receptor	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9429	vilazodone	Adrenergic receptor alpha-2	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9430	vilazodone	Adrenergic receptor alpha-1	NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
9431	axitinib	Tyrosine-protein kinase JAK3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9432	axitinib	Platelet-derived growth factor receptor beta	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9433	axitinib	Tyrosine-protein kinase ABL1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9434	axitinib	Mast/stem cell growth factor receptor Kit	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9435	axitinib	Epidermal growth factor receptor	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9436	axitinib	Tyrosine-protein kinase Lck	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9437	axitinib	Tyrosine-protein kinase Yes	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9438	axitinib	Receptor-type tyrosine-protein kinase FLT3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9439	axitinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9440	axitinib	Vascular endothelial growth factor receptor 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9441	axitinib	Vascular endothelial growth factor receptor 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9442	axitinib	Vascular endothelial growth factor receptor 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9443	axitinib	Macrophage colony-stimulating factor 1 receptor	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9444	axitinib	Platelet-derived growth factor receptor alpha	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9445	axitinib	Mitogen-activated protein kinase 8	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9446	axitinib	Fibroblast growth factor receptor 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9447	axitinib	Mitogen-activated protein kinase 10	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9448	axitinib	High affinity nerve growth factor receptor	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9449	axitinib	Tyrosine-protein kinase JAK2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9450	axitinib	Myosin light chain kinase 2, skeletal/cardiac muscle	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9451	axitinib	Tyrosine-protein kinase CSK	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9452	axitinib	Angiopoietin-1 receptor	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9453	axitinib	AP2-associated protein kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9454	axitinib	Hepatocyte growth factor receptor	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9455	axitinib	Fibroblast growth factor receptor 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9456	axitinib	Serine/threonine-protein kinase 10	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9457	axitinib	Serine/threonine-protein kinase PLK4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9458	axitinib	Aurora kinase C	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9459	axitinib	Serine/threonine-protein kinase 16	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9460	axitinib	Dual specificity protein kinase TTK	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9461	axitinib	Abelson tyrosine-protein kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9462	axitinib	Fibroblast growth factor receptor 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9463	axitinib	TRAF2 and NCK-interacting protein kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9464	axitinib	Tyrosine-protein kinase Fgr	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9465	axitinib	Aurora kinase A	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9466	axitinib	BMP-2-inducible protein kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9467	axitinib	Mitogen-activated protein kinase kinase kinase kinase 5	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9468	axitinib	Mitogen-activated protein kinase kinase kinase 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9469	axitinib	Cyclin-G-associated kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9470	axitinib	Receptor-interacting serine/threonine-protein kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9471	axitinib	Cyclin-dependent kinase 16	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9472	axitinib	Serine/threonine-protein kinase 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9473	axitinib	Activated CDC42 kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9474	axitinib	STE20-like serine/threonine-protein kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9475	axitinib	Calcium/calmodulin-dependent protein kinase kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9476	axitinib	Calcium/calmodulin-dependent protein kinase kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9477	axitinib	Epithelial discoidin domain-containing receptor 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9478	axitinib	Dual specificity mitogen-activated protein kinase kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9479	axitinib	Dual specificity mitogen-activated protein kinase kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9480	axitinib	Tyrosine-protein kinase ITK/TSK	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9481	axitinib	Tyrosine-protein kinase receptor UFO	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9482	axitinib	Serine/threonine-protein kinase N2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9483	axitinib	Serine/threonine-protein kinase 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9484	axitinib	NUAK family SNF1-like kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9485	axitinib	Non-receptor tyrosine-protein kinase TNK1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9486	axitinib	Non-receptor tyrosine-protein kinase TYK2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9487	axitinib	Mitogen-activated protein kinase kinase kinase MLT	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9488	axitinib	Serine/threonine-protein kinase RIO1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9489	axitinib	Tyrosine-protein kinase receptor Tie-1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9490	axitinib	Tyrosine-protein kinase TXK	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9491	axitinib	Casein kinase II subunit alpha'	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9492	axitinib	Serine/threonine-protein kinase RIO3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9493	axitinib	SRSF protein kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9494	axitinib	Activin receptor type-2B	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9495	axitinib	Ankyrin repeat and protein kinase domain-containing protein 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9496	axitinib	Discoidin domain-containing receptor 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9497	axitinib	Mitogen-activated protein kinase kinase kinase kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9498	axitinib	Mitogen-activated protein kinase kinase kinase kinase 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9499	axitinib	Aurora kinase B	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9500	axitinib	Tyrosine-protein kinase Blk	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9501	axitinib	Mitogen-activated protein kinase kinase kinase kinase 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9502	axitinib	Tyrosine-protein kinase Mer	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9503	axitinib	Mitogen-activated protein kinase kinase kinase 9	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9504	axitinib	Serine/threonine-protein kinase MRCK beta	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9505	axitinib	Myosin-IIIa	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9506	axitinib	Serine/threonine-protein kinase PAK 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9507	axitinib	Serine/threonine-protein kinase SIK1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9508	axitinib	Dual specificity testis-specific protein kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9509	axitinib	Interferon-induced, double-stranded RNA-activated protein kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9510	axitinib	Receptor-interacting serine/threonine-protein kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9511	axitinib	Proto-oncogene tyrosine-protein kinase ROS	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9512	axitinib	Mitogen-activated protein kinase kinase kinase kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9513	axitinib	Misshapen-like kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9514	axitinib	Cyclin-dependent kinase-like 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9515	axitinib	Ephrin type-B receptor 6	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9516	axitinib	G protein-coupled receptor kinase 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9517	axitinib	Hormonally up-regulated neu tumor-associated kinase	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9518	axitinib	Interleukin-1 receptor-associated kinase 1	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9519	axitinib	Mitogen-activated protein kinase kinase kinase 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9520	axitinib	SRSF protein kinase 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9521	axitinib	Serine/threonine-protein kinase ULK2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9522	axitinib	Serine/threonine-protein kinase ULK3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9523	axitinib	Mitogen-activated protein kinase kinase kinase 19	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9524	axitinib	Receptor-interacting serine/threonine-protein kinase 4	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9525	axitinib	Bone morphogenetic protein receptor type-1B	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9526	axitinib	Mitogen-activated protein kinase kinase kinase 12	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9527	axitinib	Dual specificity mitogen-activated protein kinase kinase 5	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9528	axitinib	Myosin light chain kinase 3	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9529	axitinib	Leucine-rich repeat serine/threonine-protein kinase 2	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
9530	ingenol mebutate	Protein kinase C gamma type	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9531	ingenol mebutate	Protein kinase C beta type	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9532	ingenol mebutate	Protein kinase C alpha type	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9533	ingenol mebutate	Protein kinase C epsilon type	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9534	ingenol mebutate	Serine/threonine-protein kinase D1	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9535	ingenol mebutate	Protein kinase C delta type	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C
9536	vismodegib	Sonic hedgehog protein	CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1
9537	vismodegib	Smoothened homolog	CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1
9538	ivacaftor	Cystic fibrosis transmembrane conductance regulator	CC(C)(C)C1=CC(=C(NC(=O)C2=CNC3=CC=CC=C3C2=O)C=C1O)C(C)(C)C
9539	tafluprost	Prostaglandin F2-alpha receptor	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1
9540	peginesatide	Erythropoietin receptor	[H]C(CCCCNC(=O)OCCOC)(NC(=O)OCCOC)C(=O)NCCC(=O)N(CC(=O)NCCCC[C@H](NC(=O)CN(C)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(C)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@]([H])(CC2=CC=CC3=C2C=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)N1)C(N)=O)CC(=O)NCCCC[C@H](NC(=O)CN(C)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(C)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@]([H])(CC2=CC=CC3=C2C=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)N1)C(N)=O
9541	avobenzone	Tyrosinase	COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C
9542	bismuth subsalicylate	Cyclooxygenase	O[Bi]1OC(=O)C2=CC=CC=C2O1
9543	tapentadol	Mu-type opioid receptor	CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
9544	tapentadol	Sodium-dependent noradrenaline transporter	CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
9545	tapentadol	Solute carrier family 22 member 1	CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
9546	apixaban	Prothrombin	COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O
9547	apixaban	Coagulation factor X	COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O
9548	cobicistat	Cytochrome P450 3A	CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1
9549	glycopyrronium bromide	Muscarinic acetylcholine receptor M1	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
9550	glycopyrronium bromide	Muscarinic acetylcholine receptor M2	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
9551	glycopyrronium bromide	Muscarinic acetylcholine receptor M3	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
9552	glycopyrronium bromide	Muscarinic acetylcholine receptor M4	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
9553	glycopyrronium bromide	Muscarinic acetylcholine receptor M5	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
9554	eslicarbazepine acetate	Sodium channel alpha subunit	CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12
9555	dapagliflozin	Sodium/glucose cotransporter 2	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1
9556	dapagliflozin	Sodium/glucose cotransporter 1	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1
9557	dapagliflozin	Sodium/myo-inositol cotransporter 2	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1
9558	dapagliflozin	Low affinity sodium-glucose cotransporter	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1
9559	avanafil	cGMP-specific 3',5'-cyclic phosphodiesterase	COC1=C(Cl)C=C(CNC2=NC(=NC=C2C(=O)NCC2=NC=CC=N2)N2CCC[C@H]2CO)C=C1
9560	avanafil	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	COC1=C(Cl)C=C(CNC2=NC(=NC=C2C(=O)NCC2=NC=CC=N2)N2CCC[C@H]2CO)C=C1
9561	lasofoxifene	Estrogen receptor	[H]C1(CCC2=CC(O)=CC=C2C1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
9562	lasofoxifene	Estrogen receptor beta	[H]C1(CCC2=CC(O)=CC=C2C1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
9563	lacosamide	Sodium channel protein type 9 subunit alpha	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9564	lacosamide	Carbonic anhydrase 2	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9565	lacosamide	Carbonic anhydrase 1	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9566	lacosamide	Carbonic anhydrase 4	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9567	lacosamide	Carbonic anhydrase 9	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9568	lacosamide	Carbonic anhydrase 12	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9569	lacosamide	Carbonic anhydrase 5A, mitochondrial	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9570	lacosamide	Carbonic anhydrase 5B, mitochondrial	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9571	lacosamide	Carbonic anhydrase 7	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9572	lacosamide	Carbonic anhydrase 3	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9573	lacosamide	Carbonic anhydrase 6	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9574	lacosamide	Carbonic anhydrase 14	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9575	lacosamide	Sodium channel protein type 2 subunit alpha	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9576	lacosamide	Carbonic anhydrase 13	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9577	lacosamide	Carbonic anhydrase 15	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9578	lacosamide	Sodium channel protein type 3 subunit alpha	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9579	lacosamide	Dihydropyrimidinase-related protein 2	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9580	lacosamide	Sodium channel protein type X alpha subunit	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
9581	afatinib	Tyrosine-protein kinase ABL1	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9582	afatinib	Epidermal growth factor receptor	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9583	afatinib	Proto-oncogene tyrosine-protein kinase Src	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9584	afatinib	Tyrosine-protein kinase Lck	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9585	afatinib	Receptor-type tyrosine-protein kinase FLT3	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9586	afatinib	Receptor tyrosine-protein kinase erbB-2	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9587	afatinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9588	afatinib	Tyrosine-protein kinase HCK	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9589	afatinib	Receptor tyrosine-protein kinase erbB-4	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9590	afatinib	Mitogen-activated protein kinase 10	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9591	afatinib	Hepatocyte growth factor receptor	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9592	afatinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9593	afatinib	Serine/threonine-protein kinase 10	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9594	afatinib	Serine/threonine-protein kinase 17A	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9595	afatinib	Ephrin type-A receptor 6	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9596	afatinib	Casein kinase I isoform epsilon	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9597	afatinib	Mitogen-activated protein kinase 14	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9598	afatinib	Tyrosine-protein kinase FRK	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9599	afatinib	Cyclin-G-associated kinase	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9600	afatinib	Receptor-interacting serine/threonine-protein kinase 2	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9601	afatinib	STE20-like serine/threonine-protein kinase	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9602	afatinib	MAP kinase-interacting serine/threonine-protein kinase 2	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9603	afatinib	Mitogen-activated protein kinase 9	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9604	afatinib	Tyrosine-protein kinase receptor UFO	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9605	afatinib	Ribosomal protein S6 kinase alpha-6	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9606	afatinib	Tyrosine-protein kinase TXK	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9607	afatinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9608	afatinib	MAP kinase-interacting serine/threonine-protein kinase 1	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9609	afatinib	Tyrosine-protein kinase Blk	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9610	afatinib	Citron Rho-interacting kinase	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9611	afatinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9612	afatinib	Dual specificity tyrosine-phosphorylation-regulated kinase 2	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9613	afatinib	Ephrin type-B receptor 6	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9614	afatinib	Homeodomain-interacting protein kinase 4	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9615	afatinib	Interleukin-1 receptor-associated kinase 1	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9616	afatinib	Receptor tyrosine-protein kinase erbB-3	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9617	afatinib	Serine/threonine-protein kinase SBK1	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9618	afatinib	Dual specificity mitogen-activated protein kinase kinase 5	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1
9619	azilsartan medoxomil	Type-1 angiotensin II receptor	CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NOC(=O)N1
9620	laropiprant	Prostaglandin E2 receptor EP1 subtype	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9621	laropiprant	Prostaglandin D2 receptor 2	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9622	laropiprant	Prostaglandin E2 receptor EP3 subtype	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9623	laropiprant	Prostacyclin receptor	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9624	laropiprant	Thromboxane A2 receptor	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9625	laropiprant	Prostaglandin E2 receptor EP2 subtype	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9626	laropiprant	Prostaglandin F2-alpha receptor	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9627	laropiprant	Prostaglandin D2 receptor	CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1
9628	pasireotide	Somatostatin receptor type 2	NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
9629	pasireotide	Somatostatin receptor type 3	NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
9630	pasireotide	Somatostatin receptor type 5	NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
9631	pasireotide	Somatostatin receptor type 1	NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
9632	bazedoxifene	Estrogen receptor	CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1
9633	bazedoxifene	Estrogen receptor beta	CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1
9634	amifampridine	Voltage-gated potassium channel	NC1=CC=NC=C1N
9635	ambrisentan	Endothelin B receptor	COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1
9636	ambrisentan	Endothelin-1 receptor	COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1
9637	alogliptin	Dipeptidyl peptidase 4	CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O
9638	zucapsaicin	Transient receptor potential cation channel subfamily V member 1	COC1=CC(CNC(=O)CCCC\C=C/C(C)C)=CC=C1O
9639	bilastine	Histamine H1 receptor	CCOCCN1C(=NC2=C1C=CC=C2)C1CCN(CCC2=CC=C(C=C2)C(C)(C)C(O)=O)CC1
9640	bosutinib	Tyrosine-protein kinase JAK3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9641	bosutinib	Macrophage-stimulating protein receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9642	bosutinib	Platelet-derived growth factor receptor beta	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9643	bosutinib	Tyrosine-protein kinase ABL1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9644	bosutinib	Mast/stem cell growth factor receptor Kit	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9645	bosutinib	Epidermal growth factor receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9646	bosutinib	Proto-oncogene tyrosine-protein kinase Src	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9647	bosutinib	Tyrosine-protein kinase Lck	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9648	bosutinib	Tyrosine-protein kinase Yes	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9649	bosutinib	Tyrosine-protein kinase Fyn	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9650	bosutinib	Ephrin type-A receptor 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9651	bosutinib	Receptor-type tyrosine-protein kinase FLT3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9652	bosutinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9653	bosutinib	Macrophage colony-stimulating factor 1 receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9654	bosutinib	Platelet-derived growth factor receptor alpha	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9655	bosutinib	Receptor tyrosine-protein kinase erbB-2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9656	bosutinib	Ribosomal protein S6 kinase alpha-3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9657	bosutinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9658	bosutinib	Myosin light chain kinase, smooth muscle	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9659	bosutinib	Rho-associated protein kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9660	bosutinib	Focal adhesion kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9661	bosutinib	Tyrosine-protein kinase HCK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9662	bosutinib	Serine/threonine-protein kinase PLK1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9663	bosutinib	Receptor tyrosine-protein kinase erbB-4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9664	bosutinib	High affinity nerve growth factor receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9665	bosutinib	Protein kinase C delta type	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9666	bosutinib	Tyrosine-protein kinase JAK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9667	bosutinib	Rho-associated protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9668	bosutinib	Tyrosine-protein kinase SYK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9669	bosutinib	Tyrosine-protein kinase CSK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9670	bosutinib	Angiopoietin-1 receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9671	bosutinib	Ephrin type-A receptor 8	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9672	bosutinib	Calcium/calmodulin-dependent protein kinase type II subunit gamma	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9673	bosutinib	AP2-associated protein kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9674	bosutinib	Hepatocyte growth factor receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9675	bosutinib	Tyrosine-protein kinase Lyn	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9676	bosutinib	Cytoplasmic tyrosine-protein kinase BMX	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9677	bosutinib	Serine/threonine-protein kinase Nek2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9678	bosutinib	Ribosomal protein S6 kinase alpha-2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9679	bosutinib	5'-AMP-activated protein kinase catalytic subunit alpha-1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9680	bosutinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9681	bosutinib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9682	bosutinib	Serine/threonine-protein kinase 10	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9683	bosutinib	Tyrosine-protein kinase Fer	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9684	bosutinib	Protein kinase C epsilon type	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9685	bosutinib	Abelson tyrosine-protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9686	bosutinib	Ephrin type-A receptor 5	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9687	bosutinib	Ephrin type-A receptor 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9688	bosutinib	Serine/threonine-protein kinase N1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9689	bosutinib	Protein kinase C theta type	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9690	bosutinib	Ephrin type-A receptor 6	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9691	bosutinib	TRAF2 and NCK-interacting protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9692	bosutinib	Casein kinase I isoform epsilon	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9693	bosutinib	Tyrosine-protein kinase Fgr	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9694	bosutinib	ALK tyrosine kinase receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9695	bosutinib	Serine/threonine-protein kinase 36	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9696	bosutinib	Ephrin type-A receptor 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9697	bosutinib	BMP-2-inducible protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9698	bosutinib	Tyrosine-protein kinase FRK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9699	bosutinib	Dual specificity protein kinase CLK1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9700	bosutinib	Dual specificity protein kinase CLK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9701	bosutinib	Dual specificity protein kinase CLK3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9702	bosutinib	Mitogen-activated protein kinase kinase kinase kinase 5	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9703	bosutinib	Mitogen-activated protein kinase kinase kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9704	bosutinib	Cyclin-G-associated kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9705	bosutinib	Receptor-interacting serine/threonine-protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9706	bosutinib	Ephrin type-B receptor 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9707	bosutinib	Calcium/calmodulin-dependent protein kinase type 1D	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9708	bosutinib	Cyclin-dependent kinase 16	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9709	bosutinib	Serine/threonine-protein kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9710	bosutinib	Activated CDC42 kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9711	bosutinib	STE20-like serine/threonine-protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9712	bosutinib	Dual specificity protein kinase CLK4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9713	bosutinib	Calcium/calmodulin-dependent protein kinase kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9714	bosutinib	Epithelial discoidin domain-containing receptor 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9715	bosutinib	Ephrin type-B receptor 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9716	bosutinib	Testis-specific serine/threonine-protein kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9717	bosutinib	Cyclin-dependent kinase 15	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9718	bosutinib	Dual specificity mitogen-activated protein kinase kinase 7	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9719	bosutinib	Dual specificity mitogen-activated protein kinase kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9720	bosutinib	Dual specificity mitogen-activated protein kinase kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9721	bosutinib	Tyrosine-protein kinase ITK/TSK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9722	bosutinib	Tyrosine-protein kinase ZAP-70	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9723	bosutinib	Tyrosine-protein kinase BTK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9724	bosutinib	Tyrosine-protein kinase Tec	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9725	bosutinib	Tyrosine-protein kinase receptor UFO	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9726	bosutinib	BDNF/NT-3 growth factors receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9727	bosutinib	Tyrosine-protein kinase receptor TYRO3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9728	bosutinib	Ephrin type-B receptor 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9729	bosutinib	Cyclin-dependent kinase 7	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9730	bosutinib	Ribosomal protein S6 kinase beta-1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9731	bosutinib	Serine/threonine-protein kinase N2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9732	bosutinib	Serine/threonine-protein kinase DCLK3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9733	bosutinib	Serine/threonine-protein kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9734	bosutinib	Ribosomal protein S6 kinase alpha-6	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9735	bosutinib	NUAK family SNF1-like kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9736	bosutinib	Non-receptor tyrosine-protein kinase TYK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9737	bosutinib	Serine/threonine-protein kinase Chk1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9738	bosutinib	Serine/threonine-protein kinase PAK 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9739	bosutinib	Cyclin-dependent kinase 14	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9740	bosutinib	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9741	bosutinib	Wee1-like protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9742	bosutinib	Serine/threonine-protein kinase 25	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9743	bosutinib	Mitogen-activated protein kinase kinase kinase MLT	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9744	bosutinib	Protein-tyrosine kinase 2-beta	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9745	bosutinib	Serine/threonine-protein kinase RIO1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9746	bosutinib	Casein kinase I isoform alpha-like	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9747	bosutinib	Casein kinase I isoform delta	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9748	bosutinib	Tyrosine-protein kinase receptor Tie-1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9749	bosutinib	Serine/threonine-protein kinase tousled-like 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9750	bosutinib	Serine/threonine-protein kinase tousled-like 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9751	bosutinib	NT-3 growth factor receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9752	bosutinib	Tyrosine-protein kinase TXK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9753	bosutinib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9754	bosutinib	Dual specificity mitogen-activated protein kinase kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9755	bosutinib	Serine/threonine-protein kinase 26	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9756	bosutinib	Serine/threonine-protein kinase NLK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9757	bosutinib	Eukaryotic translation initiation factor 2-alpha kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9758	bosutinib	Serine/threonine-protein kinase RIO3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9759	bosutinib	Serine/threonine-protein kinase SIK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9760	bosutinib	Serine/threonine-protein kinase 33	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9761	bosutinib	Serine/threonine-protein kinase TNNI3K	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9762	bosutinib	Ankyrin repeat and protein kinase domain-containing protein 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9763	bosutinib	Discoidin domain-containing receptor 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9764	bosutinib	Myotonin-protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9765	bosutinib	Leukocyte tyrosine kinase receptor	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9766	bosutinib	Mitogen-activated protein kinase kinase kinase kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9767	bosutinib	NUAK family SNF1-like kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9768	bosutinib	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9769	bosutinib	Mitogen-activated protein kinase kinase kinase kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9770	bosutinib	Tyrosine-protein kinase Blk	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9771	bosutinib	Bone morphogenetic protein receptor type-2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9772	bosutinib	Mitogen-activated protein kinase kinase kinase kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9773	bosutinib	Dual specificity mitogen-activated protein kinase kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9774	bosutinib	Dual specificity mitogen-activated protein kinase kinase 6	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9775	bosutinib	Tyrosine-protein kinase Mer	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9776	bosutinib	Mitogen-activated protein kinase kinase kinase 9	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9777	bosutinib	Mitogen-activated protein kinase kinase kinase 11	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9778	bosutinib	Serine/threonine-protein kinase 24	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9779	bosutinib	Citron Rho-interacting kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9780	bosutinib	Myosin-IIIa	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9781	bosutinib	Myosin-IIIb	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9782	bosutinib	Serine/threonine-protein kinase PAK 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9783	bosutinib	Serine/threonine-protein kinase PAK 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9784	bosutinib	Serine/threonine-protein kinase SIK1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9785	bosutinib	Tyrosine-protein kinase Srms	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9786	bosutinib	Ephrin type-A receptor 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9787	bosutinib	Ephrin type-B receptor 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9788	bosutinib	Mitogen-activated protein kinase 7	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9789	bosutinib	Serine/threonine-protein kinase D3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9790	bosutinib	Tyrosine-protein kinase Fes/Fps	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9791	bosutinib	Casein kinase I isoform alpha	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9792	bosutinib	Mitogen-activated protein kinase kinase kinase kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9793	bosutinib	Misshapen-like kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9794	bosutinib	Serine/threonine-protein kinase TBK1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9795	bosutinib	Interleukin-1 receptor-associated kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9796	bosutinib	Serine/threonine-protein kinase Chk2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9797	bosutinib	Ephrin type-B receptor 6	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9798	bosutinib	G protein-coupled receptor kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9799	bosutinib	G protein-coupled receptor kinase 7	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9800	bosutinib	Homeodomain-interacting protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9801	bosutinib	Homeodomain-interacting protein kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9802	bosutinib	Homeodomain-interacting protein kinase 4	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9803	bosutinib	Hormonally up-regulated neu tumor-associated kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9804	bosutinib	Interleukin-1 receptor-associated kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9805	bosutinib	Mitogen-activated protein kinase kinase kinase 13	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9806	bosutinib	Mitogen-activated protein kinase kinase kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9807	bosutinib	Mitogen-activated protein kinase kinase kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9808	bosutinib	Microtubule-associated serine/threonine-protein kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9809	bosutinib	Serine/threonine-protein kinase NIM1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9810	bosutinib	SRSF protein kinase 3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9811	bosutinib	STE20/SPS1-related proline-alanine-rich protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9812	bosutinib	Mitogen-activated protein kinase kinase kinase 7	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9813	bosutinib	Serine/threonine-protein kinase TAO1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9814	bosutinib	Serine/threonine-protein kinase TAO3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9815	bosutinib	Serine/threonine-protein kinase ULK1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9816	bosutinib	Serine/threonine-protein kinase ULK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9817	bosutinib	Serine/threonine-protein kinase ULK3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9818	bosutinib	Mitogen-activated protein kinase kinase kinase 19	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9819	bosutinib	Homeodomain-interacting protein kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9820	bosutinib	Serine/threonine-protein kinase PLK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9821	bosutinib	Serine/threonine-protein kinase 35	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9822	bosutinib	Megakaryocyte-associated tyrosine-protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9823	bosutinib	Receptor tyrosine-protein kinase erbB-3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9824	bosutinib	Mitogen-activated protein kinase kinase kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9825	bosutinib	Serine/threonine-protein kinase SIK3	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9826	bosutinib	Wee1-like protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9827	bosutinib	Serine/threonine-protein kinase 32A	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9828	bosutinib	Peripheral plasma membrane protein CASK	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9829	bosutinib	Serine/threonine-protein kinase VRK2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9830	bosutinib	Mitogen-activated protein kinase kinase kinase 12	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9831	bosutinib	Eukaryotic translation initiation factor 2-alpha kinase 1	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9832	bosutinib	Serine/threonine-protein kinase TAO2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9833	bosutinib	Dual specificity mitogen-activated protein kinase kinase 5	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9834	bosutinib	Serine/threonine-protein kinase Nek11	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9835	bosutinib	Leucine-rich repeat serine/threonine-protein kinase 2	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9836	bosutinib	Dual serine/threonine and tyrosine protein kinase	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9837	bosutinib	Serine/threonine-protein kinase PknB	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9838	bosutinib	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9839	bosutinib	Tyrosine-protein kinase ABL	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9840	bosutinib	Bcr/Abl fusion protein	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl
9841	chenodiol	fMet-Leu-Phe receptor	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
9842	chenodiol	Bile acid receptor	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
9843	chenodiol	G-protein coupled bile acid receptor 1	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
9844	vernakalant	Sodium channel protein type 5 subunit alpha	COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
9845	vernakalant	Potassium voltage-gated channel subfamily H member 2	COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
9846	vernakalant	Potassium voltage-gated channel subfamily D member 2	COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
9847	vernakalant	Potassium voltage-gated channel subfamily A member 5	COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
9848	lorcaserin	Sodium-dependent serotonin transporter	C[C@H]1CNCCC2=CC=C(Cl)C=C12
9849	lorcaserin	5-hydroxytryptamine receptor 2A	C[C@H]1CNCCC2=CC=C(Cl)C=C12
9850	lorcaserin	5-hydroxytryptamine receptor 2B	C[C@H]1CNCCC2=CC=C(Cl)C=C12
9851	lorcaserin	5-hydroxytryptamine receptor 2C	C[C@H]1CNCCC2=CC=C(Cl)C=C12
9852	degarelix	Gonadotropin-releasing hormone receptor	[H][C@]1(CC(=O)NC(=O)N1)C(=O)NC1=CC=C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](CC2=CN=CC=C2)NC(=O)[C@@H](CC2=CC=C(Cl)C=C2)NC(=O)[C@@H](CC2=CC3=C(C=CC=C3)C=C2)NC(C)=O)C(=O)N[C@H](CC2=CC=C(NC(N)=O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)C=C1
9853	desvenlafaxine	Sodium-dependent serotonin transporter	CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
9854	desvenlafaxine	Sodium-dependent noradrenaline transporter	CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
9855	desvenlafaxine	Alpha-1A adrenergic receptor	CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
9856	dapoxetine	Sodium-dependent serotonin transporter	CN(C)[C@@H](CCOC1=CC=CC2=C1C=CC=C2)C1=CC=CC=C1
9857	mirabegron	Beta-3 adrenergic receptor	NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1
9858	choline theophyllinate	Adenosine receptor A2a	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9859	choline theophyllinate	Adenosine receptor A1	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9860	choline theophyllinate	Adenosine receptor A2b	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9861	choline theophyllinate	Adenosine receptor A3	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9862	choline theophyllinate	Alkaline phosphatase, tissue-nonspecific isozyme	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9863	choline theophyllinate	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9864	choline theophyllinate	Uncharacterized protein	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9865	choline theophyllinate	Adenosine A2 receptor	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9866	choline theophyllinate	Phosphodiesterase 3	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9867	choline theophyllinate	Phosphodiesterase 4	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9868	choline theophyllinate	Adenosine A2b receptor	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9869	choline theophyllinate	Adenosine receptor	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9870	choline theophyllinate	Heart phosphodiesterase	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9871	choline theophyllinate	Adenosine A2a receptor	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O
9872	eltrombopag	Potassium voltage-gated channel subfamily H member 2	CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC(=CC=C2)C(O)=O)=C1O)C1=CC(C)=C(C)C=C1
9873	eltrombopag	Thrombopoietin receptor	CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC(=CC=C2)C(O)=O)=C1O)C1=CC(C)=C(C)C=C1
9874	casopitant	Sigma non-opioid intracellular receptor 1	C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=C(C)C=C(F)C=C1)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
9875	casopitant	Substance-P receptor	C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=C(C)C=C(F)C=C1)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
9876	plerixafor	C-X-C chemokine receptor type 4	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
9877	plerixafor	C-C chemokine receptor type 2	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
9878	plerixafor	Stromal cell-derived factor 1	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
9879	plerixafor	C-C chemokine receptor type 4	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
9880	plerixafor	Atypical chemokine receptor 3	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
9881	dexchlorpheniramine	Alpha-2A adrenergic receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9882	dexchlorpheniramine	Sigma non-opioid intracellular receptor 1	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9883	dexchlorpheniramine	Sodium-dependent serotonin transporter	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9884	dexchlorpheniramine	Sodium-dependent noradrenaline transporter	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9885	dexchlorpheniramine	5-hydroxytryptamine receptor 2A	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9886	dexchlorpheniramine	5-hydroxytryptamine receptor 2C	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9887	dexchlorpheniramine	Alpha-2B adrenergic receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9888	dexchlorpheniramine	Histamine H1 receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9889	dexchlorpheniramine	Histamine H2 receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9890	dexchlorpheniramine	Muscarinic acetylcholine receptor M1	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9891	dexchlorpheniramine	Muscarinic acetylcholine receptor M2	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9892	dexchlorpheniramine	Muscarinic acetylcholine receptor M3	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9893	dexchlorpheniramine	Muscarinic acetylcholine receptor M4	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9894	dexchlorpheniramine	Muscarinic acetylcholine receptor M5	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9895	dexchlorpheniramine	Sodium-dependent dopamine transporter	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9896	dexchlorpheniramine	Alpha-1D adrenergic receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9897	dexchlorpheniramine	Alpha-1B adrenergic receptor	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9898	dexchlorpheniramine	Membrane-associated progesterone receptor component 1	CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
9899	calcitonin human	Calcitonin receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC1=O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
9900	calcitonin human	Amylin receptor AMY1	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC1=O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
9901	calcitonin human	Amylin receptor AMY2	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC1=O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
9902	calcitonin human	Amylin receptor AMY3	[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC1=O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
9903	prednisolone sodium phosphate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9904	clobetasol propionate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9905	clobetasol propionate	Annexin A1	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9906	clobetasol propionate	Bile salt export pump	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9907	clobetasol propionate	Androgen receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9908	clobetasol propionate	Cytochrome P450 3A5	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9909	clobetasol propionate	Progesterone receptor	[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9910	testosterone cypionate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9911	hydrocortisone succinate	Glucocorticoid receptor	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9912	fosaprepitant	Substance-P receptor	C[C@@H](O[C@H]1OCCN(CC2=NN(C(=O)N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
9913	corbadrine	Alpha-1D adrenergic receptor	C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
9914	corbadrine	Adrenergic receptor alpha-2	C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
9915	corbadrine	Adrenergic receptor alpha-1	C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
9916	carfilzomib	Potassium voltage-gated channel subfamily H member 2	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9917	carfilzomib	Cathepsin B	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9918	carfilzomib	Proteasome subunit beta type-8	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9919	carfilzomib	Proteasome subunit beta type-1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9920	carfilzomib	Proteasome subunit beta type-2	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9921	carfilzomib	Glutathione S-transferase omega-1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9922	carfilzomib	Proteasome subunit beta type-9	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9923	carfilzomib	Proteasome subunit beta type-10	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9924	carfilzomib	Proteasome subunit beta type-5	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
9925	aclidinium bromide	Muscarinic acetylcholine receptor M1	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
9926	aclidinium bromide	Muscarinic acetylcholine receptor M2	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
9927	aclidinium bromide	Muscarinic acetylcholine receptor M3	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
9928	aclidinium bromide	Muscarinic acetylcholine receptor M4	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
9929	aclidinium bromide	Muscarinic acetylcholine receptor M5	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
9930	diflorasone diacetate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](OC(C)=O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
9931	diflorasone diacetate	Progesterone receptor	[H][C@@]12C[C@H](C)[C@](OC(C)=O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
9932	alclometasone dipropionate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C
9933	haloperidol decanoate	D(2) dopamine receptor	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
9934	haloperidol decanoate	D(3) dopamine receptor	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
9935	haloperidol decanoate	D(4) dopamine receptor	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
9936	haloperidol decanoate	D(1A) dopamine receptor	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
9937	estradiol acetate	Estrogen receptor	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(C)=O)C=C3
9938	paliperidone palmitate	Potassium voltage-gated channel subfamily H member 2	CCCCCCCCCCCCCCCC(=O)OC1CCCN2C(=O)C(CCN3CCC(CC3)C3=NOC4=C3C=CC(F)=C4)=C(C)N=C12
9939	paliperidone palmitate	D(2) dopamine receptor	CCCCCCCCCCCCCCCC(=O)OC1CCCN2C(=O)C(CCN3CCC(CC3)C3=NOC4=C3C=CC(F)=C4)=C(C)N=C12
9940	paliperidone palmitate	5-hydroxytryptamine receptor 2A	CCCCCCCCCCCCCCCC(=O)OC1CCCN2C(=O)C(CCN3CCC(CC3)C3=NOC4=C3C=CC(F)=C4)=C(C)N=C12
9941	armodafinil	D(2) dopamine receptor	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9942	armodafinil	D(3) dopamine receptor	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9943	armodafinil	Sodium-dependent dopamine transporter	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9944	armodafinil	Alpha-1B adrenergic receptor	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9945	armodafinil	Cytochrome P450 1A2	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9946	armodafinil	Cytochrome P450 2C19	NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
9947	hydrocortisone valerate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9948	choline fenofibrate	Peroxisome proliferator-activated receptor alpha	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
9949	choline fenofibrate	Fatty acid-binding protein, intestinal	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
9950	choline fenofibrate	Fatty acid-binding protein, liver	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
9951	choline fenofibrate	Solute carrier family 22 member 12	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
9952	halcinonide	Glucocorticoid receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CCl
9953	halcinonide	Androgen receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CCl
9954	halcinonide	Progesterone receptor	[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CCl
9955	lithium citrate	Glycogen synthase kinase-3	[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
9956	lithium citrate	Inositol-1(or 4)-monophosphatase 1	[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
9957	teriparatide	Parathyroid hormone/parathyroid hormone-related peptide receptor	[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
9958	teriparatide	Parathyroid hormone 2 receptor	[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
9959	tetracosactide	Melanocortin receptor 4	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O
9960	tetracosactide	Adrenocorticotropic hormone receptor	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O
9961	fluticasone furoate	Glucocorticoid receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF
9962	fluticasone furoate	Mineralocorticoid receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF
9963	fluticasone furoate	Progesterone receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF
9964	fluticasone furoate	Androgen receptor	[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF
9965	sodium oxybate	GABA-B receptor	[Na+].OCCCC([O-])=O
9966	sodium oxybate	Gamma-hydroxybutyrate receptor	[Na+].OCCCC([O-])=O
9967	hydrocortisone probutate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9968	clocortolone pivalate	Glucocorticoid receptor	[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
9969	testosterone enantate	Androgen receptor	[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9970	methylnaltrexone	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CC[N+](C)(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
9971	methylnaltrexone	Cytochrome P450 2D6	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CC[N+](C)(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
9972	methylnaltrexone	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CC[N+](C)(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
9973	methylnaltrexone	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CC[N+](C)(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
9974	linaclotide	Heat-stable enterotoxin receptor	[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
9975	enzalutamide	Androgen receptor	CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC(=C(C=C1)C#N)C(F)(F)F
9976	teriflunomide	Dihydroorotate dehydrogenase (quinone), mitochondrial	C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
9977	teriflunomide	Dihydrofolate reductase	C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
9978	teriflunomide	Dihydroorotate dehydrogenase	C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
9979	levmetamfetamine	Trace amine-associated receptor 1	CN[C@H](C)CC1=CC=CC=C1
9980	fluorometholone acetate	Glucocorticoid receptor	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
9981	regorafenib	Glycine receptor subunit alpha-1	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9982	regorafenib	Platelet-derived growth factor receptor beta	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9983	regorafenib	Mast/stem cell growth factor receptor Kit	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9984	regorafenib	RAF proto-oncogene serine/threonine-protein kinase	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9985	regorafenib	Serine/threonine-protein kinase B-raf	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9986	regorafenib	Receptor-type tyrosine-protein kinase FLT3	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9987	regorafenib	Vascular endothelial growth factor receptor 1	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9988	regorafenib	Vascular endothelial growth factor receptor 2	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9989	regorafenib	Angiopoietin-1 receptor	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9990	regorafenib	Fibroblast growth factor receptor 1	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9991	regorafenib	Bifunctional epoxide hydrolase 2	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9992	regorafenib	Vascular endothelial growth factor receptor 3	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1
9993	metamizole	Transient receptor potential cation channel subfamily A member 1	CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
9994	betamethasone phosphate	Histamine H1 receptor	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9995	betamethasone phosphate	Muscarinic acetylcholine receptor M1	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9996	betamethasone phosphate	Muscarinic acetylcholine receptor M3	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9997	betamethasone phosphate	Muscarinic acetylcholine receptor M4	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9998	betamethasone phosphate	Muscarinic acetylcholine receptor M5	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
9999	betamethasone phosphate	Glucocorticoid receptor	[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
10000	nalfurafine	Orexin receptor type 1	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10001	nalfurafine	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10002	nalfurafine	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10003	nalfurafine	Nociceptin receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10004	nalfurafine	Mitogen-activated protein kinase 3	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10005	nalfurafine	Mitogen-activated protein kinase 1	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10006	nalfurafine	Kappa-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1
10007	panobinostat	Histone deacetylase	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10008	panobinostat	Bromodomain-containing protein 4	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10009	panobinostat	Histone deacetylase 8	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10010	panobinostat	Histone deacetylase 5	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10011	panobinostat	Histone deacetylase 2	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10012	panobinostat	Histone deacetylase 1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10013	panobinostat	Histone deacetylase 3	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10014	panobinostat	Histone deacetylase 6	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10015	panobinostat	Histone deacetylase 7	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10016	panobinostat	Histone deacetylase 4	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10017	panobinostat	Histone deacetylase 9	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10018	panobinostat	Histone deacetylase 10	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10019	panobinostat	Histone deacetylase 11	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
10020	perampanel	Glutamate receptor ionotropic AMPA	O=C1N(C=C(C=C1C1=C(C=CC=C1)C#N)C1=CC=CC=N1)C1=CC=CC=C1
10021	remikiren	Renin	[H][C@@](CC1CCCCC1)(NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CC1=CC=CC=C1)CS(=O)(=O)C(C)(C)C)[C@@H](O)[C@@H](O)C1CC1
10022	tofacitinib	Tyrosine-protein kinase JAK3	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10023	tofacitinib	Tyrosine-protein kinase ABL1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10024	tofacitinib	Tyrosine-protein kinase Lck	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10025	tofacitinib	Tyrosine-protein kinase Fyn	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10026	tofacitinib	Proto-oncogene tyrosine-protein kinase receptor Ret	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10027	tofacitinib	Calcium/calmodulin-dependent protein kinase type 1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10028	tofacitinib	Rho-associated protein kinase 1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10029	tofacitinib	Tyrosine-protein kinase JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10030	tofacitinib	Protein kinase C delta type	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10031	tofacitinib	Tyrosine-protein kinase JAK2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10032	tofacitinib	Rho-associated protein kinase 2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10033	tofacitinib	Calcium/calmodulin-dependent protein kinase type II subunit delta	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10034	tofacitinib	Ribosomal protein S6 kinase alpha-2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10035	tofacitinib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10036	tofacitinib	Serine/threonine-protein kinase N1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10037	tofacitinib	BMP-2-inducible protein kinase	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10038	tofacitinib	Calcium/calmodulin-dependent protein kinase type 1D	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10039	tofacitinib	MAP kinase-interacting serine/threonine-protein kinase 2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10040	tofacitinib	Serine/threonine-protein kinase N2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10041	tofacitinib	Serine/threonine-protein kinase DCLK3	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10042	tofacitinib	Serine/threonine-protein kinase 3	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10043	tofacitinib	Ribosomal protein S6 kinase alpha-6	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10044	tofacitinib	NUAK family SNF1-like kinase 2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10045	tofacitinib	Non-receptor tyrosine-protein kinase TNK1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10046	tofacitinib	Non-receptor tyrosine-protein kinase TYK2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10047	tofacitinib	Myotonin-protein kinase	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10048	tofacitinib	Serine/threonine-protein kinase DCLK1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10049	tofacitinib	Ribosomal protein S6 kinase alpha-1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10050	tofacitinib	Mitogen-activated protein kinase kinase kinase kinase 2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10051	tofacitinib	G protein-coupled receptor kinase 7	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10052	tofacitinib	Serine/threonine-protein kinase ULK3	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10053	tofacitinib	Leucine-rich repeat serine/threonine-protein kinase 2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10054	tofacitinib	Serine/threonine-protein kinase PknB	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10055	tofacitinib	JAK1/TYK2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10056	tofacitinib	JAK1/JAK2/TYK2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10057	tofacitinib	JAK2/TYK2	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10058	tofacitinib	JAK2/JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10059	tofacitinib	JAK3/JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
10060	cabozantinib	Macrophage-stimulating protein receptor	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10061	cabozantinib	Epidermal growth factor receptor	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10062	cabozantinib	Proto-oncogene tyrosine-protein kinase Src	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10063	cabozantinib	Vascular endothelial growth factor receptor 1	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10064	cabozantinib	Vascular endothelial growth factor receptor 3	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10065	cabozantinib	Fibroblast growth factor receptor 1	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10066	cabozantinib	Aurora kinase A	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10067	cabozantinib	Tyrosine-protein kinase receptor UFO	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10068	cabozantinib	Mast/stem cell growth factor receptor Kit	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10069	cabozantinib	Receptor-type tyrosine-protein kinase FLT3	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10070	cabozantinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10071	cabozantinib	Vascular endothelial growth factor receptor 2	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10072	cabozantinib	Angiopoietin-1 receptor	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10073	cabozantinib	Hepatocyte growth factor receptor	COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC
10074	ponatinib	Platelet-derived growth factor receptor beta	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10075	ponatinib	Tyrosine-protein kinase ABL1	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10076	ponatinib	Mast/stem cell growth factor receptor Kit	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10077	ponatinib	Breakpoint cluster region protein	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10078	ponatinib	Proto-oncogene tyrosine-protein kinase Src	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10079	ponatinib	Receptor-type tyrosine-protein kinase FLT3	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10080	ponatinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10081	ponatinib	Vascular endothelial growth factor receptor 2	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10082	ponatinib	Platelet-derived growth factor receptor alpha	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10083	ponatinib	Fibroblast growth factor receptor 3	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10084	ponatinib	Tyrosine-protein kinase CSK	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10085	ponatinib	Tyrosine-protein kinase Lyn	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10086	ponatinib	Fibroblast growth factor receptor 1	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10087	ponatinib	Fibroblast growth factor receptor 2	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10088	ponatinib	Receptor-interacting serine/threonine-protein kinase 2	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10089	ponatinib	Cyclin-dependent kinase 19	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10090	ponatinib	Cyclin-dependent kinase 8	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10091	ponatinib	Receptor-interacting serine/threonine-protein kinase 1	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10092	ponatinib	Fibroblast growth factor receptor 4	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10093	ponatinib	Bcr/Abl fusion protein	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10094	ponatinib	Receptor-interacting serine/threonine-protein kinase 3	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1
10095	teduglutide	Glucagon-like peptide 2 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O
10096	lomitapide	Microsomal triglyceride transfer protein large subunit	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=C1C=CC=C2
10097	pomalidomide	Cereblon isoform 4	NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
10098	pomalidomide	Protein cereblon	NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
10099	ospemifene	Estrogen receptor	OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
10100	levobetaxolol	Beta-1 adrenergic receptor	CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1
10101	levobetaxolol	Beta-2 adrenergic receptor	CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1
10102	dimethyl fumarate	Hydroxycarboxylic acid receptor 2	COC(=O)\C=C\C(=O)OC
10103	dimethyl fumarate	Kelch-like ECH-associated protein 1	COC(=O)\C=C\C(=O)OC
10104	canagliflozin	Sodium/glucose cotransporter 2	CC1=C(CC2=CC=C(S2)C2=CC=C(F)C=C2)C=C(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
10105	canagliflozin	Sodium/glucose cotransporter 1	CC1=C(CC2=CC=C(S2)C2=CC=C(F)C=C2)C=C(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
10106	canagliflozin	Protease	CC1=C(CC2=CC=C(S2)C2=CC=C(F)C=C2)C=C(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
10107	ridaforolimus	Serine/threonine-protein kinase mTOR	[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](OP(C)(C)=O)[C@@H](C1)OC
10108	vilanterol	Beta-1 adrenergic receptor	OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl
10109	vilanterol	Beta-2 adrenergic receptor	OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl
10110	vilanterol	Beta-3 adrenergic receptor	OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl
10111	dabrafenib	RAF proto-oncogene serine/threonine-protein kinase	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10112	dabrafenib	Serine/threonine-protein kinase B-raf	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10113	dabrafenib	Receptor-interacting serine/threonine-protein kinase 2	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10114	dabrafenib	TGF-beta receptor type-1	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10115	dabrafenib	Receptor-interacting serine/threonine-protein kinase 1	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10116	dabrafenib	Dual serine/threonine and tyrosine protein kinase	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10117	dabrafenib	Serine/threonine-protein kinase A-Raf	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10118	dabrafenib	GTPase KRas	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10119	dabrafenib	Receptor-interacting serine/threonine-protein kinase 3	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
10120	trametinib	Multidrug resistance protein 1	CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1
10121	trametinib	Dual specificity mitogen-activated protein kinase kinase 1	CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1
10122	trametinib	Dual specificity mitogen-activated protein kinase kinase 2	CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1
10123	palifermin	Fibroblast growth factor receptor 2	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
10124	vortioxetine	Beta-1 adrenergic receptor	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10125	vortioxetine	Beta-2 adrenergic receptor	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10126	vortioxetine	5-hydroxytryptamine receptor 2A	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10127	vortioxetine	5-hydroxytryptamine receptor 2C	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10128	vortioxetine	5-hydroxytryptamine receptor 6	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10129	vortioxetine	Histamine H1 receptor	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10130	vortioxetine	Histamine H2 receptor	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10131	vortioxetine	5-hydroxytryptamine receptor 5A	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10132	vortioxetine	Sodium-dependent serotonin transporter	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10133	vortioxetine	Sodium-dependent dopamine transporter	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10134	vortioxetine	5-hydroxytryptamine receptor 3A	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10135	vortioxetine	5-hydroxytryptamine receptor 1D	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10136	vortioxetine	5-hydroxytryptamine receptor 7	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10137	vortioxetine	5-hydroxytryptamine receptor 1A	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10138	vortioxetine	5-hydroxytryptamine receptor 1B	CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1
10139	riociguat	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=NC=CC=C12
10140	riociguat	Guanylate cyclase soluble subunit beta-1	COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=NC=CC=C12
10141	macitentan	Endothelin-1 receptor	CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1
10142	macitentan	Endothelin B receptor	CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1
10143	ibrutinib	Potassium voltage-gated channel subfamily H member 2	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10144	ibrutinib	Tyrosine-protein kinase ABL1	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10145	ibrutinib	Epidermal growth factor receptor	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10146	ibrutinib	Proto-oncogene tyrosine-protein kinase receptor Ret	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10147	ibrutinib	Tyrosine-protein kinase CSK	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10148	ibrutinib	Cytoplasmic tyrosine-protein kinase BMX	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10149	ibrutinib	Tyrosine-protein kinase Fer	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10150	ibrutinib	Fibroblast growth factor receptor 2	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10151	ibrutinib	Protein-tyrosine kinase 6	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10152	ibrutinib	Redox-regulatory protein FAM213A	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10153	ibrutinib	Tyrosine-protein kinase Lyn	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10154	ibrutinib	Tyrosine-protein kinase JAK3	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10155	ibrutinib	Proto-oncogene tyrosine-protein kinase Src	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10156	ibrutinib	Tyrosine-protein kinase Lck	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10157	ibrutinib	Tyrosine-protein kinase Yes	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10158	ibrutinib	Tyrosine-protein kinase Fyn	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10159	ibrutinib	Receptor tyrosine-protein kinase erbB-2	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10160	ibrutinib	Tyrosine-protein kinase HCK	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10161	ibrutinib	Receptor tyrosine-protein kinase erbB-4	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10162	ibrutinib	Tyrosine-protein kinase Fgr	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10163	ibrutinib	Tyrosine-protein kinase ITK/TSK	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10164	ibrutinib	Tyrosine-protein kinase Tec	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10165	ibrutinib	Tyrosine-protein kinase TXK	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10166	ibrutinib	Tyrosine-protein kinase Blk	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10167	ibrutinib	Tyrosine-protein kinase BTK	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C
10168	olodaterol	Beta-1 adrenergic receptor	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1
10169	olodaterol	Beta-3 adrenergic receptor	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1
10170	olodaterol	Beta-2 adrenergic receptor	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1
10171	lixisenatide	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
10172	umeclidinium	Muscarinic acetylcholine receptor M4	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
10173	umeclidinium	Muscarinic acetylcholine receptor M5	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
10174	umeclidinium	Muscarinic acetylcholine receptor M1	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
10175	umeclidinium	Muscarinic acetylcholine receptor M2	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
10176	umeclidinium	Muscarinic acetylcholine receptor M3	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
10177	tasimelteon	Melatonin receptor type 1A	[H][C@@]1(CNC(=O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1
10178	tasimelteon	Melatonin receptor type 1B	[H][C@@]1(CNC(=O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1
10179	seractide	Adrenocorticotropic hormone receptor	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10180	etilefrine pivalate	Beta-1 adrenergic receptor	CCNCC(O)C1=CC(OC(=O)C(C)(C)C)=CC=C1
10181	metreleptin	Leptin receptor	[H]N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC1=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(O)=O
10182	apremilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O
10183	apremilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O
10184	apremilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O
10185	apremilast	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O
10186	empagliflozin	Sodium/glucose cotransporter 4	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1
10187	empagliflozin	Sodium/glucose cotransporter 5	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1
10188	empagliflozin	Sodium/glucose cotransporter 1	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1
10189	empagliflozin	Sodium/myo-inositol cotransporter 2	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1
10190	empagliflozin	Sodium/glucose cotransporter 2	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1
10191	naloxegol	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CC[C@@H]2OCCOCCOCCOCCOCCOCCOCCOC
10192	gemigliptin	Dipeptidyl peptidase 9	N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCC2=C(N=C(N=C2C1)C(F)(F)F)C(F)(F)F
10193	gemigliptin	Dipeptidyl peptidase 4	N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCC2=C(N=C(N=C2C1)C(F)(F)F)C(F)(F)F
10194	eliglustat	Ceramide glucosyltransferase	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1
10195	afamelanotide	Adenosine deaminase	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
10196	afamelanotide	Melanocortin receptor 4	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
10197	afamelanotide	Melanocortin receptor 5	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
10198	afamelanotide	Melanocortin receptor 3	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
10199	afamelanotide	Melanocyte-stimulating hormone receptor	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
10200	aprotinin	Plasminogen	[H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC3=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O
10201	aprotinin	Plasma kallikrein	[H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC3=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O
10202	ecallantide	Plasma kallikrein	[H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC4=CNC=N4)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC3=O)[C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C)NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O
10203	somatropin	Growth hormone receptor	[H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10204	estrone sulphate	Steryl-sulfatase	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3
10205	estrone sulphate	Solute carrier family 22 member 20	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3
10206	estrone sulphate	Estrogen receptor	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3
10207	estrone sulphate	Estrogen receptor beta	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3
10208	corticorelin	Corticotropin-releasing factor receptor 2	[H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(N)=O
10209	corticorelin	Corticotropin-releasing factor receptor 1	[H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(N)=O
10210	phenibut	GABA-B receptor	NCC(CC(O)=O)C1=CC=CC=C1
10211	levomilnacipran	Sodium-dependent dopamine transporter	CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
10212	levomilnacipran	Sodium-dependent serotonin transporter	CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
10213	levomilnacipran	Glutamate NMDA receptor	CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
10214	levomilnacipran	Sodium-dependent noradrenaline transporter	CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
10215	mebanazine	Amine oxidase [flavin-containing] B	CC(NN)C1=CC=CC=C1
10216	mebanazine	Amine oxidase [flavin-containing] A	CC(NN)C1=CC=CC=C1
10217	ceritinib	Tyrosine-protein kinase JAK3	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10218	ceritinib	Potassium voltage-gated channel subfamily H member 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10219	ceritinib	Multidrug resistance protein 1	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10220	ceritinib	Tyrosine-protein kinase ABL1	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10221	ceritinib	Mast/stem cell growth factor receptor Kit	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10222	ceritinib	Epidermal growth factor receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10223	ceritinib	Proto-oncogene tyrosine-protein kinase Src	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10224	ceritinib	Tyrosine-protein kinase Lck	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10225	ceritinib	Receptor-type tyrosine-protein kinase FLT3	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10226	ceritinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10227	ceritinib	Vascular endothelial growth factor receptor 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10228	ceritinib	Platelet-derived growth factor receptor alpha	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10229	ceritinib	Cyclin-dependent kinase 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10230	ceritinib	Fibroblast growth factor receptor 3	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10231	ceritinib	Tyrosine-protein kinase JAK1	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10232	ceritinib	High affinity nerve growth factor receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10233	ceritinib	Tyrosine-protein kinase JAK2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10234	ceritinib	Rho-associated protein kinase 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10235	ceritinib	Tyrosine-protein kinase SYK	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10236	ceritinib	Hepatocyte growth factor receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10237	ceritinib	Tyrosine-protein kinase Lyn	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10238	ceritinib	Fibroblast growth factor receptor 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10239	ceritinib	Tyrosine-protein kinase Fgr	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10240	ceritinib	MAP kinase-interacting serine/threonine-protein kinase 2	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10241	ceritinib	Tyrosine-protein kinase ZAP-70	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10242	ceritinib	Tyrosine-protein kinase BTK	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10243	ceritinib	BDNF/NT-3 growth factors receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10244	ceritinib	Fibroblast growth factor receptor 4	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10245	ceritinib	Proto-oncogene tyrosine-protein kinase ROS	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10246	ceritinib	Cyclin-dependent kinase 4	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10247	ceritinib	Transcription factor ETV6	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10248	ceritinib	Insulin-like growth factor 1 receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10249	ceritinib	Insulin receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10250	ceritinib	Testis-specific serine/threonine-protein kinase 1	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10251	ceritinib	ALK tyrosine kinase receptor	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1
10252	dexrabeprazole	Alpha-2B adrenergic receptor	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10253	dexrabeprazole	D(3) dopamine receptor	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10254	dexrabeprazole	Adenosine receptor A3	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10255	dexrabeprazole	Fatty acid synthase	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10256	dexrabeprazole	Insulin-degrading enzyme	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10257	dexrabeprazole	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10258	dexrabeprazole	Cytosolic endo-beta-N-acetylglucosaminidase	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10259	dexrabeprazole	Sterile alpha and TIR motif-containing protein 1	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10260	dexrabeprazole	Potassium-transporting ATPase	COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C
10261	vorapaxar	Proteinase-activated receptor 1	[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC
10262	belinostat	Histone deacetylase 5	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10263	belinostat	Histone deacetylase 2	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10264	belinostat	Histone deacetylase 1	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10265	belinostat	Histone deacetylase 3	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10266	belinostat	Histone deacetylase 6	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10267	belinostat	Histone deacetylase 7	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10268	belinostat	Histone deacetylase 8	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10269	belinostat	Histone deacetylase 9	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10270	belinostat	Histone deacetylase 10	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10271	belinostat	Histone deacetylase	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10272	belinostat	Histone deacetylase 11	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10273	belinostat	Bromodomain-containing protein 4	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10274	belinostat	Histone deacetylase 4	ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1
10275	idelalisib	DNA-dependent protein kinase catalytic subunit	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10276	idelalisib	Phosphatidylinositol 3-kinase catalytic subunit type 3	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10277	idelalisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10278	idelalisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10279	idelalisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10280	idelalisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
10281	suvorexant	Orexin receptor type 2	C[C@@H]1CCN(CCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
10282	suvorexant	Orexin receptor type 1	C[C@@H]1CCN(CCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
10283	istradefylline	Adenosine receptor A1	CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O
10284	istradefylline	Adenosine receptor A2b	CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O
10285	istradefylline	Adenosine receptor A3	CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O
10286	istradefylline	Amine oxidase [flavin-containing] B	CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O
10287	istradefylline	Adenosine receptor A2a	CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O
10288	cetilistat	Pancreatic triacylglycerol lipase	CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1
10289	topiroxostat	Xanthine dehydrogenase/oxidase	N#CC1=NC=CC(=C1)C1=NNC(=N1)C1=CC=NC=C1
10290	ipragliflozin	Sodium/glucose cotransporter 2	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC3=C(S2)C=CC=C3)=C(F)C=C1
10291	ipragliflozin	Sodium/glucose cotransporter 1	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC3=C(S2)C=CC=C3)=C(F)C=C1
10292	luseogliflozin	Sodium/glucose cotransporter 1	CCOC1=CC=C(CC2=C(C)C=C(OC)C(=C2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1
10293	luseogliflozin	Sodium/glucose cotransporter 2	CCOC1=CC=C(CC2=C(C)C=C(OC)C(=C2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1
10294	tofogliflozin	Sodium/glucose cotransporter 1	CCC1=CC=C(CC2=CC3=C(CO[C@]33O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1
10295	tofogliflozin	Sodium/glucose cotransporter 2	CCC1=CC=C(CC2=CC3=C(CO[C@]33O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1
10296	tipiracil	Thymidine phosphorylase	ClC1=C(CN2CCCC2=N)NC(=O)NC1=O
10297	teneligliptin	Dipeptidyl peptidase 4	[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1
10298	teneligliptin	Dipeptidyl peptidase 8	[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1
10299	teneligliptin	Dipeptidyl peptidase 9	[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1
10300	anagliptin	Prolyl endopeptidase FAP	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N
10301	anagliptin	Dipeptidyl peptidase 8	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N
10302	anagliptin	Dipeptidyl peptidase 9	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N
10303	anagliptin	Dipeptidyl peptidase 4	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N
10304	edoxaban	Coagulation factor X	CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=CC=C(Cl)C=N2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1
10305	netupitant	Substance-P receptor	CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=C(C)C=CC=C1)N1CCN(C)CC1
10306	diquafosol	P2Y purinoceptor 4	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O)N1C=CC(=O)NC1=O
10307	diquafosol	P2Y purinoceptor 2	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O)N1C=CC(=O)NC1=O
10308	insulin glargine	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)NCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10309	imidafenacin	Muscarinic acetylcholine receptor M1	CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
10310	imidafenacin	Muscarinic acetylcholine receptor M3	CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
10311	nintedanib	Tyrosine-protein kinase JAK3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10312	nintedanib	Potassium voltage-gated channel subfamily H member 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10313	nintedanib	Multidrug resistance protein 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10314	nintedanib	Platelet-derived growth factor receptor beta	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10315	nintedanib	Tyrosine-protein kinase ABL1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10316	nintedanib	Mast/stem cell growth factor receptor Kit	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10317	nintedanib	Proto-oncogene tyrosine-protein kinase Src	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10318	nintedanib	Tyrosine-protein kinase Lck	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10319	nintedanib	Tyrosine-protein kinase Yes	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10320	nintedanib	Tyrosine-protein kinase Fyn	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10321	nintedanib	Ephrin type-A receptor 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10322	nintedanib	Receptor-type tyrosine-protein kinase FLT3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10323	nintedanib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10324	nintedanib	Macrophage colony-stimulating factor 1 receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10325	nintedanib	Ribosomal protein S6 kinase alpha-3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10326	nintedanib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10327	nintedanib	Cyclin-dependent kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10328	nintedanib	Insulin-like growth factor 1 receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10329	nintedanib	Myosin light chain kinase, smooth muscle	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10330	nintedanib	Insulin receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10331	nintedanib	Death-associated protein kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10332	nintedanib	Calcium/calmodulin-dependent protein kinase type 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10333	nintedanib	Mitogen-activated protein kinase 8	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10334	nintedanib	Fibroblast growth factor receptor 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10335	nintedanib	Focal adhesion kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10336	nintedanib	Tyrosine-protein kinase HCK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10337	nintedanib	Tyrosine-protein kinase JAK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10338	nintedanib	Mitogen-activated protein kinase 10	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10339	nintedanib	Death-associated protein kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10340	nintedanib	High affinity nerve growth factor receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10341	nintedanib	Tyrosine-protein kinase JAK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10342	nintedanib	Myosin light chain kinase 2, skeletal/cardiac muscle	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10343	nintedanib	Angiopoietin-1 receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10344	nintedanib	AP2-associated protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10345	nintedanib	Serine/threonine-protein kinase MARK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10346	nintedanib	Hepatocyte growth factor receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10347	nintedanib	Tyrosine-protein kinase Lyn	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10348	nintedanib	Ribosomal protein S6 kinase alpha-2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10349	nintedanib	5'-AMP-activated protein kinase catalytic subunit alpha-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10350	nintedanib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10351	nintedanib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10352	nintedanib	Serine/threonine-protein kinase 17B	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10353	nintedanib	Serine/threonine-protein kinase 10	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10354	nintedanib	Tyrosine-protein kinase Fer	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10355	nintedanib	Serine/threonine-protein kinase PLK4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10356	nintedanib	Aurora kinase C	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10357	nintedanib	Serine/threonine-protein kinase 16	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10358	nintedanib	Dual specificity protein kinase TTK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10359	nintedanib	Abelson tyrosine-protein kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10360	nintedanib	Fibroblast growth factor receptor 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10361	nintedanib	Serine/threonine-protein kinase N1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10362	nintedanib	Protein kinase C theta type	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10363	nintedanib	Serine/threonine-protein kinase 17A	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10364	nintedanib	Ephrin type-A receptor 6	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10365	nintedanib	TRAF2 and NCK-interacting protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10366	nintedanib	Casein kinase I isoform epsilon	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10367	nintedanib	Tyrosine-protein kinase Fgr	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10368	nintedanib	ALK tyrosine kinase receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10369	nintedanib	Ephrin type-A receptor 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10370	nintedanib	BMP-2-inducible protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10371	nintedanib	Tyrosine-protein kinase FRK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10372	nintedanib	Dual specificity protein kinase CLK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10373	nintedanib	Dual specificity protein kinase CLK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10374	nintedanib	Mitogen-activated protein kinase kinase kinase kinase 5	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10375	nintedanib	Glycogen synthase kinase-3 beta	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10376	nintedanib	Ephrin type-B receptor 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10377	nintedanib	Calcium/calmodulin-dependent protein kinase type 1D	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10378	nintedanib	Cyclin-dependent kinase 16	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10379	nintedanib	Serine/threonine-protein kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10380	nintedanib	Activated CDC42 kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10381	nintedanib	Ribosomal protein S6 kinase alpha-5	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10382	nintedanib	STE20-like serine/threonine-protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10383	nintedanib	Dual specificity protein kinase CLK4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10384	nintedanib	Calcium/calmodulin-dependent protein kinase kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10385	nintedanib	MAP/microtubule affinity-regulating kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10386	nintedanib	Calcium/calmodulin-dependent protein kinase kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10387	nintedanib	Calcium/calmodulin-dependent protein kinase type 1G	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10388	nintedanib	Epithelial discoidin domain-containing receptor 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10389	nintedanib	Ephrin type-B receptor 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10390	nintedanib	Testis-specific serine/threonine-protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10391	nintedanib	Activin receptor type-1B	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10392	nintedanib	Serine/threonine-protein kinase receptor R3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10393	nintedanib	Activin receptor type-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10394	nintedanib	3-phosphoinositide-dependent protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10395	nintedanib	Dual specificity mitogen-activated protein kinase kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10396	nintedanib	Dual specificity mitogen-activated protein kinase kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10397	nintedanib	Tyrosine-protein kinase ITK/TSK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10398	nintedanib	Tyrosine-protein kinase ZAP-70	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10399	nintedanib	Glycogen synthase kinase-3 alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10400	nintedanib	Tyrosine-protein kinase BTK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10401	nintedanib	Tyrosine-protein kinase receptor UFO	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10402	nintedanib	BDNF/NT-3 growth factors receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10403	nintedanib	Tyrosine-protein kinase receptor TYRO3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10404	nintedanib	Cyclin-dependent kinase 7	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10405	nintedanib	Serine/threonine-protein kinase D1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10406	nintedanib	Ribosomal protein S6 kinase beta-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10407	nintedanib	Serine/threonine-protein kinase N2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10408	nintedanib	Serine/threonine-protein kinase DCLK3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10409	nintedanib	Serine/threonine-protein kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10410	nintedanib	Ribosomal protein S6 kinase alpha-6	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10411	nintedanib	NUAK family SNF1-like kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10412	nintedanib	Non-receptor tyrosine-protein kinase TNK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10413	nintedanib	Non-receptor tyrosine-protein kinase TYK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10414	nintedanib	Serine/threonine-protein kinase Chk1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10415	nintedanib	Serine/threonine-protein kinase PAK 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10416	nintedanib	Cyclin-dependent kinase 17	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10417	nintedanib	Cyclin-dependent kinase 18	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10418	nintedanib	Cyclin-dependent kinase 14	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10419	nintedanib	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10420	nintedanib	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10421	nintedanib	Myosin light chain kinase family member 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10422	nintedanib	Wee1-like protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10423	nintedanib	Protein-tyrosine kinase 2-beta	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10424	nintedanib	Serine/threonine-protein kinase RIO1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10425	nintedanib	Casein kinase I isoform delta	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10426	nintedanib	Tyrosine-protein kinase receptor Tie-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10427	nintedanib	NT-3 growth factor receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10428	nintedanib	Tyrosine-protein kinase TXK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10429	nintedanib	Casein kinase II subunit alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10430	nintedanib	Casein kinase II subunit alpha'	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10431	nintedanib	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10432	nintedanib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10433	nintedanib	Serine/threonine-protein kinase STK11	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10434	nintedanib	Dual specificity mitogen-activated protein kinase kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10435	nintedanib	Maternal embryonic leucine zipper kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10436	nintedanib	Serine/threonine-protein kinase 26	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10437	nintedanib	Eukaryotic translation initiation factor 2-alpha kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10438	nintedanib	Insulin receptor-related protein	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10439	nintedanib	Interleukin-1 receptor-associated kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10440	nintedanib	Serine/threonine-protein kinase RIO3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10441	nintedanib	Serine/threonine-protein kinase SIK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10442	nintedanib	SRSF protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10443	nintedanib	SRSF protein kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10444	nintedanib	Serine/threonine-protein kinase 33	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10445	nintedanib	5'-AMP-activated protein kinase catalytic subunit alpha-2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10446	nintedanib	Discoidin domain-containing receptor 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10447	nintedanib	Serine/threonine-protein kinase LATS1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10448	nintedanib	Serine/threonine-protein kinase LATS2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10449	nintedanib	Leukocyte tyrosine kinase receptor	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10450	nintedanib	Mitogen-activated protein kinase kinase kinase kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10451	nintedanib	Serine/threonine-protein kinase PAK 7	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10452	nintedanib	NUAK family SNF1-like kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10453	nintedanib	Mitogen-activated protein kinase kinase kinase kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10454	nintedanib	Aurora kinase B	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10455	nintedanib	Tyrosine-protein kinase Blk	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10456	nintedanib	Bone morphogenetic protein receptor type-2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10457	nintedanib	Mitogen-activated protein kinase kinase kinase kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10458	nintedanib	Serine/threonine-protein kinase MARK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10459	nintedanib	MAP/microtubule affinity-regulating kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10460	nintedanib	Dual specificity mitogen-activated protein kinase kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10461	nintedanib	Tyrosine-protein kinase Mer	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10462	nintedanib	Calcium/calmodulin-dependent protein kinase type IV	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10463	nintedanib	Mitogen-activated protein kinase kinase kinase 9	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10464	nintedanib	Mitogen-activated protein kinase kinase kinase 10	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10465	nintedanib	Mitogen-activated protein kinase kinase kinase 11	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10466	nintedanib	Serine/threonine-protein kinase 24	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10467	nintedanib	Muscle, skeletal receptor tyrosine-protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10468	nintedanib	Serine/threonine-protein kinase DCLK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10469	nintedanib	Myosin-IIIb	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10470	nintedanib	Serine/threonine-protein kinase PAK 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10471	nintedanib	Serine/threonine-protein kinase PAK 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10472	nintedanib	Serine/threonine-protein kinase SIK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10473	nintedanib	TGF-beta receptor type-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10474	nintedanib	Ephrin type-A receptor 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10475	nintedanib	Mitogen-activated protein kinase 7	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10476	nintedanib	Serine/threonine-protein kinase D2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10477	nintedanib	Serine/threonine-protein kinase D3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10478	nintedanib	Receptor-interacting serine/threonine-protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10479	nintedanib	Tyrosine-protein kinase Fes/Fps	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10480	nintedanib	Fibroblast growth factor receptor 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10481	nintedanib	Proto-oncogene tyrosine-protein kinase ROS	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10482	nintedanib	Ribosomal protein S6 kinase alpha-1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10483	nintedanib	Ribosomal protein S6 kinase alpha-4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10484	nintedanib	Mitogen-activated protein kinase kinase kinase kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10485	nintedanib	Misshapen-like kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10486	nintedanib	Serine/threonine-protein kinase TBK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10487	nintedanib	Interleukin-1 receptor-associated kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10488	nintedanib	Cyclin-dependent kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10489	nintedanib	Cyclin-dependent kinase-like 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10490	nintedanib	Ephrin type-B receptor 6	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10491	nintedanib	Serine/threonine-protein kinase/endoribonuclease IRE1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10492	nintedanib	Rhodopsin kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10493	nintedanib	G protein-coupled receptor kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10494	nintedanib	G protein-coupled receptor kinase 7	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10495	nintedanib	Homeodomain-interacting protein kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10496	nintedanib	Homeodomain-interacting protein kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10497	nintedanib	Homeodomain-interacting protein kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10498	nintedanib	Serine/threonine-protein kinase ICK	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10499	nintedanib	Inhibitor of nuclear factor kappa-B kinase subunit alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10500	nintedanib	Interleukin-1 receptor-associated kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10501	nintedanib	Mitogen-activated protein kinase kinase kinase 13	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10502	nintedanib	Mitogen-activated protein kinase kinase kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10503	nintedanib	Mitogen-activated protein kinase kinase kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10504	nintedanib	Microtubule-associated serine/threonine-protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10505	nintedanib	Serine/threonine-protein kinase OSR1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10506	nintedanib	SRSF protein kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10507	nintedanib	STE20/SPS1-related proline-alanine-rich protein kinase	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10508	nintedanib	Mitogen-activated protein kinase kinase kinase 7	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10509	nintedanib	Serine/threonine-protein kinase ULK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10510	nintedanib	Serine/threonine-protein kinase ULK2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10511	nintedanib	Serine/threonine-protein kinase ULK3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10512	nintedanib	Mitogen-activated protein kinase kinase kinase 19	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10513	nintedanib	Homeodomain-interacting protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10514	nintedanib	Mitogen-activated protein kinase kinase kinase 15	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10515	nintedanib	Receptor-interacting serine/threonine-protein kinase 4	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10516	nintedanib	Uncharacterized serine/threonine-protein kinase SBK3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10517	nintedanib	Serine/threonine-protein kinase 35	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10518	nintedanib	Serine/threonine-protein kinase SBK1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10519	nintedanib	Serine/threonine-protein kinase PRP4 homolog	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10520	nintedanib	Mitogen-activated protein kinase kinase kinase 12	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10521	nintedanib	Serine/threonine-protein kinase Sgk3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10522	nintedanib	Dual specificity mitogen-activated protein kinase kinase 5	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10523	nintedanib	Myosin light chain kinase 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10524	nintedanib	Leucine-rich repeat serine/threonine-protein kinase 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10525	nintedanib	Calcium-dependent protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10526	nintedanib	Vascular endothelial growth factor receptor 2	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10527	nintedanib	Serine/threonine-protein kinase PknB	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10528	nintedanib	cGMP-dependent protein kinase 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10529	nintedanib	Vascular endothelial growth factor receptor 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10530	nintedanib	Vascular endothelial growth factor receptor 3	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10531	nintedanib	Platelet-derived growth factor receptor alpha	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10532	nintedanib	Fibroblast growth factor receptor 1	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2
10533	fimasartan	Type-1 angiotensin II receptor	CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
10534	olaparib	Tankyrase-2	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10535	olaparib	Poly [ADP-ribose] polymerase 4	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10536	olaparib	Poly [ADP-ribose] polymerase 10	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10537	olaparib	Poly [ADP-ribose] polymerase 12	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10538	olaparib	Poly [ADP-ribose] polymerase 15	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10539	olaparib	Poly [ADP-ribose] polymerase 6	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10540	olaparib	Mono [ADP-ribose] polymerase PARP16	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10541	olaparib	Tankyrase-1	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10542	olaparib	Poly [ADP-ribose] polymerase 2	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10543	olaparib	Poly [ADP-ribose] polymerase 1	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10544	olaparib	Poly [ADP-ribose] polymerase 3	FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
10545	acotiamide	Acetylcholinesterase	COC1=CC(O)=C(C=C1OC)C(=O)NC1=NC(=CS1)C(=O)NCCN(C(C)C)C(C)C
10546	felypressin	Vasopressin V1a receptor	[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O
10547	safinamide	Sodium channel protein type 9 subunit alpha	C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
10548	safinamide	Amine oxidase [flavin-containing] A	C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
10549	safinamide	Sigma non-opioid intracellular receptor 1	C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
10550	safinamide	Amine oxidase [flavin-containing] B	C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
10551	safinamide	Sodium channel alpha subunits; brain (Types I, II, III)	C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
10552	albiglutide	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
10553	corticotropin	Melanocortin receptor 4	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10554	corticotropin	Melanocortin receptor 3	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10555	corticotropin	Melanocyte-stimulating hormone receptor	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10556	corticotropin	Adrenocorticotropic hormone receptor	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
10557	parathyroid hormone	Parathyroid hormone/parathyroid hormone-related peptide receptor	[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O
10558	alectinib	Vascular endothelial growth factor receptor 2	CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
10559	alectinib	SRSF protein kinase 1	CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
10560	alectinib	Proto-oncogene tyrosine-protein kinase ROS	CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
10561	alectinib	ALK tyrosine kinase receptor	CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
10562	alectinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
10563	ripasudil	cAMP-dependent protein kinase catalytic subunit alpha	[H][C@]1(C)CNCCCN1S(=O)(=O)C1=CC=CC2=C1C(F)=CN=C2
10564	ripasudil	Rho-associated protein kinase 1	[H][C@]1(C)CNCCCN1S(=O)(=O)C1=CC=CC2=C1C(F)=CN=C2
10565	ripasudil	Rho-associated protein kinase 2	[H][C@]1(C)CNCCCN1S(=O)(=O)C1=CC=CC2=C1C(F)=CN=C2
10566	palbociclib	Tyrosine-protein kinase JAK3	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10567	palbociclib	Receptor-type tyrosine-protein kinase FLT3	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10568	palbociclib	Cyclin-dependent kinase 9	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10569	palbociclib	Cyclin-dependent kinase 4/cyclin D1	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10570	palbociclib	CDK2/Cyclin A	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10571	palbociclib	CDK6/cyclin D1	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10572	palbociclib	Ribosomal protein S6 kinase alpha-1	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10573	palbociclib	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10574	palbociclib	Cyclin-dependent kinase 6	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10575	palbociclib	Cyclin-dependent kinase 4	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O
10576	lenvatinib	Carbonic anhydrase 5A, mitochondrial	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10577	lenvatinib	Platelet-derived growth factor receptor beta	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10578	lenvatinib	Epidermal growth factor receptor	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10579	lenvatinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10580	lenvatinib	Mast/stem cell growth factor receptor Kit	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10581	lenvatinib	Vascular endothelial growth factor receptor 1	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10582	lenvatinib	Vascular endothelial growth factor receptor 2	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10583	lenvatinib	Vascular endothelial growth factor receptor 3	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10584	lenvatinib	Platelet-derived growth factor receptor alpha	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10585	lenvatinib	Fibroblast growth factor receptor 1	COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2
10586	arformoterol	Beta-3 adrenergic receptor	[H]C(=O)NC1=C(O)C=CC(=C1)[C@@H](O)CN[C@H](C)CC1=CC=C(OC)C=C1
10587	arformoterol	Beta-2 adrenergic receptor	[H]C(=O)NC1=C(O)C=CC(=C1)[C@@H](O)CN[C@H](C)CC1=CC=C(OC)C=C1
10588	arformoterol	Beta-1 adrenergic receptor	[H]C(=O)NC1=C(O)C=CC(=C1)[C@@H](O)CN[C@H](C)CC1=CC=C(OC)C=C1
10589	insulin degludec	Insulin receptor	[H]NCC(=O)NC([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)NC(CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NC1CSSC[C@@H]2NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)C(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)C(CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)C(N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)NC(CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSCC(NC(=O)[C@@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=C(O)C=C2)C(=O)N[C@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC(O)=O)C(O)=O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10590	chidamide	Nicotinamide phosphoribosyltransferase	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10591	chidamide	Histone deacetylase 8	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10592	chidamide	Histone deacetylase 11	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10593	chidamide	Histone deacetylase 2	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10594	chidamide	Histone deacetylase 1	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10595	chidamide	Histone deacetylase 3	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10596	chidamide	Histone deacetylase 10	NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1
10597	triamcinolone hexacetonide	Glucocorticoid receptor	[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
10598	insulin aspart	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10599	insulin detemir	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)NC(C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC(C)C)C(=O)NC(C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10600	vonoprazan	Potassium-transporting ATPase	CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1
10601	eluxadoline	Mu-type opioid receptor	COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
10602	eluxadoline	Delta-type opioid receptor	COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
10603	eluxadoline	Kappa-type opioid receptor	COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
10604	insulin lispro	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10605	insulin human	Tyrosine-protein kinase Lck	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10606	insulin human	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10607	mirodenafil	cGMP-specific 3',5'-cyclic phosphodiesterase	CCCOC1=CC=C(C=C1C1=NC2C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1
10608	cangrelor	P2Y purinoceptor 13	CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O
10609	cangrelor	Uracil nucleotide/cysteinyl leukotriene receptor	CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O
10610	cangrelor	P2Y purinoceptor 12	CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O
10611	sonidegib	Sonic hedgehog protein	[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=NC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=C1
10612	sonidegib	Smoothened homolog	[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=NC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=C1
10613	mecasermin	Insulin receptor	[H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC4=CC=CC=C4)NC2=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N3)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O
10614	mecasermin	Insulin-like growth factor 1 receptor	[H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC4=CC=CC=C4)NC2=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N3)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O
10615	lumacaftor	Cystic fibrosis transmembrane conductance regulator	CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC=CC(=C1)C(O)=O
10616	sacubitril	Neprilysin	CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O
10617	trelagliptin	Dipeptidyl peptidase 4	CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=CC(F)=CC=C2C#N)C1=O
10618	brexpiprazole	D(2) dopamine receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10619	brexpiprazole	5-hydroxytryptamine receptor 1A	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10620	brexpiprazole	5-hydroxytryptamine receptor 2A	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10621	brexpiprazole	Beta-1 adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10622	brexpiprazole	Beta-2 adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10623	brexpiprazole	D(1A) dopamine receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10624	brexpiprazole	Alpha-2A adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10625	brexpiprazole	Sodium-dependent serotonin transporter	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10626	brexpiprazole	Sodium-dependent noradrenaline transporter	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10627	brexpiprazole	5-hydroxytryptamine receptor 2B	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10628	brexpiprazole	5-hydroxytryptamine receptor 2C	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10629	brexpiprazole	5-hydroxytryptamine receptor 6	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10630	brexpiprazole	5-hydroxytryptamine receptor 7	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10631	brexpiprazole	Alpha-1A adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10632	brexpiprazole	Alpha-2B adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10633	brexpiprazole	D(3) dopamine receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10634	brexpiprazole	Histamine H1 receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10635	brexpiprazole	5-hydroxytryptamine receptor 1B	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10636	brexpiprazole	Alpha-2C adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10637	brexpiprazole	Sodium-dependent dopamine transporter	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10638	brexpiprazole	D(4) dopamine receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10639	brexpiprazole	Alpha-1D adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10640	brexpiprazole	Alpha-1B adrenergic receptor	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10641	brexpiprazole	5-hydroxytryptamine receptor 5A	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2
10642	anakinra	Interleukin-1 receptor, type I	[H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O
10643	flibanserin	5-hydroxytryptamine receptor 1A	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10644	flibanserin	D(2) dopamine receptor	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10645	flibanserin	D(3) dopamine receptor	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10646	flibanserin	D(4) dopamine receptor	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10647	flibanserin	5-hydroxytryptamine receptor 2B	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10648	flibanserin	5-hydroxytryptamine receptor 2C	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10649	flibanserin	5-hydroxytryptamine receptor 5A	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10650	flibanserin	5-hydroxytryptamine receptor 2A	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
10651	rolapitant	Substance-P receptor	[H][C@](C)(OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
10652	cariprazine	D(1A) dopamine receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10653	cariprazine	Potassium voltage-gated channel subfamily H member 2	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10654	cariprazine	D(1B) dopamine receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10655	cariprazine	D(4) dopamine receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10656	cariprazine	D(2) dopamine receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10657	cariprazine	D(3) dopamine receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10658	cariprazine	5-hydroxytryptamine receptor 2B	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10659	cariprazine	5-hydroxytryptamine receptor 2C	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10660	cariprazine	5-hydroxytryptamine receptor 7	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10661	cariprazine	Histamine H1 receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10662	cariprazine	Alpha-1D adrenergic receptor	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10663	cariprazine	5-hydroxytryptamine receptor 1A	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10664	cariprazine	5-hydroxytryptamine receptor 2A	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
10665	cobimetinib	Serine/threonine-protein kinase B-raf	[H][C@]1(CCCCN1)C1(O)CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1
10666	cobimetinib	Dual specificity mitogen-activated protein kinase kinase 2	[H][C@]1(CCCCN1)C1(O)CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1
10667	cobimetinib	Dual specificity mitogen-activated protein kinase kinase 1	[H][C@]1(CCCCN1)C1(O)CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1
10668	saroglitazar	Peroxisome proliferator-activated receptor alpha	CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O
10669	saroglitazar	Peroxisome proliferator-activated receptor gamma	CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O
10670	pitolisant	Potassium voltage-gated channel subfamily H member 2	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
10671	pitolisant	Histamine H1 receptor	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
10672	pitolisant	Histamine H2 receptor	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
10673	pitolisant	Histamine H3 receptor	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
10674	pitolisant	Cholinesterase	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
10675	aripiprazole lauroxil	5-hydroxytryptamine receptor 1B	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10676	aripiprazole lauroxil	5-hydroxytryptamine receptor 1D	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10677	aripiprazole lauroxil	D(2) dopamine receptor	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10678	aripiprazole lauroxil	5-hydroxytryptamine receptor 2A	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10679	aripiprazole lauroxil	5-hydroxytryptamine receptor 7	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10680	aripiprazole lauroxil	D(4) dopamine receptor	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10681	aripiprazole lauroxil	5-hydroxytryptamine receptor 6	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10682	aripiprazole lauroxil	5-hydroxytryptamine receptor 2C	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10683	aripiprazole lauroxil	D(3) dopamine receptor	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10684	aripiprazole lauroxil	Histamine H1 receptor	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10685	aripiprazole lauroxil	5-hydroxytryptamine receptor 1A	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
10686	omarigliptin	Potassium voltage-gated channel subfamily H member 2	CS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=C(F)C=CC(F)=C1
10687	omarigliptin	Dipeptidyl peptidase 4	CS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=C(F)C=CC(F)=C1
10688	insulin glulisine	Insulin receptor	[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
10689	lusutrombopag	Thrombopoietin receptor	CCCCCCO[C@@H](C)C1=CC=CC(C2=CSC(NC(=O)C3=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C3)=N2)=C1OC
10690	osimertinib	Potassium voltage-gated channel subfamily H member 2	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10691	osimertinib	Insulin receptor	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10692	osimertinib	ALK tyrosine kinase receptor	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10693	osimertinib	Receptor tyrosine-protein kinase erbB-3	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10694	osimertinib	Dipeptidyl peptidase 1	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10695	osimertinib	Epidermal growth factor receptor	COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
10696	ixazomib	Proteasome subunit beta type-1	[H][C@@](CC(C)C)(NC(=O)CNC(=O)C1=C(Cl)C=CC(Cl)=C1)B(O)O
10697	ixazomib	Proteasome subunit beta type-2	[H][C@@](CC(C)C)(NC(=O)CNC(=O)C1=C(Cl)C=CC(Cl)=C1)B(O)O
10698	ixazomib	Proteasome subunit beta type-5	[H][C@@](CC(C)C)(NC(=O)CNC(=O)C1=C(Cl)C=CC(Cl)=C1)B(O)O
10699	brivaracetam	Synaptic vesicle glycoprotein 2A	[H][C@@](CC)(N1C[C@]([H])(CCC)CC1=O)C(N)=O
10700	lesinurad	Solute carrier family 22 member 11	OC(=O)CSC1=NN=C(Br)N1C1=C2C=CC=CC2=C(C=C1)C1CC1
10701	lesinurad	Solute carrier family 22 member 12	OC(=O)CSC1=NN=C(Br)N1C1=C2C=CC=CC2=C(C=C1)C1CC1
10702	selexipag	Prostaglandin E2 receptor EP2 subtype	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1
10703	selexipag	Prostaglandin E2 receptor EP4 subtype	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1
10704	selexipag	Prostaglandin D2 receptor	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1
10705	selexipag	Prostacyclin receptor	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1
10706	lobeglitazone	Peroxisome proliferator-activated receptor alpha	[H]C1(CC2=CC=C(OCCN(C)C3=NC=NC(OC4=CC=C(OC)C=C4)=C3)C=C2)SC(=O)NC1=O
10707	lobeglitazone	Peroxisome proliferator-activated receptor gamma	[H]C1(CC2=CC=C(OCCN(C)C3=NC=NC(OC4=CC=C(OC)C=C4)=C3)C=C2)SC(=O)NC1=O
10708	migalastat	Maltase-glucoamylase, intestinal	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10709	migalastat	Lysosomal alpha-glucosidase	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10710	migalastat	Non-lysosomal glucosylceramidase	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10711	migalastat	Sucrase-isomaltase, intestinal	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10712	migalastat	Glycogen debranching enzyme	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10713	migalastat	Lactase-phlorizin hydrolase	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10714	migalastat	Beta-galactosidase	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10715	migalastat	Alpha-galactosidase C	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10716	migalastat	Alpha-galactosidase	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10717	migalastat	Alpha-galactosidase A	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
10718	venetoclax	Bcl-2-like protein 1	CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1
10719	venetoclax	Apoptosis regulator Bcl-W	CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1
10720	venetoclax	Apoptosis regulator Bcl-2	CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1
10721	pimavanserin	5-hydroxytryptamine receptor 2C	CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1
10722	pimavanserin	5-hydroxytryptamine receptor 2A	CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1
10723	opicapone	Catechol O-methyltransferase	CC1=C(C2=NOC(=N2)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl
10724	obeticholic acid	G-protein coupled bile acid receptor 1	[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
10725	obeticholic acid	Bile acid receptor	[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
10726	eldecalcitol	Vitamin D3 receptor	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)[C@@]([H])(OCCCO)[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
10727	lifitegrast	Intercellular adhesion molecule 1	[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O
10728	lifitegrast	Integrin alpha-L/beta-2	[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O
10729	etelcalcetide	Extracellular calcium-sensing receptor	C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O
10730	gallium (68Ga) edotreotide	Somatostatin receptor type 2	[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
10731	radotinib	Tyrosine-protein kinase ABL1	CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F
10732	crisaborole	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12
10733	crisaborole	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12
10734	crisaborole	Phosphodiesterase 4	OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12
10735	baricitinib	Tyrosine-protein kinase JAK3	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10736	baricitinib	AP2-associated protein kinase 1	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10737	baricitinib	BMP-2-inducible protein kinase	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10738	baricitinib	Cyclin-G-associated kinase	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10739	baricitinib	Non-receptor tyrosine-protein kinase TYK2	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10740	baricitinib	Tyrosine-protein kinase JAK1	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10741	baricitinib	Tyrosine-protein kinase JAK2	CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2
10742	rucaparib	Tankyrase-2	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10743	rucaparib	Tankyrase-1	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10744	rucaparib	Poly [ADP-ribose] polymerase 4	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10745	rucaparib	Poly [ADP-ribose] polymerase 10	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10746	rucaparib	Poly [ADP-ribose] polymerase 12	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10747	rucaparib	Poly [ADP-ribose] polymerase 14	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10748	rucaparib	Poly [ADP-ribose] polymerase 15	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10749	rucaparib	Poly [ADP-ribose] polymerase 2	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10750	rucaparib	Poly [ADP-ribose] polymerase 1	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10751	rucaparib	Poly [ADP-ribose] polymerase 3	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23
10752	plecanatide	Tumor necrosis factor	[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C)C(C)C
10753	plecanatide	Tumor necrosis factor receptor superfamily member 1A	[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C)C(C)C
10754	plecanatide	Heat-stable enterotoxin receptor	[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C)C(C)C
10755	icotinib	Epidermal growth factor receptor	C#CC1=CC=CC(NC2=NC=NC3=C2C=C2OCCOCCOCCOC2=C3)=C1
10756	olmutinib	Tyrosine-protein kinase BTK	CN1CCN(CC1)C1=CC=C(NC2=NC3=C(SC=C3)C(OC3=CC=CC(NC(=O)C=C)=C3)=N2)C=C1
10757	olmutinib	Epidermal growth factor receptor	CN1CCN(CC1)C1=CC=C(NC2=NC3=C(SC=C3)C(OC3=CC=CC(NC(=O)C=C)=C3)=N2)C=C1
10758	apatinib	Tyrosine-protein kinase CSK	O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1
10759	apatinib	Mast/stem cell growth factor receptor Kit	O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1
10760	apatinib	Proto-oncogene tyrosine-protein kinase Src	O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1
10761	apatinib	Proto-oncogene tyrosine-protein kinase receptor Ret	O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1
10762	apatinib	Vascular endothelial growth factor receptor 2	O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1
10763	telotristat ethyl	Tryptophan 5-hydroxylase 1	CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=C(C=C(Cl)C=C2)N2C=CC(C)=N2)C(F)(F)F)=C1
10764	ribociclib	Cyclin-dependent kinase 2	CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1
10765	ribociclib	Cyclin-dependent kinase 6	CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1
10766	ribociclib	Cyclin-dependent kinase 4	CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1
10767	naldemedine	Delta-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O
10768	naldemedine	Mu-type opioid receptor	[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O
10769	niraparib	Tankyrase-2	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10770	niraparib	Tankyrase-1	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10771	niraparib	Poly [ADP-ribose] polymerase 3	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10772	niraparib	Poly [ADP-ribose] polymerase 4	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10773	niraparib	Poly [ADP-ribose] polymerase 10	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10774	niraparib	Poly [ADP-ribose] polymerase 12	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10775	niraparib	Poly [ADP-ribose] polymerase 14	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10776	niraparib	Poly [ADP-ribose] polymerase 15	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10777	niraparib	Poly [ADP-ribose] polymerase 2	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10778	niraparib	Poly [ADP-ribose] polymerase 1	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
10779	deutetrabenazine	Synaptic vesicular amine transporter	[H]C12CC(=O)C(CC(C)C)CN1CCC1=C2C=C(OC([2H])([2H])[2H])C(OC([2H])([2H])[2H])=C1
10780	valbenazine	Synaptic vesicular amine transporter	[H][C@]12C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1
10781	forodesine	Purine nucleoside phosphorylase	OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1NC=NC2=O
10782	midostaurin	Tyrosine-protein kinase JAK3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10783	midostaurin	Platelet-derived growth factor receptor beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10784	midostaurin	Tyrosine-protein kinase ABL1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10785	midostaurin	Mast/stem cell growth factor receptor Kit	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10786	midostaurin	Epidermal growth factor receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10787	midostaurin	Proto-oncogene tyrosine-protein kinase Src	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10788	midostaurin	Tyrosine-protein kinase Lck	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10789	midostaurin	Tyrosine-protein kinase Yes	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10790	midostaurin	Tyrosine-protein kinase Fyn	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10791	midostaurin	Proto-oncogene tyrosine-protein kinase receptor Ret	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10792	midostaurin	Vascular endothelial growth factor receptor 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10793	midostaurin	Vascular endothelial growth factor receptor 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10794	midostaurin	Vascular endothelial growth factor receptor 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10795	midostaurin	Macrophage colony-stimulating factor 1 receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10796	midostaurin	Platelet-derived growth factor receptor alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10797	midostaurin	Ribosomal protein S6 kinase alpha-3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10798	midostaurin	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10799	midostaurin	Serine/threonine-protein kinase pim-1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10800	midostaurin	Myosin light chain kinase, smooth muscle	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10801	midostaurin	Death-associated protein kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10802	midostaurin	Calcium/calmodulin-dependent protein kinase type 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10803	midostaurin	Mitogen-activated protein kinase 8	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10804	midostaurin	Fibroblast growth factor receptor 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10805	midostaurin	Rho-associated protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10806	midostaurin	Tyrosine-protein kinase HCK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10807	midostaurin	Tyrosine-protein kinase JAK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10808	midostaurin	Receptor tyrosine-protein kinase erbB-4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10809	midostaurin	Mitogen-activated protein kinase 10	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10810	midostaurin	Death-associated protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10811	midostaurin	High affinity nerve growth factor receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10812	midostaurin	Protein kinase C delta type	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10813	midostaurin	cAMP-dependent protein kinase catalytic subunit beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10814	midostaurin	Tyrosine-protein kinase JAK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10815	midostaurin	Rho-associated protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10816	midostaurin	Protein kinase C alpha type	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10817	midostaurin	Tyrosine-protein kinase SYK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10818	midostaurin	Calcium/calmodulin-dependent protein kinase type II subunit delta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10819	midostaurin	Tyrosine-protein kinase CSK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10820	midostaurin	Angiopoietin-1 receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10821	midostaurin	Calcium/calmodulin-dependent protein kinase type II subunit gamma	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10822	midostaurin	AP2-associated protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10823	midostaurin	Serine/threonine-protein kinase MARK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10824	midostaurin	Hepatocyte growth factor receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10825	midostaurin	Tyrosine-protein kinase Lyn	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10826	midostaurin	Ribosomal protein S6 kinase alpha-2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10827	midostaurin	5'-AMP-activated protein kinase catalytic subunit alpha-1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10828	midostaurin	Calcium/calmodulin-dependent protein kinase type II subunit beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10829	midostaurin	Protein kinase C eta type	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10830	midostaurin	Fibroblast growth factor receptor 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10831	midostaurin	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10832	midostaurin	Calcium/calmodulin-dependent protein kinase type II subunit alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10833	midostaurin	Serine/threonine-protein kinase 17B	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10834	midostaurin	Serine/threonine-protein kinase 10	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10835	midostaurin	Tyrosine-protein kinase Fer	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10836	midostaurin	Protein kinase C epsilon type	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10837	midostaurin	Serine/threonine-protein kinase PLK4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10838	midostaurin	Aurora kinase C	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10839	midostaurin	Serine/threonine-protein kinase 16	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10840	midostaurin	Dual specificity protein kinase TTK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10841	midostaurin	Fibroblast growth factor receptor 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10842	midostaurin	Serine/threonine-protein kinase N1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10843	midostaurin	Protein kinase C theta type	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10844	midostaurin	Serine/threonine-protein kinase 17A	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10845	midostaurin	TRAF2 and NCK-interacting protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10846	midostaurin	Tyrosine-protein kinase Fgr	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10847	midostaurin	Aurora kinase A	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10848	midostaurin	ALK tyrosine kinase receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10849	midostaurin	RAC-alpha serine/threonine-protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10850	midostaurin	BMP-2-inducible protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10851	midostaurin	Serine/threonine-protein kinase pim-2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10852	midostaurin	Tyrosine-protein kinase FRK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10853	midostaurin	Dual specificity protein kinase CLK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10854	midostaurin	Dual specificity protein kinase CLK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10855	midostaurin	Dual specificity protein kinase CLK3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10856	midostaurin	Mitogen-activated protein kinase kinase kinase kinase 5	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10857	midostaurin	Cyclin-G-associated kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10858	midostaurin	Glycogen synthase kinase-3 beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10859	midostaurin	Calcium/calmodulin-dependent protein kinase type 1D	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10860	midostaurin	Serine/threonine-protein kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10861	midostaurin	Activated CDC42 kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10862	midostaurin	Ribosomal protein S6 kinase alpha-5	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10863	midostaurin	STE20-like serine/threonine-protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10864	midostaurin	Dual specificity protein kinase CLK4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10865	midostaurin	MAP kinase-interacting serine/threonine-protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10866	midostaurin	Mitogen-activated protein kinase 9	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10867	midostaurin	Calcium/calmodulin-dependent protein kinase kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10868	midostaurin	MAP/microtubule affinity-regulating kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10869	midostaurin	Calcium/calmodulin-dependent protein kinase kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10870	midostaurin	Calcium/calmodulin-dependent protein kinase type 1G	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10871	midostaurin	Epithelial discoidin domain-containing receptor 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10872	midostaurin	Testis-specific serine/threonine-protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10873	midostaurin	Inhibitor of nuclear factor kappa-B kinase subunit beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10874	midostaurin	3-phosphoinositide-dependent protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10875	midostaurin	Tyrosine-protein kinase ZAP-70	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10876	midostaurin	Glycogen synthase kinase-3 alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10877	midostaurin	Tyrosine-protein kinase receptor UFO	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10878	midostaurin	BDNF/NT-3 growth factors receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10879	midostaurin	Tyrosine-protein kinase receptor TYRO3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10880	midostaurin	Ribosomal protein S6 kinase beta-1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10881	midostaurin	Serine/threonine-protein kinase N2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10882	midostaurin	RAC-beta serine/threonine-protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10883	midostaurin	Serine/threonine-protein kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10884	midostaurin	Ribosomal protein S6 kinase alpha-6	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10885	midostaurin	NUAK family SNF1-like kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10886	midostaurin	Non-receptor tyrosine-protein kinase TNK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10887	midostaurin	Non-receptor tyrosine-protein kinase TYK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10888	midostaurin	Serine/threonine-protein kinase Chk1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10889	midostaurin	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10890	midostaurin	Serine/threonine-protein kinase PAK 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10891	midostaurin	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10892	midostaurin	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10893	midostaurin	Myosin light chain kinase family member 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10894	midostaurin	Wee1-like protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10895	midostaurin	Serine/threonine-protein kinase 25	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10896	midostaurin	Protein-tyrosine kinase 2-beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10897	midostaurin	Serine/threonine-protein kinase RIO1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10898	midostaurin	Tyrosine-protein kinase receptor Tie-1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10899	midostaurin	NT-3 growth factor receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10900	midostaurin	Casein kinase II subunit alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10901	midostaurin	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10902	midostaurin	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10903	midostaurin	Serine/threonine-protein kinase STK11	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10904	midostaurin	Dual specificity mitogen-activated protein kinase kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10905	midostaurin	Maternal embryonic leucine zipper kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10906	midostaurin	Eukaryotic translation initiation factor 2-alpha kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10907	midostaurin	Interleukin-1 receptor-associated kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10908	midostaurin	Serine/threonine-protein kinase RIO3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10909	midostaurin	Serine/threonine-protein kinase SIK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10910	midostaurin	SRSF protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10911	midostaurin	SRSF protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10912	midostaurin	Serine/threonine-protein kinase 33	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10913	midostaurin	5'-AMP-activated protein kinase catalytic subunit alpha-2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10914	midostaurin	Myotonin-protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10915	midostaurin	RAC-gamma serine/threonine-protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10916	midostaurin	Serine/threonine-protein kinase LATS1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10917	midostaurin	Serine/threonine-protein kinase LATS2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10918	midostaurin	Leukocyte tyrosine kinase receptor	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10919	midostaurin	Mitogen-activated protein kinase kinase kinase kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10920	midostaurin	NUAK family SNF1-like kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10921	midostaurin	Serine/threonine-protein kinase pim-3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10922	midostaurin	cAMP-dependent protein kinase catalytic subunit alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10923	midostaurin	Mitogen-activated protein kinase kinase kinase kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10924	midostaurin	Aurora kinase B	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10925	midostaurin	Tyrosine-protein kinase Blk	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10926	midostaurin	Serine/threonine-protein kinase BRSK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10927	midostaurin	Mitogen-activated protein kinase kinase kinase kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10928	midostaurin	Serine/threonine-protein kinase MARK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10929	midostaurin	MAP/microtubule affinity-regulating kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10930	midostaurin	Dual specificity mitogen-activated protein kinase kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10931	midostaurin	Dual specificity mitogen-activated protein kinase kinase 6	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10932	midostaurin	Tyrosine-protein kinase Mer	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10933	midostaurin	Cyclin-dependent kinase 19	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10934	midostaurin	Mitogen-activated protein kinase kinase kinase 9	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10935	midostaurin	Mitogen-activated protein kinase kinase kinase 10	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10936	midostaurin	Mitogen-activated protein kinase kinase kinase 11	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10937	midostaurin	Death-associated protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10938	midostaurin	Serine/threonine-protein kinase PAK 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10939	midostaurin	Serine/threonine-protein kinase PAK 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10940	midostaurin	Serine/threonine-protein kinase BRSK2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10941	midostaurin	Serine/threonine-protein kinase SIK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10942	midostaurin	Tubulin alpha-1A chain	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10943	midostaurin	Serine/threonine-protein kinase D2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10944	midostaurin	Serine/threonine-protein kinase D3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10945	midostaurin	cGMP-dependent protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10946	midostaurin	Interferon-induced, double-stranded RNA-activated protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10947	midostaurin	Proto-oncogene tyrosine-protein kinase ROS	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10948	midostaurin	Ribosomal protein S6 kinase alpha-1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10949	midostaurin	Ribosomal protein S6 kinase alpha-4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10950	midostaurin	Mitogen-activated protein kinase kinase kinase kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10951	midostaurin	Misshapen-like kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10952	midostaurin	Serine/threonine-protein kinase TBK1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10953	midostaurin	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10954	midostaurin	Ephrin type-B receptor 6	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10955	midostaurin	Serine/threonine-protein kinase/endoribonuclease IRE1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10956	midostaurin	Rhodopsin kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10957	midostaurin	G protein-coupled receptor kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10958	midostaurin	G protein-coupled receptor kinase 7	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10959	midostaurin	Homeodomain-interacting protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10960	midostaurin	Homeodomain-interacting protein kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10961	midostaurin	Homeodomain-interacting protein kinase 4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10962	midostaurin	Hormonally up-regulated neu tumor-associated kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10963	midostaurin	Serine/threonine-protein kinase ICK	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10964	midostaurin	Inhibitor of nuclear factor kappa-B kinase subunit alpha	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10965	midostaurin	Mitogen-activated protein kinase kinase kinase 13	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10966	midostaurin	Mitogen-activated protein kinase kinase kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10967	midostaurin	Mitogen-activated protein kinase kinase kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10968	midostaurin	Microtubule-associated serine/threonine-protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10969	midostaurin	U4/U6 small nuclear ribonucleoprotein Prp4	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10970	midostaurin	Serine/threonine-protein kinase RIO2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10971	midostaurin	SRSF protein kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10972	midostaurin	Mitogen-activated protein kinase kinase kinase 7	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10973	midostaurin	Serine/threonine-protein kinase ULK3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10974	midostaurin	Mitogen-activated protein kinase kinase kinase 19	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10975	midostaurin	Tankyrase-2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10976	midostaurin	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10977	midostaurin	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10978	midostaurin	Serine/threonine-protein kinase SIK3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10979	midostaurin	Serine/threonine-protein kinase 32A	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10980	midostaurin	Serine/threonine-protein kinase PRP4 homolog	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10981	midostaurin	Serine/threonine-protein kinase Sgk3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10982	midostaurin	Myosin light chain kinase 3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10983	midostaurin	Leucine-rich repeat serine/threonine-protein kinase 2	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10984	midostaurin	Dual serine/threonine and tyrosine protein kinase	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10985	midostaurin	Calcium-dependent protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10986	midostaurin	cGMP-dependent protein kinase 1	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10987	midostaurin	cAMP-dependent protein kinase catalytic subunit PRKX	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10988	midostaurin	Receptor-type tyrosine-protein kinase FLT3	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1
10989	abaloparatide	Parathyroid hormone/parathyroid hormone-related peptide receptor	[H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(N)=O
10990	brigatinib	Epidermal growth factor receptor	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10991	brigatinib	Receptor-type tyrosine-protein kinase FLT3	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10992	brigatinib	Insulin-like growth factor 1 receptor	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10993	brigatinib	Insulin receptor	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10994	brigatinib	Proto-oncogene tyrosine-protein kinase ROS	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10995	brigatinib	ALK tyrosine kinase receptor	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1
10996	cenegermin	High affinity nerve growth factor receptor	[H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC1=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC3=C1C=CC=C3)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)[C@@H](C)CC
10997	cenegermin	Tumor necrosis factor receptor superfamily member 16	[H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC1=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC3=C1C=CC=C3)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)[C@@H](C)CC
10998	evogliptin	Potassium voltage-gated channel subfamily H member 2	[H][C@]1(COC(C)(C)C)N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F
10999	evogliptin	Dipeptidyl peptidase 4	[H][C@]1(COC(C)(C)C)N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F
11000	polmacoxib	Prostaglandin G/H synthase 1	CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O
11001	polmacoxib	Prostaglandin G/H synthase 2	CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O
11002	betrixaban	Potassium voltage-gated channel subfamily H member 2	COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1
11003	betrixaban	Prothrombin	COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1
11004	betrixaban	Coagulation factor X	COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1
11005	pemafibrate	Peroxisome proliferator-activated receptor gamma	CC[C@@H](OC1=CC=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=C1)C(O)=O
11006	pemafibrate	Peroxisome proliferator-activated receptor delta	CC[C@@H](OC1=CC=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=C1)C(O)=O
11007	pemafibrate	Peroxisome proliferator-activated receptor alpha	CC[C@@H](OC1=CC=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=C1)C(O)=O
11008	imrecoxib	Prostaglandin G/H synthase 2	CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O
11009	imrecoxib	Prostaglandin G/H synthase 1	CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O
11010	enasidenib	Isocitrate dehydrogenase [NADP] cytoplasmic	CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=CC=CC(=N1)C(F)(F)F
11011	enasidenib	Isocitrate dehydrogenase [NADP], mitochondrial	CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=CC=CC(=N1)C(F)(F)F
11012	neratinib	Tyrosine-protein kinase JAK3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11013	neratinib	Macrophage-stimulating protein receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11014	neratinib	Tyrosine-protein kinase ABL1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11015	neratinib	Proto-oncogene tyrosine-protein kinase Src	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11016	neratinib	Tyrosine-protein kinase Lck	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11017	neratinib	Tyrosine-protein kinase Yes	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11018	neratinib	Tyrosine-protein kinase Fyn	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11019	neratinib	Receptor-type tyrosine-protein kinase FLT3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11020	neratinib	Vascular endothelial growth factor receptor 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11021	neratinib	Macrophage colony-stimulating factor 1 receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11022	neratinib	Insulin receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11023	neratinib	Mitogen-activated protein kinase 8	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11024	neratinib	Focal adhesion kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11025	neratinib	Tyrosine-protein kinase HCK	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11026	neratinib	Mitogen-activated protein kinase 10	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11027	neratinib	Tyrosine-protein kinase SYK	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11028	neratinib	Tyrosine-protein kinase CSK	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11029	neratinib	Angiopoietin-1 receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11030	neratinib	Hepatocyte growth factor receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11031	neratinib	Tyrosine-protein kinase Lyn	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11032	neratinib	Serine/threonine-protein kinase Nek2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11033	neratinib	Ribosomal protein S6 kinase alpha-2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11034	neratinib	Serine/threonine-protein kinase 17B	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11035	neratinib	Serine/threonine-protein kinase 10	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11036	neratinib	Tyrosine-protein kinase Fer	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11037	neratinib	Serine/threonine-protein kinase 17A	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11038	neratinib	TRAF2 and NCK-interacting protein kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11039	neratinib	Casein kinase I isoform epsilon	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11040	neratinib	Tyrosine-protein kinase Fgr	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11041	neratinib	Serine/threonine-protein kinase 36	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11042	neratinib	Mitogen-activated protein kinase kinase kinase kinase 5	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11043	neratinib	Mitogen-activated protein kinase kinase kinase 4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11044	neratinib	Cyclin-G-associated kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11045	neratinib	Calcium/calmodulin-dependent protein kinase type 1D	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11046	neratinib	Cyclin-dependent kinase 16	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11047	neratinib	Serine/threonine-protein kinase 4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11048	neratinib	Activated CDC42 kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11049	neratinib	STE20-like serine/threonine-protein kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11050	neratinib	Dual specificity mitogen-activated protein kinase kinase 7	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11051	neratinib	Dual specificity mitogen-activated protein kinase kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11052	neratinib	Dual specificity mitogen-activated protein kinase kinase 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11053	neratinib	Tyrosine-protein kinase BTK	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11054	neratinib	Tyrosine-protein kinase receptor UFO	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11055	neratinib	Cyclin-dependent kinase 7	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11056	neratinib	Serine/threonine-protein kinase D1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11057	neratinib	Serine/threonine-protein kinase 3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11058	neratinib	NUAK family SNF1-like kinase 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11059	neratinib	Serine/threonine-protein kinase Chk1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11060	neratinib	Wee1-like protein kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11061	neratinib	Serine/threonine-protein kinase 25	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11062	neratinib	Mitogen-activated protein kinase kinase kinase MLT	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11063	neratinib	Protein-tyrosine kinase 2-beta	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11064	neratinib	Casein kinase I isoform gamma-2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11065	neratinib	Casein kinase I isoform gamma-3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11066	neratinib	Tyrosine-protein kinase receptor Tie-1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11067	neratinib	Tyrosine-protein kinase TXK	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11068	neratinib	Maternal embryonic leucine zipper kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11069	neratinib	Serine/threonine-protein kinase 26	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11070	neratinib	Eukaryotic translation initiation factor 2-alpha kinase 4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11071	neratinib	Insulin receptor-related protein	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11072	neratinib	Serine/threonine-protein kinase SIK2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11073	neratinib	Serine/threonine-protein kinase 33	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11074	neratinib	Mitogen-activated protein kinase kinase kinase kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11075	neratinib	Serine/threonine-protein kinase PAK 6	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11076	neratinib	NUAK family SNF1-like kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11077	neratinib	Mitogen-activated protein kinase kinase kinase kinase 3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11078	neratinib	Tyrosine-protein kinase Blk	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11079	neratinib	Mitogen-activated protein kinase kinase kinase kinase 4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11080	neratinib	Tyrosine-protein kinase Mer	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11081	neratinib	Mitogen-activated protein kinase kinase kinase 9	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11082	neratinib	Mitogen-activated protein kinase kinase kinase 10	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11083	neratinib	Mitogen-activated protein kinase kinase kinase 11	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11084	neratinib	Serine/threonine-protein kinase 24	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11085	neratinib	Serine/threonine-protein kinase PAK 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11086	neratinib	Serine/threonine-protein kinase PAK 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11087	neratinib	Serine/threonine-protein kinase SIK1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11088	neratinib	Serine/threonine-protein kinase D2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11089	neratinib	Serine/threonine-protein kinase D3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11090	neratinib	Tyrosine-protein kinase Fes/Fps	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11091	neratinib	Ribosomal protein S6 kinase alpha-1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11092	neratinib	Mitogen-activated protein kinase kinase kinase kinase 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11093	neratinib	Misshapen-like kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11094	neratinib	Serine/threonine-protein kinase Chk2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11095	neratinib	Ephrin type-B receptor 6	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11096	neratinib	Homeodomain-interacting protein kinase 4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11097	neratinib	Interleukin-1 receptor-associated kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11098	neratinib	Mitogen-activated protein kinase kinase kinase 13	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11099	neratinib	Mitogen-activated protein kinase kinase kinase 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11100	neratinib	Mitogen-activated protein kinase kinase kinase 3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11101	neratinib	Microtubule-associated serine/threonine-protein kinase 1	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11102	neratinib	Serine/threonine-protein kinase TAO3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11103	neratinib	Mitogen-activated protein kinase kinase kinase 19	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11104	neratinib	Serine/threonine-protein kinase 35	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11105	neratinib	Receptor tyrosine-protein kinase erbB-3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11106	neratinib	Wee1-like protein kinase 2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11107	neratinib	Serine/threonine-protein kinase Nek3	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11108	neratinib	Mitogen-activated protein kinase kinase kinase 12	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11109	neratinib	Dual specificity mitogen-activated protein kinase kinase 5	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11110	neratinib	Dual serine/threonine and tyrosine protein kinase	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11111	neratinib	Serine/threonine-protein kinase 32B	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11112	neratinib	Receptor tyrosine-protein kinase erbB-4	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11113	neratinib	Epidermal growth factor receptor	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11114	neratinib	Receptor tyrosine-protein kinase erbB-2	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C
11115	copanlisib	Serine/threonine-protein kinase mTOR	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
11116	copanlisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
11117	copanlisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
11118	copanlisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
11119	copanlisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
11120	tivozanib	Platelet-derived growth factor receptor alpha	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11121	tivozanib	Ephrin type-B receptor 2	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11122	tivozanib	Platelet-derived growth factor receptor beta	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11123	tivozanib	Mast/stem cell growth factor receptor Kit	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11124	tivozanib	Receptor-type tyrosine-protein kinase FLT3	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11125	tivozanib	Hepatocyte growth factor receptor	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11126	tivozanib	Fibroblast growth factor receptor 1	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11127	tivozanib	Vascular endothelial growth factor receptor 1	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11128	tivozanib	Vascular endothelial growth factor receptor 2	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11129	tivozanib	Vascular endothelial growth factor receptor 3	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1
11130	abemaciclib	Potassium voltage-gated channel subfamily H member 2	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11131	abemaciclib	Cyclin-dependent kinase 1	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11132	abemaciclib	Cyclin-dependent kinase 9	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11133	abemaciclib	Cyclin-dependent kinase 7	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11134	abemaciclib	Cyclin-dependent kinase 6	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11135	abemaciclib	Cyclin-dependent kinase 4	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
11136	acalabrutinib	Receptor tyrosine-protein kinase erbB-2	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11137	acalabrutinib	Tyrosine-protein kinase Lyn	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11138	acalabrutinib	Receptor tyrosine-protein kinase erbB-4	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11139	acalabrutinib	Cytoplasmic tyrosine-protein kinase BMX	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11140	acalabrutinib	Tyrosine-protein kinase Tec	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11141	acalabrutinib	Tyrosine-protein kinase TXK	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11142	acalabrutinib	Tyrosine-protein kinase BTK	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
11143	latanoprostene bunod	Prostaglandin F2-alpha receptor	[H][C@]1(CC[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@H](O)[C@]1([H])C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O
11144	semaglutide	Glucagon-like peptide 1 receptor	[H]N[C@@H](CC1=CNC=N1)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CO)C(=O)NC(CO)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)[C@H](CCC(O)=O)NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NC(CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
11145	netarsudil	Rho-associated protein kinase 1	CC1=CC=C(C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC2=CC3=C(C=C2)C=NC=C3)C(C)=C1
11146	netarsudil	Rho-associated protein kinase 2	CC1=CC=C(C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC2=CC3=C(C=C2)C=NC=C3)C(C)=C1
11147	ertugliflozin	Sodium/glucose cotransporter 2	CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1
11148	ertugliflozin	Low affinity sodium-glucose cotransporter	CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1
11149	ertugliflozin	Sodium/glucose cotransporter 1	CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1
11150	macimorelin	Growth hormone secretagogue receptor type 1	[H]C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@@H](CC1=CC2=C(N1)C=CC=C2)NC(=O)C(C)(C)N
11151	angiotensin II	Type-2 angiotensin II receptor	[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
11152	angiotensin II	Type-1B angiotensin II receptor	[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
11153	angiotensin II	Type-1 angiotensin II receptor	[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
11154	angiotensin II	Type-1A angiotensin II receptor	[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
11155	lutetium (177Lu) oxodotreotide	Somatostatin receptor type 2	[177Lu].C[C@@H](O)[C@H](NC(=O)C1CSSC[C@H](NC(=O)C(CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O
11156	tezacaftor	Cystic fibrosis transmembrane conductance regulator	CC(C)(CO)C1=CC2=C(C=C(F)C(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C2)N1C[C@@H](O)CO
11157	elobixibat	Ileal sodium/bile acid cotransporter	CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=C(C=C(OCC(=O)N[C@@H](C(=O)NCC(O)=O)C3=CC=CC=C3)C(SC)=C2)S(=O)(=O)C1
11158	apalutamide	Androgen receptor	CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
11159	fostamatinib	Proto-oncogene tyrosine-protein kinase receptor Ret	COC1=CC(NC2=NC(NC3=CC=C4OC(C)(C)C(=O)N(COP(O)(O)=O)C4=N3)=C(F)C=N2)=CC(OC)=C1OC
11160	fostamatinib	Vascular endothelial growth factor receptor 2	COC1=CC(NC2=NC(NC3=CC=C4OC(C)(C)C(=O)N(COP(O)(O)=O)C4=N3)=C(F)C=N2)=CC(OC)=C1OC
11161	fostamatinib	Adenosine receptor A3	COC1=CC(NC2=NC(NC3=CC=C4OC(C)(C)C(=O)N(COP(O)(O)=O)C4=N3)=C(F)C=N2)=CC(OC)=C1OC
11162	fostamatinib	Tyrosine-protein kinase SYK	COC1=CC(NC2=NC(NC3=CC=C4OC(C)(C)C(=O)N(COP(O)(O)=O)C4=N3)=C(F)C=N2)=CC(OC)=C1OC
11163	fosnetupitant	Substance-P receptor	CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=C(C)C=CC=C1)N1CC[N+](C)(COP(O)(O)=O)CC1
11164	avatrombopag	Thrombopoietin receptor	OC(=O)C1CCN(CC1)C1=NC=C(C=C1Cl)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1
11165	cannabidiol	Cannabinoid receptor 1	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11166	cannabidiol	Cannabinoid receptor 2	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11167	cannabidiol	N-arachidonyl glycine receptor	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11168	cannabidiol	Fatty-acid amide hydrolase 1	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11169	cannabidiol	Transient receptor potential cation channel subfamily V member 2	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11170	cannabidiol	Transient receptor potential cation channel subfamily V member 1	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11171	cannabidiol	G-protein coupled receptor 55	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
11172	encorafenib	Mitogen-activated protein kinase 14	COC(=O)N[C@@H](C)CNC1=NC(=CC=N1)C1=CN(N=C1C1=C(F)C(NS(C)(=O)=O)=CC(Cl)=C1)C(C)C
11173	encorafenib	RAF proto-oncogene serine/threonine-protein kinase	COC(=O)N[C@@H](C)CNC1=NC(=CC=N1)C1=CN(N=C1C1=C(F)C(NS(C)(=O)=O)=CC(Cl)=C1)C(C)C
11174	encorafenib	Serine/threonine-protein kinase B-raf	COC(=O)N[C@@H](C)CNC1=NC(=CC=N1)C1=CN(N=C1C1=C(F)C(NS(C)(=O)=O)=CC(Cl)=C1)C(C)C
11175	binimetinib	Dual specificity mitogen-activated protein kinase kinase 1	CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
11176	binimetinib	Dual specificity mitogen-activated protein kinase kinase 2	CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
11177	ivosidenib	Isocitrate dehydrogenase [NADP] cytoplasmic	FC1=CN=CC(=C1)N([C@H](C(=O)NC1CC(F)(F)C1)C1=CC=CC=C1Cl)C(=O)[C@@H]1CCC(=O)N1C1=NC=CC(=C1)C#N
11178	elagolix	Gonadotropin-releasing hormone receptor	[H][C@@](CN1C(=O)N(CC2=C(F)C=CC=C2C(F)(F)F)C(C)=C(C1=O)C1=C(F)C(OC)=CC=C1)(NCCCC(O)=O)C1=CC=CC=C1
11179	duvelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1
11180	duvelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1
11181	duvelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1
11182	duvelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1
11183	dacomitinib	Tyrosine-protein kinase JAK3	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11184	dacomitinib	Proto-oncogene tyrosine-protein kinase Src	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11185	dacomitinib	Tyrosine-protein kinase Lck	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11186	dacomitinib	Epidermal growth factor receptor	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11187	dacomitinib	Receptor tyrosine-protein kinase erbB-2	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11188	dacomitinib	Receptor tyrosine-protein kinase erbB-4	COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1
11189	talazoparib tosylate	Poly [ADP-ribose] polymerase 2	CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
11190	talazoparib tosylate	Poly [ADP-ribose] polymerase 1	CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
11191	lorlatinib	Tyrosine-protein kinase FRK	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11192	lorlatinib	ALK tyrosine kinase receptor	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11193	lorlatinib	Proto-oncogene tyrosine-protein kinase ROS	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11194	lorlatinib	Focal adhesion kinase 1	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11195	lorlatinib	High affinity nerve growth factor receptor	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11196	lorlatinib	Tyrosine-protein kinase Fer	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11197	lorlatinib	Activated CDC42 kinase 1	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11198	lorlatinib	BDNF/NT-3 growth factors receptor	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11199	lorlatinib	Protein-tyrosine kinase 2-beta	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11200	lorlatinib	NT-3 growth factor receptor	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11201	lorlatinib	Leukocyte tyrosine kinase receptor	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11202	lorlatinib	Tyrosine-protein kinase Fes/Fps	C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12
11203	revefenacin	Muscarinic acetylcholine receptor M1	CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
11204	revefenacin	Muscarinic acetylcholine receptor M2	CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
11205	revefenacin	Muscarinic acetylcholine receptor M3	CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
11206	revefenacin	Muscarinic acetylcholine receptor M4	CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
11207	revefenacin	Muscarinic acetylcholine receptor M5	CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
11208	glasdegib	Smoothened homolog	CN1CC[C@H](C[C@@H]1C1=NC2=C(N1)C=CC=C2)NC(=O)NC1=CC=C(C=C1)C#N
11209	larotrectinib	High affinity nerve growth factor receptor	O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=CC(F)=CC=C1F
11210	larotrectinib	BDNF/NT-3 growth factors receptor	O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=CC(F)=CC=C1F
11211	larotrectinib	NT-3 growth factor receptor	O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=CC(F)=CC=C1F
11212	gilteritinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11213	gilteritinib	High affinity nerve growth factor receptor	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11214	gilteritinib	ALK tyrosine kinase receptor	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11215	gilteritinib	Tyrosine-protein kinase receptor UFO	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11216	gilteritinib	Leukocyte tyrosine kinase receptor	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11217	gilteritinib	Tyrosine-protein kinase Mer	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11218	gilteritinib	Proto-oncogene tyrosine-protein kinase ROS	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11219	gilteritinib	Receptor-type tyrosine-protein kinase FLT3	CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)N=C1NC1CCOCC1
11220	evocalcet	Extracellular calcium-sensing receptor	C[C@@H](N[C@H]1CCN(C1)C1=CC=C(CC(O)=O)C=C1)C1=CC=CC2=CC=CC=C12
11221	vibegron	Beta-3 adrenergic receptor	[H][C@@]1(CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)CC[C@@]([H])(N1)[C@H](O)C1=CC=CC=C1
11222	omidenepag isopropyl	Prostaglandin E2 receptor EP2 subtype	CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1
11223	siponimod	Sphingosine 1-phosphate receptor 4	CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
11224	siponimod	Sphingosine 1-phosphate receptor 3	CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
11225	siponimod	Sphingosine 1-phosphate receptor 2	CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
11226	siponimod	Sphingosine 1-phosphate receptor 1	CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
11227	siponimod	Sphingosine 1-phosphate receptor 5	CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
11228	erdafitinib	Vascular endothelial growth factor receptor 2	COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1
11229	erdafitinib	Fibroblast growth factor receptor 3	COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1
11230	erdafitinib	Fibroblast growth factor receptor 1	COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1
11231	erdafitinib	Fibroblast growth factor receptor 2	COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1
11232	erdafitinib	Fibroblast growth factor receptor 4	COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1
11233	alpelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
11234	alpelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
11235	alpelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
11236	alpelisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
11237	bremelanotide	Melanocortin receptor 5	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
11238	bremelanotide	Melanocortin receptor 3	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
11239	bremelanotide	Melanocyte-stimulating hormone receptor	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
11240	bremelanotide	Adrenocorticotropic hormone receptor	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
11241	bremelanotide	Melanocortin receptor 4	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
11242	selinexor	Exportin-1	FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F
11243	darolutamide	Androgen receptor	C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)[C@@H](C)O
11244	darolutamide	Progesterone receptor	C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)[C@@H](C)O
11245	sotagliflozin	Sodium/glucose cotransporter 2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1
11246	sotagliflozin	Sodium/glucose cotransporter 1	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1
11247	quizartinib	Platelet-derived growth factor receptor beta	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11248	quizartinib	Tyrosine-protein kinase ABL1	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11249	quizartinib	Mast/stem cell growth factor receptor Kit	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11250	quizartinib	Tyrosine-protein kinase Lck	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11251	quizartinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11252	quizartinib	Vascular endothelial growth factor receptor 1	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11253	quizartinib	Vascular endothelial growth factor receptor 2	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11254	quizartinib	Vascular endothelial growth factor receptor 3	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11255	quizartinib	Macrophage colony-stimulating factor 1 receptor	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11256	quizartinib	Platelet-derived growth factor receptor alpha	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11257	quizartinib	Myosin light chain kinase, smooth muscle	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11258	quizartinib	High affinity nerve growth factor receptor	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11259	quizartinib	Tyrosine-protein kinase Lyn	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11260	quizartinib	Serine/threonine-protein kinase 10	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11261	quizartinib	Ephrin type-A receptor 6	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11262	quizartinib	TRAF2 and NCK-interacting protein kinase	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11263	quizartinib	Ephrin type-A receptor 3	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11264	quizartinib	Tyrosine-protein kinase FRK	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11265	quizartinib	Mitogen-activated protein kinase kinase kinase kinase 5	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11266	quizartinib	Receptor-interacting serine/threonine-protein kinase 2	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11267	quizartinib	Ephrin type-A receptor 7	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11268	quizartinib	STE20-like serine/threonine-protein kinase	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11269	quizartinib	MAP kinase-interacting serine/threonine-protein kinase 2	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11270	quizartinib	Epithelial discoidin domain-containing receptor 1	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11271	quizartinib	BDNF/NT-3 growth factors receptor	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11272	quizartinib	Tyrosine-protein kinase receptor Tie-1	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11273	quizartinib	NT-3 growth factor receptor	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11274	quizartinib	Discoidin domain-containing receptor 2	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11275	quizartinib	Mitogen-activated protein kinase kinase kinase kinase 4	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11276	quizartinib	Muscle, skeletal receptor tyrosine-protein kinase	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11277	quizartinib	Mitogen-activated protein kinase 15	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11278	quizartinib	Receptor-interacting serine/threonine-protein kinase 1	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11279	quizartinib	Ephrin type-B receptor 6	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11280	quizartinib	Homeodomain-interacting protein kinase 4	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11281	quizartinib	Mitogen-activated protein kinase kinase kinase 7	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11282	quizartinib	Mitogen-activated protein kinase kinase kinase 19	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11283	quizartinib	Myosin light chain kinase 3	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11284	quizartinib	Receptor-type tyrosine-protein kinase FLT3	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
11285	pexidartinib	Tyrosine-protein kinase Lck	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11286	pexidartinib	Vascular endothelial growth factor receptor 1	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11287	pexidartinib	Vascular endothelial growth factor receptor 2	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11288	pexidartinib	NT-3 growth factor receptor	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11289	pexidartinib	Cyclin-dependent kinase 19	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11290	pexidartinib	Mast/stem cell growth factor receptor Kit	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11291	pexidartinib	Receptor-type tyrosine-protein kinase FLT3	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11292	pexidartinib	Macrophage colony-stimulating factor 1 receptor	FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
11293	upadacitinib	Non-receptor tyrosine-protein kinase TYK2	CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
11294	upadacitinib	Tyrosine-protein kinase JAK3	CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
11295	upadacitinib	Tyrosine-protein kinase JAK1	CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
11296	upadacitinib	Tyrosine-protein kinase JAK2	CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
11297	fedratinib	Platelet-derived growth factor receptor beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11298	fedratinib	Tyrosine-protein kinase ABL1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11299	fedratinib	Mast/stem cell growth factor receptor Kit	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11300	fedratinib	Epidermal growth factor receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11301	fedratinib	Proto-oncogene tyrosine-protein kinase Src	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11302	fedratinib	Tyrosine-protein kinase Lck	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11303	fedratinib	Tyrosine-protein kinase Yes	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11304	fedratinib	Tyrosine-protein kinase Fyn	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11305	fedratinib	Ephrin type-A receptor 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11306	fedratinib	Serine/threonine-protein kinase B-raf	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11307	fedratinib	Proto-oncogene tyrosine-protein kinase receptor Ret	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11308	fedratinib	Vascular endothelial growth factor receptor 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11309	fedratinib	Vascular endothelial growth factor receptor 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11310	fedratinib	Vascular endothelial growth factor receptor 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11311	fedratinib	Macrophage colony-stimulating factor 1 receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11312	fedratinib	Platelet-derived growth factor receptor alpha	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11313	fedratinib	Ribosomal protein S6 kinase alpha-3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11314	fedratinib	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11315	fedratinib	Insulin-like growth factor 1 receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11316	fedratinib	Myosin light chain kinase, smooth muscle	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11317	fedratinib	Insulin receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11318	fedratinib	Death-associated protein kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11319	fedratinib	Calcium/calmodulin-dependent protein kinase type 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11320	fedratinib	Mitogen-activated protein kinase 8	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11321	fedratinib	Fibroblast growth factor receptor 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11322	fedratinib	Rho-associated protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11323	fedratinib	Focal adhesion kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11324	fedratinib	Tyrosine-protein kinase HCK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11325	fedratinib	Serine/threonine-protein kinase PLK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11326	fedratinib	Receptor tyrosine-protein kinase erbB-4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11327	fedratinib	Mitogen-activated protein kinase 10	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11328	fedratinib	Death-associated protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11329	fedratinib	High affinity nerve growth factor receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11330	fedratinib	Rho-associated protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11331	fedratinib	Tyrosine-protein kinase SYK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11332	fedratinib	Calcium/calmodulin-dependent protein kinase type II subunit delta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11333	fedratinib	Myosin light chain kinase 2, skeletal/cardiac muscle	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11334	fedratinib	Tyrosine-protein kinase CSK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11335	fedratinib	Angiopoietin-1 receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11336	fedratinib	Ephrin type-A receptor 8	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11337	fedratinib	Calcium/calmodulin-dependent protein kinase type II subunit gamma	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11338	fedratinib	AP2-associated protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11339	fedratinib	Serine/threonine-protein kinase MARK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11340	fedratinib	Hepatocyte growth factor receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11341	fedratinib	Tyrosine-protein kinase Lyn	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11342	fedratinib	Cytoplasmic tyrosine-protein kinase BMX	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11343	fedratinib	Serine/threonine-protein kinase Nek2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11344	fedratinib	LIM domain kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11345	fedratinib	Ribosomal protein S6 kinase alpha-2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11346	fedratinib	5'-AMP-activated protein kinase catalytic subunit alpha-1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11347	fedratinib	Calcium/calmodulin-dependent protein kinase type II subunit beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11348	fedratinib	Fibroblast growth factor receptor 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11349	fedratinib	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11350	fedratinib	Calcium/calmodulin-dependent protein kinase type II subunit alpha	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11351	fedratinib	Serine/threonine-protein kinase 17B	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11352	fedratinib	Serine/threonine-protein kinase 10	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11353	fedratinib	Tyrosine-protein kinase Fer	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11354	fedratinib	Protein kinase C epsilon type	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11355	fedratinib	Serine/threonine-protein kinase PLK4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11356	fedratinib	Aurora kinase C	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11357	fedratinib	Serine/threonine-protein kinase 16	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11358	fedratinib	Dual specificity protein kinase TTK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11359	fedratinib	Abelson tyrosine-protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11360	fedratinib	Ephrin type-A receptor 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11361	fedratinib	Fibroblast growth factor receptor 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11362	fedratinib	Serine/threonine-protein kinase N1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11363	fedratinib	Serine/threonine-protein kinase 17A	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11364	fedratinib	Ephrin type-A receptor 6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11365	fedratinib	Tyrosine-protein kinase Fgr	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11366	fedratinib	Aurora kinase A	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11367	fedratinib	ALK tyrosine kinase receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11368	fedratinib	Serine/threonine-protein kinase 36	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11369	fedratinib	Ephrin type-A receptor 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11370	fedratinib	BMP-2-inducible protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11371	fedratinib	Tyrosine-protein kinase FRK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11372	fedratinib	Dual specificity protein kinase CLK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11373	fedratinib	Dual specificity protein kinase CLK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11374	fedratinib	Mitogen-activated protein kinase kinase kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11375	fedratinib	Cyclin-G-associated kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11376	fedratinib	Receptor-interacting serine/threonine-protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11377	fedratinib	Ephrin type-B receptor 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11378	fedratinib	Calcium/calmodulin-dependent protein kinase type 1D	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11379	fedratinib	Cyclin-dependent kinase 16	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11380	fedratinib	Activated CDC42 kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11381	fedratinib	Ephrin type-A receptor 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11382	fedratinib	Ribosomal protein S6 kinase alpha-5	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11383	fedratinib	STE20-like serine/threonine-protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11384	fedratinib	Dual specificity protein kinase CLK4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11385	fedratinib	MAP kinase-interacting serine/threonine-protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11386	fedratinib	Mitogen-activated protein kinase 9	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11387	fedratinib	Calcium/calmodulin-dependent protein kinase kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11388	fedratinib	MAP/microtubule affinity-regulating kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11389	fedratinib	Calcium/calmodulin-dependent protein kinase kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11390	fedratinib	Calcium/calmodulin-dependent protein kinase type 1G	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11391	fedratinib	Epithelial discoidin domain-containing receptor 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11392	fedratinib	Ephrin type-B receptor 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11393	fedratinib	Testis-specific serine/threonine-protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11394	fedratinib	Activin receptor type-1B	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11395	fedratinib	Serine/threonine-protein kinase receptor R3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11396	fedratinib	Activin receptor type-1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11397	fedratinib	Cyclin-dependent kinase 15	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11398	fedratinib	Inhibitor of nuclear factor kappa-B kinase subunit beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11399	fedratinib	TGF-beta receptor type-2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11400	fedratinib	Dual specificity mitogen-activated protein kinase kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11401	fedratinib	Dual specificity mitogen-activated protein kinase kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11402	fedratinib	Tyrosine-protein kinase ITK/TSK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11403	fedratinib	Tyrosine-protein kinase ZAP-70	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11404	fedratinib	Cyclin-dependent kinase 9	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11405	fedratinib	Protein-tyrosine kinase 6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11406	fedratinib	Tyrosine-protein kinase BTK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11407	fedratinib	Tyrosine-protein kinase receptor UFO	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11408	fedratinib	BDNF/NT-3 growth factors receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11409	fedratinib	Ephrin type-B receptor 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11410	fedratinib	Cyclin-dependent kinase 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11411	fedratinib	Ribosomal protein S6 kinase beta-1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11412	fedratinib	Serine/threonine-protein kinase DCLK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11413	fedratinib	Ribosomal protein S6 kinase alpha-6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11414	fedratinib	NUAK family SNF1-like kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11415	fedratinib	Non-receptor tyrosine-protein kinase TNK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11416	fedratinib	Serine/threonine-protein kinase Chk1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11417	fedratinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11418	fedratinib	Cyclin-dependent kinase 17	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11419	fedratinib	Cyclin-dependent kinase 18	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11420	fedratinib	Cyclin-dependent kinase 14	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11421	fedratinib	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11422	fedratinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11423	fedratinib	Myosin light chain kinase family member 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11424	fedratinib	Wee1-like protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11425	fedratinib	Serine/threonine-protein kinase 25	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11426	fedratinib	Mitogen-activated protein kinase kinase kinase MLT	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11427	fedratinib	Protein-tyrosine kinase 2-beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11428	fedratinib	Serine/threonine-protein kinase RIO1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11429	fedratinib	Tyrosine-protein kinase receptor Tie-1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11430	fedratinib	Serine/threonine-protein kinase tousled-like 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11431	fedratinib	Serine/threonine-protein kinase tousled-like 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11432	fedratinib	NT-3 growth factor receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11433	fedratinib	Tyrosine-protein kinase TXK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11434	fedratinib	Casein kinase II subunit alpha	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11435	fedratinib	Casein kinase II subunit alpha'	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11436	fedratinib	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11437	fedratinib	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11438	fedratinib	LIM domain kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11439	fedratinib	Serine/threonine-protein kinase STK11	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11440	fedratinib	Dual specificity mitogen-activated protein kinase kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11441	fedratinib	Maternal embryonic leucine zipper kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11442	fedratinib	MAP kinase-interacting serine/threonine-protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11443	fedratinib	Serine/threonine-protein kinase 26	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11444	fedratinib	Serine/threonine-protein kinase Nek7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11445	fedratinib	Eukaryotic translation initiation factor 2-alpha kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11446	fedratinib	Insulin receptor-related protein	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11447	fedratinib	Interleukin-1 receptor-associated kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11448	fedratinib	Serine/threonine-protein kinase RIO3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11449	fedratinib	Serine/threonine-protein kinase SIK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11450	fedratinib	SRSF protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11451	fedratinib	SRSF protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11452	fedratinib	Serine/threonine-protein kinase 33	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11453	fedratinib	Serine/threonine-protein kinase TNNI3K	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11454	fedratinib	5'-AMP-activated protein kinase catalytic subunit alpha-2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11455	fedratinib	Ankyrin repeat and protein kinase domain-containing protein 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11456	fedratinib	Discoidin domain-containing receptor 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11457	fedratinib	Myotonin-protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11458	fedratinib	Chaperone activity of bc1 complex-like, mitochondrial	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11459	fedratinib	Serine/threonine-protein kinase LATS2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11460	fedratinib	Leukocyte tyrosine kinase receptor	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11461	fedratinib	Mitogen-activated protein kinase kinase kinase kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11462	fedratinib	Serine/threonine-protein kinase PAK 6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11463	fedratinib	Serine/threonine-protein kinase PAK 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11464	fedratinib	NUAK family SNF1-like kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11465	fedratinib	Mitogen-activated protein kinase kinase kinase kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11466	fedratinib	Aurora kinase B	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11467	fedratinib	Tyrosine-protein kinase Blk	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11468	fedratinib	Bone morphogenetic protein receptor type-2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11469	fedratinib	Serine/threonine-protein kinase MARK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11470	fedratinib	MAP/microtubule affinity-regulating kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11471	fedratinib	Dual specificity mitogen-activated protein kinase kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11472	fedratinib	Tyrosine-protein kinase Mer	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11473	fedratinib	Mitogen-activated protein kinase kinase kinase 9	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11474	fedratinib	Mitogen-activated protein kinase kinase kinase 10	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11475	fedratinib	Mitogen-activated protein kinase kinase kinase 11	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11476	fedratinib	Muscle, skeletal receptor tyrosine-protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11477	fedratinib	Citron Rho-interacting kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11478	fedratinib	Death-associated protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11479	fedratinib	Serine/threonine-protein kinase DCLK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11480	fedratinib	Serine/threonine-protein kinase DCLK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11481	fedratinib	Serine/threonine-protein kinase Nek5	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11482	fedratinib	Serine/threonine-protein kinase Nek9	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11483	fedratinib	Serine/threonine-protein kinase PAK 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11484	fedratinib	Serine/threonine-protein kinase PAK 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11485	fedratinib	Serine/threonine-protein kinase PAK 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11486	fedratinib	AarF domain-containing protein kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11487	fedratinib	Serine/threonine-protein kinase SIK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11488	fedratinib	Tyrosine-protein kinase Srms	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11489	fedratinib	Dual specificity testis-specific protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11490	fedratinib	Ephrin type-A receptor 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11491	fedratinib	Serine/threonine-protein kinase PLK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11492	fedratinib	Mitogen-activated protein kinase 6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11493	fedratinib	Mitogen-activated protein kinase 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11494	fedratinib	Mitogen-activated protein kinase 15	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11495	fedratinib	Serine/threonine-protein kinase D3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11496	fedratinib	cGMP-dependent protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11497	fedratinib	Interferon-induced, double-stranded RNA-activated protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11498	fedratinib	Receptor-interacting serine/threonine-protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11499	fedratinib	Tyrosine-protein kinase Fes/Fps	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11500	fedratinib	Fibroblast growth factor receptor 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11501	fedratinib	Proto-oncogene tyrosine-protein kinase ROS	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11502	fedratinib	Ribosomal protein S6 kinase alpha-1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11503	fedratinib	Ribosomal protein S6 kinase alpha-4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11504	fedratinib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11505	fedratinib	Mitogen-activated protein kinase kinase kinase kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11506	fedratinib	Misshapen-like kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11507	fedratinib	Serine/threonine-protein kinase TBK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11508	fedratinib	Interleukin-1 receptor-associated kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11509	fedratinib	Cyclin-dependent kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11510	fedratinib	Cyclin-dependent kinase-like 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11511	fedratinib	Ephrin type-B receptor 6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11512	fedratinib	Serine/threonine-protein kinase/endoribonuclease IRE1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11513	fedratinib	G protein-coupled receptor kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11514	fedratinib	G protein-coupled receptor kinase 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11515	fedratinib	Homeodomain-interacting protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11516	fedratinib	Homeodomain-interacting protein kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11517	fedratinib	Homeodomain-interacting protein kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11518	fedratinib	Serine/threonine-protein kinase ICK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11519	fedratinib	Inhibitor of nuclear factor kappa-B kinase subunit alpha	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11520	fedratinib	Interleukin-1 receptor-associated kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11521	fedratinib	Mitogen-activated protein kinase kinase kinase 13	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11522	fedratinib	Mitogen-activated protein kinase kinase kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11523	fedratinib	Mitogen-activated protein kinase kinase kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11524	fedratinib	Serine/threonine-protein kinase 38	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11525	fedratinib	Serine/threonine-protein kinase NIM1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11526	fedratinib	Serine/threonine-protein kinase RIO2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11527	fedratinib	SRSF protein kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11528	fedratinib	STE20/SPS1-related proline-alanine-rich protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11529	fedratinib	Mitogen-activated protein kinase kinase kinase 7	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11530	fedratinib	Serine/threonine-protein kinase TAO1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11531	fedratinib	Serine/threonine-protein kinase TAO3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11532	fedratinib	Serine/threonine-protein kinase ULK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11533	fedratinib	Serine/threonine-protein kinase ULK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11534	fedratinib	Serine/threonine-protein kinase ULK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11535	fedratinib	Mitogen-activated protein kinase kinase kinase 19	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11536	fedratinib	Homeodomain-interacting protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11537	fedratinib	Serine/threonine-protein kinase PLK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11538	fedratinib	Receptor-interacting serine/threonine-protein kinase 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11539	fedratinib	Uncharacterized serine/threonine-protein kinase SBK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11540	fedratinib	Cyclin-dependent kinase-like 5	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11541	fedratinib	Megakaryocyte-associated tyrosine-protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11542	fedratinib	Phosphatidylinositol 4-kinase beta	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11543	fedratinib	Serine/threonine-protein kinase SIK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11544	fedratinib	Wee1-like protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11545	fedratinib	Bone morphogenetic protein receptor type-1B	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11546	fedratinib	Serine/threonine-protein kinase SBK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11547	fedratinib	Serine/threonine-protein kinase Nek3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11548	fedratinib	Peripheral plasma membrane protein CASK	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11549	fedratinib	Serine/threonine-protein kinase PRP4 homolog	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11550	fedratinib	Mitogen-activated protein kinase kinase kinase 12	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11551	fedratinib	Serine/threonine-protein kinase Sgk3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11552	fedratinib	Eukaryotic translation initiation factor 2-alpha kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11553	fedratinib	Serine/threonine-protein kinase TAO2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11554	fedratinib	SNF-related serine/threonine-protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11555	fedratinib	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11556	fedratinib	Dual specificity mitogen-activated protein kinase kinase 5	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11557	fedratinib	Serine/threonine-protein kinase Nek11	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11558	fedratinib	Myosin light chain kinase 3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11559	fedratinib	Leucine-rich repeat serine/threonine-protein kinase 2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11560	fedratinib	Dual serine/threonine and tyrosine protein kinase	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11561	fedratinib	Calcium-dependent protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11562	fedratinib	Bromodomain-containing protein 4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11563	fedratinib	Serine/threonine-protein kinase PknB	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11564	fedratinib	Serine/threonine-protein kinase Nek6	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11565	fedratinib	cGMP-dependent protein kinase 1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11566	fedratinib	Serine/threonine-protein kinase Nek4	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11567	fedratinib	Bromodomain testis-specific protein	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11568	fedratinib	Serine/threonine-protein kinase Nek1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11569	fedratinib	Tyrosine-protein kinase JAK3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11570	fedratinib	Tyrosine-protein kinase JAK1	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11571	fedratinib	Non-receptor tyrosine-protein kinase TYK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11572	fedratinib	Receptor-type tyrosine-protein kinase FLT3	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11573	fedratinib	Tyrosine-protein kinase JAK2	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
11574	tenapanor	Sodium/hydrogen exchanger 3	CN1C[C@@H](C2=CC=CC(=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C(Cl)C=C(Cl)C=C23)C2=CC(Cl)=CC(Cl)=C2C1
11575	trifarotene	Retinoic acid receptor alpha	CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=C(OCCO)C=CC(=C1)C1=CC=C(C=C1)C(O)=O
11576	trifarotene	Retinoic acid receptor beta	CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=C(OCCO)C=CC(=C1)C1=CC=C(C=C1)C(O)=O
11577	trifarotene	Retinoic acid receptor gamma	CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=C(OCCO)C=CC(=C1)C1=CC=C(C=C1)C(O)=O
11578	lasmiditan	5-hydroxytryptamine receptor 1F	CN1CCC(CC1)C(=O)C1=NC(NC(=O)C2=C(F)C=C(F)C=C2F)=CC=C1
11579	zanubrutinib	Tyrosine-protein kinase BTK	NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1
11580	voxelotor	Cytochrome P450 3A4	CC(C)N1N=CC=C1C1=C(COC2=C(C=O)C(O)=CC=C2)C=CC=N1
11581	voxelotor	Cytochrome P450 2C8	CC(C)N1N=CC=C1C1=C(COC2=C(C=O)C(O)=CC=C2)C=CC=N1
11582	voxelotor	Cytochrome P450 2C9	CC(C)N1N=CC=C1C1=C(COC2=C(C=O)C(O)=CC=C2)C=CC=N1
11583	voxelotor	hemoglobin subunit alpha	CC(C)N1N=CC=C1C1=C(COC2=C(C=O)C(O)=CC=C2)C=CC=N1
11584	lumateperone	5-hydroxytryptamine receptor 1A	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11585	lumateperone	5-hydroxytryptamine receptor 2C	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11586	lumateperone	Alpha-1A adrenergic receptor	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11587	lumateperone	D(4) dopamine receptor	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11588	lumateperone	Alpha-1B adrenergic receptor	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11589	lumateperone	D(2) dopamine receptor	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11590	lumateperone	D(1A) dopamine receptor	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11591	lumateperone	Sodium-dependent serotonin transporter	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11592	lumateperone	5-hydroxytryptamine receptor 2A	[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1
11593	lemborexant	Potassium voltage-gated channel subfamily H member 2	CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=CC=C(F)C=N2)C2=CC=CC(F)=C2)C(C)=N1
11594	lemborexant	Orexin receptor type 1	CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=CC=C(F)C=N2)C2=CC=CC(F)=C2)C(C)=N1
11595	lemborexant	Orexin receptor type 2	CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=CC=C(F)C=N2)C2=CC=CC(F)=C2)C(C)=N1
11596	ubrogepant	Calcitonin gene-related peptide type 1 receptor	C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1
11597	roxadustat	Alpha-ketoglutarate-dependent dioxygenase FTO	CC1=C2C=C(OC3=CC=CC=C3)C=CC2=C(O)C(=N1)C(=O)NCC(O)=O
11598	roxadustat	Egl nine homolog 1	CC1=C2C=C(OC3=CC=CC=C3)C=CC2=C(O)C(=N1)C(=O)NCC(O)=O
11599	roxadustat	Egl nine homolog 2	CC1=C2C=C(OC3=CC=CC=C3)C=CC2=C(O)C(=N1)C(=O)NCC(O)=O
11600	roxadustat	Egl nine homolog 3	CC1=C2C=C(OC3=CC=CC=C3)C=CC2=C(O)C(=N1)C(=O)NCC(O)=O
11601	elexacaftor	Cystic fibrosis transmembrane conductance regulator	C[C@@H]1CN(C2=C(C=CC(=N2)N2C=CC(OCC(C)(C)C(F)(F)F)=N2)C(=O)NS(=O)(=O)C2=CN(C)N=C2C)C(C)(C)C1
11602	cepharanthine	Trypanothione reductase	[H][C@]12CC3=CC(OC4=CC=C(C[C@@H]5N(C)CCC6=CC7=C(OCO7)C(OC7=C(OC)C=C(CCN1C)C2=C7)=C56)C=C4)=C(OC)C=C3
11603	cepharanthine	5'-AMP-activated protein kinase catalytic subunit alpha-1	[H][C@]12CC3=CC(OC4=CC=C(C[C@@H]5N(C)CCC6=CC7=C(OCO7)C(OC7=C(OC)C=C(CCN1C)C2=C7)=C56)C=C4)=C(OC)C=C3
11604	cepharanthine	Nuclear factor NF-kappa-B p105 subunit	[H][C@]12CC3=CC(OC4=CC=C(C[C@@H]5N(C)CCC6=CC7=C(OCO7)C(OC7=C(OC)C=C(CCN1C)C2=C7)=C56)C=C4)=C(OC)C=C3
11605	avapritinib	Mast/stem cell growth factor receptor Kit	CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1
11606	avapritinib	Platelet-derived growth factor receptor alpha	CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1
11607	tazemetostat	Polycomb protein EED	CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1
11608	tazemetostat	Histone-lysine N-methyltransferase EZH1	CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1
11609	tazemetostat	Histone-lysine N-methyltransferase EZH2	CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1
11610	rimegepant	Calcitonin gene-related peptide type 1 receptor	[H][C@]1(CC[C@@H](C2=C(F)C(F)=CC=C2)[C@]([H])(N)C2=CC=CN=C12)OC(=O)N1CCC(CC1)N1C(=O)NC2=NC=CC=C12
11611	bempedoic acid	ATP-citrate synthase	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O
11612	ozanimod	Sphingosine 1-phosphate receptor 4	CC(C)OC1=CC=C(C=C1C#N)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1
11613	ozanimod	Sphingosine 1-phosphate receptor 3	CC(C)OC1=CC=C(C=C1C#N)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1
11614	ozanimod	Sphingosine 1-phosphate receptor 2	CC(C)OC1=CC=C(C=C1C#N)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1
11615	ozanimod	Sphingosine 1-phosphate receptor 1	CC(C)OC1=CC=C(C=C1C#N)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1
11616	ozanimod	Sphingosine 1-phosphate receptor 5	CC(C)OC1=CC=C(C=C1C#N)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1
11617	osilodrostat	Aromatase	FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12
11618	osilodrostat	Cytochrome P450 11B2, mitochondrial	FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12
11619	osilodrostat	Cytochrome P450 11B1, mitochondrial	FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12
11620	selumetinib	Epidermal growth factor receptor	CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3Cl)=C(C=C12)C(=O)NOCCO
11621	selumetinib	Dual specificity mitogen-activated protein kinase kinase 1	CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3Cl)=C(C=C12)C(=O)NOCCO
11622	selumetinib	Dual specificity mitogen-activated protein kinase kinase 2	CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3Cl)=C(C=C12)C(=O)NOCCO
11623	tucatinib	Epidermal growth factor receptor	CC1=CC(NC2=NC=NC3=C2C=C(NC2=NC(C)(C)CO2)C=C3)=CC=C1OC1=CC2=NC=NN2C=C1
11624	tucatinib	Receptor tyrosine-protein kinase erbB-4	CC1=CC(NC2=NC=NC3=C2C=C(NC2=NC(C)(C)CO2)C=C3)=CC=C1OC1=CC2=NC=NN2C=C1
11625	tucatinib	ERBB2/ERBB3	CC1=CC(NC2=NC=NC3=C2C=C(NC2=NC(C)(C)CO2)C=C3)=CC=C1OC1=CC2=NC=NN2C=C1
11626	pemigatinib	Fibroblast growth factor receptor 4	CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
11627	pemigatinib	Fibroblast growth factor receptor 3	CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
11628	pemigatinib	Fibroblast growth factor receptor 1	CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
11629	pemigatinib	Fibroblast growth factor receptor 2	CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
